data_2kqp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kqp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.517 0.675 . . . . 30.100000000000001 110.125 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.715 ' ND2' ' H ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -116.68 107.25 14.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.941 -1.133 . . . . 32.240000000000002 107.941 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.4 mm100 -153.65 165.52 35.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.317 -0.865 . . . . 30.210000000000001 109.512 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -78.34 101.63 7.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.07 -2.196 . . . . 24.0 105.07 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -98.65 135.41 40.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.336 -0.853 . . . . 19.629999999999999 112.297 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.67 -161.16 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.275 -0.891 . . . . 17.190000000000001 111.656 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.11 -55.11 1.51 Allowed Glycine 0 N--CA 1.49 2.266 0 CA-C-N 115.899 -0.591 . . . . 16.550000000000001 112.75 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.7 p -76.73 -61.56 1.93 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.5 -1.588 . . . . 19.550000000000001 110.983 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -55.51 33.99 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.123 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' CYS . 30.6 tp -50.82 -49.9 57.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 14.16 108.476 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.76 -56.71 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.532 -1.284 . . . . 15.31 107.532 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -55.9 -61.0 2.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.026 -1.101 . . . . 29.640000000000001 108.026 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.19 -59.75 2.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.101 -0.999 . . . . 13.960000000000001 109.825 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.72 -50.48 60.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.425 -1.422 . . . . 17.789999999999999 107.891 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -55.29 -43.7 75.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 16.84 109.183 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.6 mt -56.53 -25.29 51.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 22.760000000000002 108.176 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.37 -64.43 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 17.440000000000001 109.431 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 18.539999999999999 110.005 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.98 -122.59 13.42 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.665 -1.255 . . . . 23.170000000000002 110.125 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.62 -18.67 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.425 -1.044 . . . . 39.770000000000003 110.237 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 22' ' ' ARG . 9.5 mtt-85 -70.12 -53.07 18.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.974 -1.079 . . . . 26.649999999999999 110.097 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 64.02 0.5 Allowed Glycine 0 N--CA 1.508 3.475 0 C-N-CA 119.726 -1.226 . . . . 20.260000000000002 111.759 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 20.8 p90 . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.269 . . . . 17.789999999999999 110.098 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 tt . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.583 -0.895 . . . . 17.420000000000002 108.583 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 t -51.66 -41.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.2 -0.938 . . . . 18.82 109.425 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -76.48 10.31 2.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.3 -0.875 . . . . 38.5 110.014 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.4 mt-30 -136.51 -12.78 1.79 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.156 -0.965 . . . . 36.829999999999998 110.707 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.2 m -119.88 -27.12 5.47 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.376 -0.828 . . . . 18.16 109.071 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.2 t -86.36 -38.19 17.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.053 . . . . 18.460000000000001 108.515 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -87.76 -14.93 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.534 -0.729 . . . . 0.0 109.261 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 m -141.78 -141.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.527 -0.916 . . . . 30.34 108.527 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -145.8 128.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.958 . . . . 27.510000000000002 109.209 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -111.39 176.82 4.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.591 -0.693 . . . . 23.34 109.931 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -112.62 -170.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.472 0.653 . . . . 22.640000000000001 109.623 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.24 -59.8 4.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.449 -0.782 . . . . 23.280000000000001 109.359 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -43.05 -57.92 2.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.768 . . . . 37.859999999999999 110.38 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -48.74 -45.02 39.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.857 -1.152 . . . . 31.390000000000001 109.018 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.47 -37.64 88.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 24.48 108.705 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.43 -18.72 64.99 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.795 . . . . 31.48 109.669 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.08 -30.36 63.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.527 -0.733 . . . . 22.48 111.581 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -98.05 12.07 35.54 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 19.59 111.975 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.9 m -76.55 -175.68 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.551 -1.343 . . . . 20.620000000000001 108.982 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.504 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.22 -0.659 . . . . 30.100000000000001 109.22 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.723 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.33 107.76 8.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.345 -0.983 . . . . 32.240000000000002 108.345 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -156.76 166.04 34.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -0.813 . . . . 30.210000000000001 110.083 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -77.26 100.99 6.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.64 136.88 38.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.72 . . . . 19.629999999999999 111.749 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.84 -160.51 0.85 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.216 1.007 . . . . 17.190000000000001 111.849 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.53 -54.06 1.76 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 115.552 -0.749 . . . . 16.550000000000001 112.772 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -78.9 -56.82 4.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.341 -1.682 . . . . 19.550000000000001 110.976 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.49 -55.54 26.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.928 -1.107 . . . . 0.0 110.337 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' CYS . 29.6 tp -51.75 -48.55 63.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.797 -1.19 . . . . 14.16 108.453 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 3.2 t -48.84 -55.17 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.307 -1.368 . . . . 15.31 107.307 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.11 -61.91 2.06 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.75 -59.73 2.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.092 -1.005 . . . . 13.960000000000001 109.842 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -51.98 -52.06 53.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.484 -1.385 . . . . 17.789999999999999 107.977 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -53.84 -46.32 71.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.527 -0.733 . . . . 16.84 109.216 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.23 -31.52 61.55 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.008 -1.058 . . . . 22.760000000000002 108.501 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.47 -64.67 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.785 . . . . 17.440000000000001 109.257 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 m -63.81 -76.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 18.539999999999999 109.414 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.09 -139.69 22.97 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.538 -1.425 . . . . 23.170000000000002 109.538 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.4 pm0 -47.28 -15.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -1.166 . . . . 39.770000000000003 109.535 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' GLY . 56.1 mtt180 -57.33 -52.3 65.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -0.926 . . . . 26.649999999999999 109.036 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.38 64.82 0.48 Allowed Glycine 0 N--CA 1.507 3.399 0 C-N-CA 119.73 -1.224 . . . . 20.260000000000002 111.902 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.3 p90 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.282 -1.128 . . . . 17.789999999999999 110.111 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 3.0 tt . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 109.382 -0.599 . . . . 17.420000000000002 109.382 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 4.0 t -54.83 -31.59 24.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.829 -1.17 . . . . 18.82 108.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.77 10.56 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 38.5 109.397 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -136.67 -14.45 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.185 -0.947 . . . . 36.829999999999998 110.617 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m -115.41 -27.14 7.29 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.285 -0.884 . . . . 18.16 109.054 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.8 t -86.6 -42.03 13.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.826 -1.171 . . . . 18.460000000000001 108.413 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -82.37 -16.14 50.21 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -142.76 -139.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.491 -0.929 . . . . 30.34 108.491 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.33 148.7 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.018 -1.051 . . . . 27.510000000000002 109.332 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.6 m -133.61 175.61 9.28 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 23.34 109.852 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OE1' ' A' ' 80' ' ' GLN . 2.9 p -112.73 179.47 3.96 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.541 0.686 . . . . 22.640000000000001 109.8 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -52.34 -60.62 3.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 23.280000000000001 109.423 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -42.61 -56.86 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.536 -0.727 . . . . 37.859999999999999 110.376 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' OE1' ' OG ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -48.98 -48.48 43.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.815 -1.178 . . . . 31.390000000000001 108.801 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -60.67 -39.41 88.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 24.48 109.097 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.43 -19.01 64.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 31.48 109.966 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.81 -29.34 63.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 22.48 111.552 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.7 12.34 35.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.191 -0.943 . . . . 19.59 111.898 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.57 -175.81 3.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.569 -1.332 . . . . 20.620000000000001 109.306 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 118.007 -0.996 . . . . 24.649999999999999 109.424 179.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.331 -0.618 . . . . 30.100000000000001 109.331 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.726 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.64 107.25 9.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.485 -0.931 . . . . 32.240000000000002 108.485 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -157.12 165.17 36.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 30.210000000000001 109.715 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -78.14 100.37 6.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.164 -2.161 . . . . 24.0 105.164 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.63 137.82 36.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.547 -0.721 . . . . 19.629999999999999 111.615 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 m -125.68 -160.49 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.038 0.923 . . . . 17.190000000000001 112.538 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -49.25 1.34 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 115.946 -0.57 . . . . 16.550000000000001 112.793 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -83.27 -60.71 2.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.402 -1.646 . . . . 19.550000000000001 110.802 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -55.57 31.86 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 110.308 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.7 tp -51.38 -46.39 62.77 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.688 -1.258 . . . . 14.16 108.347 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.5 t -50.1 -56.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.932 -1.507 . . . . 15.31 106.932 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -56.07 -61.59 2.28 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.099 -1.041 . . . . 29.640000000000001 108.233 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.25 -60.04 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.807 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -51.26 -49.04 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.612 -1.305 . . . . 17.789999999999999 107.919 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.8 -43.06 85.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 16.84 109.232 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.37 -27.68 62.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.933 -1.105 . . . . 22.760000000000002 108.215 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.74 -64.66 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 17.440000000000001 109.535 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.0 m -63.14 -74.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 18.539999999999999 109.567 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -132.54 11.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.92 -1.272 . . . . 23.170000000000002 109.92 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -57.24 -12.62 2.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.427 -1.043 . . . . 39.770000000000003 109.556 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 22' ' ' ARG . 12.1 mtt-85 -57.79 -51.86 67.85 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.007 -1.058 . . . . 26.649999999999999 109.233 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 65.47 0.48 Allowed Glycine 0 N--CA 1.508 3.451 0 C-N-CA 119.628 -1.272 . . . . 20.260000000000002 111.446 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 31.1 p90 . . . . . 0 C--N 1.299 -1.611 0 O-C-N 121.301 -1.117 . . . . 17.789999999999999 110.271 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.597 -0.89 . . . . 17.420000000000002 108.597 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.36 -27.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.275 -0.891 . . . . 18.82 109.556 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -90.9 10.89 24.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 38.5 109.872 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mt-30 -137.18 -10.43 1.72 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.075 -1.015 . . . . 36.829999999999998 110.841 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -120.32 -26.05 5.52 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.271 -0.893 . . . . 18.16 109.42 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.7 t -87.94 -37.91 16.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.93 -1.106 . . . . 18.460000000000001 108.112 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 t -86.08 -23.9 26.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -134.01 -140.71 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.443 -0.947 . . . . 30.34 108.443 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.4 mt -145.68 131.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.043 -1.036 . . . . 27.510000000000002 109.099 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.2 m -114.41 175.14 5.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.555 -0.716 . . . . 23.34 110.105 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m -112.52 -178.24 3.35 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.604 -0.685 . . . . 22.640000000000001 109.749 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.55 -61.8 2.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.482 -0.761 . . . . 23.280000000000001 109.716 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -42.04 -57.24 2.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.418 -0.801 . . . . 37.859999999999999 110.249 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -48.46 -45.58 36.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.852 -1.155 . . . . 31.390000000000001 109.14 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.97 -38.72 92.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 24.48 108.86 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.42 -19.0 64.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 31.48 109.786 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -72.74 -29.65 63.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 22.48 111.356 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -97.9 12.53 33.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.186 -0.946 . . . . 19.59 111.925 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.13 -175.93 3.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.58 -1.325 . . . . 20.620000000000001 109.101 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.025 -0.988 . . . . 24.649999999999999 109.589 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.8 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.406 0.622 . . . . 30.100000000000001 109.539 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.738 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.58 107.48 9.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.475 -0.935 . . . . 32.240000000000002 108.475 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -156.85 161.93 39.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 30.210000000000001 109.46 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -76.97 100.95 5.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.285 -2.117 . . . . 24.0 105.285 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.27 133.63 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 19.629999999999999 111.808 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -159.76 0.78 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.136 -0.977 . . . . 17.190000000000001 111.532 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.82 -53.45 1.47 Allowed Glycine 0 N--CA 1.49 2.291 0 CA-C-N 115.843 -0.617 . . . . 16.550000000000001 112.977 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.4 m -78.7 -62.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.516 -1.579 . . . . 19.550000000000001 111.068 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.6 -55.5 34.05 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.215 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' VAL . 31.5 tp -50.49 -51.71 44.77 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.64 -1.288 . . . . 14.16 108.311 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -45.92 -55.46 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.643 -1.243 . . . . 15.31 107.643 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.45 -61.73 2.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.946 -1.131 . . . . 29.640000000000001 107.946 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.36 -59.59 2.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.161 -0.962 . . . . 13.960000000000001 109.708 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mt -51.77 -53.92 34.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.381 -1.449 . . . . 17.789999999999999 108.072 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.1 -48.26 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 16.84 109.018 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.34 -29.3 33.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.094 -1.004 . . . . 22.760000000000002 108.439 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.66 -64.72 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 17.440000000000001 109.586 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.1 m -64.8 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 18.539999999999999 109.684 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 76.71 -129.01 9.53 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.715 -1.354 . . . . 23.170000000000002 109.715 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -49.99 -18.9 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.364 -1.08 . . . . 39.770000000000003 109.256 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -57.14 -54.01 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 26.649999999999999 109.097 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.12 62.75 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.893 -1.146 . . . . 20.260000000000002 111.502 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 22.9 p90 . . . . . 0 C--N 1.298 -1.645 0 O-C-N 121.1 -1.235 . . . . 17.789999999999999 109.638 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 4.4 tt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.928 0.344 . . . . 17.420000000000002 111.928 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.457 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 5.6 t -54.66 -17.36 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.524 -1.36 . . . . 18.82 110.012 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -100.74 9.97 41.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 38.5 109.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -137.65 -16.02 1.36 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.108 -0.995 . . . . 36.829999999999998 110.242 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.7 m -112.16 -30.87 7.06 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.362 -0.836 . . . . 18.16 109.256 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.6 -42.51 16.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 18.460000000000001 108.667 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -80.9 -22.4 39.79 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 m -139.98 -136.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.496 -0.927 . . . . 30.34 108.496 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.7 149.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 27.510000000000002 109.301 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.9 m -133.08 175.93 8.94 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 23.34 109.583 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m -112.24 -178.32 3.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 22.640000000000001 109.765 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 tp -55.16 -57.63 10.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.575 -0.703 . . . . 23.280000000000001 109.267 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -44.15 -51.64 7.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.423 -0.798 . . . . 37.859999999999999 110.001 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -54.93 -51.84 64.83 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.787 -1.196 . . . . 31.390000000000001 108.733 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.92 -39.5 74.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 24.48 108.855 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.76 -18.62 64.25 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.468 -0.77 . . . . 31.48 109.863 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -73.67 -30.04 62.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.826 . . . . 22.48 111.746 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -99.01 12.01 37.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.205 -0.934 . . . . 19.59 111.782 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.2 m -76.7 -175.4 3.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 20.620000000000001 109.194 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 118.019 -0.991 . . . . 24.649999999999999 109.359 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.442 0.639 . . . . 30.100000000000001 109.572 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.73 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.78 107.14 7.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.35 -0.981 . . . . 32.240000000000002 108.35 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.58 161.21 39.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 30.210000000000001 109.261 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.59 100.77 5.44 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.251 -2.129 . . . . 24.0 105.251 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.11 132.8 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.784 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 -157.01 0.69 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.21 -0.931 . . . . 17.190000000000001 111.831 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -37.02 -55.24 1.46 Allowed Glycine 0 N--CA 1.49 2.288 0 CA-C-N 115.869 -0.605 . . . . 16.550000000000001 113.189 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.0 m -79.55 -58.41 3.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.483 -1.598 . . . . 19.550000000000001 111.42 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -55.37 34.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 110.39 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 12' ' ' VAL . 31.2 tp -50.4 -50.51 51.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.74 -1.225 . . . . 14.16 108.24 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.25 -55.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.516 -1.29 . . . . 15.31 107.516 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.11 -61.76 2.23 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.878 -1.129 . . . . 29.640000000000001 108.421 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.39 -59.43 2.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 13.960000000000001 109.839 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -51.36 -52.19 47.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 17.789999999999999 107.881 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -53.44 -45.89 69.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 16.84 109.141 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.44 -26.94 33.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.858 -1.151 . . . . 22.760000000000002 108.307 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.46 -64.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.448 -0.783 . . . . 17.440000000000001 109.401 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 24' ' ' PHE . 6.7 m -62.18 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 18.539999999999999 109.842 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.08 -125.02 24.11 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.596 -1.288 . . . . 23.170000000000002 110.046 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -45.79 -22.11 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -1.074 . . . . 39.770000000000003 109.429 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 20' ' ' GLY . 13.8 mmt180 -61.81 -54.65 39.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.346 -0.846 . . . . 26.649999999999999 110.0 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.75 62.49 0.5 Allowed Glycine 0 N--CA 1.51 3.62 0 C-N-CA 119.915 -1.136 . . . . 20.260000000000002 112.075 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 15.1 p90 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.338 . . . . 17.789999999999999 109.869 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.492 ' C ' ' H ' ' A' ' 69' ' ' GLU . 3.3 tt . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.658 -0.497 . . . . 17.420000000000002 109.658 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.407 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 18.1 t -57.16 -7.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.893 -1.129 . . . . 18.82 109.19 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 67' ' ' ILE . 22.1 tt0 -109.83 9.5 24.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.49 -0.756 . . . . 38.5 109.313 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -137.56 -15.67 1.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.227 -0.921 . . . . 36.829999999999998 109.691 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.86 -29.94 7.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.529 -0.732 . . . . 18.16 109.12 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 52.5 t -84.85 -44.51 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 18.460000000000001 108.701 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -81.34 -17.91 47.51 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.445 -0.784 . . . . 0.0 109.093 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 m -144.07 -137.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.296 -1.001 . . . . 30.34 108.296 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.45 150.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 27.510000000000002 109.333 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 m -133.18 175.88 9.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 23.34 109.55 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -111.62 -174.89 2.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.703 . . . . 22.640000000000001 109.566 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.75 -57.56 12.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 23.280000000000001 109.608 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -44.5 -55.23 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.39 -0.819 . . . . 37.859999999999999 110.038 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -50.55 -49.85 54.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.816 -1.177 . . . . 31.390000000000001 108.898 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.53 -40.97 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.921 -0.77 . . . . 24.48 108.921 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -61.88 -19.04 62.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.448 -0.783 . . . . 31.48 109.651 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -73.14 -30.18 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.598 -0.688 . . . . 22.48 111.889 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -100.07 11.8 38.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.157 -0.965 . . . . 19.59 111.939 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.0 m -76.82 -175.72 3.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.601 -1.312 . . . . 20.620000000000001 108.833 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.038 -0.982 . . . . 24.649999999999999 109.287 179.541 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.369 0.604 . . . . 30.100000000000001 109.644 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.71 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.73 107.85 8.64 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.485 -0.932 . . . . 32.240000000000002 108.485 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -156.86 164.23 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 30.210000000000001 109.64 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.52 100.6 5.33 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.168 -2.16 . . . . 24.0 105.168 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.08 135.96 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.78 . . . . 19.629999999999999 111.59 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.1 m -124.14 -157.3 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.006 0.908 . . . . 17.190000000000001 112.693 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.79 -53.8 1.45 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 115.977 -0.556 . . . . 16.550000000000001 112.884 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.84 -58.47 2.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.315 -1.697 . . . . 19.550000000000001 111.096 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -60.47 -55.76 29.63 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.925 -1.11 . . . . 0.0 110.464 -178.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' VAL . 25.7 tp -51.15 -50.04 59.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.203 . . . . 14.16 108.211 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -46.88 -55.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.525 -1.287 . . . . 15.31 107.525 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 20.6 tt0 -57.12 -61.8 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.018 -1.105 . . . . 29.640000000000001 108.018 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.18 -59.67 2.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 13.960000000000001 109.537 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.1 mt -51.57 -55.14 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.546 -1.346 . . . . 17.789999999999999 108.009 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.42 -50.48 40.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 16.84 108.952 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -52.22 -29.78 24.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 22.760000000000002 108.514 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.02 -64.45 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.296 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' LEU . 5.7 m -65.66 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 18.539999999999999 109.946 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.3 -112.57 4.91 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.614 -1.279 . . . . 23.170000000000002 110.275 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -52.93 -20.5 3.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 39.770000000000003 110.116 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -69.03 -52.59 27.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 26.649999999999999 109.974 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.19 63.17 0.49 Allowed Glycine 0 N--CA 1.507 3.393 0 C-N-CA 119.729 -1.224 . . . . 20.260000000000002 111.689 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 p90 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.047 -1.266 . . . . 17.789999999999999 109.221 -179.625 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.755 -0.461 . . . . 17.420000000000002 109.755 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -53.67 -31.71 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 18.82 109.247 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 9.99 6.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.956 -1.09 . . . . 38.5 110.119 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -141.16 -11.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.032 -1.043 . . . . 36.829999999999998 110.729 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.5 m -117.89 -26.45 6.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.408 -0.807 . . . . 18.16 109.357 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 t -88.83 -43.28 11.34 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.144 -1.058 . . . . 18.460000000000001 108.144 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 t -82.05 -28.04 32.66 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.514 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 25.6 t -131.75 -140.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.52 -0.918 . . . . 30.34 108.52 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.514 ' H ' ' HG ' ' A' ' 74' ' ' SER . 29.0 mt -142.82 151.55 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.156 -0.965 . . . . 27.510000000000002 109.258 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -136.49 174.55 10.49 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 23.34 109.683 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -112.23 -178.46 3.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.546 -0.721 . . . . 22.640000000000001 109.736 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 79' ' ' TYR . 4.4 tp -53.0 -61.51 2.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 23.280000000000001 109.573 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' C ' ' O ' ' A' ' 78' ' ' LEU . 1.7 m-85 -41.31 -55.83 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.449 -0.782 . . . . 37.859999999999999 110.356 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -49.46 -51.09 38.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.84 -1.162 . . . . 31.390000000000001 108.819 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.23 -41.3 83.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.451 -0.781 . . . . 24.48 109.071 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.75 -18.76 61.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.408 -0.808 . . . . 31.48 110.075 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -74.31 -29.27 61.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 22.48 111.811 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -99.51 12.06 37.45 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.074 -1.016 . . . . 19.59 111.898 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.51 -175.74 3.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.745 -1.222 . . . . 20.620000000000001 108.931 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.046 -0.978 . . . . 24.649999999999999 109.399 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.361 -0.607 . . . . 30.100000000000001 109.361 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.719 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.0 106.85 8.92 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.389 -0.967 . . . . 32.240000000000002 108.389 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 83.0 mm-40 -156.5 164.53 38.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.298 -0.876 . . . . 30.210000000000001 109.62 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -77.93 101.05 6.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -98.82 136.18 39.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.427 -0.796 . . . . 19.629999999999999 111.776 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.19 -160.38 0.83 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.189 -0.945 . . . . 17.190000000000001 111.691 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.15 -54.18 1.57 Allowed Glycine 0 N--CA 1.489 2.184 0 CA-C-N 115.685 -0.689 . . . . 16.550000000000001 112.667 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -77.8 -61.91 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.543 -1.563 . . . . 19.550000000000001 110.924 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -55.75 30.93 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.027 . . . . 0.0 110.427 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' CYS . 28.2 tp -51.85 -47.7 64.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.723 -1.236 . . . . 14.16 108.499 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.17 -56.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.336 -1.357 . . . . 15.31 107.336 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.86 -61.23 2.51 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.971 -1.092 . . . . 29.640000000000001 108.246 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.28 -59.54 2.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 13.960000000000001 110.097 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -51.75 -51.55 55.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.715 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.122 -0.696 . . . . 16.84 109.122 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -56.74 -24.36 49.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.946 -1.096 . . . . 22.760000000000002 108.285 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.51 -64.55 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.35 -0.844 . . . . 17.440000000000001 109.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -64.39 -78.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 18.539999999999999 109.649 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.68 -132.23 11.77 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.72 -1.352 . . . . 23.170000000000002 109.72 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -49.69 -14.73 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -1.097 . . . . 39.770000000000003 109.518 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 20' ' ' GLY . 1.0 OUTLIER -59.78 -53.61 55.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 26.649999999999999 109.161 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.4 63.9 0.49 Allowed Glycine 0 N--CA 1.506 3.357 0 C-N-CA 119.951 -1.119 . . . . 20.260000000000002 111.245 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.7 p90 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.069 -1.254 . . . . 17.789999999999999 110.063 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.44 -0.578 . . . . 17.420000000000002 109.44 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 t -55.4 -22.05 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 18.82 109.467 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -95.49 10.45 36.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 38.5 109.703 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -137.38 -15.12 1.46 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 36.829999999999998 110.557 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.46 -27.86 7.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.305 -0.872 . . . . 18.16 109.425 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.29 -41.04 13.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.111 . . . . 18.460000000000001 108.519 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.7 t -83.63 -16.33 45.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 m -143.2 -139.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -145.11 137.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 27.510000000000002 109.257 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.6 m -119.47 176.97 5.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.676 -0.64 . . . . 23.34 110.261 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.9 175.74 5.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.506 0.67 . . . . 22.640000000000001 109.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tp -51.8 -61.15 2.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.475 -0.766 . . . . 23.280000000000001 109.469 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -43.52 -54.7 4.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.795 . . . . 37.859999999999999 110.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -49.75 -44.8 48.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.757 -1.214 . . . . 31.390000000000001 109.002 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.25 -36.92 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 24.48 108.864 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.08 -18.93 64.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.417 -0.802 . . . . 31.48 109.78 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.31 -29.48 61.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 22.48 111.571 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -97.03 11.89 34.53 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.14 -0.975 . . . . 19.59 111.585 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 83.4 m -77.0 -175.52 3.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.761 -1.212 . . . . 20.620000000000001 109.315 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.956 -1.021 . . . . 24.649999999999999 109.233 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.375 -0.602 . . . . 30.100000000000001 109.375 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.707 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.57 107.4 8.83 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.416 -0.957 . . . . 32.240000000000002 108.416 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -157.11 164.46 37.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 30.210000000000001 109.846 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.442 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 6.0 m-70 -76.76 100.85 5.59 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.217 -2.142 . . . . 24.0 105.217 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.47 136.04 38.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 19.629999999999999 111.809 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.75 -161.34 0.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.023 0.916 . . . . 17.190000000000001 111.758 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.5 -53.08 1.81 Allowed Glycine 0 N--CA 1.49 2.248 0 CA-C-N 115.781 -0.645 . . . . 16.550000000000001 112.603 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 17.5 p -77.96 -60.91 2.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.486 -1.597 . . . . 19.550000000000001 110.898 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' H ' ' HG ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -59.42 -55.53 33.55 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.334 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' CYS . 27.5 tp -51.4 -47.54 62.9 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.823 -1.173 . . . . 14.16 108.381 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.49 -56.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.192 -1.41 . . . . 15.31 107.192 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -55.18 -61.75 2.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.959 -1.096 . . . . 29.640000000000001 108.101 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.93 -60.0 2.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.246 -0.909 . . . . 13.960000000000001 109.709 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -51.75 -51.59 55.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.441 -1.412 . . . . 17.789999999999999 108.164 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.91 -40.49 73.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 16.84 109.457 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -60.62 -24.61 65.65 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.083 -1.08 . . . . 22.760000000000002 108.083 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.3 -64.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.543 -0.723 . . . . 17.440000000000001 109.294 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -64.24 -76.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 18.539999999999999 109.638 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.87 -138.29 20.59 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.675 -1.37 . . . . 23.170000000000002 109.675 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 8.2 tp10 -48.37 -17.03 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -1.104 . . . . 39.770000000000003 109.167 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' GLY . 50.3 mtt180 -54.88 -52.84 61.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 26.649999999999999 109.255 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.52 65.14 0.48 Allowed Glycine 0 N--CA 1.508 3.478 0 C-N-CA 119.745 -1.217 . . . . 20.260000000000002 111.722 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.7 p90 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.265 -1.138 . . . . 17.789999999999999 110.218 -179.148 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 tt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 120.996 0.427 . . . . 17.420000000000002 109.875 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.21 -41.53 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.973 -1.079 . . . . 18.82 109.781 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -78.54 10.9 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 38.5 109.94 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -134.03 -13.82 2.43 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.058 -1.026 . . . . 36.829999999999998 110.837 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.2 m -119.28 -25.53 6.09 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.257 -0.902 . . . . 18.16 109.043 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.12 -37.36 17.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.961 -1.087 . . . . 18.460000000000001 108.483 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -89.36 -9.87 48.77 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -146.77 -144.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.507 -0.923 . . . . 30.34 108.507 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 mt -145.89 122.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.061 -1.024 . . . . 27.510000000000002 109.365 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.9 m -106.24 175.5 5.48 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.625 -0.672 . . . . 23.34 109.541 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 m -112.4 176.49 5.0 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.551 0.691 . . . . 22.640000000000001 109.826 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -48.78 -60.08 3.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.651 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -43.5 -56.03 3.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.332 -0.855 . . . . 37.859999999999999 110.226 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -49.93 -46.47 52.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.727 -1.233 . . . . 31.390000000000001 108.918 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.99 -38.64 89.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.686 -0.857 . . . . 24.48 108.686 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -64.2 -18.92 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.479 -0.763 . . . . 31.48 109.728 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.12 -29.74 63.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 22.48 111.63 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.0 12.17 35.12 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 19.59 111.804 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.8 m -76.59 -175.64 3.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.608 -1.307 . . . . 20.620000000000001 109.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.955 -1.021 . . . . 24.649999999999999 109.343 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.447 0.642 . . . . 30.100000000000001 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -117.97 106.27 12.76 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.78 -1.192 . . . . 32.240000000000002 107.78 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.3 mm100 -154.42 162.16 41.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.711 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -79.14 101.14 7.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.351 -2.092 . . . . 24.0 105.351 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.21 136.09 39.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.51 -0.744 . . . . 19.629999999999999 111.958 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.54 -162.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.07 0.938 . . . . 17.190000000000001 111.484 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.98 -51.68 1.55 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 115.662 -0.699 . . . . 16.550000000000001 112.774 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 p -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.458 -1.613 . . . . 19.550000000000001 110.792 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -55.2 38.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 7' ' ' CYS . 29.6 tp -51.29 -48.22 62.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.899 -1.125 . . . . 14.16 108.495 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -48.87 -55.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.204 -1.406 . . . . 15.31 107.204 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -56.06 -61.58 2.28 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.019 -1.104 . . . . 29.640000000000001 108.019 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.52 -59.54 2.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.01 -1.057 . . . . 13.960000000000001 109.679 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -51.53 -53.49 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.457 -1.402 . . . . 17.789999999999999 107.934 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.78 -49.92 61.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.508 -0.745 . . . . 16.84 109.108 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.86 -26.12 9.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.046 -1.034 . . . . 22.760000000000002 108.643 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.95 -64.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.352 -0.843 . . . . 17.440000000000001 109.44 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.9 m -64.32 -77.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 18.539999999999999 109.831 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 78.52 -133.82 13.28 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.773 -1.331 . . . . 23.170000000000002 109.773 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.42 -14.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.399 -1.06 . . . . 39.770000000000003 109.621 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 20' ' ' GLY . 8.8 mtp180 -59.01 -53.02 63.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 26.649999999999999 109.086 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.08 64.36 0.48 Allowed Glycine 0 N--CA 1.506 3.322 0 C-N-CA 119.744 -1.217 . . . . 20.260000000000002 111.531 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 29.8 p90 . . . . . 0 C--N 1.299 -1.627 0 O-C-N 121.287 -1.125 . . . . 17.789999999999999 109.848 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.004 -0.739 . . . . 17.420000000000002 109.004 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -52.3 -32.24 15.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.107 -0.996 . . . . 18.82 109.493 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -83.66 11.01 7.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 38.5 110.021 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 19.0 mt-30 -139.34 -12.89 1.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.051 . . . . 36.829999999999998 110.697 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.7 m -117.23 -30.58 5.57 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.407 -0.808 . . . . 18.16 109.099 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.34 -40.62 16.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 18.460000000000001 108.563 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -85.14 -12.52 52.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.477 -0.765 . . . . 0.0 109.213 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -145.72 -141.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.528 -0.916 . . . . 30.34 108.528 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.68 126.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.174 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.0 m -108.09 177.07 4.92 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.605 -0.685 . . . . 23.34 110.094 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.1 m -112.6 -178.99 3.53 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.49 0.662 . . . . 22.640000000000001 109.448 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.36 -56.05 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.779 . . . . 23.280000000000001 109.446 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -47.27 -50.94 20.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.395 -0.815 . . . . 37.859999999999999 110.171 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.96 -45.79 74.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.696 -1.253 . . . . 31.390000000000001 108.749 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.55 -37.72 84.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 24.48 108.643 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.29 -18.8 64.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.456 -0.778 . . . . 31.48 109.766 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -74.14 -29.51 61.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.711 . . . . 22.48 111.539 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -97.51 12.08 34.61 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.106 -0.997 . . . . 19.59 111.762 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 86.1 m -76.57 -175.77 3.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.597 -1.314 . . . . 20.620000000000001 109.207 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.441 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.379 0.609 . . . . 30.100000000000001 109.376 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.731 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.52 107.88 8.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 32.240000000000002 108.533 179.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -156.55 162.75 39.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.511 -0.743 . . . . 30.210000000000001 109.417 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -76.46 100.72 5.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.25 -2.13 . . . . 24.0 105.25 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.21 136.05 39.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.386 -0.822 . . . . 19.629999999999999 111.707 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 m -124.06 -159.04 0.84 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.896 0.855 . . . . 17.190000000000001 112.168 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.49 -51.45 1.37 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.89 -0.506 . . . . 16.550000000000001 112.946 -176.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 m -81.82 -62.07 1.74 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.316 -1.696 . . . . 19.550000000000001 110.941 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -55.58 33.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 110.131 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' VAL . 26.7 tp -50.47 -51.36 47.74 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.782 -1.199 . . . . 14.16 108.369 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -46.66 -54.31 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.561 -1.274 . . . . 15.31 107.561 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.95 -61.85 2.24 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.51 -59.8 2.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.038 -1.039 . . . . 13.960000000000001 109.728 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.17 -52.41 44.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.444 -1.41 . . . . 17.789999999999999 108.023 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -53.19 -45.8 68.71 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.1 -0.704 . . . . 16.84 109.1 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.08 -33.91 63.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.897 -1.127 . . . . 22.760000000000002 108.387 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.32 -64.84 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.378 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.18 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.897 . . . . 18.539999999999999 109.229 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.03 -130.55 10.53 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.772 -1.331 . . . . 23.170000000000002 109.772 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -50.22 -19.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 39.770000000000003 109.059 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' ' C ' ' A' ' 20' ' ' GLY . 7.6 mmt180 -55.47 -54.0 49.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 26.649999999999999 109.161 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.33 63.47 0.49 Allowed Glycine 0 N--CA 1.505 3.293 0 C-N-CA 119.958 -1.115 . . . . 20.260000000000002 111.681 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 18.6 p90 . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.04 -1.271 . . . . 17.789999999999999 109.75 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 69' ' ' GLU . 3.4 tt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.353 -0.61 . . . . 17.420000000000002 109.353 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.98 -6.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.386 -0.821 . . . . 18.82 109.712 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 67' ' ' ILE . 6.7 tt0 -108.52 9.59 27.4 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 38.5 109.039 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 4.4 mt-30 -137.82 -15.23 1.37 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.236 -0.915 . . . . 36.829999999999998 109.936 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.5 m -114.24 -24.18 9.07 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.479 -0.763 . . . . 18.16 109.273 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 51.6 t -91.48 -43.05 9.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 18.460000000000001 108.551 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -85.16 -21.42 29.21 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.628 0.728 . . . . 0.0 109.12 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -139.38 -136.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.478 -0.934 . . . . 30.34 108.478 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -145.86 147.48 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 27.510000000000002 109.204 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 1.9 m -131.09 174.64 9.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.539 -0.726 . . . . 23.34 109.313 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -112.39 -179.04 3.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.476 -0.765 . . . . 22.640000000000001 109.849 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 tp -53.46 -55.49 24.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.707 . . . . 23.280000000000001 109.371 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -46.01 -55.93 6.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 37.859999999999999 109.901 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -50.57 -50.43 53.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.821 -1.175 . . . . 31.390000000000001 108.997 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.38 -41.3 84.5 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.448 -0.783 . . . . 24.48 108.936 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -62.64 -18.76 62.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 31.48 109.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -72.59 -29.74 63.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.423 -0.798 . . . . 22.48 111.742 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -100.62 12.16 37.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 19.59 112.051 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.3 m -76.87 -175.81 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.584 -1.323 . . . . 20.620000000000001 109.188 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.301 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.5 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.545 0.688 . . . . 30.100000000000001 109.89 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.691 HD21 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.91 106.65 6.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.007 -1.109 . . . . 32.240000000000002 108.007 179.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -156.33 167.42 30.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 30.210000000000001 109.865 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -78.51 101.06 7.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.17 -2.159 . . . . 24.0 105.17 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.4 mt -99.2 136.5 39.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.514 -0.742 . . . . 19.629999999999999 111.903 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.34 -162.89 0.94 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.973 . . . . 17.190000000000001 111.44 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.89 -50.96 1.51 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-N 115.751 -0.659 . . . . 16.550000000000001 112.723 -176.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.4 m -79.17 -62.93 1.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.475 -1.603 . . . . 19.550000000000001 110.686 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.47 -55.45 34.63 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.033 -1.042 . . . . 0.0 110.038 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 7' ' ' CYS . 30.2 tp -50.7 -50.12 55.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.824 -1.172 . . . . 14.16 108.452 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.83 -56.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.58 -1.267 . . . . 15.31 107.58 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -55.65 -61.57 2.26 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.883 -1.154 . . . . 29.640000000000001 107.883 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.58 -59.61 2.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.03 -1.044 . . . . 13.960000000000001 109.762 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.44 -54.0 31.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.481 -1.387 . . . . 17.789999999999999 107.822 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -50.86 -50.4 57.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.526 -0.733 . . . . 16.84 109.127 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.1 mt -51.01 -26.93 6.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 22.760000000000002 108.6 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.37 -64.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.419 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 m -66.04 -83.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 18.539999999999999 109.982 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.77 -124.56 12.21 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.583 -1.294 . . . . 23.170000000000002 110.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -45.25 -20.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -1.048 . . . . 39.770000000000003 110.076 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 20' ' ' GLY . 84.4 mtt180 -66.75 -53.13 36.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -0.951 . . . . 26.649999999999999 109.807 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.49 64.15 0.49 Allowed Glycine 0 N--CA 1.508 3.457 0 C-N-CA 119.634 -1.27 . . . . 20.260000000000002 111.782 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.1 p90 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.296 . . . . 17.789999999999999 109.808 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.723 -0.473 . . . . 17.420000000000002 109.723 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -54.26 -23.98 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.98 -1.075 . . . . 18.82 109.726 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -94.73 10.2 36.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.06 -1.025 . . . . 38.5 109.797 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.1 mt-30 -135.64 -14.26 1.92 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.067 -1.021 . . . . 36.829999999999998 110.391 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.28 -28.48 6.52 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.355 -0.841 . . . . 18.16 109.399 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.96 -38.85 16.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 18.460000000000001 108.656 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.4 t -87.83 -12.39 45.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.798 . . . . 0.0 109.062 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 6.9 t -145.8 -142.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.644 -0.873 . . . . 30.34 108.644 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.619 ' H ' ' HG ' ' A' ' 74' ' ' SER . 11.8 mt -144.83 125.19 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.996 -1.065 . . . . 27.510000000000002 109.481 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -108.72 175.74 5.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.581 -0.7 . . . . 23.34 109.932 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -112.51 176.22 5.11 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.507 0.67 . . . . 22.640000000000001 109.644 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 tp -48.21 -60.02 2.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.518 -0.739 . . . . 23.280000000000001 109.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -42.03 -58.78 1.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 37.859999999999999 110.404 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 12.1 mp0 -48.62 -46.9 40.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.834 -1.166 . . . . 31.390000000000001 108.992 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.15 -38.81 90.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.704 -0.85 . . . . 24.48 108.704 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.58 -18.66 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.768 . . . . 31.48 109.631 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -74.05 -29.76 62.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.483 -0.76 . . . . 22.48 111.57 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -97.88 11.77 36.26 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.099 -1.001 . . . . 19.59 111.734 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.0 m -76.91 -175.76 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.606 -1.309 . . . . 20.620000000000001 109.111 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 117.967 -1.016 . . . . 24.649999999999999 109.255 179.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.481 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.5 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.445 0.64 . . . . 30.100000000000001 109.754 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.682 HD21 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.2 106.58 7.66 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.204 -1.036 . . . . 32.240000000000002 108.204 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -156.57 164.08 38.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.226 -0.921 . . . . 30.210000000000001 109.382 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -77.46 101.17 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.154 -2.165 . . . . 24.0 105.154 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.38 132.21 44.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.875 . . . . 19.629999999999999 111.922 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.54 -158.53 0.74 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.163 -0.961 . . . . 17.190000000000001 111.697 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.26 -54.56 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 115.826 -0.625 . . . . 16.550000000000001 113.201 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -79.04 -63.25 1.46 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.273 -1.722 . . . . 19.550000000000001 111.085 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -55.81 28.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 110.371 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 12' ' ' VAL . 35.1 tp -50.42 -52.15 40.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.709 -1.244 . . . . 14.16 108.554 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.8 t -45.83 -55.83 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.71 -1.218 . . . . 15.31 107.71 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -56.46 -61.43 2.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.868 -1.16 . . . . 29.640000000000001 107.868 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.3 -59.73 2.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.011 . . . . 13.960000000000001 109.882 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.8 mt -52.16 -53.84 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.315 -1.491 . . . . 17.789999999999999 107.888 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -50.7 -47.41 58.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.009 -0.737 . . . . 16.84 109.009 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.48 -26.77 33.34 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.011 -1.056 . . . . 22.760000000000002 108.348 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LEU . 2.7 t -96.21 -64.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.887 . . . . 17.440000000000001 109.393 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' LEU . 7.2 m -65.37 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.902 . . . . 18.539999999999999 110.036 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.37 -123.36 16.82 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.496 -1.335 . . . . 23.170000000000002 109.883 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.3 pm0 -44.9 -18.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.463 -1.022 . . . . 39.770000000000003 110.587 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 20' ' ' GLY . 26.1 mtt-85 -70.72 -52.67 19.41 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.936 -1.103 . . . . 26.649999999999999 110.159 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.22 64.34 0.5 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 119.611 -1.281 . . . . 20.260000000000002 111.529 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.145 -1.209 . . . . 17.789999999999999 109.426 -179.218 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 3.6 tt . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 112.163 0.431 . . . . 17.420000000000002 112.163 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.485 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 15.4 t -57.97 -7.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.626 -1.296 . . . . 18.82 109.603 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 67' ' ' ILE . 20.5 tp10 -113.02 9.26 18.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.144 -0.687 . . . . 38.5 109.144 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.9 mt-30 -138.88 -8.67 1.38 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 36.829999999999998 109.533 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.55 -31.9 4.46 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.6 -0.889 . . . . 18.16 108.6 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.06 -43.1 18.33 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 18.460000000000001 108.323 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 t -82.2 -21.79 36.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -136.81 -137.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.496 -0.928 . . . . 30.34 108.496 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.52 150.03 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.993 . . . . 27.510000000000002 109.294 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.4 m -135.14 176.65 8.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.388 -0.82 . . . . 23.34 109.956 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -112.37 -163.91 0.88 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.671 -0.643 . . . . 22.640000000000001 109.48 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.83 -60.75 2.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -0.755 . . . . 23.280000000000001 109.547 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -41.5 -57.38 2.24 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.574 -0.703 . . . . 37.859999999999999 110.522 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.71 -47.22 41.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.786 -1.196 . . . . 31.390000000000001 108.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.2 -38.18 88.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.291 -0.881 . . . . 24.48 108.987 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -18.79 64.84 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.504 -0.747 . . . . 31.48 109.75 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.32 -30.38 63.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 22.48 111.758 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.05 11.96 35.88 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.026 -1.046 . . . . 19.59 111.891 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.3 m -76.74 -175.62 3.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.682 -1.261 . . . . 20.620000000000001 109.096 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.984 -1.008 . . . . 24.649999999999999 109.403 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.7 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.326 -0.62 . . . . 30.100000000000001 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.734 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.23 107.76 9.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.583 -0.895 . . . . 32.240000000000002 108.583 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -156.73 163.04 39.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.557 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -77.18 100.83 5.93 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.164 -2.162 . . . . 24.0 105.164 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.44 134.68 41.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.784 . . . . 19.629999999999999 111.731 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.5 -159.63 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.802 0.81 . . . . 17.190000000000001 112.103 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -35.92 -53.15 1.18 Allowed Glycine 0 N--CA 1.493 2.48 0 O-C-N 121.858 -0.526 . . . . 16.550000000000001 113.233 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 m -80.37 -62.25 1.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.385 -1.656 . . . . 19.550000000000001 110.932 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -57.58 -55.4 35.3 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.911 -1.118 . . . . 0.0 110.276 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' VAL . 29.7 tp -50.89 -50.49 57.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.813 -1.179 . . . . 14.16 108.619 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.2 -57.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.459 -1.312 . . . . 15.31 107.459 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -55.56 -61.43 2.35 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.903 -1.147 . . . . 29.640000000000001 107.903 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -59.56 2.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.022 -1.049 . . . . 13.960000000000001 110.045 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.43 -55.0 21.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.342 -1.474 . . . . 17.789999999999999 107.703 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -49.33 -51.17 36.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.025 -0.732 . . . . 16.84 109.025 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.6 -26.87 5.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.063 -1.023 . . . . 22.760000000000002 108.62 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.81 -64.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.247 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -64.61 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 18.539999999999999 109.825 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 66.8 -120.12 13.65 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.632 -1.27 . . . . 23.170000000000002 110.12 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -48.74 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -1.071 . . . . 39.770000000000003 110.04 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -78.31 -52.76 8.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.888 -1.133 . . . . 26.649999999999999 109.646 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.76 63.36 0.48 Allowed Glycine 0 N--CA 1.508 3.46 0 C-N-CA 119.939 -1.124 . . . . 20.260000000000002 111.64 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.955 -1.32 . . . . 17.789999999999999 109.975 -179.299 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 4.0 tt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.675 0.25 . . . . 17.420000000000002 111.675 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 9.9 t -57.17 -7.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.646 -1.284 . . . . 18.82 109.97 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 67' ' ' ILE . 64.3 mm-40 -110.99 9.65 22.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.175 -0.953 . . . . 38.5 109.403 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.1 mt-30 -138.38 -8.93 1.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.402 -0.811 . . . . 36.829999999999998 109.876 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.4 m -120.25 -23.54 6.2 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.439 -0.788 . . . . 18.16 109.065 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 41.3 t -91.21 -41.84 10.76 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.203 -1.036 . . . . 18.460000000000001 108.203 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -85.19 -27.64 25.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -129.66 -138.21 0.22 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.511 -0.922 . . . . 30.34 108.511 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.25 149.61 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.003 . . . . 27.510000000000002 109.258 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -133.97 171.81 13.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.429 -0.794 . . . . 23.34 109.766 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -106.88 -153.93 0.51 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.493 -0.754 . . . . 22.640000000000001 109.479 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -77.78 -59.94 2.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.922 . . . . 23.280000000000001 109.014 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -42.21 -55.99 3.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.674 -0.641 . . . . 37.859999999999999 110.309 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -48.74 -47.15 41.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.932 -1.105 . . . . 31.390000000000001 109.005 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mp -63.13 -39.42 94.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 24.48 108.942 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.64 -19.0 61.78 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.399 -0.813 . . . . 31.48 109.878 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.43 -29.68 61.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 22.48 111.568 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -97.94 11.78 36.32 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.147 -0.971 . . . . 19.59 111.73 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.7 m -77.05 -175.71 3.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.641 -1.287 . . . . 20.620000000000001 109.196 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 118.029 -0.986 . . . . 24.649999999999999 109.368 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.4 p . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.439 0.638 . . . . 30.100000000000001 109.461 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.692 HD21 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.78 106.98 7.17 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.252 -1.018 . . . . 32.240000000000002 108.252 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -157.34 165.09 36.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 30.210000000000001 110.08 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -77.28 100.61 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.161 -2.163 . . . . 24.0 105.161 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.36 134.94 41.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 19.629999999999999 111.799 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.33 -162.44 0.89 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.152 -0.968 . . . . 17.190000000000001 111.636 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.458 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.51 -52.2 1.38 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 115.761 -0.654 . . . . 16.550000000000001 112.864 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -78.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.648 . . . . 19.550000000000001 110.669 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -55.47 33.28 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.106 -0.997 . . . . 0.0 110.136 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' CYS . 34.7 tp -51.09 -50.29 59.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.865 -1.147 . . . . 14.16 108.744 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.9 t -47.89 -55.87 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.65 -1.241 . . . . 15.31 107.65 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.09 -61.69 2.21 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.969 -1.123 . . . . 29.640000000000001 107.969 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.37 -59.32 2.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.975 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.88 -55.38 20.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.328 -1.482 . . . . 17.789999999999999 107.77 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -49.53 -48.94 47.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.255 -0.646 . . . . 16.84 109.255 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.4 mt -52.96 -25.88 13.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.984 -1.073 . . . . 22.760000000000002 108.587 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.92 -64.61 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 17.440000000000001 109.435 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -64.24 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 18.539999999999999 109.606 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 22' ' ' ARG . . . 77.01 -133.14 12.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.718 -1.353 . . . . 23.170000000000002 109.718 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -49.45 -11.29 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -1.111 . . . . 39.770000000000003 109.594 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -63.7 -53.05 57.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 26.649999999999999 108.778 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.93 63.58 0.48 Allowed Glycine 0 N--CA 1.506 3.363 0 C-N-CA 119.941 -1.124 . . . . 20.260000000000002 111.562 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 26.0 p90 . . . . . 0 C--N 1.299 -1.61 0 O-C-N 121.166 -1.197 . . . . 17.789999999999999 109.935 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.157 -0.683 . . . . 17.420000000000002 109.157 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -52.09 -46.48 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.099 -1.001 . . . . 18.82 109.56 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.36 10.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 38.5 109.768 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.5 mt-30 -135.76 -10.56 2.08 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.127 -0.983 . . . . 36.829999999999998 110.843 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.5 m -123.84 -25.98 4.18 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.297 -0.877 . . . . 18.16 108.766 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.67 -39.68 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.299 -1.0 . . . . 18.460000000000001 108.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -88.03 -16.2 34.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 11.3 t -138.59 -142.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.461 -0.94 . . . . 30.34 108.461 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.447 ' H ' ' HG ' ' A' ' 74' ' ' SER . 13.0 mt -144.91 142.0 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.15 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -129.07 173.58 10.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 23.34 109.631 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -112.17 -165.85 1.03 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.556 -0.715 . . . . 22.640000000000001 109.836 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 tp -64.26 -58.11 7.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 23.280000000000001 109.55 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -44.0 -58.19 2.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.813 . . . . 37.859999999999999 110.203 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -47.88 -47.64 31.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.147 . . . . 31.390000000000001 109.186 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.23 -40.03 94.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.02 -0.733 . . . . 24.48 109.02 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.98 -18.97 62.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 31.48 109.747 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -74.46 -29.87 61.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 22.48 111.48 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -97.16 11.79 35.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.114 -0.991 . . . . 19.59 111.796 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.6 m -77.38 -175.68 3.84 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.611 -1.305 . . . . 20.620000000000001 109.258 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 36.5 t-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.004 -0.998 . . . . 24.649999999999999 109.221 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.346 0.594 . . . . 30.100000000000001 109.492 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.99 106.94 8.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.455 -0.943 . . . . 32.240000000000002 108.455 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -157.59 163.01 38.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 30.210000000000001 109.686 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -77.45 100.78 6.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.125 -2.176 . . . . 24.0 105.125 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -97.68 132.93 42.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 19.629999999999999 111.996 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.67 -162.1 0.86 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.904 0.859 . . . . 17.190000000000001 111.427 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.14 -50.97 1.63 Allowed Glycine 0 N--CA 1.491 2.354 0 CA-C-N 115.957 -0.565 . . . . 16.550000000000001 112.888 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 p -79.38 -63.38 1.43 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.4 -1.647 . . . . 19.550000000000001 110.872 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -55.09 39.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 110.073 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 12' ' ' VAL . 29.0 tp -50.6 -49.77 55.67 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.728 -1.233 . . . . 14.16 108.429 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -48.24 -56.2 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.393 -1.336 . . . . 15.31 107.393 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -55.79 -61.46 2.35 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.843 -1.143 . . . . 29.640000000000001 108.036 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.98 2.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 13.960000000000001 109.662 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -51.22 -50.25 59.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.565 -1.334 . . . . 17.789999999999999 108.026 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -56.06 -41.99 75.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 16.84 109.211 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.79 -28.19 65.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.785 -1.197 . . . . 22.760000000000002 107.961 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.83 -64.66 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.547 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.5 m -64.6 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 18.539999999999999 109.801 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 76.51 -134.18 15.02 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.756 -1.338 . . . . 23.170000000000002 109.756 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -48.26 -11.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.415 -1.05 . . . . 39.770000000000003 109.8 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' GLY . 51.7 mtt180 -65.33 -52.52 53.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.058 . . . . 26.649999999999999 108.95 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.37 0.49 Allowed Glycine 0 N--CA 1.506 3.325 0 C-N-CA 119.786 -1.197 . . . . 20.260000000000002 111.663 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.0 p90 . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 109.896 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.17 -0.678 . . . . 17.420000000000002 109.17 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.6 t -48.77 -49.76 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.202 -0.936 . . . . 18.82 109.822 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -69.77 10.65 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 38.5 110.221 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.497 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 30.4 mt-30 -132.75 -16.53 2.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.215 -0.928 . . . . 36.829999999999998 110.781 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.0 m -119.35 -25.09 6.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.42 -0.8 . . . . 18.16 108.965 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.2 t -85.92 -37.85 18.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 18.460000000000001 108.676 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -90.37 -8.91 49.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 108.857 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -148.42 -145.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.624 -0.88 . . . . 30.34 108.624 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 mt -143.76 123.13 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.17 -0.956 . . . . 27.510000000000002 109.132 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.3 m -104.15 177.87 4.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.535 -0.728 . . . . 23.34 109.531 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 m -112.11 176.72 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.522 -0.737 . . . . 22.640000000000001 109.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -51.01 -59.64 3.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 23.280000000000001 109.495 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -43.68 -55.0 4.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.438 -0.789 . . . . 37.859999999999999 110.163 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -49.48 -48.16 47.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.723 -1.236 . . . . 31.390000000000001 108.907 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.58 -38.65 88.32 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 24.48 108.967 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.98 -18.98 64.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.394 -0.816 . . . . 31.48 109.827 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -73.95 -29.4 61.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 22.48 111.522 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.83 11.72 36.33 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.133 -0.979 . . . . 19.59 111.693 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.71 -175.83 3.57 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.567 -1.333 . . . . 20.620000000000001 109.271 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 118.082 -0.961 . . . . 24.649999999999999 109.495 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.503 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.4 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.636 0.731 . . . . 30.100000000000001 110.107 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.687 HD21 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -135.03 107.8 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.13 -1.063 . . . . 32.240000000000002 108.13 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -156.82 166.95 31.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 30.210000000000001 109.657 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -77.34 100.66 6.0 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.025 -2.213 . . . . 24.0 105.025 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' CYS . 14.2 mt -99.15 134.55 41.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.527 -0.733 . . . . 19.629999999999999 111.683 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 m -122.63 -157.36 0.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.951 0.881 . . . . 17.190000000000001 112.473 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -54.35 1.38 Allowed Glycine 0 N--CA 1.493 2.496 0 CA-C-N 116.042 -0.526 . . . . 16.550000000000001 113.012 -176.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -80.45 -60.38 2.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.47 -1.606 . . . . 19.550000000000001 111.04 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -55.63 32.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 110.474 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.5 tp -51.78 -47.03 64.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.68 -1.263 . . . . 14.16 108.42 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -49.72 -57.13 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.237 -1.394 . . . . 15.31 107.237 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -55.69 -61.34 2.43 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.009 -1.077 . . . . 29.640000000000001 108.276 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.87 -59.62 2.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.087 -1.008 . . . . 13.960000000000001 109.747 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.73 -51.46 55.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.94 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -54.16 -43.56 70.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.466 -0.771 . . . . 16.84 109.113 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.61 -28.88 61.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.926 -1.109 . . . . 22.760000000000002 108.238 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.03 -64.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 17.440000000000001 109.493 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.21 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 18.539999999999999 109.856 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 73.09 -129.81 13.13 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.635 -1.269 . . . . 23.170000000000002 110.034 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.3 pm0 -46.54 -13.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 110.018 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' GLY . 60.7 mtt180 -68.06 -52.89 30.11 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.088 -1.008 . . . . 26.649999999999999 109.522 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.9 64.15 0.48 Allowed Glycine 0 N--CA 1.508 3.442 0 C-N-CA 119.717 -1.23 . . . . 20.260000000000002 111.698 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 26.1 p90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.165 -1.197 . . . . 17.789999999999999 110.039 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.946 -0.761 . . . . 17.420000000000002 108.946 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.0 t -50.85 -48.83 28.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 18.82 109.411 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.16 10.46 0.15 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.2 -0.937 . . . . 38.5 110.721 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.0 mt-30 -137.79 -14.21 1.43 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.921 -1.112 . . . . 36.829999999999998 111.005 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.1 m -120.82 -21.62 6.54 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.934 . . . . 18.16 109.108 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.7 t -90.82 -39.85 12.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.101 -1.074 . . . . 18.460000000000001 108.101 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -88.39 -18.77 27.68 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -140.12 -144.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.351 -0.981 . . . . 30.34 108.351 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.65 151.27 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.111 -0.993 . . . . 27.510000000000002 109.031 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -135.55 172.29 13.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.475 -0.765 . . . . 23.34 109.68 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 m -111.63 -176.47 2.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.519 -0.738 . . . . 22.640000000000001 110.076 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.48 -57.33 12.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.46 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -44.0 -50.57 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 37.859999999999999 110.027 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -57.06 -53.26 60.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.981 -1.074 . . . . 31.390000000000001 108.814 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.51 -39.63 70.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.777 -0.823 . . . . 24.48 108.777 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.98 -18.71 65.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.528 -0.733 . . . . 31.48 109.944 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.95 -28.44 61.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 22.48 111.568 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -101.0 12.08 38.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.252 -0.905 . . . . 19.59 111.991 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.1 m -76.75 -175.62 3.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.614 -1.304 . . . . 20.620000000000001 109.134 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 118.037 -0.982 . . . . 24.649999999999999 109.446 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.6 p . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.229 -0.656 . . . . 30.100000000000001 109.229 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.731 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.65 108.11 9.95 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.736 -0.839 . . . . 32.240000000000002 108.736 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -156.64 163.66 39.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 30.210000000000001 109.5 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -76.18 100.73 5.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.246 -2.131 . . . . 24.0 105.246 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.0 134.63 41.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 19.629999999999999 111.738 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.49 -161.46 0.89 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.093 -1.005 . . . . 17.190000000000001 111.806 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.22 -47.37 1.44 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.703 -0.68 . . . . 16.550000000000001 112.77 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -82.94 -62.46 1.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.349 -1.677 . . . . 19.550000000000001 110.734 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -55.49 34.5 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.006 -1.059 . . . . 0.0 109.993 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 12' ' ' VAL . 29.8 tp -49.97 -50.92 45.15 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.698 -1.251 . . . . 14.16 108.269 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.05 -54.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.453 -1.314 . . . . 15.31 107.453 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.17 -61.71 2.28 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.949 -1.1 . . . . 29.640000000000001 108.257 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.34 -59.87 2.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.118 -0.989 . . . . 13.960000000000001 109.518 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.5 mt -51.05 -49.14 61.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.585 -1.322 . . . . 17.789999999999999 108.102 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.51 -40.72 79.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 16.84 109.011 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.63 -29.54 68.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.915 -1.116 . . . . 22.760000000000002 108.086 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.28 -64.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.479 -0.763 . . . . 17.440000000000001 109.555 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' LEU . 7.8 m -64.34 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 18.539999999999999 109.685 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.59 -122.96 11.02 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.617 -1.277 . . . . 23.170000000000002 110.077 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -50.64 -11.7 0.09 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -1.055 . . . . 39.770000000000003 110.386 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' GLY . 31.1 mtt-85 -73.32 -52.09 15.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.871 -1.143 . . . . 26.649999999999999 109.668 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.03 64.31 0.48 Allowed Glycine 0 N--CA 1.508 3.467 0 C-N-CA 119.756 -1.211 . . . . 20.260000000000002 111.685 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.2 p90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.004 -1.292 . . . . 17.789999999999999 109.169 -179.538 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 4.0 tt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.753 0.311 . . . . 17.420000000000002 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 5.1 t -54.96 -12.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.748 -1.22 . . . . 18.82 110.222 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -105.14 9.91 34.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 38.5 109.773 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -137.01 -14.91 1.55 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.283 -0.886 . . . . 36.829999999999998 109.857 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.8 m -112.49 -29.26 7.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.402 -0.811 . . . . 18.16 108.993 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.44 -44.47 11.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.105 . . . . 18.460000000000001 108.825 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -81.44 -14.56 56.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.488 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 6.4 t -147.71 -137.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.444 -0.947 . . . . 30.34 108.444 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.488 ' H ' ' HG ' ' A' ' 74' ' ' SER . 9.7 mt -145.81 149.59 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.076 -1.015 . . . . 27.510000000000002 109.349 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -131.47 176.32 8.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.487 -0.758 . . . . 23.34 109.587 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' NE2' ' A' ' 80' ' ' GLN . 2.8 p -112.26 171.17 7.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.661 -0.649 . . . . 22.640000000000001 109.444 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 tp -45.09 -61.16 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 23.280000000000001 109.502 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -41.33 -54.73 2.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.692 . . . . 37.859999999999999 110.531 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.4 mp0 -52.16 -49.49 63.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 31.390000000000001 108.578 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.56 -40.01 81.84 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.655 -0.868 . . . . 24.48 108.655 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.84 -18.75 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.426 -0.796 . . . . 31.48 109.923 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.87 -29.02 61.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.813 . . . . 22.48 111.692 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -99.56 11.98 37.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.139 -0.976 . . . . 19.59 111.857 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -76.81 -175.82 3.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.579 -1.326 . . . . 20.620000000000001 109.025 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.292 179.771 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.349 -0.612 . . . . 30.100000000000001 109.349 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.738 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -127.54 106.4 9.15 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.547 -0.909 . . . . 32.240000000000002 108.547 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -157.09 164.27 38.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 30.210000000000001 109.574 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -78.37 100.61 6.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.264 -2.124 . . . . 24.0 105.264 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.22 135.02 40.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 19.629999999999999 111.671 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.8 m -123.99 -158.35 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.895 0.855 . . . . 17.190000000000001 112.438 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.56 -51.29 1.39 Allowed Glycine 0 N--CA 1.492 2.429 0 CA-C-N 115.991 -0.55 . . . . 16.550000000000001 112.997 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m -82.48 -60.95 2.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.382 -1.658 . . . . 19.550000000000001 110.975 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -55.68 31.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.376 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' VAL . 23.8 tp -50.53 -48.4 57.16 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.677 -1.264 . . . . 14.16 108.36 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.14 -54.3 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.128 -1.434 . . . . 15.31 107.128 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.78 -61.48 2.49 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.951 -1.1 . . . . 29.640000000000001 108.322 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.15 -60.3 2.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 13.960000000000001 109.653 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.3 mt -51.22 -48.34 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.559 -1.338 . . . . 17.789999999999999 108.046 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -58.86 -39.49 81.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.535 -0.728 . . . . 16.84 109.119 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.65 -31.22 70.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 22.760000000000002 108.08 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.65 -64.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.519 -0.738 . . . . 17.440000000000001 109.496 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.0 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 18.539999999999999 109.37 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.97 -132.84 12.21 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.564 -1.414 . . . . 23.170000000000002 109.564 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 -13.65 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -1.132 . . . . 39.770000000000003 109.49 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -60.32 -53.27 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.94 . . . . 26.649999999999999 109.217 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.66 64.5 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.885 -1.15 . . . . 20.260000000000002 111.196 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.4 p90 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 110.172 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 108.79 -0.818 . . . . 17.420000000000002 108.79 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.45 -53.62 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.054 -1.029 . . . . 18.82 109.461 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.52 10.61 0.09 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.309 -0.869 . . . . 38.5 110.248 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 68' ' ' VAL . 11.4 mt-30 -135.1 -16.28 1.92 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.979 -1.075 . . . . 36.829999999999998 110.69 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.65 -23.73 6.45 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.41 -0.806 . . . . 18.16 109.096 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.6 t -87.44 -36.74 17.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.342 -0.984 . . . . 18.460000000000001 108.342 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -91.45 -16.87 26.64 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -138.71 -144.66 0.18 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -145.11 117.29 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.982 -1.074 . . . . 27.510000000000002 109.37 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -100.5 177.41 5.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.382 -0.824 . . . . 23.34 109.852 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 m -112.36 -175.38 2.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.548 -0.72 . . . . 22.640000000000001 109.752 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 tp -57.26 -56.46 21.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.514 -0.741 . . . . 23.280000000000001 109.478 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -44.91 -57.43 3.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 37.859999999999999 109.933 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -48.6 -48.52 39.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.87 -1.144 . . . . 31.390000000000001 108.987 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.95 -39.93 91.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.814 -0.809 . . . . 24.48 108.814 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.27 -18.95 64.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 31.48 109.662 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -73.19 -29.78 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 22.48 111.589 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.04 12.21 36.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.036 -1.04 . . . . 19.59 111.788 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 77.9 m -76.66 -175.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.658 -1.277 . . . . 20.620000000000001 109.253 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.95 -1.024 . . . . 24.649999999999999 109.452 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.421 0.629 . . . . 30.100000000000001 109.533 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.686 HD21 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.97 106.77 7.87 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.298 -1.001 . . . . 32.240000000000002 108.298 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -157.38 164.62 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 30.210000000000001 109.824 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -77.67 100.57 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.173 -2.158 . . . . 24.0 105.173 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.8 mt -99.44 135.31 41.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 19.629999999999999 111.72 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.2 m -122.91 -157.58 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.97 0.89 . . . . 17.190000000000001 112.424 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.72 -55.47 1.35 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-N 116.043 -0.526 . . . . 16.550000000000001 113.06 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -79.63 -58.49 3.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.383 -1.657 . . . . 19.550000000000001 111.152 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -55.94 27.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 110.419 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 12' ' ' VAL . 24.9 tp -51.12 -48.83 61.67 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.69 -1.256 . . . . 14.16 108.359 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.8 t -48.28 -55.06 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.451 -1.315 . . . . 15.31 107.451 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.97 -61.76 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.119 -1.067 . . . . 29.640000000000001 108.119 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.47 -59.6 2.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.102 -0.999 . . . . 13.960000000000001 109.686 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.2 mt -51.61 -53.46 38.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.486 -1.384 . . . . 17.789999999999999 107.906 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -52.11 -45.63 64.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.497 -0.752 . . . . 16.84 109.176 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -56.45 -30.98 63.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.957 -1.09 . . . . 22.760000000000002 108.336 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.94 -64.6 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.389 -0.819 . . . . 17.440000000000001 109.223 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' LEU . 5.9 m -64.13 -79.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 18.539999999999999 109.45 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 22' ' ' ARG . . . 75.81 -131.72 12.25 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.816 -1.314 . . . . 23.170000000000002 109.816 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -50.09 -10.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -1.088 . . . . 39.770000000000003 109.521 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.47 -52.97 49.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 26.649999999999999 108.994 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.75 63.93 0.49 Allowed Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.936 -1.126 . . . . 20.260000000000002 111.46 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 23.9 p90 . . . . . 0 C--N 1.3 -1.576 0 O-C-N 121.146 -1.208 . . . . 17.789999999999999 110.162 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.9 tt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.18 -0.674 . . . . 17.420000000000002 109.18 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.93 -50.3 19.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.208 -0.932 . . . . 18.82 109.663 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.23 10.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 38.5 110.644 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 68' ' ' VAL . 10.5 mt-30 -137.83 -16.11 1.32 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.819 -1.176 . . . . 36.829999999999998 110.651 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.0 m -118.62 -23.06 7.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.339 -0.85 . . . . 18.16 109.216 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.3 t -89.72 -37.83 14.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.466 -0.939 . . . . 18.460000000000001 108.466 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 m -133.58 -141.96 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.839 . . . . 30.34 108.736 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.05 130.08 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.995 . . . . 27.510000000000002 109.23 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -114.27 175.54 5.43 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.672 -0.643 . . . . 23.34 109.77 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 m -112.53 -178.08 3.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.622 -0.674 . . . . 22.640000000000001 109.758 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.37 -60.82 2.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.494 -0.754 . . . . 23.280000000000001 109.629 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -42.33 -56.75 2.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 37.859999999999999 110.39 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -49.2 -47.65 45.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.761 -1.212 . . . . 31.390000000000001 108.921 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.35 -39.27 89.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 24.48 108.806 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 -18.82 64.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.495 -0.753 . . . . 31.48 109.745 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -73.21 -30.21 63.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 22.48 111.644 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.8 12.14 36.58 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.145 -0.972 . . . . 19.59 111.805 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.6 m -76.71 -175.81 3.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.593 -1.317 . . . . 20.620000000000001 109.328 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 117.987 -1.006 . . . . 24.649999999999999 109.342 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.255 0.55 . . . . 30.100000000000001 109.546 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.734 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.37 107.66 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.471 -0.937 . . . . 32.240000000000002 108.471 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -156.63 163.14 39.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 30.210000000000001 109.448 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.02 101.09 5.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.212 -2.144 . . . . 24.0 105.212 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.15 136.85 37.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.769 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.33 -164.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.145 -0.972 . . . . 17.190000000000001 111.675 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.51 -44.94 1.31 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 115.673 -0.694 . . . . 16.550000000000001 112.553 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.64 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 83.9 p -83.39 -62.77 1.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.388 -1.654 . . . . 19.550000000000001 110.494 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.64 ' H ' ' HG ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -58.88 -55.2 38.16 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' CYS . 30.3 tp -49.72 -50.88 42.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.747 -1.221 . . . . 14.16 108.32 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.45 -55.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.489 -1.3 . . . . 15.31 107.489 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -56.93 -61.39 2.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.959 -1.126 . . . . 29.640000000000001 107.959 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.6 -59.55 2.68 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 13.960000000000001 109.692 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.57 -53.39 38.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.522 -1.361 . . . . 17.789999999999999 108.009 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -51.86 -48.36 64.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 16.84 109.151 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.12 -28.63 26.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.053 . . . . 22.760000000000002 108.588 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.9 -64.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.424 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -65.13 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 18.539999999999999 109.909 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.93 -122.91 17.44 Favored Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.605 -1.284 . . . . 23.170000000000002 110.191 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.03 -19.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 109.776 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 73.0 mtt180 -67.07 -52.92 36.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.199 -0.938 . . . . 26.649999999999999 109.788 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.25 0.48 Allowed Glycine 0 N--CA 1.508 3.454 0 C-N-CA 119.728 -1.225 . . . . 20.260000000000002 111.931 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 18.2 p90 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.987 -1.302 . . . . 17.789999999999999 109.262 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 108.245 -1.02 . . . . 17.420000000000002 108.245 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 t -52.37 -36.43 21.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.381 -0.824 . . . . 18.82 109.597 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -80.79 10.36 5.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 38.5 109.627 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.5 mt-30 -136.44 -10.11 1.91 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.042 -1.036 . . . . 36.829999999999998 110.57 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.7 m -121.85 -26.05 4.9 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.338 -0.852 . . . . 18.16 108.987 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.5 t -88.26 -39.5 14.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 18.460000000000001 108.607 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -84.77 -15.25 45.63 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -143.93 -138.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.114 -1.069 . . . . 30.34 108.114 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -145.52 148.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 27.510000000000002 109.045 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.6 m -131.05 173.57 10.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 23.34 109.707 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.8 m -112.16 -176.65 2.97 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.684 . . . . 22.640000000000001 109.613 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 tp -56.53 -59.25 5.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 23.280000000000001 109.412 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -43.12 -55.07 4.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 37.859999999999999 110.262 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -52.39 -48.97 65.33 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.877 -1.139 . . . . 31.390000000000001 108.952 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -60.09 -40.51 89.86 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.713 -0.847 . . . . 24.48 108.713 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.82 -18.87 61.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.506 -0.746 . . . . 31.48 109.952 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -29.82 62.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 22.48 111.742 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -97.79 11.56 36.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.082 -1.011 . . . . 19.59 111.807 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.96 -175.77 3.67 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.558 -1.339 . . . . 20.620000000000001 109.063 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 118.015 -0.993 . . . . 24.649999999999999 109.494 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.485 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 15.2 t80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.159 -0.682 . . . . 24.77 109.159 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p -86.47 148.17 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.231 -0.918 . . . . 30.100000000000001 110.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.715 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -116.68 107.25 14.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.941 -1.133 . . . . 32.240000000000002 107.941 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.4 mm100 -153.65 165.52 35.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.317 -0.865 . . . . 30.210000000000001 109.512 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -78.34 101.63 7.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.07 -2.196 . . . . 24.0 105.07 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -98.65 135.41 40.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.336 -0.853 . . . . 19.629999999999999 112.297 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.67 -161.16 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.275 -0.891 . . . . 17.190000000000001 111.656 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.11 -55.11 1.51 Allowed Glycine 0 N--CA 1.49 2.266 0 CA-C-N 115.899 -0.591 . . . . 16.550000000000001 112.75 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.7 p -76.73 -61.56 1.93 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.5 -1.588 . . . . 19.550000000000001 110.983 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -55.51 33.99 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.123 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 7' ' ' CYS . 30.6 tp -50.82 -49.9 57.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 14.16 108.476 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.76 -56.71 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.532 -1.284 . . . . 15.31 107.532 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -55.9 -61.0 2.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.026 -1.101 . . . . 29.640000000000001 108.026 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.19 -59.75 2.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.101 -0.999 . . . . 13.960000000000001 109.825 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.72 -50.48 60.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.425 -1.422 . . . . 17.789999999999999 107.891 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -55.29 -43.7 75.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 16.84 109.183 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.6 mt -56.53 -25.29 51.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 22.760000000000002 108.176 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -97.37 -64.43 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 17.440000000000001 109.431 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.8 m -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 18.539999999999999 110.005 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.98 -122.59 13.42 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.665 -1.255 . . . . 23.170000000000002 110.125 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.62 -18.67 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.425 -1.044 . . . . 39.770000000000003 110.237 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 22' ' ' ARG . 9.5 mtt-85 -70.12 -53.07 18.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.974 -1.079 . . . . 26.649999999999999 110.097 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 64.02 0.5 Allowed Glycine 0 N--CA 1.508 3.475 0 C-N-CA 119.726 -1.226 . . . . 20.260000000000002 111.759 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 20.8 p90 -76.22 127.11 32.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.269 . . . . 17.789999999999999 110.098 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.88 104.16 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.838 -1.171 . . . . 18.550000000000001 107.838 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.14 128.27 36.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.087 -1.008 . . . . 21.489999999999998 109.27 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.3 p -126.13 147.22 49.66 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.568 -0.707 . . . . 31.5 109.413 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -160.28 102.09 1.38 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.387 -0.821 . . . . 0.0 108.924 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.89 -29.99 88.15 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.77 0.98 . . . . 0.0 110.514 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 30' ' ' THR . 15.0 t -69.74 77.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.527 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -86.85 -21.88 26.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -156.0 62.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -46.91 120.49 3.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.588 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . -74.43 -144.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 58.32 -4.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.588 ' H ' ' C ' ' A' ' 34' ' ' ALA . 21.8 t0 -96.65 -12.09 24.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.02 -1.05 . . . . 0.0 109.248 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.14 -160.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.3 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.0 mp0 -62.49 -160.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 109.53 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 t 61.68 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.68 -105.96 3.36 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.536 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.18 102.41 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -1.15 . . . . 0.0 108.287 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.78 -41.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.602 -0.686 . . . . 0.0 109.248 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -176.36 -25.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 46' ' ' GLY . 10.2 mp -91.34 57.46 3.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.66 -75.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -175.02 74.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.72 66.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.087 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.43 -11.24 8.1 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.362 1.375 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.57 160.84 43.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.49 66.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.153 . . . . 0.0 109.552 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.71 18.61 65.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 t -80.22 -33.03 38.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' CD2' ' H ' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -78.13 161.81 27.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.096 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 159.25 80.72 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.53 130.36 29.69 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.121 1.214 . . . . 0.0 109.739 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.55 -27.22 57.14 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.408 -0.808 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.06 -61.06 2.37 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.316 -0.865 . . . . 0.0 110.006 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 62' ' ' LEU . 3.8 mm? -59.62 -37.48 78.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.255 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -46.13 -34.81 4.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.91 -44.56 5.68 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LYS . 28.5 p -78.42 -7.5 57.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -1.155 . . . . 0.0 109.803 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -50.35 -61.34 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 108.849 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -86.34 -41.1 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -89.27 -160.23 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.057 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -150.91 -3.38 0.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.103 -0.998 . . . . 0.0 109.102 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.27 170.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 19.620000000000001 109.943 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 tt -134.41 -42.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.967 . . . . 17.420000000000002 108.583 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 t -51.66 -41.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.2 -0.938 . . . . 18.82 109.425 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -76.48 10.31 2.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.3 -0.875 . . . . 38.5 110.014 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.4 mt-30 -136.51 -12.78 1.79 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.156 -0.965 . . . . 36.829999999999998 110.707 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.2 m -119.88 -27.12 5.47 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.376 -0.828 . . . . 18.16 109.071 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.2 t -86.36 -38.19 17.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.053 . . . . 18.460000000000001 108.515 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -87.76 -14.93 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.534 -0.729 . . . . 0.0 109.261 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 m -141.78 -141.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.527 -0.916 . . . . 30.34 108.527 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -145.8 128.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.958 . . . . 27.510000000000002 109.209 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -111.39 176.82 4.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.591 -0.693 . . . . 23.34 109.931 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -112.62 -170.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.472 0.653 . . . . 22.640000000000001 109.623 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.485 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.1 tp -62.24 -59.8 4.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.449 -0.782 . . . . 23.280000000000001 109.359 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -43.05 -57.92 2.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.768 . . . . 37.859999999999999 110.38 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -48.74 -45.02 39.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.857 -1.152 . . . . 31.390000000000001 109.018 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.47 -37.64 88.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 24.48 108.705 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.43 -18.72 64.99 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.795 . . . . 31.48 109.669 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.08 -30.36 63.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.527 -0.733 . . . . 22.48 111.581 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -98.05 12.07 35.54 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 19.59 111.975 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.9 m -76.55 -175.68 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.551 -1.343 . . . . 20.620000000000001 108.982 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.504 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.434 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.8 t80 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.294 -0.632 . . . . 24.77 109.294 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.452 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p -168.08 160.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 30.100000000000001 109.22 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.723 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.33 107.76 8.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.345 -0.983 . . . . 32.240000000000002 108.345 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -156.76 166.04 34.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -0.813 . . . . 30.210000000000001 110.083 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -77.26 100.99 6.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.64 136.88 38.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.72 . . . . 19.629999999999999 111.749 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.84 -160.51 0.85 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.216 1.007 . . . . 17.190000000000001 111.849 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.53 -54.06 1.76 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 115.552 -0.749 . . . . 16.550000000000001 112.772 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -78.9 -56.82 4.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.341 -1.682 . . . . 19.550000000000001 110.976 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.49 -55.54 26.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.928 -1.107 . . . . 0.0 110.337 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' CYS . 29.6 tp -51.75 -48.55 63.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.797 -1.19 . . . . 14.16 108.453 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 3.2 t -48.84 -55.17 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.307 -1.368 . . . . 15.31 107.307 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.11 -61.91 2.06 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.75 -59.73 2.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.092 -1.005 . . . . 13.960000000000001 109.842 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -51.98 -52.06 53.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.484 -1.385 . . . . 17.789999999999999 107.977 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -53.84 -46.32 71.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.527 -0.733 . . . . 16.84 109.216 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.23 -31.52 61.55 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.008 -1.058 . . . . 22.760000000000002 108.501 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -89.47 -64.67 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.785 . . . . 17.440000000000001 109.257 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 12.9 m -63.81 -76.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 18.539999999999999 109.414 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.09 -139.69 22.97 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.538 -1.425 . . . . 23.170000000000002 109.538 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 pm0 -47.28 -15.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -1.166 . . . . 39.770000000000003 109.535 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' GLY . 56.1 mtt180 -57.33 -52.3 65.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -0.926 . . . . 26.649999999999999 109.036 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.38 64.82 0.48 Allowed Glycine 0 N--CA 1.507 3.399 0 C-N-CA 119.73 -1.224 . . . . 20.260000000000002 111.902 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.3 p90 -75.62 134.11 40.72 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.282 -1.128 . . . . 17.789999999999999 110.111 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.22 114.34 26.02 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.636 -0.875 . . . . 18.550000000000001 108.636 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -90.36 157.66 17.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 21.489999999999998 109.092 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.4 p -152.76 115.06 4.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.069 -1.019 . . . . 31.5 109.863 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' HZ2' ' H ' ' A' ' 8' ' ' GLY . 8.5 ttmt -172.77 88.02 0.41 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -54.71 -29.2 60.68 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.043 1.162 . . . . 0.0 110.295 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.32 169.46 4.62 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -165.6 -89.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.031 . . . . 0.0 110.003 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -77.8 67.57 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.9 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -83.5 92.59 7.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.298 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . -157.24 -177.7 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.539 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 34' ' ' ALA . 47.8 mt-10 51.17 179.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.3 p30 -73.13 112.09 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.4 mm? -69.04 105.08 2.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.11 163.29 24.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.187 -0.946 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.4 t -147.05 158.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.426 -0.796 . . . . 0.0 109.263 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . -43.18 94.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER 20.0 75.72 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.233 0.54 . . . . 0.0 112.196 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 4.0 m -104.71 20.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 6.5 tt0 77.56 153.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.672 ' H ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.2 4.31 31.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.652 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -79.19 -18.47 74.31 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.55 80.59 0.14 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.52 67.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.56 -62.94 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.44 1.427 . . . . 0.0 109.937 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 163.82 102.49 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.38 59.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 -128.74 33.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -159.65 104.55 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 mt -136.05 -122.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.397 -0.814 . . . . 0.0 109.22 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -86.34 153.88 56.61 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 108.998 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.29 138.08 82.47 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.978 1.119 . . . . 0.0 109.845 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.9 mt -54.9 -37.65 66.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.56 -56.5 19.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.909 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.501 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -63.11 -45.04 93.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.98 . . . . 0.0 109.523 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -47.41 -28.46 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 109.794 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.12 -64.48 1.41 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -42.88 -30.11 0.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -1.045 . . . . 0.0 110.522 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.55 -31.56 71.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.48 -44.88 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 109.799 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -77.4 141.53 39.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.817 -1.177 . . . . 0.0 108.925 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -54.11 -57.31 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.445 ' O ' ' OH ' ' A' ' 84' ' ' TYR . . . 154.08 40.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.535 -1.317 . . . . 19.620000000000001 111.089 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.463 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 3.0 tt -142.27 -50.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.311 . . . . 17.420000000000002 109.382 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 4.0 t -54.83 -31.59 24.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.829 -1.17 . . . . 18.82 108.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.77 10.56 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 38.5 109.397 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -136.67 -14.45 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.185 -0.947 . . . . 36.829999999999998 110.617 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m -115.41 -27.14 7.29 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.285 -0.884 . . . . 18.16 109.054 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.8 t -86.6 -42.03 13.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.826 -1.171 . . . . 18.460000000000001 108.413 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -82.37 -16.14 50.21 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -142.76 -139.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.491 -0.929 . . . . 30.34 108.491 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.33 148.7 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.018 -1.051 . . . . 27.510000000000002 109.332 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.6 m -133.61 175.61 9.28 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 23.34 109.852 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OE1' ' A' ' 80' ' ' GLN . 2.9 p -112.73 179.47 3.96 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.541 0.686 . . . . 22.640000000000001 109.8 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -52.34 -60.62 3.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 23.280000000000001 109.423 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -42.61 -56.86 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.536 -0.727 . . . . 37.859999999999999 110.376 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' OE1' ' OG ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -48.98 -48.48 43.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.815 -1.178 . . . . 31.390000000000001 108.801 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -60.67 -39.41 88.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 24.48 109.097 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.43 -19.01 64.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 31.48 109.966 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.81 -29.34 63.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 22.48 111.552 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 66' ' ' GLY . 27.8 m-85 -98.7 12.34 35.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.191 -0.943 . . . . 19.59 111.898 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.57 -175.81 3.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.569 -1.332 . . . . 20.620000000000001 109.306 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 118.007 -0.996 . . . . 24.649999999999999 109.424 179.781 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.7 t80 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.168 -0.678 . . . . 24.77 109.168 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.441 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p -165.54 160.03 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 30.100000000000001 109.331 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.726 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.64 107.25 9.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.485 -0.931 . . . . 32.240000000000002 108.485 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -157.12 165.17 36.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 30.210000000000001 109.715 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -78.14 100.37 6.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.164 -2.161 . . . . 24.0 105.164 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.63 137.82 36.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.547 -0.721 . . . . 19.629999999999999 111.615 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 m -125.68 -160.49 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.038 0.923 . . . . 17.190000000000001 112.538 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -49.25 1.34 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 115.946 -0.57 . . . . 16.550000000000001 112.793 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -83.27 -60.71 2.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.402 -1.646 . . . . 19.550000000000001 110.802 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -55.57 31.86 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 110.308 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 24.7 tp -51.38 -46.39 62.77 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.688 -1.258 . . . . 14.16 108.347 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.5 t -50.1 -56.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.932 -1.507 . . . . 15.31 106.932 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -56.07 -61.59 2.28 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.099 -1.041 . . . . 29.640000000000001 108.233 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.25 -60.04 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.807 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -51.26 -49.04 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.612 -1.305 . . . . 17.789999999999999 107.919 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.8 -43.06 85.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 16.84 109.232 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.37 -27.68 62.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.933 -1.105 . . . . 22.760000000000002 108.215 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.74 -64.66 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 17.440000000000001 109.535 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 18.0 m -63.14 -74.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 18.539999999999999 109.567 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -132.54 11.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.92 -1.272 . . . . 23.170000000000002 109.92 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -57.24 -12.62 2.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.427 -1.043 . . . . 39.770000000000003 109.556 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.466 ' HG2' HH11 ' A' ' 22' ' ' ARG . 12.1 mtt-85 -57.79 -51.86 67.85 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.007 -1.058 . . . . 26.649999999999999 109.233 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 65.47 0.48 Allowed Glycine 0 N--CA 1.508 3.451 0 C-N-CA 119.628 -1.272 . . . . 20.260000000000002 111.446 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 31.1 p90 -75.53 123.01 24.73 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.301 -1.117 . . . . 17.789999999999999 110.271 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.78 112.8 20.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.481 -0.762 . . . . 18.550000000000001 108.974 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -95.61 146.9 24.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 21.489999999999998 109.139 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -148.4 146.21 28.37 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 31.5 109.086 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.591 ' C ' ' H ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -139.33 141.78 30.24 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.216 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 30' ' ' THR . 4.1 Cg_exo -55.26 -6.7 0.89 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.591 ' H ' ' C ' ' A' ' 28' ' ' LYS . 3.6 m 100.26 34.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 123.643 0.777 . . . . 0.0 109.157 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 31' ' ' ARG . 29.2 mtm-85 43.09 -130.17 0.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.512 -0.742 . . . . 0.0 110.162 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.525 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.76 -166.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.26 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 57.06 43.55 24.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 36' ' ' ASP . . . -72.5 115.58 11.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 50.26 16.26 0.25 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.234 -0.916 . . . . 0.0 109.37 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' N ' ' C ' ' A' ' 34' ' ' ALA . 21.3 t0 64.0 87.97 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.35 -160.37 0.79 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -141.6 137.89 32.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.5 m -86.03 60.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.223 -0.923 . . . . 0.0 109.695 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . -172.5 122.47 0.94 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 40' ' ' GLY . 4.8 tp-100 48.74 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -174.55 -30.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.27 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 45' ' ' GLY . 11.9 pt-20 -125.55 -30.84 3.04 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.098 -1.002 . . . . 0.0 111.123 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.703 ' H ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -74.63 26.76 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.571 -1.331 . . . . 0.0 109.68 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.521 ' H ' ' C ' ' A' ' 43' ' ' GLU . . . -152.87 -39.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.25 -156.82 28.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -115.31 4.3 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 49' ' ' GLY . 6.0 Cg_exo -56.31 -30.77 82.14 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 CA-C-N 119.143 1.471 . . . . 0.0 109.683 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 48' ' ' PRO . . . -50.44 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.36 -16.77 9.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -1.164 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.0 74.67 0.25 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -52.79 -43.07 65.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.086 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -81.06 -161.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.406 -0.809 . . . . 0.0 109.111 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.88 151.22 73.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 108.709 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -65.23 -178.84 0.91 Allowed 'Trans proline' 0 C--O 1.209 -0.959 0 N-CA-C 109.033 -1.18 . . . . 0.0 109.033 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.88 -31.69 8.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -59.56 3.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 110.171 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.8 mm? -50.24 -45.82 54.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.073 -1.017 . . . . 0.0 109.009 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -44.59 -35.28 2.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.6 -0.687 . . . . 0.0 109.726 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' SER . . . -87.07 -69.1 1.32 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' LYS . 51.7 p -37.57 -40.09 0.37 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.069 -0.665 . . . . 0.0 111.138 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -48.24 -18.15 0.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.876 -1.14 . . . . 0.0 108.915 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 61' ' ' SER . 39.0 tt0 -106.53 -18.46 13.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.742 -0.599 . . . . 0.0 109.974 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -154.28 -179.1 7.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.011 -1.055 . . . . 0.0 110.336 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -86.85 -34.46 19.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 108.759 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.59 129.22 3.67 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.38 -1.088 . . . . 19.620000000000001 110.38 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 tt -118.66 -40.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.673 -0.898 . . . . 17.420000000000002 108.597 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.36 -27.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.275 -0.891 . . . . 18.82 109.556 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -90.9 10.89 24.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 38.5 109.872 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mt-30 -137.18 -10.43 1.72 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.075 -1.015 . . . . 36.829999999999998 110.841 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -120.32 -26.05 5.52 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.271 -0.893 . . . . 18.16 109.42 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.7 t -87.94 -37.91 16.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.93 -1.106 . . . . 18.460000000000001 108.112 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 t -86.08 -23.9 26.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -134.01 -140.71 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.443 -0.947 . . . . 30.34 108.443 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.4 mt -145.68 131.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.043 -1.036 . . . . 27.510000000000002 109.099 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.2 m -114.41 175.14 5.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.555 -0.716 . . . . 23.34 110.105 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m -112.52 -178.24 3.35 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.604 -0.685 . . . . 22.640000000000001 109.749 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -54.55 -61.8 2.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.482 -0.761 . . . . 23.280000000000001 109.716 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -42.04 -57.24 2.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.418 -0.801 . . . . 37.859999999999999 110.249 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -48.46 -45.58 36.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.852 -1.155 . . . . 31.390000000000001 109.14 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.97 -38.72 92.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 24.48 108.86 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.42 -19.0 64.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 31.48 109.786 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -72.74 -29.65 63.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 22.48 111.356 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -97.9 12.53 33.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.186 -0.946 . . . . 19.59 111.925 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.13 -175.93 3.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.58 -1.325 . . . . 20.620000000000001 109.101 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.025 -0.988 . . . . 24.649999999999999 109.589 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.51 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 19.6 t80 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.209 -0.663 . . . . 24.77 109.209 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.8 p -165.12 159.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 30.100000000000001 109.539 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.738 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.58 107.48 9.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.475 -0.935 . . . . 32.240000000000002 108.475 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -156.85 161.93 39.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 30.210000000000001 109.46 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -76.97 100.95 5.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.285 -2.117 . . . . 24.0 105.285 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.27 133.63 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 19.629999999999999 111.808 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -159.76 0.78 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.136 -0.977 . . . . 17.190000000000001 111.532 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.82 -53.45 1.47 Allowed Glycine 0 N--CA 1.49 2.291 0 CA-C-N 115.843 -0.617 . . . . 16.550000000000001 112.977 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.4 m -78.7 -62.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.516 -1.579 . . . . 19.550000000000001 111.068 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.6 -55.5 34.05 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.215 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' VAL . 31.5 tp -50.49 -51.71 44.77 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.64 -1.288 . . . . 14.16 108.311 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.445 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -45.92 -55.46 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.643 -1.243 . . . . 15.31 107.643 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.45 -61.73 2.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.946 -1.131 . . . . 29.640000000000001 107.946 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.36 -59.59 2.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.161 -0.962 . . . . 13.960000000000001 109.708 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.0 mt -51.77 -53.92 34.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.381 -1.449 . . . . 17.789999999999999 108.072 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.1 -48.26 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 16.84 109.018 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.34 -29.3 33.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.094 -1.004 . . . . 22.760000000000002 108.439 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -92.66 -64.72 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 17.440000000000001 109.586 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.1 m -64.8 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 18.539999999999999 109.684 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 76.71 -129.01 9.53 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.715 -1.354 . . . . 23.170000000000002 109.715 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -49.99 -18.9 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.364 -1.08 . . . . 39.770000000000003 109.256 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -57.14 -54.01 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 26.649999999999999 109.097 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.12 62.75 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.893 -1.146 . . . . 20.260000000000002 111.502 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.9 p90 -76.7 121.87 23.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.1 -1.235 . . . . 17.789999999999999 109.638 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.29 105.05 17.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.139 -0.976 . . . . 18.550000000000001 108.909 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.47 125.22 28.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.158 -0.964 . . . . 21.489999999999998 109.24 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.3 p -100.86 160.72 14.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.534 -0.729 . . . . 31.5 109.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 tttp 70.75 67.02 0.4 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.993 -0.442 . . . . 0.0 110.514 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.41 129.17 27.2 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.168 1.245 . . . . 0.0 108.867 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.424 ' OG1' ' OE1' ' A' ' 33' ' ' GLU . 9.0 t -145.93 142.28 28.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.989 -1.069 . . . . 0.0 110.005 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.7 -32.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.4 OUTLIER -152.75 47.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 108.877 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.424 ' OE1' ' OG1' ' A' ' 30' ' ' THR . 11.2 pt-20 -69.09 11.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . -63.63 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 49.2 -172.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.648 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.4 p30 -70.82 129.83 40.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.1 97.51 8.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.39 -24.24 18.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.243 -0.91 . . . . 0.0 109.7 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.79 -38.24 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 29.08 4.23 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.98 75.24 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -1.007 . . . . 0.0 108.519 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.75 151.49 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -48.69 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.442 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -159.17 -5.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.648 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -46.24 -41.35 11.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.34 74.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.29 68.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.8 -169.16 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.439 1.426 . . . . 0.0 109.708 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.68 43.31 2.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -23.05 50.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.452 -1.028 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 152.01 -15.23 0.78 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m 62.9 -71.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -1.013 . . . . 0.0 109.684 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLY . 17.7 mt 57.41 -143.33 0.69 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.903 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -76.87 154.73 83.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 108.702 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.41 134.25 57.37 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.029 1.153 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.2 mt -50.67 -41.31 55.5 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.576 -0.703 . . . . 0.0 109.511 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.59 -57.76 10.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.216 -0.928 . . . . 0.0 109.612 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -58.16 -45.48 87.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.192 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -50.38 -20.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.283 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.51 -55.46 3.93 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 t -49.46 -36.17 21.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -1.216 . . . . 0.0 109.427 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.5 -34.18 76.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.312 -0.868 . . . . 0.0 109.162 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.87 -52.25 6.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.256 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 2.9 mptp? -73.4 -172.72 1.22 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 108.97 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -153.04 -44.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.778 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.36 -97.08 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.846 -1.645 . . . . 19.620000000000001 111.383 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 4.4 tt -43.39 -51.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.43 -1.041 . . . . 17.420000000000002 111.928 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.457 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 5.6 t -54.66 -17.36 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.524 -1.36 . . . . 18.82 110.012 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -100.74 9.97 41.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 38.5 109.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -137.65 -16.02 1.36 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.108 -0.995 . . . . 36.829999999999998 110.242 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.7 m -112.16 -30.87 7.06 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.362 -0.836 . . . . 18.16 109.256 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.6 -42.51 16.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 18.460000000000001 108.667 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -80.9 -22.4 39.79 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 m -139.98 -136.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.496 -0.927 . . . . 30.34 108.496 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.7 149.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 27.510000000000002 109.301 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.9 m -133.08 175.93 8.94 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 23.34 109.583 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m -112.24 -178.32 3.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 22.640000000000001 109.765 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.7 tp -55.16 -57.63 10.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.575 -0.703 . . . . 23.280000000000001 109.267 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -44.15 -51.64 7.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.423 -0.798 . . . . 37.859999999999999 110.001 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -54.93 -51.84 64.83 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.787 -1.196 . . . . 31.390000000000001 108.733 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -56.92 -39.5 74.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 24.48 108.855 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.76 -18.62 64.25 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.468 -0.77 . . . . 31.48 109.863 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -73.67 -30.04 62.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.826 . . . . 22.48 111.746 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -99.01 12.01 37.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.205 -0.934 . . . . 19.59 111.782 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.2 m -76.7 -175.4 3.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 20.620000000000001 109.194 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 118.019 -0.991 . . . . 24.649999999999999 109.359 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 20.4 t80 . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 109.27 -0.641 . . . . 24.77 109.27 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -163.99 161.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.949 -1.094 . . . . 30.100000000000001 109.572 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.73 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.78 107.14 7.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.35 -0.981 . . . . 32.240000000000002 108.35 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.58 161.21 39.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 30.210000000000001 109.261 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.59 100.77 5.44 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.251 -2.129 . . . . 24.0 105.251 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.11 132.8 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.784 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 -157.01 0.69 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.21 -0.931 . . . . 17.190000000000001 111.831 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -37.02 -55.24 1.46 Allowed Glycine 0 N--CA 1.49 2.288 0 CA-C-N 115.869 -0.605 . . . . 16.550000000000001 113.189 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.0 m -79.55 -58.41 3.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.483 -1.598 . . . . 19.550000000000001 111.42 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -55.37 34.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 110.39 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 12' ' ' VAL . 31.2 tp -50.4 -50.51 51.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.74 -1.225 . . . . 14.16 108.24 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.25 -55.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.516 -1.29 . . . . 15.31 107.516 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.11 -61.76 2.23 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.878 -1.129 . . . . 29.640000000000001 108.421 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.39 -59.43 2.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 13.960000000000001 109.839 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -51.36 -52.19 47.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 17.789999999999999 107.881 178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -53.44 -45.89 69.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 16.84 109.141 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.44 -26.94 33.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.858 -1.151 . . . . 22.760000000000002 108.307 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.46 -64.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.448 -0.783 . . . . 17.440000000000001 109.401 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 24' ' ' PHE . 6.7 m -62.18 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 18.539999999999999 109.842 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.08 -125.02 24.11 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.596 -1.288 . . . . 23.170000000000002 110.046 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -45.79 -22.11 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -1.074 . . . . 39.770000000000003 109.429 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 20' ' ' GLY . 13.8 mmt180 -61.81 -54.65 39.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.346 -0.846 . . . . 26.649999999999999 110.0 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.75 62.49 0.5 Allowed Glycine 0 N--CA 1.51 3.62 0 C-N-CA 119.915 -1.136 . . . . 20.260000000000002 112.075 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 15.1 p90 -77.06 130.02 36.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.338 . . . . 17.789999999999999 109.869 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.48 ' N ' ' CD1' ' A' ' 25' ' ' PHE . 2.9 p90 -96.82 104.45 16.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 18.550000000000001 109.162 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -78.51 168.62 19.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 21.489999999999998 109.578 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -145.12 159.63 42.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 31.5 109.267 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt 59.39 67.18 1.96 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.544 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.86 -18.72 50.96 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.521 1.481 . . . . 0.0 109.881 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 m -87.53 138.62 31.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.447 0.641 . . . . 0.0 109.983 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' C ' ' CD ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -95.48 -72.29 0.63 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.345 -0.847 . . . . 0.0 108.781 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -110.49 143.75 40.36 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.41 44.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.95 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.23 63.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.715 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 37' ' ' LEU . 72.7 mm-40 -67.89 -114.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -80.11 22.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 35' ' ' GLU . 24.8 tp -82.7 -35.22 26.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -71.72 131.97 43.88 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.265 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -47.78 115.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.16 -27.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.32 60.83 5.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -1.082 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.08 -42.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 108.719 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.97 -161.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 10.2 mp -94.63 -15.97 23.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.099 -1.001 . . . . 0.0 109.354 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.05 42.55 0.25 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.71 -141.03 1.17 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.87 68.61 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.73 -76.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.488 1.458 . . . . 0.0 110.234 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -68.99 -19.14 73.44 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.15 2.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -1.124 . . . . 0.0 109.764 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 49' ' ' GLY . . . -83.97 -155.45 21.32 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 53' ' ' LEU . 11.0 t 51.31 30.89 6.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.152 -1.204 . . . . 0.0 109.214 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 52' ' ' SER . 12.3 mt -36.54 -43.46 0.4 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.132 0.492 . . . . 0.0 110.756 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.72 152.07 37.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.222 -0.924 . . . . 0.0 108.829 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 9.5 Cg_endo -71.75 157.45 55.37 Favored 'Trans proline' 0 C--O 1.206 -1.09 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.8 mt -107.98 -16.99 14.16 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.595 -0.691 . . . . 0.0 110.497 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -37.34 21.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 112.14 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -24.04 13.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.89 -1.131 . . . . 0.0 111.432 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -51.67 -25.52 7.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.237 -1.539 . . . . 0.0 108.883 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.509 ' C ' ' H ' ' A' ' 62' ' ' LEU . . . -87.55 -39.51 7.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.6 m -51.17 -10.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.413 -1.051 . . . . 0.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' A' ' 60' ' ' GLY . 23.1 mt -82.62 -44.11 16.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.048 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 64' ' ' LYS . 14.6 mm100 -76.6 10.62 2.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.277 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.66 173.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.97 . . . . 0.0 109.717 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -88.61 -41.84 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 84' ' ' TYR . . . 141.76 13.97 0.43 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.219 -1.152 . . . . 19.620000000000001 110.219 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.492 ' C ' ' H ' ' A' ' 69' ' ' GLU . 3.3 tt -136.78 -45.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.206 -1.173 . . . . 17.420000000000002 109.658 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 18.1 t -57.16 -7.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.893 -1.129 . . . . 18.82 109.19 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 67' ' ' ILE . 22.1 tt0 -109.83 9.5 24.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.49 -0.756 . . . . 38.5 109.313 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -137.56 -15.67 1.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.227 -0.921 . . . . 36.829999999999998 109.691 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.86 -29.94 7.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.529 -0.732 . . . . 18.16 109.12 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 52.5 t -84.85 -44.51 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 18.460000000000001 108.701 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -81.34 -17.91 47.51 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.445 -0.784 . . . . 0.0 109.093 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 m -144.07 -137.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.296 -1.001 . . . . 30.34 108.296 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.45 150.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 27.510000000000002 109.333 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 m -133.18 175.88 9.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 23.34 109.55 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -111.62 -174.89 2.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.703 . . . . 22.640000000000001 109.566 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.6 tp -57.75 -57.56 12.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 23.280000000000001 109.608 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -44.5 -55.23 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.39 -0.819 . . . . 37.859999999999999 110.038 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -50.55 -49.85 54.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.816 -1.177 . . . . 31.390000000000001 108.898 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.53 -40.97 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.921 -0.77 . . . . 24.48 108.921 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -61.88 -19.04 62.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.448 -0.783 . . . . 31.48 109.651 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -73.14 -30.18 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.598 -0.688 . . . . 22.48 111.889 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.408 ' CE1' ' O ' ' A' ' 66' ' ' GLY . 22.7 m-85 -100.07 11.8 38.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.157 -0.965 . . . . 19.59 111.939 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.0 m -76.82 -175.72 3.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.601 -1.312 . . . . 20.620000000000001 108.833 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.038 -0.982 . . . . 24.649999999999999 109.287 179.541 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.496 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.4 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.267 -0.642 . . . . 24.77 109.267 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p -167.28 161.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.07 -1.019 . . . . 30.100000000000001 109.644 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.71 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.73 107.85 8.64 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.485 -0.932 . . . . 32.240000000000002 108.485 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -156.86 164.23 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 30.210000000000001 109.64 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -76.52 100.6 5.33 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.168 -2.16 . . . . 24.0 105.168 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.08 135.96 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.78 . . . . 19.629999999999999 111.59 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.1 m -124.14 -157.3 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.006 0.908 . . . . 17.190000000000001 112.693 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.79 -53.8 1.45 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 115.977 -0.556 . . . . 16.550000000000001 112.884 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.84 -58.47 2.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.315 -1.697 . . . . 19.550000000000001 111.096 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -60.47 -55.76 29.63 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.925 -1.11 . . . . 0.0 110.464 -178.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' VAL . 25.7 tp -51.15 -50.04 59.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.203 . . . . 14.16 108.211 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -46.88 -55.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.525 -1.287 . . . . 15.31 107.525 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 20.6 tt0 -57.12 -61.8 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.018 -1.105 . . . . 29.640000000000001 108.018 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 13' ' ' GLU . . . -45.18 -59.67 2.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 13.960000000000001 109.537 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.1 mt -51.57 -55.14 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.546 -1.346 . . . . 17.789999999999999 108.009 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.42 -50.48 40.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 16.84 108.952 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -52.22 -29.78 24.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 22.760000000000002 108.514 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.02 -64.45 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.296 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' LEU . 5.7 m -65.66 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 18.539999999999999 109.946 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.3 -112.57 4.91 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.614 -1.279 . . . . 23.170000000000002 110.275 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -52.93 -20.5 3.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 39.770000000000003 110.116 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -69.03 -52.59 27.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 26.649999999999999 109.974 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.19 63.17 0.49 Allowed Glycine 0 N--CA 1.507 3.393 0 C-N-CA 119.729 -1.224 . . . . 20.260000000000002 111.689 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -76.13 137.41 40.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.047 -1.266 . . . . 17.789999999999999 109.221 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -106.42 106.49 17.04 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.398 -0.814 . . . . 18.550000000000001 109.892 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -81.81 120.12 24.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 21.489999999999998 109.135 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.2 p -153.31 117.01 4.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.152 -0.968 . . . . 31.5 109.266 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -171.8 108.92 0.38 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.0 . . . . 0.0 109.699 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.39 -14.1 15.08 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.71 134.25 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.536 0.684 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -61.35 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.064 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -59.03 132.09 53.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.842 . . . . 0.0 109.927 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 35' ' ' GLU . 76.4 mt-10 -156.13 135.2 12.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . 72.31 -31.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.525 -0.734 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 33' ' ' GLU . 33.5 tt0 -56.38 -104.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.38 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 37' ' ' LEU . 9.5 t70 -80.96 162.56 23.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 4.1 mp -139.82 -130.17 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.427 -0.796 . . . . 0.0 109.248 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.493 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 4.0 mp0 -62.07 -167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.928 . . . . 0.0 109.299 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 p -69.46 156.03 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.274 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.37 90.18 0.11 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? 48.27 80.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -1.121 . . . . 0.0 109.65 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.8 p -167.43 -46.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 47' ' ' GLY . 29.8 tt0 -172.06 161.5 5.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 0.0 109.035 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 5.9 mp -96.24 5.44 51.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.577 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.55 70.06 0.26 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.85 -118.5 5.51 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' N ' ' OE1' ' A' ' 43' ' ' GLU . . . -157.44 177.53 34.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.3 Cg_endo -59.9 126.98 21.85 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.637 1.558 . . . . 0.0 110.108 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 48' ' ' PRO . . . 59.65 152.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.47 23.6 2.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -1.126 . . . . 0.0 109.435 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 91.11 20.11 40.19 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.9 m 52.26 -86.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.536 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -65.69 -171.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -62.32 148.75 89.08 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 108.93 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.24 134.07 46.88 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.934 1.089 . . . . 0.0 109.659 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.9 mt -57.41 -30.23 64.79 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.706 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.39 -55.15 26.73 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.309 -0.87 . . . . 0.0 109.815 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.5 mm? -63.17 -38.06 89.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 0.0 109.1 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -49.91 -31.72 12.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.51 -37.4 8.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.9 p -62.82 -16.72 59.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.163 . . . . 0.0 109.65 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.99 -52.67 5.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -85.58 18.76 2.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.76 140.06 3.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -171.06 -9.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.427 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.79 134.01 12.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.631 -1.388 . . . . 19.620000000000001 109.631 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 tt -56.61 -46.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 17.420000000000002 109.755 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.8 t -53.67 -31.71 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 18.82 109.247 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 9.99 6.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.956 -1.09 . . . . 38.5 110.119 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -141.16 -11.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.032 -1.043 . . . . 36.829999999999998 110.729 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.5 m -117.89 -26.45 6.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.408 -0.807 . . . . 18.16 109.357 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 t -88.83 -43.28 11.34 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.144 -1.058 . . . . 18.460000000000001 108.144 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 t -82.05 -28.04 32.66 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.514 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 25.6 t -131.75 -140.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.52 -0.918 . . . . 30.34 108.52 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.514 ' H ' ' HG ' ' A' ' 74' ' ' SER . 29.0 mt -142.82 151.55 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.156 -0.965 . . . . 27.510000000000002 109.258 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -136.49 174.55 10.49 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 23.34 109.683 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -112.23 -178.46 3.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.546 -0.721 . . . . 22.640000000000001 109.736 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.4 tp -53.0 -61.51 2.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 23.280000000000001 109.573 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' C ' ' O ' ' A' ' 78' ' ' LEU . 1.7 m-85 -41.31 -55.83 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.449 -0.782 . . . . 37.859999999999999 110.356 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -49.46 -51.09 38.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.84 -1.162 . . . . 31.390000000000001 108.819 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.23 -41.3 83.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.451 -0.781 . . . . 24.48 109.071 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.75 -18.76 61.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.408 -0.808 . . . . 31.48 110.075 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -74.31 -29.27 61.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 22.48 111.811 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -99.51 12.06 37.45 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.074 -1.016 . . . . 19.59 111.898 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.51 -175.74 3.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.745 -1.222 . . . . 20.620000000000001 108.931 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.046 -0.978 . . . . 24.649999999999999 109.399 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 15.1 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.287 -0.634 . . . . 24.77 109.287 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.3 p -165.93 159.26 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 30.100000000000001 109.361 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.719 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.0 106.85 8.92 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.389 -0.967 . . . . 32.240000000000002 108.389 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 83.0 mm-40 -156.5 164.53 38.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.298 -0.876 . . . . 30.210000000000001 109.62 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -77.93 101.05 6.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -98.82 136.18 39.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.427 -0.796 . . . . 19.629999999999999 111.776 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.19 -160.38 0.83 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.189 -0.945 . . . . 17.190000000000001 111.691 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.15 -54.18 1.57 Allowed Glycine 0 N--CA 1.489 2.184 0 CA-C-N 115.685 -0.689 . . . . 16.550000000000001 112.667 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -77.8 -61.91 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.543 -1.563 . . . . 19.550000000000001 110.924 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -55.75 30.93 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.027 . . . . 0.0 110.427 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 7' ' ' CYS . 28.2 tp -51.85 -47.7 64.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.723 -1.236 . . . . 14.16 108.499 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.17 -56.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.336 -1.357 . . . . 15.31 107.336 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.86 -61.23 2.51 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.971 -1.092 . . . . 29.640000000000001 108.246 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.28 -59.54 2.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 13.960000000000001 110.097 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -51.75 -51.55 55.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.715 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.122 -0.696 . . . . 16.84 109.122 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -56.74 -24.36 49.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.946 -1.096 . . . . 22.760000000000002 108.285 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.51 -64.55 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.35 -0.844 . . . . 17.440000000000001 109.557 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.4 m -64.39 -78.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 18.539999999999999 109.649 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.68 -132.23 11.77 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.72 -1.352 . . . . 23.170000000000002 109.72 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -49.69 -14.73 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -1.097 . . . . 39.770000000000003 109.518 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 20' ' ' GLY . 1.0 OUTLIER -59.78 -53.61 55.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 26.649999999999999 109.161 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.4 63.9 0.49 Allowed Glycine 0 N--CA 1.506 3.357 0 C-N-CA 119.951 -1.119 . . . . 20.260000000000002 111.245 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.7 p90 -75.61 124.68 27.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.069 -1.254 . . . . 17.789999999999999 110.063 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 33.9 p90 -92.79 109.84 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 18.550000000000001 108.971 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -70.61 165.75 22.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 21.489999999999998 109.231 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 p -146.17 144.37 29.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.127 -0.983 . . . . 31.5 109.771 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 30' ' ' THR . 14.4 ptmt -175.04 70.36 0.28 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.332 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -49.42 -14.21 0.56 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.497 ' H ' ' C ' ' A' ' 28' ' ' LYS . 2.3 p -92.06 104.59 16.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -100.68 124.72 46.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 109.597 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? 48.92 64.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.529 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -80.27 66.57 5.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -174.27 155.6 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 49.06 13.1 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ALA . 14.4 m-20 -143.28 52.05 1.36 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.389 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 mt -80.74 -149.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.922 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -148.71 11.7 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 40' ' ' GLY . 11.4 p -76.07 -15.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . 49.86 -178.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -75.68 129.87 37.82 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.63 -0.924 . . . . 0.0 108.909 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -146.25 -165.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -85.01 78.09 9.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.251 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 9.0 mp 49.04 -106.94 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.24 27.08 16.72 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.74 -49.12 67.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.15 67.99 1.78 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.15 -66.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.457 1.438 . . . . 0.0 109.76 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.79 135.23 46.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' GLY . . . -80.22 36.03 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -1.142 . . . . 0.0 109.575 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' ALA . . . -52.57 -98.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 53' ' ' LEU . 8.4 t 55.28 22.6 4.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -1.155 . . . . 0.0 109.502 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 52' ' ' SER . 22.5 mt -58.79 -153.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.522 -0.736 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.564 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -62.36 131.97 93.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.021 -1.049 . . . . 0.0 109.006 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.56 134.17 43.16 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.873 1.048 . . . . 0.0 109.763 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -54.42 -36.69 64.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.461 -0.774 . . . . 0.0 109.56 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.95 -56.01 27.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 0.0 109.934 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.5 mm? -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.449 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -47.77 -21.57 0.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.643 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.63 -44.77 6.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.54 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 48.1 p -71.21 -13.94 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.177 . . . . 0.0 109.696 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -85.63 -32.14 22.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' O ' ' C ' ' A' ' 64' ' ' LYS . 66.0 mm-40 -92.22 -34.09 14.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.272 -0.892 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 26.81 57.9 0.07 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.243 0.544 . . . . 0.0 111.529 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -142.91 77.99 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.12 -0.987 . . . . 0.0 109.611 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 172.86 120.98 0.58 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.597 -1.401 . . . . 19.620000000000001 109.597 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -52.67 -41.23 37.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.446 -1.032 . . . . 17.420000000000002 109.44 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 t -55.4 -22.05 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 18.82 109.467 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -95.49 10.45 36.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 38.5 109.703 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -137.38 -15.12 1.46 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 36.829999999999998 110.557 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.46 -27.86 7.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.305 -0.872 . . . . 18.16 109.425 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.29 -41.04 13.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.111 . . . . 18.460000000000001 108.519 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.7 t -83.63 -16.33 45.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 m -143.2 -139.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -145.11 137.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 27.510000000000002 109.257 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.6 m -119.47 176.97 5.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.676 -0.64 . . . . 23.34 110.261 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.9 175.74 5.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.506 0.67 . . . . 22.640000000000001 109.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 6.0 tp -51.8 -61.15 2.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.475 -0.766 . . . . 23.280000000000001 109.469 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -43.52 -54.7 4.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.795 . . . . 37.859999999999999 110.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -49.75 -44.8 48.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.757 -1.214 . . . . 31.390000000000001 109.002 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.25 -36.92 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 24.48 108.864 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.08 -18.93 64.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.417 -0.802 . . . . 31.48 109.78 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.31 -29.48 61.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 22.48 111.571 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -97.03 11.89 34.53 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.14 -0.975 . . . . 19.59 111.585 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 83.4 m -77.0 -175.52 3.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.761 -1.212 . . . . 20.620000000000001 109.315 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.956 -1.021 . . . . 24.649999999999999 109.233 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.3 t80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.223 -0.658 . . . . 24.77 109.223 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.454 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.0 p -165.8 161.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 30.100000000000001 109.375 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.707 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.57 107.4 8.83 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.416 -0.957 . . . . 32.240000000000002 108.416 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -157.11 164.46 37.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 30.210000000000001 109.846 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.442 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 6.0 m-70 -76.76 100.85 5.59 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.217 -2.142 . . . . 24.0 105.217 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.47 136.04 38.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 19.629999999999999 111.809 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.75 -161.34 0.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.023 0.916 . . . . 17.190000000000001 111.758 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.5 -53.08 1.81 Allowed Glycine 0 N--CA 1.49 2.248 0 CA-C-N 115.781 -0.645 . . . . 16.550000000000001 112.603 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.543 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 17.5 p -77.96 -60.91 2.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.486 -1.597 . . . . 19.550000000000001 110.898 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' H ' ' HG ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -59.42 -55.53 33.55 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.334 -178.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' CYS . 27.5 tp -51.4 -47.54 62.9 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.823 -1.173 . . . . 14.16 108.381 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.49 -56.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.192 -1.41 . . . . 15.31 107.192 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -55.18 -61.75 2.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.959 -1.096 . . . . 29.640000000000001 108.101 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.93 -60.0 2.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.246 -0.909 . . . . 13.960000000000001 109.709 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.9 mt -51.75 -51.59 55.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.441 -1.412 . . . . 17.789999999999999 108.164 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.91 -40.49 73.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 16.84 109.457 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 mt -60.62 -24.61 65.65 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.083 -1.08 . . . . 22.760000000000002 108.083 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -97.3 -64.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.543 -0.723 . . . . 17.440000000000001 109.294 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.6 m -64.24 -76.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 18.539999999999999 109.638 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.87 -138.29 20.59 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.675 -1.37 . . . . 23.170000000000002 109.675 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 8.2 tp10 -48.37 -17.03 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -1.104 . . . . 39.770000000000003 109.167 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' GLY . 50.3 mtt180 -54.88 -52.84 61.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 26.649999999999999 109.255 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.52 65.14 0.48 Allowed Glycine 0 N--CA 1.508 3.478 0 C-N-CA 119.745 -1.217 . . . . 20.260000000000002 111.722 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -76.04 131.23 39.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -1.138 . . . . 17.789999999999999 110.218 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.75 112.47 24.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.66 -0.65 . . . . 18.550000000000001 109.586 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -98.25 156.52 16.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 21.489999999999998 108.561 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.6 p -152.43 120.49 6.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.078 -1.014 . . . . 31.5 109.447 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 30' ' ' THR . 14.3 pttm -152.72 64.65 5.47 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 109.81 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -51.55 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 109.396 -1.04 . . . . 0.0 109.396 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -156.75 -7.19 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 56.49 6.07 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 108.818 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 ttm-85 -170.67 -111.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.422 -0.799 . . . . 0.0 108.868 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -157.04 8.97 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.667 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.26 120.95 2.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 109.75 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -91.21 -89.9 0.17 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -145.39 40.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.233 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.99 -11.95 51.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -66.69 -173.97 0.27 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.217 -0.927 . . . . 0.0 109.533 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 m -95.46 35.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 0.0 109.572 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 42' ' ' VAL . . . -71.6 62.79 1.16 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 52.13 -82.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.895 . . . . 0.0 109.65 -179.579 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 40' ' ' GLY . 1.8 p 33.41 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 121.492 0.663 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 44' ' ' LEU . 34.6 tt0 41.29 81.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.459 -0.775 . . . . 0.0 109.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.614 ' H ' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -39.26 -31.59 0.08 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.27 0.557 . . . . 0.0 110.074 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.55 91.01 1.37 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.42 -173.76 50.97 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.9 -174.96 50.07 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.37 -25.37 56.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.677 1.585 . . . . 0.0 109.803 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -47.44 132.24 15.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.17 -0.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -1.069 . . . . 0.0 109.088 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.98 -175.79 47.93 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t -74.2 -32.46 63.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -1.14 . . . . 0.0 109.316 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -49.53 152.87 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.857 . . . . 0.0 109.226 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -57.51 148.36 55.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 108.645 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.37 124.68 14.22 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 120.875 1.05 . . . . 0.0 109.91 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -53.32 -28.67 29.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.0 109.188 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.51 -63.75 1.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.9 mm? -53.23 -43.2 67.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 108.847 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -49.25 -17.95 0.3 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 64' ' ' LYS . . . -87.27 -65.1 1.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 p -55.76 -13.69 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -1.15 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -73.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' LYS . 6.6 pt20 -93.44 -10.26 35.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 108.692 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 60' ' ' GLY . 22.9 mttt 52.55 174.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' A' ' 65' ' ' ARG . 3.0 mtt-85 -81.46 -27.35 34.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.398 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.3 -137.87 14.52 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.703 -1.359 . . . . 19.620000000000001 109.703 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 tt -45.54 -42.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -1.128 . . . . 17.420000000000002 109.875 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.21 -41.53 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.973 -1.079 . . . . 18.82 109.781 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -78.54 10.9 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 38.5 109.94 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -134.03 -13.82 2.43 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.058 -1.026 . . . . 36.829999999999998 110.837 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.2 m -119.28 -25.53 6.09 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.257 -0.902 . . . . 18.16 109.043 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.12 -37.36 17.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.961 -1.087 . . . . 18.460000000000001 108.483 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -89.36 -9.87 48.77 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -146.77 -144.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.507 -0.923 . . . . 30.34 108.507 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 mt -145.89 122.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.061 -1.024 . . . . 27.510000000000002 109.365 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.9 m -106.24 175.5 5.48 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.625 -0.672 . . . . 23.34 109.541 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 m -112.4 176.49 5.0 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.551 0.691 . . . . 22.640000000000001 109.826 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -48.78 -60.08 3.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.651 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -43.5 -56.03 3.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.332 -0.855 . . . . 37.859999999999999 110.226 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -49.93 -46.47 52.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.727 -1.233 . . . . 31.390000000000001 108.918 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.99 -38.64 89.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.686 -0.857 . . . . 24.48 108.686 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -64.2 -18.92 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.479 -0.763 . . . . 31.48 109.728 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.12 -29.74 63.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 22.48 111.63 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.0 12.17 35.12 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 19.59 111.804 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.8 m -76.59 -175.64 3.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.608 -1.307 . . . . 20.620000000000001 109.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.955 -1.021 . . . . 24.649999999999999 109.343 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.517 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.139 -0.689 . . . . 24.77 109.139 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -168.66 150.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 30.100000000000001 109.696 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.706 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -117.97 106.27 12.76 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.78 -1.192 . . . . 32.240000000000002 107.78 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.3 mm100 -154.42 162.16 41.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.711 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -79.14 101.14 7.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.351 -2.092 . . . . 24.0 105.351 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.21 136.09 39.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.51 -0.744 . . . . 19.629999999999999 111.958 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.54 -162.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.07 0.938 . . . . 17.190000000000001 111.484 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.98 -51.68 1.55 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 115.662 -0.699 . . . . 16.550000000000001 112.774 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 p -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.458 -1.613 . . . . 19.550000000000001 110.792 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -55.2 38.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 7' ' ' CYS . 29.6 tp -51.29 -48.22 62.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.899 -1.125 . . . . 14.16 108.495 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.443 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -48.87 -55.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.204 -1.406 . . . . 15.31 107.204 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -56.06 -61.58 2.28 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.019 -1.104 . . . . 29.640000000000001 108.019 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.52 -59.54 2.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.01 -1.057 . . . . 13.960000000000001 109.679 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -51.53 -53.49 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.457 -1.402 . . . . 17.789999999999999 107.934 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.78 -49.92 61.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.508 -0.745 . . . . 16.84 109.108 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.86 -26.12 9.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.046 -1.034 . . . . 22.760000000000002 108.643 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.95 -64.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.352 -0.843 . . . . 17.440000000000001 109.44 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.9 m -64.32 -77.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 18.539999999999999 109.831 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 78.52 -133.82 13.28 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.773 -1.331 . . . . 23.170000000000002 109.773 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.42 -14.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.399 -1.06 . . . . 39.770000000000003 109.621 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 20' ' ' GLY . 8.8 mtp180 -59.01 -53.02 63.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 26.649999999999999 109.086 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.08 64.36 0.48 Allowed Glycine 0 N--CA 1.506 3.322 0 C-N-CA 119.744 -1.217 . . . . 20.260000000000002 111.531 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 29.8 p90 -75.77 124.35 27.15 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.287 -1.125 . . . . 17.789999999999999 109.848 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -88.68 110.77 21.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.753 . . . . 18.550000000000001 109.638 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -95.03 146.78 24.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.429 -0.795 . . . . 21.489999999999998 108.873 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -150.04 140.67 22.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.092 -1.005 . . . . 31.5 109.467 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' O ' ' OG1' ' A' ' 30' ' ' THR . 32.5 pttt -176.8 70.99 0.24 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.238 -0.913 . . . . 0.0 110.107 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' ARG . 12.9 Cg_exo -50.3 -24.69 12.17 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 28' ' ' LYS . 1.9 m 43.97 15.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.253 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER 45.74 61.66 2.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 109.956 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.494 HH22 ' NH1' ' A' ' 31' ' ' ARG . 31.9 mtm-85 48.35 25.02 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 109.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 51.45 11.89 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 109.903 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . -82.53 -178.66 7.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.129 -0.982 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 50.96 9.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.668 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' H ' ' C ' ' A' ' 34' ' ' ALA . 49.1 t0 -74.6 -74.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' O ' ' CB ' ' A' ' 38' ' ' GLN . 1.9 pt? -58.57 -157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 37' ' ' LEU . 7.5 tt0 76.93 179.0 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.745 . . . . 0.0 109.208 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t 60.9 112.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 109.297 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.93 -108.99 0.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -77.6 99.64 5.83 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.725 -0.868 . . . . 0.0 109.035 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -147.34 -3.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 26.1 tt0 84.3 167.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.5 mp -79.9 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.689 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.47 81.89 1.67 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.3 109.73 0.26 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.01 -175.15 37.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.11 156.1 61.04 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.686 1.59 . . . . 0.0 109.671 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.07 170.35 10.08 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.44 43.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -1.144 . . . . 0.0 109.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 52' ' ' SER . . . 77.45 160.18 12.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 51' ' ' GLY . 7.9 m 55.57 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -1.147 . . . . 0.0 109.763 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.51 154.46 18.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.201 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -102.66 125.74 34.92 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.198 -0.939 . . . . 0.0 108.742 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.09 138.49 67.65 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.845 1.03 . . . . 0.0 109.881 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.1 mt -54.43 -30.93 54.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.472 -0.767 . . . . 0.0 109.398 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.27 -60.5 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.961 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -60.39 -34.65 74.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.579 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 13.6 mm-40 -48.43 -22.97 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 109.689 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -87.1 -75.97 1.27 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 60' ' ' GLY . 4.4 m -38.17 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.874 -0.78 . . . . 0.0 110.988 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -50.75 -51.67 48.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.05 . . . . 0.0 109.062 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -88.3 -18.06 29.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.925 -1.11 . . . . 0.0 109.855 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 66' ' ' GLY . 9.8 mmmt -100.33 109.13 21.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.143 -0.973 . . . . 0.0 109.117 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -64.11 68.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.01 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -64.12 168.5 24.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.458 -1.457 . . . . 19.620000000000001 109.458 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.3 tt -92.31 -41.79 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -1.185 . . . . 17.420000000000002 109.004 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 t -52.3 -32.24 15.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.107 -0.996 . . . . 18.82 109.493 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -83.66 11.01 7.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 38.5 110.021 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 19.0 mt-30 -139.34 -12.89 1.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.051 . . . . 36.829999999999998 110.697 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.7 m -117.23 -30.58 5.57 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.407 -0.808 . . . . 18.16 109.099 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.34 -40.62 16.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 18.460000000000001 108.563 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -85.14 -12.52 52.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.477 -0.765 . . . . 0.0 109.213 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -145.72 -141.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.528 -0.916 . . . . 30.34 108.528 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.68 126.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.174 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.0 m -108.09 177.07 4.92 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.605 -0.685 . . . . 23.34 110.094 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.1 m -112.6 -178.99 3.53 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.49 0.662 . . . . 22.640000000000001 109.448 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -57.36 -56.05 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.779 . . . . 23.280000000000001 109.446 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -47.27 -50.94 20.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.395 -0.815 . . . . 37.859999999999999 110.171 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.96 -45.79 74.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.696 -1.253 . . . . 31.390000000000001 108.749 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.55 -37.72 84.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 24.48 108.643 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.29 -18.8 64.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.456 -0.778 . . . . 31.48 109.766 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -74.14 -29.51 61.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.711 . . . . 22.48 111.539 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -97.51 12.08 34.61 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.106 -0.997 . . . . 19.59 111.762 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 86.1 m -76.57 -175.77 3.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.597 -1.314 . . . . 20.620000000000001 109.207 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.441 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 17.8 t80 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.302 -0.629 . . . . 24.77 109.302 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -165.76 161.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 30.100000000000001 109.376 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.731 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.52 107.88 8.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 32.240000000000002 108.533 179.064 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -156.55 162.75 39.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.511 -0.743 . . . . 30.210000000000001 109.417 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -76.46 100.72 5.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.25 -2.13 . . . . 24.0 105.25 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.21 136.05 39.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.386 -0.822 . . . . 19.629999999999999 111.707 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 m -124.06 -159.04 0.84 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.896 0.855 . . . . 17.190000000000001 112.168 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.49 -51.45 1.37 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.89 -0.506 . . . . 16.550000000000001 112.946 -176.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 m -81.82 -62.07 1.74 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.316 -1.696 . . . . 19.550000000000001 110.941 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -55.58 33.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 110.131 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' VAL . 26.7 tp -50.47 -51.36 47.74 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.782 -1.199 . . . . 14.16 108.369 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -46.66 -54.31 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.561 -1.274 . . . . 15.31 107.561 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.95 -61.85 2.24 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.51 -59.8 2.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.038 -1.039 . . . . 13.960000000000001 109.728 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -51.17 -52.41 44.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.444 -1.41 . . . . 17.789999999999999 108.023 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -53.19 -45.8 68.71 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.1 -0.704 . . . . 16.84 109.1 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.08 -33.91 63.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.897 -1.127 . . . . 22.760000000000002 108.387 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.32 -64.84 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.378 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.9 m -63.18 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.897 . . . . 18.539999999999999 109.229 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.03 -130.55 10.53 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.772 -1.331 . . . . 23.170000000000002 109.772 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -50.22 -19.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 39.770000000000003 109.059 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' ' C ' ' A' ' 20' ' ' GLY . 7.6 mmt180 -55.47 -54.0 49.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 26.649999999999999 109.161 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.33 63.47 0.49 Allowed Glycine 0 N--CA 1.505 3.293 0 C-N-CA 119.958 -1.115 . . . . 20.260000000000002 111.681 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 18.6 p90 -75.97 122.71 24.59 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.04 -1.271 . . . . 17.789999999999999 109.75 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 7.3 p90 -93.5 103.67 15.85 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.292 -1.003 . . . . 18.550000000000001 108.292 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -59.85 154.52 18.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.196 -0.94 . . . . 21.489999999999998 108.639 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 18.1 p -140.63 161.6 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -0.848 . . . . 31.5 109.592 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 27' ' ' THR . 8.4 mmtt 120.06 129.41 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 C-N-CA 124.751 1.22 . . . . 0.0 107.81 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -49.68 -22.57 6.95 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.403 ' N ' ' C ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER 177.56 -85.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -178.56 -55.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 33' ' ' GLU . 28.4 ptt180 -110.45 -20.82 12.45 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' ARG . 35.8 mt-10 54.6 167.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.497 0.665 . . . . 0.0 109.889 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.49 -50.78 6.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' OE2' ' OD1' ' A' ' 36' ' ' ASP . 18.5 tt0 59.11 -132.21 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' OD1' ' OE2' ' A' ' 35' ' ' GLU . 10.5 p-10 -96.52 121.5 38.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.5 mm? -76.35 135.9 39.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 109.149 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' LEU . 5.3 tt0 -63.2 -128.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.65 84.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.777 -1.202 . . . . 0.0 109.839 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.65 178.27 43.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -67.59 -5.75 16.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -1.152 . . . . 0.0 108.588 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.9 m 38.85 -145.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.56 ' OE2' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -56.71 127.58 32.23 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.142 -1.423 . . . . 0.0 107.24 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -42.87 90.07 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.344 -0.847 . . . . 0.0 112.088 -178.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 64.85 70.06 1.18 Allowed Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.998 -1.064 . . . . 0.0 111.612 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 43' ' ' GLU . . . -166.27 -125.25 0.76 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' CD ' ' A' ' 43' ' ' GLU . . . -163.51 129.58 2.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.74 116.32 3.17 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 118.931 1.365 . . . . 0.0 109.892 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.92 -169.09 22.4 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.79 -31.26 69.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.158 . . . . 0.0 109.463 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 46.86 70.31 0.71 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 48.1 m -66.7 -71.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -1.163 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? 43.24 -166.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -86.34 150.94 52.9 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 57' ' ' ALA . 7.4 Cg_endo -65.54 117.83 4.95 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.103 1.202 . . . . 0.0 110.214 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.97 -8.86 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.33 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 55' ' ' PRO . . . -67.26 -76.82 0.08 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 111.269 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.44 -17.08 64.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 110.444 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -47.0 -39.27 12.24 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.949 -1.095 . . . . 0.0 109.555 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.46 -53.24 2.82 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -50.83 -14.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -77.87 -31.43 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.0 109.356 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -104.86 -32.6 8.73 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.395 -0.816 . . . . 0.0 109.688 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -80.58 154.5 27.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.727 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.491 ' H ' ' NZ ' ' A' ' 28' ' ' LYS . 25.2 ptt180 -175.13 27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -177.63 22.46 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.87 -1.292 . . . . 19.620000000000001 109.87 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 ' C ' ' H ' ' A' ' 69' ' ' GLU . 3.4 tt -49.61 -43.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -1.079 . . . . 17.420000000000002 109.353 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.98 -6.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.386 -0.821 . . . . 18.82 109.712 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 67' ' ' ILE . 6.7 tt0 -108.52 9.59 27.4 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 38.5 109.039 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 4.4 mt-30 -137.82 -15.23 1.37 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.236 -0.915 . . . . 36.829999999999998 109.936 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.5 m -114.24 -24.18 9.07 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.479 -0.763 . . . . 18.16 109.273 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 51.6 t -91.48 -43.05 9.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 18.460000000000001 108.551 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -85.16 -21.42 29.21 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.628 0.728 . . . . 0.0 109.12 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -139.38 -136.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.478 -0.934 . . . . 30.34 108.478 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -145.86 147.48 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 27.510000000000002 109.204 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 1.9 m -131.09 174.64 9.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.539 -0.726 . . . . 23.34 109.313 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -112.39 -179.04 3.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.476 -0.765 . . . . 22.640000000000001 109.849 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.0 tp -53.46 -55.49 24.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.707 . . . . 23.280000000000001 109.371 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -46.01 -55.93 6.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 37.859999999999999 109.901 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -50.57 -50.43 53.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.821 -1.175 . . . . 31.390000000000001 108.997 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.38 -41.3 84.5 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.448 -0.783 . . . . 24.48 108.936 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -62.64 -18.76 62.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 31.48 109.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -72.59 -29.74 63.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.423 -0.798 . . . . 22.48 111.742 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -100.62 12.16 37.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 19.59 112.051 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.3 m -76.87 -175.81 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.584 -1.323 . . . . 20.620000000000001 109.188 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.301 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 18.8 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.323 -0.621 . . . . 24.77 109.323 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.5 p -81.05 164.33 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 30.100000000000001 109.89 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.691 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.91 106.65 6.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.007 -1.109 . . . . 32.240000000000002 108.007 179.308 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -156.33 167.42 30.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 30.210000000000001 109.865 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -78.51 101.06 7.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.17 -2.159 . . . . 24.0 105.17 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.4 mt -99.2 136.5 39.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.514 -0.742 . . . . 19.629999999999999 111.903 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.34 -162.89 0.94 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.973 . . . . 17.190000000000001 111.44 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.89 -50.96 1.51 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-N 115.751 -0.659 . . . . 16.550000000000001 112.723 -176.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.4 m -79.17 -62.93 1.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.475 -1.603 . . . . 19.550000000000001 110.686 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.47 -55.45 34.63 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.033 -1.042 . . . . 0.0 110.038 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.416 ' N ' ' O ' ' A' ' 7' ' ' CYS . 30.2 tp -50.7 -50.12 55.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.824 -1.172 . . . . 14.16 108.452 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.83 -56.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.58 -1.267 . . . . 15.31 107.58 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -55.65 -61.57 2.26 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.883 -1.154 . . . . 29.640000000000001 107.883 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.58 -59.61 2.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.03 -1.044 . . . . 13.960000000000001 109.762 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.44 -54.0 31.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.481 -1.387 . . . . 17.789999999999999 107.822 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -50.86 -50.4 57.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.526 -0.733 . . . . 16.84 109.127 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.1 mt -51.01 -26.93 6.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 22.760000000000002 108.6 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.37 -64.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.419 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 m -66.04 -83.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 18.539999999999999 109.982 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.77 -124.56 12.21 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.583 -1.294 . . . . 23.170000000000002 110.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -45.25 -20.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -1.048 . . . . 39.770000000000003 110.076 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 20' ' ' GLY . 84.4 mtt180 -66.75 -53.13 36.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -0.951 . . . . 26.649999999999999 109.807 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.49 64.15 0.49 Allowed Glycine 0 N--CA 1.508 3.457 0 C-N-CA 119.634 -1.27 . . . . 20.260000000000002 111.782 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.1 p90 -75.78 126.69 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.296 . . . . 17.789999999999999 109.808 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 13.6 p90 -96.91 104.37 16.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 18.550000000000001 108.864 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -66.14 163.05 18.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 21.489999999999998 109.171 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -147.06 134.47 20.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 31.5 109.88 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 30' ' ' THR . 20.0 pttm -173.62 65.92 0.32 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.232 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -51.52 -10.03 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.137 1.224 . . . . 0.0 109.314 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.553 ' H ' ' C ' ' A' ' 28' ' ' LYS . 6.0 m -145.01 142.51 29.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.545 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -91.71 -29.15 16.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 34' ' ' ALA . 8.2 tpm_? -161.75 94.67 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.47 39.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.515 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . 55.22 -105.9 0.29 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.346 -0.846 . . . . 0.0 110.311 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 67.52 -21.24 0.12 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.544 -0.723 . . . . 0.0 110.358 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -157.25 -30.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.012 -1.055 . . . . 0.0 109.735 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt 49.72 -119.4 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -87.76 -132.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.21 151.46 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.153 -0.967 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.54 -136.77 4.56 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -73.14 73.49 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -1.105 . . . . 0.0 109.192 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.92 -46.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.403 ' C ' ' H ' ' A' ' 45' ' ' GLY . 11.3 pt-20 -105.27 -20.14 13.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.352 -0.843 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.36 21.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 109.271 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 43' ' ' GLU . . . -155.86 -15.79 0.05 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.84 66.25 2.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.43 -67.43 1.58 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.5 124.29 15.89 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.436 1.424 . . . . 0.0 110.021 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 51' ' ' GLY . . . -79.52 -10.85 85.45 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 69.13 -58.14 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.632 -0.923 . . . . 0.0 109.835 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 151.31 -154.4 25.54 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.6 t -172.63 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -1.124 . . . . 0.0 109.457 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.96 -96.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.703 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.67 152.61 95.0 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.029 . . . . 0.0 108.952 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.24 135.26 57.05 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 120.668 0.912 . . . . 0.0 109.858 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.2 mt -57.66 -17.61 15.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.553 -0.717 . . . . 0.0 110.427 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.531 ' C ' ' H ' ' A' ' 59' ' ' GLU . . . -77.21 -77.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.037 -1.04 . . . . 0.0 110.679 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -73.72 17.36 0.16 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.908 -1.12 . . . . 0.0 109.558 -179.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -68.64 -48.01 65.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -89.11 -24.19 32.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 m -44.41 -14.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -1.188 . . . . 0.0 111.334 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER -99.54 -24.47 14.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.892 -1.13 . . . . 0.0 108.884 178.926 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 60' ' ' GLY . 15.1 mm-40 -107.99 6.02 26.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -43.63 142.01 1.33 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.017 -1.052 . . . . 0.0 110.125 -179.343 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' CG ' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.23 -57.32 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.683 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.81 -145.7 12.55 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.818 -1.313 . . . . 19.620000000000001 109.818 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.7 tt -53.12 -43.22 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 17.420000000000002 109.723 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 t -54.26 -23.98 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.98 -1.075 . . . . 18.82 109.726 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -94.73 10.2 36.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.06 -1.025 . . . . 38.5 109.797 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.1 mt-30 -135.64 -14.26 1.92 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.067 -1.021 . . . . 36.829999999999998 110.391 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.28 -28.48 6.52 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.355 -0.841 . . . . 18.16 109.399 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.96 -38.85 16.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 18.460000000000001 108.656 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.4 t -87.83 -12.39 45.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.798 . . . . 0.0 109.062 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 6.9 t -145.8 -142.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.644 -0.873 . . . . 30.34 108.644 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.619 ' H ' ' HG ' ' A' ' 74' ' ' SER . 11.8 mt -144.83 125.19 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.996 -1.065 . . . . 27.510000000000002 109.481 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -108.72 175.74 5.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.581 -0.7 . . . . 23.34 109.932 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -112.51 176.22 5.11 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.507 0.67 . . . . 22.640000000000001 109.644 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.8 tp -48.21 -60.02 2.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.518 -0.739 . . . . 23.280000000000001 109.506 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -42.03 -58.78 1.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 37.859999999999999 110.404 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 12.1 mp0 -48.62 -46.9 40.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.834 -1.166 . . . . 31.390000000000001 108.992 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.15 -38.81 90.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.704 -0.85 . . . . 24.48 108.704 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.58 -18.66 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.768 . . . . 31.48 109.631 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -74.05 -29.76 62.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.483 -0.76 . . . . 22.48 111.57 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -97.88 11.77 36.26 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.099 -1.001 . . . . 19.59 111.734 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.0 m -76.91 -175.76 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.606 -1.309 . . . . 20.620000000000001 109.111 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 117.967 -1.016 . . . . 24.649999999999999 109.255 179.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.248 -0.649 . . . . 24.77 109.248 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.481 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.5 p -163.28 163.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 30.100000000000001 109.754 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.682 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.2 106.58 7.66 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.204 -1.036 . . . . 32.240000000000002 108.204 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -156.57 164.08 38.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.226 -0.921 . . . . 30.210000000000001 109.382 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -77.46 101.17 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.154 -2.165 . . . . 24.0 105.154 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.38 132.21 44.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.875 . . . . 19.629999999999999 111.922 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.54 -158.53 0.74 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.163 -0.961 . . . . 17.190000000000001 111.697 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.26 -54.56 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 115.826 -0.625 . . . . 16.550000000000001 113.201 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -79.04 -63.25 1.46 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.273 -1.722 . . . . 19.550000000000001 111.085 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -55.81 28.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 110.371 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 ' O ' ' C ' ' A' ' 12' ' ' VAL . 35.1 tp -50.42 -52.15 40.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.709 -1.244 . . . . 14.16 108.554 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.8 t -45.83 -55.83 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.71 -1.218 . . . . 15.31 107.71 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -56.46 -61.43 2.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.868 -1.16 . . . . 29.640000000000001 107.868 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.3 -59.73 2.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.011 . . . . 13.960000000000001 109.882 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.8 mt -52.16 -53.84 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.315 -1.491 . . . . 17.789999999999999 107.888 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -50.7 -47.41 58.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.009 -0.737 . . . . 16.84 109.009 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.48 -26.77 33.34 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.011 -1.056 . . . . 22.760000000000002 108.348 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LEU . 2.7 t -96.21 -64.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.887 . . . . 17.440000000000001 109.393 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' N ' ' O ' ' A' ' 15' ' ' LEU . 7.2 m -65.37 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.902 . . . . 18.539999999999999 110.036 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.37 -123.36 16.82 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.496 -1.335 . . . . 23.170000000000002 109.883 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.535 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.3 pm0 -44.9 -18.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.463 -1.022 . . . . 39.770000000000003 110.587 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 20' ' ' GLY . 26.1 mtt-85 -70.72 -52.67 19.41 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.936 -1.103 . . . . 26.649999999999999 110.159 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.22 64.34 0.5 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 119.611 -1.281 . . . . 20.260000000000002 111.529 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -75.3 134.96 40.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -1.209 . . . . 17.789999999999999 109.426 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 10.5 p90 -100.83 107.54 19.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 18.550000000000001 110.412 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -88.59 145.93 25.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.415 -0.803 . . . . 21.489999999999998 108.967 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -148.27 103.62 3.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.935 -1.103 . . . . 31.5 110.456 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -165.63 66.18 1.07 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' O ' ' OG1' ' A' ' 30' ' ' THR . 5.6 Cg_exo -59.88 105.14 0.26 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.473 1.449 . . . . 0.0 110.047 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 27.0 m -165.99 117.3 1.04 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 33' ' ' GLU . 9.8 tpp180 -95.75 113.95 25.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 32' ' ' ARG . 4.2 mtt-85 48.82 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.321 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.518 ' H ' ' C ' ' A' ' 31' ' ' ARG . 14.7 pt-20 36.33 33.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.763 -0.585 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -128.39 104.27 7.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.456 -0.778 . . . . 0.0 109.414 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -157.78 -55.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.812 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.39 36.52 1.15 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.315 -0.866 . . . . 0.0 110.042 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' A' ' 37' ' ' LEU . 3.8 mm? -82.04 -14.97 55.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 109.068 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -83.79 169.96 14.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.246 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLY . 16.2 t -138.07 -15.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.508 -0.745 . . . . 0.0 109.708 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . 50.82 -179.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -1.212 . . . . 0.0 108.848 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' CG2' ' N ' ' A' ' 43' ' ' GLU . 13.1 m -146.42 -47.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.117 -0.989 . . . . 0.0 109.521 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 29.9 tt0 -173.44 152.08 2.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.16 29.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.822 . . . . 0.0 108.912 179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.19 -54.13 0.31 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.73 -102.73 0.16 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.073 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 49' ' ' GLY . . . -157.77 79.56 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.43 4.9 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.368 1.379 . . . . 0.0 110.133 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 47' ' ' GLY . . . -71.83 118.74 7.17 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 52' ' ' SER . . . -78.05 -17.19 57.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -1.141 . . . . 0.0 109.675 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' LEU . . . 79.1 -33.39 1.97 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 50' ' ' ALA . 8.0 t 57.12 3.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -1.115 . . . . 0.0 109.792 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' GLY . 39.9 mt -60.52 169.51 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 109.213 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -68.06 148.42 98.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.707 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.71 127.64 20.2 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.768 0.978 . . . . 0.0 109.623 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -56.1 -23.66 35.52 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.394 -0.817 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.61 9.06 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.959 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.7 mm? -64.9 -37.19 86.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.226 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -47.48 -35.35 8.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.5 -32.96 36.28 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -87.42 -7.68 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 109.242 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 58' ' ' LEU . 1.6 tt -74.02 -67.48 0.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.88 -29.18 14.34 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.196 -0.94 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp 54.68 38.29 29.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.576 -0.702 . . . . 0.0 110.381 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.4 -68.03 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.862 -1.149 . . . . 0.0 108.192 179.138 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . 98.46 -72.89 0.58 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.395 -0.907 . . . . 19.620000000000001 111.807 177.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 3.6 tt -42.84 -52.48 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.535 -0.979 . . . . 17.420000000000002 112.163 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.485 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 15.4 t -57.97 -7.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.626 -1.296 . . . . 18.82 109.603 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 67' ' ' ILE . 20.5 tp10 -113.02 9.26 18.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.144 -0.687 . . . . 38.5 109.144 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.9 mt-30 -138.88 -8.67 1.38 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 36.829999999999998 109.533 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.55 -31.9 4.46 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.6 -0.889 . . . . 18.16 108.6 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.06 -43.1 18.33 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 18.460000000000001 108.323 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 t -82.2 -21.79 36.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -136.81 -137.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.496 -0.928 . . . . 30.34 108.496 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.52 150.03 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.993 . . . . 27.510000000000002 109.294 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.4 m -135.14 176.65 8.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.388 -0.82 . . . . 23.34 109.956 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -112.37 -163.91 0.88 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.671 -0.643 . . . . 22.640000000000001 109.48 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.7 tp -67.83 -60.75 2.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -0.755 . . . . 23.280000000000001 109.547 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -41.5 -57.38 2.24 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.574 -0.703 . . . . 37.859999999999999 110.522 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.71 -47.22 41.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.786 -1.196 . . . . 31.390000000000001 108.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.2 -38.18 88.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.291 -0.881 . . . . 24.48 108.987 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -18.79 64.84 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.504 -0.747 . . . . 31.48 109.75 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.32 -30.38 63.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 22.48 111.758 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.05 11.96 35.88 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.026 -1.046 . . . . 19.59 111.891 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.3 m -76.74 -175.62 3.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.682 -1.261 . . . . 20.620000000000001 109.096 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.984 -1.008 . . . . 24.649999999999999 109.403 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.156 -0.683 . . . . 24.77 109.156 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.7 p -165.57 159.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 30.100000000000001 109.326 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.734 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.23 107.76 9.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.583 -0.895 . . . . 32.240000000000002 108.583 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -156.73 163.04 39.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.557 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -77.18 100.83 5.93 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.164 -2.162 . . . . 24.0 105.164 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.44 134.68 41.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.784 . . . . 19.629999999999999 111.731 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.5 -159.63 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.802 0.81 . . . . 17.190000000000001 112.103 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -35.92 -53.15 1.18 Allowed Glycine 0 N--CA 1.493 2.48 0 O-C-N 121.858 -0.526 . . . . 16.550000000000001 113.233 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 m -80.37 -62.25 1.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.385 -1.656 . . . . 19.550000000000001 110.932 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -57.58 -55.4 35.3 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.911 -1.118 . . . . 0.0 110.276 -178.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 12' ' ' VAL . 29.7 tp -50.89 -50.49 57.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.813 -1.179 . . . . 14.16 108.619 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.2 -57.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.459 -1.312 . . . . 15.31 107.459 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -55.56 -61.43 2.35 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.903 -1.147 . . . . 29.640000000000001 107.903 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -59.56 2.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.022 -1.049 . . . . 13.960000000000001 110.045 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.43 -55.0 21.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.342 -1.474 . . . . 17.789999999999999 107.703 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -49.33 -51.17 36.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.025 -0.732 . . . . 16.84 109.025 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.6 -26.87 5.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.063 -1.023 . . . . 22.760000000000002 108.62 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.81 -64.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.247 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -64.61 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 18.539999999999999 109.825 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 66.8 -120.12 13.65 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.632 -1.27 . . . . 23.170000000000002 110.12 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -48.74 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -1.071 . . . . 39.770000000000003 110.04 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -78.31 -52.76 8.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.888 -1.133 . . . . 26.649999999999999 109.646 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.76 63.36 0.48 Allowed Glycine 0 N--CA 1.508 3.46 0 C-N-CA 119.939 -1.124 . . . . 20.260000000000002 111.64 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -76.28 131.18 39.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.955 -1.32 . . . . 17.789999999999999 109.975 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -96.87 106.96 19.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.522 -0.736 . . . . 18.550000000000001 109.793 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -96.85 140.75 30.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 21.489999999999998 109.512 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.689 ' HG1' ' HE ' ' A' ' 65' ' ' ARG . 73.7 p -150.47 104.08 3.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.659 -0.867 . . . . 31.5 108.659 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' C ' ' H ' ' A' ' 30' ' ' THR . 11.0 ptpt -100.79 109.25 57.25 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.346 -0.846 . . . . 0.0 109.83 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.7 Cg_exo -60.02 -11.1 14.24 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 2.9 p 62.52 132.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.325 0.583 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.492 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.8 mtt-85 -77.91 85.43 4.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.853 . . . . 0.0 109.863 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' C ' ' H ' ' A' ' 34' ' ' ALA . 11.2 tpp180 54.88 103.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.596 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.31 37.94 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.362 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . -158.35 84.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.333 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.9 pm0 -96.9 -173.13 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.289 -0.882 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.4 t0 58.17 36.89 26.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.6 mt -83.13 -124.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.42 164.88 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.958 . . . . 0.0 109.255 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.3 m -151.49 127.78 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.854 . . . . 0.0 109.499 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.73 -148.84 11.51 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 3.6 pp0? -78.33 117.23 19.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -1.23 . . . . 0.0 109.22 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.19 15.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 108.547 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 68.55 162.54 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.563 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.1 mp -81.68 11.91 4.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.588 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.03 71.98 0.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.2 -71.01 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.35 1.26 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.5 -160.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.49 1.46 . . . . 0.0 110.071 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -157.46 16.49 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.2 9.79 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 49.17 -129.03 23.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 m 52.81 -87.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.067 . . . . 0.0 109.703 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 51' ' ' GLY . 0.1 OUTLIER -67.95 -177.1 0.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.129 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 16.6 mp0 -77.88 148.55 75.85 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 57' ' ' ALA . 2.6 Cg_endo -57.79 126.15 20.88 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 121.002 1.135 . . . . 0.0 109.944 179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.9 mt -55.97 -11.58 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 55' ' ' PRO . . . -68.7 -79.03 0.06 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 111.076 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -59.29 -26.71 65.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 0.0 109.806 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -45.21 -41.09 7.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.003 -1.061 . . . . 0.0 109.647 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.03 -41.22 61.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 p -83.8 -7.17 59.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -1.094 . . . . 0.0 109.869 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' LEU . 3.3 tt -71.72 -57.27 4.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 109.598 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.76 -19.19 16.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.291 -0.881 . . . . 0.0 109.85 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 10.86 99.56 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.739 0 CA-C-O 121.559 0.695 . . . . 0.0 112.104 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.689 ' HE ' ' HG1' ' A' ' 27' ' ' THR . 6.9 ttm-85 -46.85 -75.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.35 -91.14 0.13 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.624 -1.274 . . . . 19.620000000000001 111.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 4.0 tt -49.37 -50.12 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 17.420000000000002 111.675 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 9.9 t -57.17 -7.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.646 -1.284 . . . . 18.82 109.97 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 67' ' ' ILE . 64.3 mm-40 -110.99 9.65 22.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.175 -0.953 . . . . 38.5 109.403 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.1 mt-30 -138.38 -8.93 1.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.402 -0.811 . . . . 36.829999999999998 109.876 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.4 m -120.25 -23.54 6.2 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.439 -0.788 . . . . 18.16 109.065 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 41.3 t -91.21 -41.84 10.76 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.203 -1.036 . . . . 18.460000000000001 108.203 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -85.19 -27.64 25.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -129.66 -138.21 0.22 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.511 -0.922 . . . . 30.34 108.511 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.25 149.61 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.003 . . . . 27.510000000000002 109.258 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -133.97 171.81 13.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.429 -0.794 . . . . 23.34 109.766 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -106.88 -153.93 0.51 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.493 -0.754 . . . . 22.640000000000001 109.479 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -77.78 -59.94 2.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.922 . . . . 23.280000000000001 109.014 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -42.21 -55.99 3.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.674 -0.641 . . . . 37.859999999999999 110.309 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -48.74 -47.15 41.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.932 -1.105 . . . . 31.390000000000001 109.005 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mp -63.13 -39.42 94.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 24.48 108.942 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.64 -19.0 61.78 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.399 -0.813 . . . . 31.48 109.878 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.43 -29.68 61.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 22.48 111.568 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -97.94 11.78 36.32 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.147 -0.971 . . . . 19.59 111.73 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.7 m -77.05 -175.71 3.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.641 -1.287 . . . . 20.620000000000001 109.196 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 118.029 -0.986 . . . . 24.649999999999999 109.368 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.423 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.3 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.198 -0.667 . . . . 24.77 109.198 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.4 p -166.49 164.0 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.997 . . . . 30.100000000000001 109.461 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.692 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.78 106.98 7.17 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.252 -1.018 . . . . 32.240000000000002 108.252 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -157.34 165.09 36.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 30.210000000000001 110.08 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -77.28 100.61 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.161 -2.163 . . . . 24.0 105.161 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.36 134.94 41.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 19.629999999999999 111.799 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.33 -162.44 0.89 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.152 -0.968 . . . . 17.190000000000001 111.636 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.458 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.51 -52.2 1.38 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 115.761 -0.654 . . . . 16.550000000000001 112.864 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -78.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.648 . . . . 19.550000000000001 110.669 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -55.47 33.28 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.106 -0.997 . . . . 0.0 110.136 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' CYS . 34.7 tp -51.09 -50.29 59.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.865 -1.147 . . . . 14.16 108.744 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.9 t -47.89 -55.87 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.65 -1.241 . . . . 15.31 107.65 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.09 -61.69 2.21 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.969 -1.123 . . . . 29.640000000000001 107.969 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.37 -59.32 2.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.975 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.88 -55.38 20.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.328 -1.482 . . . . 17.789999999999999 107.77 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -49.53 -48.94 47.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.255 -0.646 . . . . 16.84 109.255 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.4 mt -52.96 -25.88 13.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.984 -1.073 . . . . 22.760000000000002 108.587 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.92 -64.61 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 17.440000000000001 109.435 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -64.24 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 18.539999999999999 109.606 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 22' ' ' ARG . . . 77.01 -133.14 12.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.718 -1.353 . . . . 23.170000000000002 109.718 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -49.45 -11.29 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -1.111 . . . . 39.770000000000003 109.594 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -63.7 -53.05 57.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 26.649999999999999 108.778 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.93 63.58 0.48 Allowed Glycine 0 N--CA 1.506 3.363 0 C-N-CA 119.941 -1.124 . . . . 20.260000000000002 111.562 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.0 p90 -76.12 123.17 25.4 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.166 -1.197 . . . . 17.789999999999999 109.935 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 9.1 p90 -92.74 107.0 18.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.845 . . . . 18.550000000000001 109.079 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.48 162.48 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 21.489999999999998 109.486 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -154.05 151.61 29.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 31.5 109.681 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 30' ' ' THR . 12.1 pttm -173.14 65.56 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -50.95 92.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.154 1.236 . . . . 0.0 110.007 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 28' ' ' LYS . 4.3 m -162.37 81.27 0.53 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.48 0.657 . . . . 0.0 109.266 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 31' ' ' ARG . 26.8 mtm-85 -83.08 -43.12 16.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.803 . . . . 0.0 109.603 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.1 OUTLIER -67.38 99.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.585 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -153.65 110.52 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . -166.15 153.15 9.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.413 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -39.76 166.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.522 0.677 . . . . 0.0 111.076 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' OD2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 78.99 23.07 0.58 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.554 0.692 . . . . 0.0 109.332 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 39' ' ' VAL . 2.3 mm? -67.73 152.1 46.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.003 -1.061 . . . . 0.0 108.399 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 52.43 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.533 -0.729 . . . . 0.0 109.677 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 37' ' ' LEU . 38.5 t -48.7 115.83 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . 170.19 135.57 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER 21.49 74.38 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.224 0.535 . . . . 0.0 112.005 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 p -153.64 150.12 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.07 -1.019 . . . . 0.0 109.372 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.01 134.34 21.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.59 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -47.74 -58.2 4.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.85 33.56 0.73 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 44' ' ' LEU . . . 51.29 -163.07 1.24 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -67.19 0.23 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.68 -48.52 16.59 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.403 1.402 . . . . 0.0 109.851 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 163.7 157.0 9.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.02 -23.81 59.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -1.211 . . . . 0.0 109.587 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.7 -175.52 50.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.555 ' HG ' ' N ' ' A' ' 53' ' ' LEU . 25.1 p -160.67 -32.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.394 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.555 ' N ' ' HG ' ' A' ' 52' ' ' SER . 0.3 OUTLIER -92.03 177.86 6.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.336 -0.853 . . . . 0.0 109.124 179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -52.9 149.11 12.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.288 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.62 137.63 74.74 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.92 1.08 . . . . 0.0 109.86 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.4 mt -54.2 -35.11 62.03 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.398 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 -61.17 2.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 109.713 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.8 mm? -56.46 -43.95 80.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 109.163 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.8 -14.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.81 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . -84.4 -57.78 2.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 t -73.74 -7.99 54.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.274 -1.133 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 tt -70.65 -57.21 4.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.164 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 65' ' ' ARG . 4.8 pt20 -90.62 -26.71 19.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 30.46 31.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.129 0.49 . . . . 0.0 111.468 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 63' ' ' GLN . 50.5 ttt180 -174.37 57.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.47 154.47 22.07 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.742 -1.343 . . . . 19.620000000000001 109.742 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.9 tt -103.99 -40.18 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.534 -0.98 . . . . 17.420000000000002 109.157 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 t -52.09 -46.48 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.099 -1.001 . . . . 18.82 109.56 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.36 10.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 38.5 109.768 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.5 mt-30 -135.76 -10.56 2.08 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.127 -0.983 . . . . 36.829999999999998 110.843 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.5 m -123.84 -25.98 4.18 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.297 -0.877 . . . . 18.16 108.766 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.67 -39.68 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.299 -1.0 . . . . 18.460000000000001 108.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -88.03 -16.2 34.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 11.3 t -138.59 -142.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.461 -0.94 . . . . 30.34 108.461 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.447 ' H ' ' HG ' ' A' ' 74' ' ' SER . 13.0 mt -144.91 142.0 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.15 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -129.07 173.58 10.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 23.34 109.631 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -112.17 -165.85 1.03 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.556 -0.715 . . . . 22.640000000000001 109.836 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.6 tp -64.26 -58.11 7.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 23.280000000000001 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -44.0 -58.19 2.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.813 . . . . 37.859999999999999 110.203 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -47.88 -47.64 31.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.147 . . . . 31.390000000000001 109.186 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.23 -40.03 94.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.02 -0.733 . . . . 24.48 109.02 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.98 -18.97 62.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 31.48 109.747 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -74.46 -29.87 61.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 22.48 111.48 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -97.16 11.79 35.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.114 -0.991 . . . . 19.59 111.796 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.6 m -77.38 -175.68 3.84 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.611 -1.305 . . . . 20.620000000000001 109.258 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 36.5 t-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.004 -0.998 . . . . 24.649999999999999 109.221 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 13.2 t80 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 24.77 109.237 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.1 p -164.78 163.87 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 30.100000000000001 109.492 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.673 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.99 106.94 8.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.455 -0.943 . . . . 32.240000000000002 108.455 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -157.59 163.01 38.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 30.210000000000001 109.686 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -77.45 100.78 6.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.125 -2.176 . . . . 24.0 105.125 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -97.68 132.93 42.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 19.629999999999999 111.996 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.67 -162.1 0.86 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.904 0.859 . . . . 17.190000000000001 111.427 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.14 -50.97 1.63 Allowed Glycine 0 N--CA 1.491 2.354 0 CA-C-N 115.957 -0.565 . . . . 16.550000000000001 112.888 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 p -79.38 -63.38 1.43 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.4 -1.647 . . . . 19.550000000000001 110.872 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -55.09 39.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 110.073 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 12' ' ' VAL . 29.0 tp -50.6 -49.77 55.67 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.728 -1.233 . . . . 14.16 108.429 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -48.24 -56.2 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.393 -1.336 . . . . 15.31 107.393 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -55.79 -61.46 2.35 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.843 -1.143 . . . . 29.640000000000001 108.036 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.98 2.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 13.960000000000001 109.662 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -51.22 -50.25 59.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.565 -1.334 . . . . 17.789999999999999 108.026 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -56.06 -41.99 75.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 16.84 109.211 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.79 -28.19 65.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.785 -1.197 . . . . 22.760000000000002 107.961 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.83 -64.66 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.547 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.5 m -64.6 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 18.539999999999999 109.801 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 76.51 -134.18 15.02 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.756 -1.338 . . . . 23.170000000000002 109.756 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -48.26 -11.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.415 -1.05 . . . . 39.770000000000003 109.8 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' GLY . 51.7 mtt180 -65.33 -52.52 53.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.058 . . . . 26.649999999999999 108.95 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.37 0.49 Allowed Glycine 0 N--CA 1.506 3.325 0 C-N-CA 119.786 -1.197 . . . . 20.260000000000002 111.663 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.0 p90 -76.11 123.41 25.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 109.896 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 19.2 p90 -91.38 106.89 18.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.396 -0.815 . . . . 18.550000000000001 109.015 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -75.75 145.0 41.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 21.489999999999998 109.415 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.4 p -155.71 159.41 39.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 31.5 109.5 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' HZ2' ' CG ' ' A' ' 31' ' ' ARG . 12.0 pttp -158.96 109.3 1.58 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.165 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' THR . 4.7 Cg_exo -56.95 -21.31 40.61 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.66 0.907 . . . . 0.0 109.931 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.661 ' HG1' ' N ' ' A' ' 31' ' ' ARG . 25.0 p -61.4 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.5 -0.75 . . . . 0.0 109.777 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.661 ' N ' ' HG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER 74.32 -72.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.015 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -95.39 95.42 8.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -0.799 . . . . 0.0 108.971 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.31 41.14 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.32 74.77 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 12.9 mp0 -81.05 -43.69 19.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.618 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -170.24 45.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.523 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt -72.15 109.0 5.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.262 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.56 133.62 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.316 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 m -61.94 97.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . -176.69 104.86 0.19 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 40' ' ' GLY . 3.2 pp0? 25.42 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.73 0.776 . . . . 0.0 111.772 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' GLY . 13.4 m -143.7 -22.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.04 -1.038 . . . . 0.0 109.334 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.5 pt-20 -85.15 -9.49 57.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 10.4 mp -47.51 98.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.99 . . . . 0.0 109.507 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 87.96 -50.67 3.96 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -171.0 -178.37 41.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 46' ' ' GLY . . . -50.96 179.18 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.35 -52.91 5.45 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.439 1.426 . . . . 0.0 109.869 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.11 85.4 0.69 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.67 36.06 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -1.12 . . . . 0.0 109.41 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.18 -125.63 0.78 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -161.4 13.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -1.172 . . . . 0.0 109.489 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.59 178.67 6.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.0 109.177 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' OE1' ' OE2' ' A' ' 59' ' ' GLU . 50.8 mt-30 -80.99 152.91 72.11 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 57' ' ' ALA . 2.1 Cg_endo -58.72 126.15 20.37 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.004 1.136 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 mt -54.13 -10.0 0.32 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.542 -0.723 . . . . 0.0 109.675 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 55' ' ' PRO . . . -71.69 -78.32 0.08 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.953 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -63.05 -20.44 65.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.923 -1.111 . . . . 0.0 109.82 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' OE2' ' OE1' ' A' ' 54' ' ' GLN . 16.1 mm-40 -45.67 -33.57 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.134 -0.979 . . . . 0.0 109.097 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 64' ' ' LYS . . . -84.43 -54.65 2.92 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -48.97 -28.57 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -1.103 . . . . 0.0 109.728 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mp -48.97 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.051 -1.03 . . . . 0.0 108.247 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 64' ' ' LYS . 19.6 mt-30 -96.25 5.97 49.82 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 54.25 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.405 0.622 . . . . 0.0 109.861 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -136.23 -22.39 1.35 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.315 -0.866 . . . . 0.0 109.223 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.75 17.89 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.682 -1.367 . . . . 19.620000000000001 109.682 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 tt -100.56 -42.1 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -1.048 . . . . 17.420000000000002 109.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.6 t -48.77 -49.76 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.202 -0.936 . . . . 18.82 109.822 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -69.77 10.65 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 38.5 110.221 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.525 HE22 ' CG ' ' A' ' 64' ' ' LYS . 30.4 mt-30 -132.75 -16.53 2.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.215 -0.928 . . . . 36.829999999999998 110.781 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.0 m -119.35 -25.09 6.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.42 -0.8 . . . . 18.16 108.965 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.2 t -85.92 -37.85 18.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 18.460000000000001 108.676 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -90.37 -8.91 49.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 108.857 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -148.42 -145.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.624 -0.88 . . . . 30.34 108.624 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 mt -143.76 123.13 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.17 -0.956 . . . . 27.510000000000002 109.132 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.3 m -104.15 177.87 4.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.535 -0.728 . . . . 23.34 109.531 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 m -112.11 176.72 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.522 -0.737 . . . . 22.640000000000001 109.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -51.01 -59.64 3.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 23.280000000000001 109.495 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -43.68 -55.0 4.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.438 -0.789 . . . . 37.859999999999999 110.163 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -49.48 -48.16 47.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.723 -1.236 . . . . 31.390000000000001 108.907 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.58 -38.65 88.32 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 24.48 108.967 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.98 -18.98 64.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.394 -0.816 . . . . 31.48 109.827 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -73.95 -29.4 61.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 22.48 111.522 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.83 11.72 36.33 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.133 -0.979 . . . . 19.59 111.693 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.71 -175.83 3.57 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.567 -1.333 . . . . 20.620000000000001 109.271 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 118.082 -0.961 . . . . 24.649999999999999 109.495 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 21.8 t80 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.322 -0.621 . . . . 24.77 109.322 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.503 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.4 p -77.11 163.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.27 -0.894 . . . . 30.100000000000001 110.107 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.687 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -135.03 107.8 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.13 -1.063 . . . . 32.240000000000002 108.13 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -156.82 166.95 31.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 30.210000000000001 109.657 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -77.34 100.66 6.0 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.025 -2.213 . . . . 24.0 105.025 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' CYS . 14.2 mt -99.15 134.55 41.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.527 -0.733 . . . . 19.629999999999999 111.683 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 m -122.63 -157.36 0.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.951 0.881 . . . . 17.190000000000001 112.473 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -54.35 1.38 Allowed Glycine 0 N--CA 1.493 2.496 0 CA-C-N 116.042 -0.526 . . . . 16.550000000000001 113.012 -176.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -80.45 -60.38 2.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.47 -1.606 . . . . 19.550000000000001 111.04 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -55.63 32.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 110.474 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.5 tp -51.78 -47.03 64.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.68 -1.263 . . . . 14.16 108.42 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -49.72 -57.13 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.237 -1.394 . . . . 15.31 107.237 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -55.69 -61.34 2.43 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.009 -1.077 . . . . 29.640000000000001 108.276 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -44.87 -59.62 2.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.087 -1.008 . . . . 13.960000000000001 109.747 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.73 -51.46 55.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.94 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -54.16 -43.56 70.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.466 -0.771 . . . . 16.84 109.113 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.61 -28.88 61.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.926 -1.109 . . . . 22.760000000000002 108.238 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.03 -64.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 17.440000000000001 109.493 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.3 m -64.21 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 18.539999999999999 109.856 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 73.09 -129.81 13.13 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.635 -1.269 . . . . 23.170000000000002 110.034 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.54 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.3 pm0 -46.54 -13.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 110.018 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' GLY . 60.7 mtt180 -68.06 -52.89 30.11 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.088 -1.008 . . . . 26.649999999999999 109.522 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.9 64.15 0.48 Allowed Glycine 0 N--CA 1.508 3.442 0 C-N-CA 119.717 -1.23 . . . . 20.260000000000002 111.698 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.1 p90 -76.34 131.62 39.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -1.197 . . . . 17.789999999999999 110.039 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 28.2 p90 -98.09 109.42 22.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 18.550000000000001 109.133 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.32 165.34 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 21.489999999999998 109.213 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -154.43 130.28 10.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.082 -1.011 . . . . 31.5 109.851 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -169.38 49.54 0.15 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.442 -0.786 . . . . 0.0 110.288 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 11.9 Cg_exo -43.13 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.582 1.521 . . . . 0.0 110.218 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.448 ' N ' ' O ' ' A' ' 28' ' ' LYS . 6.4 t -139.78 96.79 3.13 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -93.65 -76.39 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.672 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.597 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.1 OUTLIER -107.66 74.93 0.98 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.0 109.298 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.57 32.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.277 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.35 17.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.118 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -122.84 2.94 9.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.594 -0.691 . . . . 0.0 109.548 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 38' ' ' GLN . 32.3 t70 -152.0 4.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 39' ' ' VAL . 4.3 mp -56.07 -4.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.076 -1.015 . . . . 0.0 108.911 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.542 ' H ' ' C ' ' A' ' 36' ' ' ASP . 11.2 mm100 -62.4 1.56 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.219 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' H ' ' C ' ' A' ' 37' ' ' LEU . 10.1 p -44.06 126.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . -158.82 141.56 7.7 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLY . 1.2 tt0 57.39 107.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.404 -1.057 . . . . 0.0 109.056 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -145.33 -15.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.1 -1.0 . . . . 0.0 108.946 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 47' ' ' GLY . 6.1 tt0 -172.85 -166.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.515 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 7.8 mp -90.89 16.6 9.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 109.195 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.76 -31.9 1.21 Allowed Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -87.59 -134.88 4.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 43' ' ' GLU . . . 153.17 176.93 26.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.19 -59.84 0.62 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.493 1.462 . . . . 0.0 109.633 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.51 52.38 9.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.37 -5.22 6.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.379 -1.071 . . . . 0.0 109.2 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 26.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 53' ' ' LEU . 59.1 m -60.47 -67.74 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -1.14 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.9 mm? 43.72 -166.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.65 148.82 96.53 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.429 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.28 126.79 16.96 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.577 -0.971 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -58.51 -17.84 24.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.1 -73.19 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 58' ' ' LEU . 2.7 mm? -57.01 -30.21 63.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -43.75 -29.04 0.48 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.268 -0.895 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -84.32 -51.9 3.76 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -40.73 -20.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.743 -0.857 . . . . 0.0 111.074 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 60' ' ' GLY . 23.8 mt -75.71 -29.03 58.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.145 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -96.19 -21.13 18.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.023 -1.048 . . . . 0.0 110.632 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.38 163.98 12.83 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.924 -1.11 . . . . 0.0 109.209 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 65.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.29 128.72 10.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.95 -1.26 . . . . 19.620000000000001 109.95 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.32 -39.13 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -1.052 . . . . 17.420000000000002 108.946 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.0 t -50.85 -48.83 28.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 18.82 109.411 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.16 10.46 0.15 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.2 -0.937 . . . . 38.5 110.721 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.0 mt-30 -137.79 -14.21 1.43 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.921 -1.112 . . . . 36.829999999999998 111.005 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.1 m -120.82 -21.62 6.54 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.934 . . . . 18.16 109.108 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.7 t -90.82 -39.85 12.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.101 -1.074 . . . . 18.460000000000001 108.101 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -88.39 -18.77 27.68 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -140.12 -144.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.351 -0.981 . . . . 30.34 108.351 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.65 151.27 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.111 -0.993 . . . . 27.510000000000002 109.031 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -135.55 172.29 13.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.475 -0.765 . . . . 23.34 109.68 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 m -111.63 -176.47 2.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.519 -0.738 . . . . 22.640000000000001 110.076 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.2 tp -55.48 -57.33 12.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.46 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -44.0 -50.57 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 37.859999999999999 110.027 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -57.06 -53.26 60.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.981 -1.074 . . . . 31.390000000000001 108.814 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.5 mp -55.51 -39.63 70.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.777 -0.823 . . . . 24.48 108.777 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.98 -18.71 65.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.528 -0.733 . . . . 31.48 109.944 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.95 -28.44 61.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 22.48 111.568 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -101.0 12.08 38.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.252 -0.905 . . . . 19.59 111.991 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.1 m -76.75 -175.62 3.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.614 -1.304 . . . . 20.620000000000001 109.134 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 118.037 -0.982 . . . . 24.649999999999999 109.446 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.502 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 11.3 t80 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.187 -0.671 . . . . 24.77 109.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.6 p -139.46 159.87 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.238 -0.914 . . . . 30.100000000000001 109.229 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.731 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.65 108.11 9.95 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.736 -0.839 . . . . 32.240000000000002 108.736 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -156.64 163.66 39.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 30.210000000000001 109.5 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -76.18 100.73 5.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.246 -2.131 . . . . 24.0 105.246 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.0 134.63 41.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 19.629999999999999 111.738 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.49 -161.46 0.89 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.093 -1.005 . . . . 17.190000000000001 111.806 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.22 -47.37 1.44 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.703 -0.68 . . . . 16.550000000000001 112.77 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -82.94 -62.46 1.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.349 -1.677 . . . . 19.550000000000001 110.734 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -55.49 34.5 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.006 -1.059 . . . . 0.0 109.993 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 12' ' ' VAL . 29.8 tp -49.97 -50.92 45.15 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.698 -1.251 . . . . 14.16 108.269 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.05 -54.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.453 -1.314 . . . . 15.31 107.453 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.17 -61.71 2.28 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.949 -1.1 . . . . 29.640000000000001 108.257 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.34 -59.87 2.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.118 -0.989 . . . . 13.960000000000001 109.518 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.5 mt -51.05 -49.14 61.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.585 -1.322 . . . . 17.789999999999999 108.102 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.51 -40.72 79.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 16.84 109.011 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.63 -29.54 68.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.915 -1.116 . . . . 22.760000000000002 108.086 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -92.28 -64.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.479 -0.763 . . . . 17.440000000000001 109.555 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' N ' ' O ' ' A' ' 15' ' ' LEU . 7.8 m -64.34 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 18.539999999999999 109.685 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 22' ' ' ARG . . . 70.59 -122.96 11.02 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.617 -1.277 . . . . 23.170000000000002 110.077 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -50.64 -11.7 0.09 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -1.055 . . . . 39.770000000000003 110.386 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' GLY . 31.1 mtt-85 -73.32 -52.09 15.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.871 -1.143 . . . . 26.649999999999999 109.668 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.03 64.31 0.48 Allowed Glycine 0 N--CA 1.508 3.467 0 C-N-CA 119.756 -1.211 . . . . 20.260000000000002 111.685 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -75.08 135.6 41.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.004 -1.292 . . . . 17.789999999999999 109.169 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 24.1 p90 -103.69 107.66 18.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.458 -0.776 . . . . 18.550000000000001 110.663 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -87.97 143.76 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.226 -1.027 . . . . 21.489999999999998 108.226 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.53 ' OG1' ' NE ' ' A' ' 65' ' ' ARG . 17.5 p -146.25 98.53 3.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.866 -1.146 . . . . 31.5 110.36 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -174.33 68.89 0.31 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.43 108.19 0.35 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.508 1.472 . . . . 0.0 110.231 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -155.34 95.54 1.71 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 108.869 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -110.21 -94.99 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.622 -0.673 . . . . 0.0 110.031 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 33' ' ' GLU . 11.7 tpp180 -44.5 -26.06 0.32 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.0 110.033 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 32' ' ' ARG . 5.6 pt-20 27.08 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.788 0.804 . . . . 0.0 111.611 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 33' ' ' GLU . . . 74.34 129.77 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.077 -1.015 . . . . 0.0 109.151 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -88.18 -94.86 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.083 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.2 p30 -61.72 103.79 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.37 -1.25 57.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.126 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -52.61 160.97 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.334 -0.853 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 40' ' ' GLY . 17.2 m -92.95 29.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . -62.41 -140.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -80.66 81.29 6.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -1.154 . . . . 0.0 109.541 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 1.2 m -142.85 13.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.263 -0.898 . . . . 0.0 108.821 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 12.2 tt0 81.01 146.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -99.93 73.4 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.462 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.46 -2.15 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.0 163.87 14.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.35 -179.08 46.34 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.6 -47.01 14.84 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.608 1.539 . . . . 0.0 109.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.39 122.55 0.47 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.08 -9.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -1.161 . . . . 0.0 109.554 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . -66.67 -116.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.6 p 73.07 -44.43 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -1.106 . . . . 0.0 109.644 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' A' ' 51' ' ' GLY . 15.6 mt -59.62 -75.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -92.86 154.37 41.99 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.13 136.83 77.14 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.507 1.471 . . . . 0.0 110.881 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -44.06 -39.66 4.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.715 -0.615 . . . . 0.0 110.064 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -51.8 67.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -0.997 . . . . 0.0 109.75 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.4 mm? -68.21 -37.57 81.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.353 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -51.36 -29.82 16.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.978 . . . . 0.0 109.52 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.9 -7.71 73.93 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 p -84.06 -40.27 18.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.077 -1.249 . . . . 0.0 110.611 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -88.52 -0.85 57.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.776 -1.203 . . . . 0.0 109.297 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' O ' ' C ' ' A' ' 64' ' ' LYS . 12.2 mt-30 -105.03 -66.35 0.98 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 14.61 64.65 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-O 121.609 0.719 . . . . 0.0 111.734 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' OG1' ' A' ' 27' ' ' THR . 20.5 tpt180 -45.33 -77.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 109.613 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.08 -114.19 0.5 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.346 -1.407 . . . . 19.620000000000001 110.412 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 68' ' ' VAL . 4.0 tt -50.74 -49.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -1.015 . . . . 17.420000000000002 111.131 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' N ' ' CG2' ' A' ' 67' ' ' ILE . 5.1 t -54.96 -12.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.748 -1.22 . . . . 18.82 110.222 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -105.14 9.91 34.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 38.5 109.773 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -137.01 -14.91 1.55 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.283 -0.886 . . . . 36.829999999999998 109.857 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.8 m -112.49 -29.26 7.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.402 -0.811 . . . . 18.16 108.993 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.44 -44.47 11.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.105 . . . . 18.460000000000001 108.825 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -81.44 -14.56 56.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.488 ' HG ' ' H ' ' A' ' 75' ' ' ILE . 6.4 t -147.71 -137.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.444 -0.947 . . . . 30.34 108.444 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.488 ' H ' ' HG ' ' A' ' 74' ' ' SER . 9.7 mt -145.81 149.59 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.076 -1.015 . . . . 27.510000000000002 109.349 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -131.47 176.32 8.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.487 -0.758 . . . . 23.34 109.587 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' NE2' ' A' ' 80' ' ' GLN . 2.8 p -112.26 171.17 7.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.661 -0.649 . . . . 22.640000000000001 109.444 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.502 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.4 tp -45.09 -61.16 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 23.280000000000001 109.502 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -41.33 -54.73 2.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.692 . . . . 37.859999999999999 110.531 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.685 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.4 mp0 -52.16 -49.49 63.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 31.390000000000001 108.578 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -58.56 -40.01 81.84 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.655 -0.868 . . . . 24.48 108.655 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.84 -18.75 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.426 -0.796 . . . . 31.48 109.923 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.87 -29.02 61.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.813 . . . . 22.48 111.692 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -99.56 11.98 37.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.139 -0.976 . . . . 19.59 111.857 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -76.81 -175.82 3.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.579 -1.326 . . . . 20.620000000000001 109.025 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.292 179.771 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.519 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.4 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.239 -0.652 . . . . 24.77 109.239 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.3 p -162.04 158.02 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 30.100000000000001 109.349 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.738 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -127.54 106.4 9.15 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.547 -0.909 . . . . 32.240000000000002 108.547 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -157.09 164.27 38.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 30.210000000000001 109.574 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -78.37 100.61 6.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.264 -2.124 . . . . 24.0 105.264 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.22 135.02 40.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 19.629999999999999 111.671 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.8 m -123.99 -158.35 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.895 0.855 . . . . 17.190000000000001 112.438 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.56 -51.29 1.39 Allowed Glycine 0 N--CA 1.492 2.429 0 CA-C-N 115.991 -0.55 . . . . 16.550000000000001 112.997 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m -82.48 -60.95 2.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.382 -1.658 . . . . 19.550000000000001 110.975 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -55.68 31.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.376 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' VAL . 23.8 tp -50.53 -48.4 57.16 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.677 -1.264 . . . . 14.16 108.36 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.14 -54.3 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.128 -1.434 . . . . 15.31 107.128 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.78 -61.48 2.49 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.951 -1.1 . . . . 29.640000000000001 108.322 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.15 -60.3 2.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 13.960000000000001 109.653 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.3 mt -51.22 -48.34 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.559 -1.338 . . . . 17.789999999999999 108.046 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -58.86 -39.49 81.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.535 -0.728 . . . . 16.84 109.119 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.65 -31.22 70.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 22.760000000000002 108.08 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -89.65 -64.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.519 -0.738 . . . . 17.440000000000001 109.496 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 m -64.0 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 18.539999999999999 109.37 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.97 -132.84 12.21 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.564 -1.414 . . . . 23.170000000000002 109.564 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 -13.65 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -1.132 . . . . 39.770000000000003 109.49 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -60.32 -53.27 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.94 . . . . 26.649999999999999 109.217 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.66 64.5 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.885 -1.15 . . . . 20.260000000000002 111.196 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.4 p90 -75.82 124.74 27.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 110.172 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 11.6 p90 -92.3 104.61 16.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.454 -0.779 . . . . 18.550000000000001 109.048 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -62.01 168.69 3.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.276 -0.89 . . . . 21.489999999999998 108.908 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 16.5 p -142.77 159.83 41.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.29 -0.881 . . . . 31.5 109.511 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 27' ' ' THR . 28.5 ttmt 76.18 69.92 0.22 Allowed Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.89 101.99 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.417 1.411 . . . . 0.0 110.098 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.566 ' CG2' ' H ' ' A' ' 31' ' ' ARG . 1.8 t -140.05 -109.67 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.402 -0.811 . . . . 0.0 109.057 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.566 ' H ' ' CG2' ' A' ' 30' ' ' THR . 21.6 ttt180 73.84 -61.21 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HG2' HH11 ' A' ' 32' ' ' ARG . 2.7 ttt-85 -155.95 119.08 4.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 0.0 109.227 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -153.36 -69.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.291 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.74 68.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -116.1 161.51 18.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.557 -0.714 . . . . 0.0 109.426 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 52.96 69.65 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.787 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.6 mm? -86.45 -109.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 109.051 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.437 ' C ' ' H ' ' A' ' 40' ' ' GLY . 25.1 mt-30 -111.21 140.28 45.9 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.425 -0.797 . . . . 0.0 109.281 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 m -79.12 32.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 38' ' ' GLN . . . -159.32 47.97 0.41 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.67 46.37 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -1.05 . . . . 0.0 108.214 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.63 -10.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 45' ' ' GLY . 21.7 tt0 64.44 98.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -44.17 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 110.33 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . -117.49 53.08 0.66 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.12 -171.45 34.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.36 179.33 44.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.07 -33.62 98.62 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.491 1.46 . . . . 0.0 109.759 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.08 138.07 5.82 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.55 4.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -1.158 . . . . 0.0 109.208 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.77 171.04 7.44 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.9 m -83.76 103.46 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -1.184 . . . . 0.0 109.638 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 mt -140.54 -171.78 3.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.7 144.89 96.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.03 -1.044 . . . . 0.0 108.66 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.41 131.34 33.57 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.783 0.989 . . . . 0.0 109.743 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.1 mt -57.86 -21.74 44.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -52.74 19.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 62' ' ' LEU . 3.5 mm? -71.18 -32.84 69.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.063 -1.023 . . . . 0.0 109.519 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -46.81 -43.69 18.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.39 -39.58 6.74 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 64' ' ' LYS . 32.0 t -80.89 -7.32 59.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.117 -1.225 . . . . 0.0 110.74 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -47.48 -64.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.29 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.05 -33.45 16.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 109.794 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 10.9 mptt -89.0 151.73 22.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 109.706 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -50.11 9.49 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.21 146.85 8.71 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.96 -1.256 . . . . 19.620000000000001 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.0 tt -127.3 -42.39 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.608 -0.936 . . . . 17.420000000000002 108.79 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.45 -53.62 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.054 -1.029 . . . . 18.82 109.461 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.52 10.61 0.09 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.309 -0.869 . . . . 38.5 110.248 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 68' ' ' VAL . 11.4 mt-30 -135.1 -16.28 1.92 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.979 -1.075 . . . . 36.829999999999998 110.69 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.65 -23.73 6.45 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.41 -0.806 . . . . 18.16 109.096 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.6 t -87.44 -36.74 17.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.342 -0.984 . . . . 18.460000000000001 108.342 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -91.45 -16.87 26.64 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -138.71 -144.66 0.18 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -145.11 117.29 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.982 -1.074 . . . . 27.510000000000002 109.37 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -100.5 177.41 5.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.382 -0.824 . . . . 23.34 109.852 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 m -112.36 -175.38 2.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.548 -0.72 . . . . 22.640000000000001 109.752 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.5 tp -57.26 -56.46 21.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.514 -0.741 . . . . 23.280000000000001 109.478 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -44.91 -57.43 3.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 37.859999999999999 109.933 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -48.6 -48.52 39.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.87 -1.144 . . . . 31.390000000000001 108.987 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -60.95 -39.93 91.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.814 -0.809 . . . . 24.48 108.814 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.27 -18.95 64.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 31.48 109.662 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -73.19 -29.78 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 22.48 111.589 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.04 12.21 36.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.036 -1.04 . . . . 19.59 111.788 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 77.9 m -76.66 -175.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.658 -1.277 . . . . 20.620000000000001 109.253 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.95 -1.024 . . . . 24.649999999999999 109.452 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.8 t80 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.275 -0.639 . . . . 24.77 109.275 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 2.3 p -164.14 163.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 30.100000000000001 109.533 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.686 ' N ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.97 106.77 7.87 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.298 -1.001 . . . . 32.240000000000002 108.298 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -157.38 164.62 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 30.210000000000001 109.824 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -77.67 100.57 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.173 -2.158 . . . . 24.0 105.173 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.8 mt -99.44 135.31 41.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 19.629999999999999 111.72 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.2 m -122.91 -157.58 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.97 0.89 . . . . 17.190000000000001 112.424 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.72 -55.47 1.35 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-N 116.043 -0.526 . . . . 16.550000000000001 113.06 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -79.63 -58.49 3.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.383 -1.657 . . . . 19.550000000000001 111.152 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -55.94 27.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 110.419 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 12' ' ' VAL . 24.9 tp -51.12 -48.83 61.67 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.69 -1.256 . . . . 14.16 108.359 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.8 t -48.28 -55.06 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.451 -1.315 . . . . 15.31 107.451 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.97 -61.76 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.119 -1.067 . . . . 29.640000000000001 108.119 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.47 -59.6 2.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.102 -0.999 . . . . 13.960000000000001 109.686 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.2 mt -51.61 -53.46 38.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.486 -1.384 . . . . 17.789999999999999 107.906 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -52.11 -45.63 64.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.497 -0.752 . . . . 16.84 109.176 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -56.45 -30.98 63.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.957 -1.09 . . . . 22.760000000000002 108.336 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.94 -64.6 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.389 -0.819 . . . . 17.440000000000001 109.223 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 15' ' ' LEU . 5.9 m -64.13 -79.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 18.539999999999999 109.45 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.515 ' C ' ' H ' ' A' ' 22' ' ' ARG . . . 75.81 -131.72 12.25 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.816 -1.314 . . . . 23.170000000000002 109.816 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -50.09 -10.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -1.088 . . . . 39.770000000000003 109.521 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.47 -52.97 49.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 26.649999999999999 108.994 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.75 63.93 0.49 Allowed Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.936 -1.126 . . . . 20.260000000000002 111.46 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 23.9 p90 -76.24 122.42 24.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.146 -1.208 . . . . 17.789999999999999 110.162 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 12.0 p90 -89.7 104.43 16.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.567 -0.901 . . . . 18.550000000000001 108.567 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 27' ' ' THR . 12.3 t80 -65.39 168.2 7.5 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.176 -0.952 . . . . 21.489999999999998 109.175 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.457 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.3 p -143.71 160.15 41.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.566 -0.901 . . . . 31.5 108.566 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 27' ' ' THR . 32.4 tttt 79.65 65.04 0.17 Allowed Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.15 -19.66 21.58 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 N-CA-C 108.848 -1.251 . . . . 0.0 108.848 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 128.89 38.35 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -143.91 4.07 1.27 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.237 -0.914 . . . . 0.0 109.221 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -158.56 53.18 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.375 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -73.18 91.46 1.66 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -164.31 -177.66 5.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' LEU . 20.7 mt-10 61.32 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 34' ' ' ALA . 30.3 t0 -44.34 -23.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 37' ' ' LEU . 10.0 mp -69.38 67.75 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.027 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 40' ' ' GLY . 38.6 tt0 -75.67 128.12 34.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.2 p -49.86 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.205 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 38' ' ' GLN . . . -85.07 -175.7 50.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -73.42 101.12 3.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.423 -1.045 . . . . 0.0 109.281 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.21 154.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.159 -0.963 . . . . 0.0 109.243 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.17 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 44' ' ' LEU . 0.8 OUTLIER -175.09 2.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.925 . . . . 0.0 109.479 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.51 49.35 0.09 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.21 68.46 1.49 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.42 142.22 94.77 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.429 1.419 . . . . 0.0 109.968 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.03 138.12 18.83 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.07 16.15 10.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.247 -1.149 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.77 -43.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.9 m -46.96 117.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -1.172 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 mt -80.56 -43.99 19.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -81.41 140.2 48.43 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 108.936 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.2 110.62 2.04 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 120.797 0.998 . . . . 0.0 109.796 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.7 mt -63.46 -6.94 5.61 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.533 -0.73 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.37 -59.65 2.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 111.245 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.99 -15.07 42.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.892 -1.13 . . . . 0.0 110.476 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -45.94 -45.83 15.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 109.815 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 62' ' ' LEU . . . -87.53 -52.05 3.12 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -55.33 -8.66 0.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.31 -1.112 . . . . 0.0 110.304 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 60' ' ' GLY . 3.1 mt -71.8 -36.41 70.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 109.257 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -101.71 -35.38 9.1 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 10.8 mptt -84.88 -177.19 6.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 60.86 73.08 0.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.77 -113.65 3.56 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.096 -1.602 . . . . 19.620000000000001 109.096 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.9 tt -50.61 -40.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -1.106 . . . . 17.420000000000002 109.18 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.93 -50.3 19.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.208 -0.932 . . . . 18.82 109.663 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.23 10.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 38.5 110.644 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 68' ' ' VAL . 10.5 mt-30 -137.83 -16.11 1.32 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.819 -1.176 . . . . 36.829999999999998 110.651 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.0 m -118.62 -23.06 7.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.339 -0.85 . . . . 18.16 109.216 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.3 t -89.72 -37.83 14.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.466 -0.939 . . . . 18.460000000000001 108.466 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 m -133.58 -141.96 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.839 . . . . 30.34 108.736 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.05 130.08 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.995 . . . . 27.510000000000002 109.23 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -114.27 175.54 5.43 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.672 -0.643 . . . . 23.34 109.77 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 m -112.53 -178.08 3.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.622 -0.674 . . . . 22.640000000000001 109.758 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.7 tp -53.37 -60.82 2.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.494 -0.754 . . . . 23.280000000000001 109.629 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -42.33 -56.75 2.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 37.859999999999999 110.39 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -49.2 -47.65 45.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.761 -1.212 . . . . 31.390000000000001 108.921 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.35 -39.27 89.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 24.48 108.806 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 -18.82 64.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.495 -0.753 . . . . 31.48 109.745 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -73.21 -30.21 63.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 22.48 111.644 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -98.8 12.14 36.58 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.145 -0.972 . . . . 19.59 111.805 -177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.6 m -76.71 -175.81 3.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.593 -1.317 . . . . 20.620000000000001 109.328 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 117.987 -1.006 . . . . 24.649999999999999 109.342 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PHE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 18.5 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.286 -0.635 . . . . 24.77 109.286 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -168.74 160.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.022 . . . . 30.100000000000001 109.546 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.734 ' H ' HD21 ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.37 107.66 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.471 -0.937 . . . . 32.240000000000002 108.471 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -156.63 163.14 39.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 30.210000000000001 109.448 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.02 101.09 5.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.212 -2.144 . . . . 24.0 105.212 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.15 136.85 37.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.769 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.33 -164.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.145 -0.972 . . . . 17.190000000000001 111.675 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.51 -44.94 1.31 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 115.673 -0.694 . . . . 16.550000000000001 112.553 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.64 ' HG ' ' H ' ' A' ' 10' ' ' ASP . 83.9 p -83.39 -62.77 1.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.388 -1.654 . . . . 19.550000000000001 110.494 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.64 ' H ' ' HG ' ' A' ' 9' ' ' SER . 0.3 OUTLIER -58.88 -55.2 38.16 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.27 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 7' ' ' CYS . 30.3 tp -49.72 -50.88 42.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.747 -1.221 . . . . 14.16 108.32 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.45 -55.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.489 -1.3 . . . . 15.31 107.489 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -56.93 -61.39 2.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.959 -1.126 . . . . 29.640000000000001 107.959 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.6 -59.55 2.68 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 13.960000000000001 109.692 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.57 -53.39 38.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.522 -1.361 . . . . 17.789999999999999 108.009 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -51.86 -48.36 64.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 16.84 109.151 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.12 -28.63 26.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.053 . . . . 22.760000000000002 108.588 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.9 -64.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.424 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 m -65.13 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 18.539999999999999 109.909 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.93 -122.91 17.44 Favored Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.605 -1.284 . . . . 23.170000000000002 110.191 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.03 -19.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 109.776 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 73.0 mtt180 -67.07 -52.92 36.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.199 -0.938 . . . . 26.649999999999999 109.788 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.25 0.48 Allowed Glycine 0 N--CA 1.508 3.454 0 C-N-CA 119.728 -1.225 . . . . 20.260000000000002 111.931 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.403 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 18.2 p90 -75.67 132.22 40.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.987 -1.302 . . . . 17.789999999999999 109.262 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.49 104.7 16.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.742 . . . . 18.550000000000001 109.832 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -82.86 137.94 34.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.923 -1.139 . . . . 21.489999999999998 107.923 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -149.54 101.23 3.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.771 -1.206 . . . . 31.5 110.417 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.553 ' C ' ' H ' ' A' ' 30' ' ' THR . 13.0 tttt -171.8 70.4 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 108.816 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 30' ' ' THR . 2.3 Cg_endo -67.0 15.39 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.027 1.818 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.553 ' H ' ' C ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -37.9 -86.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.104 0.478 . . . . 0.0 110.646 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 51.94 -113.75 0.76 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.123 -0.985 . . . . 0.0 109.113 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.94 129.4 37.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.0 109.409 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -151.44 71.89 1.02 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.151 -0.968 . . . . 0.0 109.302 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.53 128.71 37.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.218 -0.926 . . . . 0.0 109.525 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -162.37 -82.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.912 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.85 74.29 1.59 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.482 0.658 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' A' ' 37' ' ' LEU . 3.5 mm? -82.79 -37.05 25.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.772 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -71.74 125.32 26.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.84 133.26 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 161.36 10.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.2 64.16 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -1.082 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' CG2' ' N ' ' A' ' 43' ' ' GLU . 1.2 p -175.45 -95.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 10.1 pt-20 -48.76 -41.02 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 109.371 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -65.63 -36.52 83.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.63 -35.72 81.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.31 -90.34 0.08 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 49' ' ' GLY . . . 158.53 73.9 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.27 -0.42 2.26 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 121.477 1.451 . . . . 0.0 109.704 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 47' ' ' GLY . . . 179.22 165.73 33.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.27 -36.66 9.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -1.167 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' A' ' 53' ' ' LEU . . . 153.05 14.97 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 70.34 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -1.062 . . . . 0.0 109.437 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 51' ' ' GLY . 1.2 pp -177.78 179.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.35 150.0 36.58 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.167 -0.958 . . . . 0.0 108.718 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.94 128.66 27.44 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 120.9 1.067 . . . . 0.0 109.739 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.3 mt -56.94 -23.37 44.89 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 -59.06 4.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.245 -0.909 . . . . 0.0 109.906 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.7 mm? -62.07 -40.07 94.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 109.306 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -48.91 -38.88 24.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 0.0 109.781 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.59 -38.53 7.56 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.3 t -80.5 -11.47 59.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -1.23 . . . . 0.0 110.347 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 58' ' ' LEU . 3.0 mt -64.12 -34.18 77.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.84 -43.37 5.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.374 -0.829 . . . . 0.0 109.805 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 11.0 mptt -90.39 144.44 25.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 109.795 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -61.45 -56.72 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 108.533 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.6 1.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 19.620000000000001 110.612 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.0 tt -121.98 -41.17 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.245 -1.02 . . . . 17.420000000000002 108.245 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 t -52.37 -36.43 21.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.381 -0.824 . . . . 18.82 109.597 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -80.79 10.36 5.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 38.5 109.627 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.5 mt-30 -136.44 -10.11 1.91 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.042 -1.036 . . . . 36.829999999999998 110.57 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.7 m -121.85 -26.05 4.9 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.338 -0.852 . . . . 18.16 108.987 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.5 t -88.26 -39.5 14.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 18.460000000000001 108.607 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -84.77 -15.25 45.63 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -143.93 -138.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.114 -1.069 . . . . 30.34 108.114 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -145.52 148.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 27.510000000000002 109.045 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.6 m -131.05 173.57 10.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 23.34 109.707 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.8 m -112.16 -176.65 2.97 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.684 . . . . 22.640000000000001 109.613 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.9 tp -56.53 -59.25 5.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 23.280000000000001 109.412 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -43.12 -55.07 4.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 37.859999999999999 110.262 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -52.39 -48.97 65.33 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.877 -1.139 . . . . 31.390000000000001 108.952 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -60.09 -40.51 89.86 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.713 -0.847 . . . . 24.48 108.713 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.82 -18.87 61.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.506 -0.746 . . . . 31.48 109.952 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -29.82 62.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 22.48 111.742 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -97.79 11.56 36.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.082 -1.011 . . . . 19.59 111.807 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.96 -175.77 3.67 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.558 -1.339 . . . . 20.620000000000001 109.063 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 118.015 -0.993 . . . . 24.649999999999999 109.494 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.517 0.675 . . . . 30.1 110.125 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.557 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 6.7 p30 -116.68 107.25 14.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.941 -1.133 . . . . 32.24 107.941 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 9.0 mm-40 -153.65 165.52 35.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.317 -0.865 . . . . 30.21 109.512 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -78.34 101.63 7.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.07 -2.196 . . . . 24.0 105.07 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -98.65 135.41 40.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.336 -0.853 . . . . 19.63 112.297 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.67 -161.16 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.275 -0.891 . . . . 17.19 111.656 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.11 -55.11 1.51 Allowed Glycine 0 N--CA 1.49 2.266 0 CA-C-N 115.899 -0.591 . . . . 16.55 112.75 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.7 p -76.73 -61.56 1.93 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.5 -1.588 . . . . 19.55 110.983 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -55.51 33.99 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.123 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 67' ' ' ILE . 30.6 tp -50.82 -49.9 57.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 14.16 108.476 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.76 -56.71 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.532 -1.284 . . . . 15.31 107.532 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -55.9 -61.0 2.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.026 -1.101 . . . . 29.64 108.026 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.19 -59.75 2.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.101 -0.999 . . . . 13.96 109.825 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.72 -50.48 60.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.425 -1.422 . . . . 17.79 107.891 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -55.29 -43.7 75.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 16.84 109.183 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.6 mt -56.53 -25.29 51.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 22.76 108.176 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -97.37 -64.43 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 17.44 109.431 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.8 m -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 18.54 110.005 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.98 -122.59 13.42 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.665 -1.255 . . . . 23.17 110.125 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.62 -18.67 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.425 -1.044 . . . . 39.77 110.237 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.526 HH11 ' HG2' ' A' ' 22' ' ' ARG . 9.5 mtt-85 -70.12 -53.07 18.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.974 -1.079 . . . . 26.65 110.097 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 64.02 0.5 Allowed Glycine 0 N--CA 1.508 3.475 0 C-N-CA 119.726 -1.226 . . . . 20.26 111.759 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 20.8 p90 . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.269 . . . . 17.79 110.098 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 11' ' ' LEU . 2.7 tt . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.583 -0.895 . . . . 17.42 108.583 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -51.66 -41.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.2 -0.938 . . . . 18.82 109.425 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -76.48 10.31 2.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.3 -0.875 . . . . 38.5 110.014 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 35.6 mt-30 -136.51 -12.78 1.79 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.156 -0.965 . . . . 36.83 110.707 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.2 m -119.88 -27.12 5.47 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.376 -0.828 . . . . 18.16 109.071 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.2 t -86.36 -38.19 17.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.053 . . . . 18.46 108.515 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -87.76 -14.93 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.534 -0.729 . . . . 0.0 109.261 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 m -141.78 -141.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.527 -0.916 . . . . 30.34 108.527 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 75' ' ' ILE . 12.5 mt -145.8 128.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.958 . . . . 27.51 109.209 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -111.39 176.82 4.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.591 -0.693 . . . . 23.34 109.931 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -112.62 -170.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.472 0.653 . . . . 22.64 109.623 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.24 -59.8 4.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.449 -0.782 . . . . 23.28 109.359 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -43.05 -57.92 2.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.768 . . . . 37.86 110.38 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -48.74 -45.02 39.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.857 -1.152 . . . . 31.39 109.018 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.47 -37.64 88.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 24.48 108.705 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.43 -18.72 64.99 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.795 . . . . 31.48 109.669 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.08 -30.36 63.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.527 -0.733 . . . . 22.48 111.581 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -98.05 12.07 35.54 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 19.59 111.975 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.9 m -76.55 -175.68 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.551 -1.343 . . . . 20.62 108.982 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.0 -1.0 . . . . 24.65 109.504 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.22 -0.659 . . . . 30.1 109.22 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.465 ' N ' HG22 ' A' ' 2' ' ' VAL . 7.7 p30 -133.33 107.76 8.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.345 -0.983 . . . . 32.24 108.345 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -156.76 166.04 34.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -0.813 . . . . 30.21 110.083 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -77.26 100.99 6.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.64 136.88 38.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.72 . . . . 19.63 111.749 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.84 -160.51 0.85 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.216 1.007 . . . . 17.19 111.849 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.53 -54.06 1.76 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 115.552 -0.749 . . . . 16.55 112.772 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -78.9 -56.82 4.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.341 -1.682 . . . . 19.55 110.976 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.49 -55.54 26.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.928 -1.107 . . . . 0.0 110.337 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.75 -48.55 63.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.797 -1.19 . . . . 14.16 108.453 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 8' ' ' GLY . 3.2 t -48.84 -55.17 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.307 -1.368 . . . . 15.31 107.307 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.11 -61.91 2.06 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.098 -1.075 . . . . 29.64 108.098 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.75 -59.73 2.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.092 -1.005 . . . . 13.96 109.842 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.481 HD11 HD13 ' A' ' 67' ' ' ILE . 10.7 mt -51.98 -52.06 53.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.484 -1.385 . . . . 17.79 107.977 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -53.84 -46.32 71.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.527 -0.733 . . . . 16.84 109.216 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.23 -31.52 61.55 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.008 -1.058 . . . . 22.76 108.501 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -89.47 -64.67 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.785 . . . . 17.44 109.257 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' N ' HG12 ' A' ' 18' ' ' VAL . 12.9 m -63.81 -76.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 18.54 109.414 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.09 -139.69 22.97 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.538 -1.425 . . . . 23.17 109.538 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.4 pm0 -47.28 -15.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -1.166 . . . . 39.77 109.535 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' GLY . 56.1 mtt180 -57.33 -52.3 65.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -0.926 . . . . 26.65 109.036 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.38 64.82 0.48 Allowed Glycine 0 N--CA 1.507 3.399 0 C-N-CA 119.73 -1.224 . . . . 20.26 111.902 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.417 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 27.3 p90 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.282 -1.128 . . . . 17.79 110.111 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.0 tt . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 109.382 -0.599 . . . . 17.42 109.382 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.612 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.0 t -54.83 -31.59 24.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.829 -1.17 . . . . 18.82 108.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.77 10.56 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 38.5 109.397 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -136.67 -14.45 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.185 -0.947 . . . . 36.83 110.617 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m -115.41 -27.14 7.29 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.285 -0.884 . . . . 18.16 109.054 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.8 t -86.6 -42.03 13.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.826 -1.171 . . . . 18.46 108.413 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -82.37 -16.14 50.21 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -142.76 -139.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.491 -0.929 . . . . 30.34 108.491 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.33 148.7 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.018 -1.051 . . . . 27.51 109.332 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.6 m -133.61 175.61 9.28 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 23.34 109.852 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OE1' ' A' ' 80' ' ' GLN . 2.9 p -112.73 179.47 3.96 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.541 0.686 . . . . 22.64 109.8 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -52.34 -60.62 3.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 23.28 109.423 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -42.61 -56.86 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.536 -0.727 . . . . 37.86 110.376 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' OE1' ' OG ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -48.98 -48.48 43.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.815 -1.178 . . . . 31.39 108.801 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.45 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.67 -39.41 88.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 24.48 109.097 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.43 -19.01 64.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 31.48 109.966 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.81 -29.34 63.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 22.48 111.552 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.7 12.34 35.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.191 -0.943 . . . . 19.59 111.898 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.57 -175.81 3.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.569 -1.332 . . . . 20.62 109.306 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 118.007 -0.996 . . . . 24.65 109.424 179.781 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.331 -0.618 . . . . 30.1 109.331 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 8.5 p30 -130.64 107.25 9.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.485 -0.931 . . . . 32.24 108.485 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -157.12 165.17 36.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 30.21 109.715 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -78.14 100.37 6.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.164 -2.161 . . . . 24.0 105.164 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.63 137.82 36.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.547 -0.721 . . . . 19.63 111.615 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 m -125.68 -160.49 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.038 0.923 . . . . 17.19 112.538 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -49.25 1.34 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 115.946 -0.57 . . . . 16.55 112.793 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -83.27 -60.71 2.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.402 -1.646 . . . . 19.55 110.802 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -55.57 31.86 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 110.308 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 67' ' ' ILE . 24.7 tp -51.38 -46.39 62.77 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.688 -1.258 . . . . 14.16 108.347 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.5 t -50.1 -56.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.932 -1.507 . . . . 15.31 106.932 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -56.07 -61.59 2.28 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.099 -1.041 . . . . 29.64 108.233 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.25 -60.04 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.073 -1.017 . . . . 13.96 109.807 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.26 -49.04 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.612 -1.305 . . . . 17.79 107.919 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.8 -43.06 85.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 16.84 109.232 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.37 -27.68 62.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.933 -1.105 . . . . 22.76 108.215 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -93.74 -64.66 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 17.44 109.535 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 18' ' ' VAL . 18.0 m -63.14 -74.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 18.54 109.567 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -132.54 11.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.92 -1.272 . . . . 23.17 109.92 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -57.24 -12.62 2.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.427 -1.043 . . . . 39.77 109.556 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 22' ' ' ARG . 12.1 mtt-85 -57.79 -51.86 67.85 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.007 -1.058 . . . . 26.65 109.233 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 65.47 0.48 Allowed Glycine 0 N--CA 1.508 3.451 0 C-N-CA 119.628 -1.272 . . . . 20.26 111.446 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 31.1 p90 . . . . . 0 C--N 1.299 -1.611 0 O-C-N 121.301 -1.117 . . . . 17.79 110.271 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.4 tt . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.597 -0.89 . . . . 17.42 108.597 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.5 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.8 t -55.36 -27.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.275 -0.891 . . . . 18.82 109.556 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -90.9 10.89 24.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 38.5 109.872 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.1 mt-30 -137.18 -10.43 1.72 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.075 -1.015 . . . . 36.83 110.841 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -120.32 -26.05 5.52 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.271 -0.893 . . . . 18.16 109.42 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.7 t -87.94 -37.91 16.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.93 -1.106 . . . . 18.46 108.112 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 t -86.08 -23.9 26.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -134.01 -140.71 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.443 -0.947 . . . . 30.34 108.443 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.4 mt -145.68 131.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.043 -1.036 . . . . 27.51 109.099 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.2 m -114.41 175.14 5.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.555 -0.716 . . . . 23.34 110.105 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m -112.52 -178.24 3.35 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.604 -0.685 . . . . 22.64 109.749 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.55 -61.8 2.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.482 -0.761 . . . . 23.28 109.716 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -42.04 -57.24 2.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.418 -0.801 . . . . 37.86 110.249 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -48.46 -45.58 36.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.852 -1.155 . . . . 31.39 109.14 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.97 -38.72 92.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 24.48 108.86 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.42 -19.0 64.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 31.48 109.786 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -72.74 -29.65 63.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 22.48 111.356 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -97.9 12.53 33.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.186 -0.946 . . . . 19.59 111.925 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.13 -175.93 3.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.58 -1.325 . . . . 20.62 109.101 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.025 -0.988 . . . . 24.65 109.589 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.8 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.406 0.622 . . . . 30.1 109.539 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 8.4 p30 -130.58 107.48 9.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.475 -0.935 . . . . 32.24 108.475 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -156.85 161.93 39.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 30.21 109.46 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -76.97 100.95 5.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.285 -2.117 . . . . 24.0 105.285 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.27 133.63 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 19.63 111.808 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -159.76 0.78 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.136 -0.977 . . . . 17.19 111.532 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.82 -53.45 1.47 Allowed Glycine 0 N--CA 1.49 2.291 0 CA-C-N 115.843 -0.617 . . . . 16.55 112.977 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.4 m -78.7 -62.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.516 -1.579 . . . . 19.55 111.068 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.6 -55.5 34.05 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.215 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 67' ' ' ILE . 31.5 tp -50.49 -51.71 44.77 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.64 -1.288 . . . . 14.16 108.311 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -45.92 -55.46 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.643 -1.243 . . . . 15.31 107.643 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.45 -61.73 2.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.946 -1.131 . . . . 29.64 107.946 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.36 -59.59 2.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.161 -0.962 . . . . 13.96 109.708 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 67' ' ' ILE . 11.0 mt -51.77 -53.92 34.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.381 -1.449 . . . . 17.79 108.072 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.1 -48.26 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 16.84 109.018 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.34 -29.3 33.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.094 -1.004 . . . . 22.76 108.439 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -92.66 -64.72 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 17.44 109.586 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.1 m -64.8 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 18.54 109.684 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 76.71 -129.01 9.53 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.715 -1.354 . . . . 23.17 109.715 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -49.99 -18.9 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.364 -1.08 . . . . 39.77 109.256 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -57.14 -54.01 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 26.65 109.097 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.12 62.75 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.893 -1.146 . . . . 20.26 111.502 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.9 p90 . . . . . 0 C--N 1.298 -1.645 0 O-C-N 121.1 -1.235 . . . . 17.79 109.638 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 11' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.928 0.344 . . . . 17.42 111.928 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.602 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -54.66 -17.36 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.524 -1.36 . . . . 18.82 110.012 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -100.74 9.97 41.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 38.5 109.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -137.65 -16.02 1.36 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.108 -0.995 . . . . 36.83 110.242 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.7 m -112.16 -30.87 7.06 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.362 -0.836 . . . . 18.16 109.256 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.6 -42.51 16.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 18.46 108.667 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -80.9 -22.4 39.79 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 m -139.98 -136.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.496 -0.927 . . . . 30.34 108.496 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.7 149.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 27.51 109.301 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.9 m -133.08 175.93 8.94 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 23.34 109.583 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m -112.24 -178.32 3.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 22.64 109.765 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 tp -55.16 -57.63 10.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.575 -0.703 . . . . 23.28 109.267 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -44.15 -51.64 7.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.423 -0.798 . . . . 37.86 110.001 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -54.93 -51.84 64.83 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.787 -1.196 . . . . 31.39 108.733 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -56.92 -39.5 74.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 24.48 108.855 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.76 -18.62 64.25 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.468 -0.77 . . . . 31.48 109.863 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -73.67 -30.04 62.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.826 . . . . 22.48 111.746 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -99.01 12.01 37.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.205 -0.934 . . . . 19.59 111.782 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.2 m -76.7 -175.4 3.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 20.62 109.194 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 118.019 -0.991 . . . . 24.65 109.359 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.442 0.639 . . . . 30.1 109.572 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.473 ' N ' HG22 ' A' ' 2' ' ' VAL . 5.5 p30 -133.78 107.14 7.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.35 -0.981 . . . . 32.24 108.35 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -156.58 161.21 39.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 30.21 109.261 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -76.59 100.77 5.44 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.251 -2.129 . . . . 24.0 105.251 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.11 132.8 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.464 -0.772 . . . . 19.63 111.784 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 -157.01 0.69 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.21 -0.931 . . . . 17.19 111.831 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -37.02 -55.24 1.46 Allowed Glycine 0 N--CA 1.49 2.288 0 CA-C-N 115.869 -0.605 . . . . 16.55 113.189 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.0 m -79.55 -58.41 3.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.483 -1.598 . . . . 19.55 111.42 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -55.37 34.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 110.39 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 31.2 tp -50.4 -50.51 51.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.74 -1.225 . . . . 14.16 108.24 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.25 -55.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.516 -1.29 . . . . 15.31 107.516 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.11 -61.76 2.23 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.878 -1.129 . . . . 29.64 108.421 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.39 -59.43 2.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 13.96 109.839 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.7 mt -51.36 -52.19 47.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 17.79 107.881 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -53.44 -45.89 69.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 16.84 109.141 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.44 -26.94 33.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.858 -1.151 . . . . 22.76 108.307 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.46 -64.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.448 -0.783 . . . . 17.44 109.401 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.455 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.7 m -62.18 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 18.54 109.842 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.08 -125.02 24.11 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.596 -1.288 . . . . 23.17 110.046 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -45.79 -22.11 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -1.074 . . . . 39.77 109.429 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 20' ' ' GLY . 13.8 mmt180 -61.81 -54.65 39.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.346 -0.846 . . . . 26.65 110.0 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.75 62.49 0.5 Allowed Glycine 0 N--CA 1.51 3.62 0 C-N-CA 119.915 -1.136 . . . . 20.26 112.075 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 15.1 p90 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.338 . . . . 17.79 109.869 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.658 -0.497 . . . . 17.42 109.658 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 67' ' ' ILE . 18.1 t -57.16 -7.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.893 -1.129 . . . . 18.82 109.19 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 67' ' ' ILE . 22.1 tt0 -109.83 9.5 24.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.49 -0.756 . . . . 38.5 109.313 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -137.56 -15.67 1.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.227 -0.921 . . . . 36.83 109.691 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.86 -29.94 7.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.529 -0.732 . . . . 18.16 109.12 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 52.5 t -84.85 -44.51 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 18.46 108.701 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -81.34 -17.91 47.51 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.445 -0.784 . . . . 0.0 109.093 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 m -144.07 -137.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.296 -1.001 . . . . 30.34 108.296 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.45 150.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 27.51 109.333 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 m -133.18 175.88 9.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 23.34 109.55 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -111.62 -174.89 2.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.703 . . . . 22.64 109.566 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.75 -57.56 12.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 23.28 109.608 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -44.5 -55.23 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.39 -0.819 . . . . 37.86 110.038 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -50.55 -49.85 54.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.816 -1.177 . . . . 31.39 108.898 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.407 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -59.53 -40.97 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.921 -0.77 . . . . 24.48 108.921 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -61.88 -19.04 62.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.448 -0.783 . . . . 31.48 109.651 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -73.14 -30.18 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.598 -0.688 . . . . 22.48 111.889 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.404 ' CD2' HD12 ' A' ' 67' ' ' ILE . 22.7 m-85 -100.07 11.8 38.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.157 -0.965 . . . . 19.59 111.939 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.0 m -76.82 -175.72 3.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.601 -1.312 . . . . 20.62 108.833 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.038 -0.982 . . . . 24.65 109.287 179.541 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.369 0.604 . . . . 30.1 109.644 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 2' ' ' VAL . 9.7 p30 -132.73 107.85 8.64 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.485 -0.932 . . . . 32.24 108.485 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -156.86 164.23 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 30.21 109.64 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -76.52 100.6 5.33 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.168 -2.16 . . . . 24.0 105.168 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.08 135.96 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.78 . . . . 19.63 111.59 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.1 m -124.14 -157.3 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.006 0.908 . . . . 17.19 112.693 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.79 -53.8 1.45 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 115.977 -0.556 . . . . 16.55 112.884 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.84 -58.47 2.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.315 -1.697 . . . . 19.55 111.096 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -60.47 -55.76 29.63 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.925 -1.11 . . . . 0.0 110.464 -178.564 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 25.7 tp -51.15 -50.04 59.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.203 . . . . 14.16 108.211 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -46.88 -55.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.525 -1.287 . . . . 15.31 107.525 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 20.6 tt0 -57.12 -61.8 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.018 -1.105 . . . . 29.64 108.018 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.18 -59.67 2.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 13.96 109.537 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.1 mt -51.57 -55.14 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.546 -1.346 . . . . 17.79 108.009 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.42 -50.48 40.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 16.84 108.952 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -52.22 -29.78 24.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 22.76 108.514 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -92.02 -64.45 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 17.44 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.447 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.7 m -65.66 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 18.54 109.946 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.3 -112.57 4.91 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.614 -1.279 . . . . 23.17 110.275 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -52.93 -20.5 3.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 39.77 110.116 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -69.03 -52.59 27.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 26.65 109.974 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.19 63.17 0.49 Allowed Glycine 0 N--CA 1.507 3.393 0 C-N-CA 119.729 -1.224 . . . . 20.26 111.689 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.0 p90 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.047 -1.266 . . . . 17.79 109.221 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 11' ' ' LEU . 4.0 tt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.755 -0.461 . . . . 17.42 109.755 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' N ' HG23 ' A' ' 67' ' ' ILE . 13.8 t -53.67 -31.71 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 18.82 109.247 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 9.99 6.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.956 -1.09 . . . . 38.5 110.119 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 38.2 mt-30 -141.16 -11.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.032 -1.043 . . . . 36.83 110.729 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.5 m -117.89 -26.45 6.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.408 -0.807 . . . . 18.16 109.357 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 t -88.83 -43.28 11.34 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.144 -1.058 . . . . 18.46 108.144 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 t -82.05 -28.04 32.66 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -131.75 -140.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.52 -0.918 . . . . 30.34 108.52 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mt -142.82 151.55 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.156 -0.965 . . . . 27.51 109.258 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -136.49 174.55 10.49 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 23.34 109.683 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -112.23 -178.46 3.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.546 -0.721 . . . . 22.64 109.736 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 79' ' ' TYR . 4.4 tp -53.0 -61.51 2.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 23.28 109.573 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' C ' ' O ' ' A' ' 78' ' ' LEU . 1.7 m-85 -41.31 -55.83 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.449 -0.782 . . . . 37.86 110.356 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -49.46 -51.09 38.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.84 -1.162 . . . . 31.39 108.819 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.4 mp -58.23 -41.3 83.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.451 -0.781 . . . . 24.48 109.071 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.75 -18.76 61.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.408 -0.808 . . . . 31.48 110.075 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -74.31 -29.27 61.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 22.48 111.811 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 67' ' ' ILE . 23.8 m-85 -99.51 12.06 37.45 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.074 -1.016 . . . . 19.59 111.898 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.51 -175.74 3.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.745 -1.222 . . . . 20.62 108.931 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.046 -0.978 . . . . 24.65 109.399 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.361 -0.607 . . . . 30.1 109.361 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.457 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.8 p30 -130.0 106.85 8.92 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.389 -0.967 . . . . 32.24 108.389 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 83.0 mm-40 -156.5 164.53 38.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.298 -0.876 . . . . 30.21 109.62 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -77.93 101.05 6.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -98.82 136.18 39.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.427 -0.796 . . . . 19.63 111.776 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.19 -160.38 0.83 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.189 -0.945 . . . . 17.19 111.691 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.15 -54.18 1.57 Allowed Glycine 0 N--CA 1.489 2.184 0 CA-C-N 115.685 -0.689 . . . . 16.55 112.667 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -77.8 -61.91 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.543 -1.563 . . . . 19.55 110.924 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -55.75 30.93 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.027 . . . . 0.0 110.427 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD11 ' A' ' 67' ' ' ILE . 28.2 tp -51.85 -47.7 64.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.723 -1.236 . . . . 14.16 108.499 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.17 -56.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.336 -1.357 . . . . 15.31 107.336 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.86 -61.23 2.51 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.971 -1.092 . . . . 29.64 108.246 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.28 -59.54 2.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 13.96 110.097 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 67' ' ' ILE . 10.1 mt -51.75 -51.55 55.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.389 -1.444 . . . . 17.79 107.715 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.122 -0.696 . . . . 16.84 109.122 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -56.74 -24.36 49.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.946 -1.096 . . . . 22.76 108.285 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -97.51 -64.55 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.35 -0.844 . . . . 17.44 109.557 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.476 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.4 m -64.39 -78.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 18.54 109.649 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.68 -132.23 11.77 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.72 -1.352 . . . . 23.17 109.72 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -49.69 -14.73 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -1.097 . . . . 39.77 109.518 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 20' ' ' GLY . 1.0 OUTLIER -59.78 -53.61 55.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 26.65 109.161 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.4 63.9 0.49 Allowed Glycine 0 N--CA 1.506 3.357 0 C-N-CA 119.951 -1.119 . . . . 20.26 111.245 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.7 p90 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.069 -1.254 . . . . 17.79 110.063 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.512 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.44 -0.578 . . . . 17.42 109.44 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -55.4 -22.05 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 18.82 109.467 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -95.49 10.45 36.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 38.5 109.703 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -137.38 -15.12 1.46 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 36.83 110.557 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.46 -27.86 7.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.305 -0.872 . . . . 18.16 109.425 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.29 -41.04 13.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.111 . . . . 18.46 108.519 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.7 t -83.63 -16.33 45.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 m -143.2 -139.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -145.11 137.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 27.51 109.257 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.6 m -119.47 176.97 5.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.676 -0.64 . . . . 23.34 110.261 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.9 175.74 5.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.506 0.67 . . . . 22.64 109.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tp -51.8 -61.15 2.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.475 -0.766 . . . . 23.28 109.469 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -43.52 -54.7 4.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.795 . . . . 37.86 110.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -49.75 -44.8 48.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.757 -1.214 . . . . 31.39 109.002 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.25 -36.92 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 24.48 108.864 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.08 -18.93 64.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.417 -0.802 . . . . 31.48 109.78 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.31 -29.48 61.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 22.48 111.571 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -97.03 11.89 34.53 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.14 -0.975 . . . . 19.59 111.585 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 83.4 m -77.0 -175.52 3.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.761 -1.212 . . . . 20.62 109.315 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.956 -1.021 . . . . 24.65 109.233 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.375 -0.602 . . . . 30.1 109.375 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 6.8 p30 -131.57 107.4 8.83 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.416 -0.957 . . . . 32.24 108.416 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -157.11 164.46 37.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 30.21 109.846 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -76.76 100.85 5.59 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.217 -2.142 . . . . 24.0 105.217 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.47 136.04 38.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 19.63 111.809 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.75 -161.34 0.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.023 0.916 . . . . 17.19 111.758 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.5 -53.08 1.81 Allowed Glycine 0 N--CA 1.49 2.248 0 CA-C-N 115.781 -0.645 . . . . 16.55 112.603 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -77.96 -60.91 2.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.486 -1.597 . . . . 19.55 110.898 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -55.53 33.55 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.334 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 67' ' ' ILE . 27.5 tp -51.4 -47.54 62.9 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.823 -1.173 . . . . 14.16 108.381 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.49 -56.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.192 -1.41 . . . . 15.31 107.192 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -55.18 -61.75 2.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.959 -1.096 . . . . 29.64 108.101 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -44.93 -60.0 2.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.246 -0.909 . . . . 13.96 109.709 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 67' ' ' ILE . 10.9 mt -51.75 -51.59 55.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.441 -1.412 . . . . 17.79 108.164 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.91 -40.49 73.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 16.84 109.457 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 14' ' ' ALA . 63.8 mt -60.62 -24.61 65.65 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.083 -1.08 . . . . 22.76 108.083 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -97.3 -64.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.543 -0.723 . . . . 17.44 109.294 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' VAL . 11.6 m -64.24 -76.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 18.54 109.638 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.87 -138.29 20.59 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.675 -1.37 . . . . 23.17 109.675 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 8.2 tp10 -48.37 -17.03 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -1.104 . . . . 39.77 109.167 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' GLY . 50.3 mtt180 -54.88 -52.84 61.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 26.65 109.255 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.52 65.14 0.48 Allowed Glycine 0 N--CA 1.508 3.478 0 C-N-CA 119.745 -1.217 . . . . 20.26 111.722 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 28.7 p90 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.265 -1.138 . . . . 17.79 110.218 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 11' ' ' LEU . 2.6 tt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 120.996 0.427 . . . . 17.42 109.875 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -50.21 -41.53 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.973 -1.079 . . . . 18.82 109.781 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -78.54 10.9 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 38.5 109.94 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -134.03 -13.82 2.43 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.058 -1.026 . . . . 36.83 110.837 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.2 m -119.28 -25.53 6.09 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.257 -0.902 . . . . 18.16 109.043 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.12 -37.36 17.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.961 -1.087 . . . . 18.46 108.483 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -89.36 -9.87 48.77 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -146.77 -144.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.507 -0.923 . . . . 30.34 108.507 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 mt -145.89 122.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.061 -1.024 . . . . 27.51 109.365 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.9 m -106.24 175.5 5.48 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.625 -0.672 . . . . 23.34 109.541 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 m -112.4 176.49 5.0 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.551 0.691 . . . . 22.64 109.826 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -48.78 -60.08 3.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.566 -0.709 . . . . 23.28 109.651 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -43.5 -56.03 3.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.332 -0.855 . . . . 37.86 110.226 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -49.93 -46.47 52.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.727 -1.233 . . . . 31.39 108.918 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.444 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.99 -38.64 89.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.686 -0.857 . . . . 24.48 108.686 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -64.2 -18.92 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.479 -0.763 . . . . 31.48 109.728 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.12 -29.74 63.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 22.48 111.63 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.0 12.17 35.12 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 19.59 111.804 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.8 m -76.59 -175.64 3.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.608 -1.307 . . . . 20.62 109.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.955 -1.021 . . . . 24.65 109.343 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.447 0.642 . . . . 30.1 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.581 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 4.2 p30 -117.97 106.27 12.76 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.78 -1.192 . . . . 32.24 107.78 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 7.9 mm-40 -154.42 162.16 41.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.347 -0.846 . . . . 30.21 109.711 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -79.14 101.14 7.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.351 -2.092 . . . . 24.0 105.351 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.21 136.09 39.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.51 -0.744 . . . . 19.63 111.958 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.54 -162.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.07 0.938 . . . . 17.19 111.484 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.98 -51.68 1.55 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 115.662 -0.699 . . . . 16.55 112.774 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 p -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.458 -1.613 . . . . 19.55 110.792 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -55.2 38.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.29 -48.22 62.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.899 -1.125 . . . . 14.16 108.495 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -48.87 -55.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.204 -1.406 . . . . 15.31 107.204 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -56.06 -61.58 2.28 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.019 -1.104 . . . . 29.64 108.019 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.52 -59.54 2.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.01 -1.057 . . . . 13.96 109.679 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.53 -53.49 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.457 -1.402 . . . . 17.79 107.934 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.78 -49.92 61.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.508 -0.745 . . . . 16.84 109.108 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.86 -26.12 9.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.046 -1.034 . . . . 22.76 108.643 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.95 -64.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.352 -0.843 . . . . 17.44 109.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 9.9 m -64.32 -77.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 18.54 109.831 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 78.52 -133.82 13.28 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.773 -1.331 . . . . 23.17 109.773 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.42 -14.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.399 -1.06 . . . . 39.77 109.621 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 20' ' ' GLY . 8.8 mtp180 -59.01 -53.02 63.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 26.65 109.086 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.08 64.36 0.48 Allowed Glycine 0 N--CA 1.506 3.322 0 C-N-CA 119.744 -1.217 . . . . 20.26 111.531 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 29.8 p90 . . . . . 0 C--N 1.299 -1.627 0 O-C-N 121.287 -1.125 . . . . 17.79 109.848 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.004 -0.739 . . . . 17.42 109.004 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.478 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.5 t -52.3 -32.24 15.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.107 -0.996 . . . . 18.82 109.493 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -83.66 11.01 7.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 38.5 110.021 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 19.0 mt-30 -139.34 -12.89 1.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.051 . . . . 36.83 110.697 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.7 m -117.23 -30.58 5.57 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.407 -0.808 . . . . 18.16 109.099 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.34 -40.62 16.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 18.46 108.563 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -85.14 -12.52 52.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.477 -0.765 . . . . 0.0 109.213 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -145.72 -141.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.528 -0.916 . . . . 30.34 108.528 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.68 126.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.041 -1.037 . . . . 27.51 109.174 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.0 m -108.09 177.07 4.92 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.605 -0.685 . . . . 23.34 110.094 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.1 m -112.6 -178.99 3.53 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.49 0.662 . . . . 22.64 109.448 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.36 -56.05 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.779 . . . . 23.28 109.446 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -47.27 -50.94 20.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.395 -0.815 . . . . 37.86 110.171 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.96 -45.79 74.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.696 -1.253 . . . . 31.39 108.749 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.55 -37.72 84.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 24.48 108.643 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.29 -18.8 64.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.456 -0.778 . . . . 31.48 109.766 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -74.14 -29.51 61.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.711 . . . . 22.48 111.539 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -97.51 12.08 34.61 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.106 -0.997 . . . . 19.59 111.762 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 86.1 m -76.57 -175.77 3.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.597 -1.314 . . . . 20.62 109.207 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.018 -0.991 . . . . 24.65 109.441 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.379 0.609 . . . . 30.1 109.376 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.457 ' N ' ' CG2' ' A' ' 2' ' ' VAL . 10.7 p30 -132.52 107.88 8.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 32.24 108.533 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -156.55 162.75 39.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.511 -0.743 . . . . 30.21 109.417 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -76.46 100.72 5.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.25 -2.13 . . . . 24.0 105.25 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.21 136.05 39.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.386 -0.822 . . . . 19.63 111.707 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 m -124.06 -159.04 0.84 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.896 0.855 . . . . 17.19 112.168 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.49 -51.45 1.37 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.89 -0.506 . . . . 16.55 112.946 -176.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 m -81.82 -62.07 1.74 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.316 -1.696 . . . . 19.55 110.941 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -55.58 33.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 110.131 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 67' ' ' ILE . 26.7 tp -50.47 -51.36 47.74 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.782 -1.199 . . . . 14.16 108.369 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -46.66 -54.31 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.561 -1.274 . . . . 15.31 107.561 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.95 -61.85 2.24 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 29.64 108.098 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.51 -59.8 2.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.038 -1.039 . . . . 13.96 109.728 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 11.1 mt -51.17 -52.41 44.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.444 -1.41 . . . . 17.79 108.023 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -53.19 -45.8 68.71 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.1 -0.704 . . . . 16.84 109.1 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.08 -33.91 63.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.897 -1.127 . . . . 22.76 108.387 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -87.32 -64.84 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.369 -0.832 . . . . 17.44 109.378 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -63.18 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.897 . . . . 18.54 109.229 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.03 -130.55 10.53 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.772 -1.331 . . . . 23.17 109.772 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -50.22 -19.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 39.77 109.059 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' ' C ' ' A' ' 20' ' ' GLY . 7.6 mmt180 -55.47 -54.0 49.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 26.65 109.161 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.33 63.47 0.49 Allowed Glycine 0 N--CA 1.505 3.293 0 C-N-CA 119.958 -1.115 . . . . 20.26 111.681 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 18.6 p90 . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.04 -1.271 . . . . 17.79 109.75 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 11' ' ' LEU . 3.4 tt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.353 -0.61 . . . . 17.42 109.353 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' ILE . 22.0 t -56.98 -6.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.386 -0.821 . . . . 18.82 109.712 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' ILE . 6.7 tt0 -108.52 9.59 27.4 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 38.5 109.039 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 17.6 mt-30 -137.82 -15.23 1.37 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.236 -0.915 . . . . 36.83 109.936 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.5 m -114.24 -24.18 9.07 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.479 -0.763 . . . . 18.16 109.273 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 51.6 t -91.48 -43.05 9.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 18.46 108.551 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -85.16 -21.42 29.21 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.628 0.728 . . . . 0.0 109.12 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -139.38 -136.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.478 -0.934 . . . . 30.34 108.478 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -145.86 147.48 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 27.51 109.204 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 1.9 m -131.09 174.64 9.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.539 -0.726 . . . . 23.34 109.313 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -112.39 -179.04 3.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.476 -0.765 . . . . 22.64 109.849 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 tp -53.46 -55.49 24.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.707 . . . . 23.28 109.371 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -46.01 -55.93 6.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 37.86 109.901 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -50.57 -50.43 53.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.821 -1.175 . . . . 31.39 108.997 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.2 mp -58.38 -41.3 84.5 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.448 -0.783 . . . . 24.48 108.936 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -62.64 -18.76 62.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 31.48 109.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -72.59 -29.74 63.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.423 -0.798 . . . . 22.48 111.742 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -100.62 12.16 37.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 19.59 112.051 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.3 m -76.87 -175.81 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.584 -1.323 . . . . 20.62 109.188 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.0 -1.0 . . . . 24.65 109.301 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.545 0.688 . . . . 30.1 109.89 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.557 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.5 p-10 -134.91 106.65 6.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.007 -1.109 . . . . 32.24 108.007 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -156.33 167.42 30.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 30.21 109.865 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -78.51 101.06 7.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.17 -2.159 . . . . 24.0 105.17 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.4 mt -99.2 136.5 39.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.514 -0.742 . . . . 19.63 111.903 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.34 -162.89 0.94 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.973 . . . . 17.19 111.44 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.89 -50.96 1.51 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-N 115.751 -0.659 . . . . 16.55 112.723 -176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.4 m -79.17 -62.93 1.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.475 -1.603 . . . . 19.55 110.686 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.47 -55.45 34.63 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.033 -1.042 . . . . 0.0 110.038 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 67' ' ' ILE . 30.2 tp -50.7 -50.12 55.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.824 -1.172 . . . . 14.16 108.452 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.83 -56.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.58 -1.267 . . . . 15.31 107.58 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -55.65 -61.57 2.26 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.883 -1.154 . . . . 29.64 107.883 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.58 -59.61 2.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.03 -1.044 . . . . 13.96 109.762 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.44 -54.0 31.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.481 -1.387 . . . . 17.79 107.822 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -50.86 -50.4 57.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.526 -0.733 . . . . 16.84 109.127 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.1 mt -51.01 -26.93 6.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 22.76 108.6 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.37 -64.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.375 -0.828 . . . . 17.44 109.419 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.3 m -66.04 -83.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 18.54 109.982 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.77 -124.56 12.21 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.583 -1.294 . . . . 23.17 110.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -45.25 -20.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -1.048 . . . . 39.77 110.076 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 20' ' ' GLY . 84.4 mtt180 -66.75 -53.13 36.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -0.951 . . . . 26.65 109.807 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.49 64.15 0.49 Allowed Glycine 0 N--CA 1.508 3.457 0 C-N-CA 119.634 -1.27 . . . . 20.26 111.782 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.1 p90 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.296 . . . . 17.79 109.808 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.553 HD11 HD11 ' A' ' 11' ' ' LEU . 3.7 tt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.723 -0.473 . . . . 17.42 109.723 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' ILE . 6.3 t -54.26 -23.98 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.98 -1.075 . . . . 18.82 109.726 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -94.73 10.2 36.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.06 -1.025 . . . . 38.5 109.797 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.5 mt-30 -135.64 -14.26 1.92 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.067 -1.021 . . . . 36.83 110.391 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.28 -28.48 6.52 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.355 -0.841 . . . . 18.16 109.399 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.96 -38.85 16.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 18.46 108.656 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.4 t -87.83 -12.39 45.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.798 . . . . 0.0 109.062 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -145.8 -142.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.644 -0.873 . . . . 30.34 108.644 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.83 125.19 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.996 -1.065 . . . . 27.51 109.481 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -108.72 175.74 5.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.581 -0.7 . . . . 23.34 109.932 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -112.51 176.22 5.11 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.507 0.67 . . . . 22.64 109.644 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 tp -48.21 -60.02 2.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.518 -0.739 . . . . 23.28 109.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -42.03 -58.78 1.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 37.86 110.404 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 12.1 mp0 -48.62 -46.9 40.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.834 -1.166 . . . . 31.39 108.992 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.15 -38.81 90.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.704 -0.85 . . . . 24.48 108.704 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.58 -18.66 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.768 . . . . 31.48 109.631 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -74.05 -29.76 62.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.483 -0.76 . . . . 22.48 111.57 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -97.88 11.77 36.26 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.099 -1.001 . . . . 19.59 111.734 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.0 m -76.91 -175.76 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.606 -1.309 . . . . 20.62 109.111 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 117.967 -1.016 . . . . 24.65 109.255 179.732 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.445 0.64 . . . . 30.1 109.754 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.55 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.3 p-10 -133.2 106.58 7.66 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.204 -1.036 . . . . 32.24 108.204 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -156.57 164.08 38.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.226 -0.921 . . . . 30.21 109.382 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -77.46 101.17 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.154 -2.165 . . . . 24.0 105.154 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.38 132.21 44.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.875 . . . . 19.63 111.922 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.54 -158.53 0.74 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.163 -0.961 . . . . 17.19 111.697 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.26 -54.56 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 115.826 -0.625 . . . . 16.55 113.201 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -79.04 -63.25 1.46 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.273 -1.722 . . . . 19.55 111.085 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -55.81 28.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 110.371 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 67' ' ' ILE . 35.1 tp -50.42 -52.15 40.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.709 -1.244 . . . . 14.16 108.554 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -45.83 -55.83 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.71 -1.218 . . . . 15.31 107.71 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -56.46 -61.43 2.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.868 -1.16 . . . . 29.64 107.868 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.3 -59.73 2.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.011 . . . . 13.96 109.882 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 10.8 mt -52.16 -53.84 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.315 -1.491 . . . . 17.79 107.888 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -50.7 -47.41 58.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.009 -0.737 . . . . 16.84 109.009 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.48 -26.77 33.34 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.011 -1.056 . . . . 22.76 108.348 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.21 -64.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.887 . . . . 17.44 109.393 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.2 m -65.37 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.902 . . . . 18.54 110.036 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.37 -123.36 16.82 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.496 -1.335 . . . . 23.17 109.883 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.3 pm0 -44.9 -18.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.463 -1.022 . . . . 39.77 110.587 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 20' ' ' GLY . 26.1 mtt-85 -70.72 -52.67 19.41 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.936 -1.103 . . . . 26.65 110.159 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.22 64.34 0.5 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 119.611 -1.281 . . . . 20.26 111.529 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.4 p90 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.145 -1.209 . . . . 17.79 109.426 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 11' ' ' LEU . 3.6 tt . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 112.163 0.431 . . . . 17.42 112.163 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.63 ' N ' HG23 ' A' ' 67' ' ' ILE . 15.4 t -57.97 -7.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.626 -1.296 . . . . 18.82 109.603 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 67' ' ' ILE . 20.5 tp10 -113.02 9.26 18.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.144 -0.687 . . . . 38.5 109.144 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.8 mt-30 -138.88 -8.67 1.38 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 36.83 109.533 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.55 -31.9 4.46 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.6 -0.889 . . . . 18.16 108.6 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.06 -43.1 18.33 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 18.46 108.323 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 t -82.2 -21.79 36.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -136.81 -137.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.496 -0.928 . . . . 30.34 108.496 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.52 150.03 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.993 . . . . 27.51 109.294 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.4 m -135.14 176.65 8.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.388 -0.82 . . . . 23.34 109.956 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -112.37 -163.91 0.88 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.671 -0.643 . . . . 22.64 109.48 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.83 -60.75 2.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -0.755 . . . . 23.28 109.547 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -41.5 -57.38 2.24 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.574 -0.703 . . . . 37.86 110.522 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.71 -47.22 41.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.786 -1.196 . . . . 31.39 108.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.2 -38.18 88.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.291 -0.881 . . . . 24.48 108.987 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -18.79 64.84 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.504 -0.747 . . . . 31.48 109.75 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.32 -30.38 63.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 22.48 111.758 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.05 11.96 35.88 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.026 -1.046 . . . . 19.59 111.891 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.3 m -76.74 -175.62 3.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.682 -1.261 . . . . 20.62 109.096 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.984 -1.008 . . . . 24.65 109.403 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.7 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.326 -0.62 . . . . 30.1 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 9.1 p30 -129.23 107.76 9.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.583 -0.895 . . . . 32.24 108.583 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -156.73 163.04 39.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.846 . . . . 30.21 109.557 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -77.18 100.83 5.93 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.164 -2.162 . . . . 24.0 105.164 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.44 134.68 41.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.784 . . . . 19.63 111.731 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.5 -159.63 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.802 0.81 . . . . 17.19 112.103 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -35.92 -53.15 1.18 Allowed Glycine 0 N--CA 1.493 2.48 0 O-C-N 121.858 -0.526 . . . . 16.55 113.233 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 m -80.37 -62.25 1.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.385 -1.656 . . . . 19.55 110.932 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -55.4 35.3 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.911 -1.118 . . . . 0.0 110.276 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 67' ' ' ILE . 29.7 tp -50.89 -50.49 57.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.813 -1.179 . . . . 14.16 108.619 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.4 t -46.2 -57.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.459 -1.312 . . . . 15.31 107.459 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -55.56 -61.43 2.35 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.903 -1.147 . . . . 29.64 107.903 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -59.56 2.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.022 -1.049 . . . . 13.96 110.045 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.43 -55.0 21.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.342 -1.474 . . . . 17.79 107.703 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -49.33 -51.17 36.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.025 -0.732 . . . . 16.84 109.025 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.6 -26.87 5.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.063 -1.023 . . . . 22.76 108.62 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.81 -64.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.375 -0.828 . . . . 17.44 109.247 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.8 m -64.61 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 18.54 109.825 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 66.8 -120.12 13.65 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.632 -1.27 . . . . 23.17 110.12 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -48.74 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -1.071 . . . . 39.77 110.04 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -78.31 -52.76 8.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.888 -1.133 . . . . 26.65 109.646 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.76 63.36 0.48 Allowed Glycine 0 N--CA 1.508 3.46 0 C-N-CA 119.939 -1.124 . . . . 20.26 111.64 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 16.7 p90 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.955 -1.32 . . . . 17.79 109.975 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.675 0.25 . . . . 17.42 111.675 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 67' ' ' ILE . 9.9 t -57.17 -7.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.646 -1.284 . . . . 18.82 109.97 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -110.99 9.65 22.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.175 -0.953 . . . . 38.5 109.403 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 37.9 mt-30 -138.38 -8.93 1.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.402 -0.811 . . . . 36.83 109.876 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.4 m -120.25 -23.54 6.2 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.439 -0.788 . . . . 18.16 109.065 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 41.3 t -91.21 -41.84 10.76 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.203 -1.036 . . . . 18.46 108.203 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -85.19 -27.64 25.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -129.66 -138.21 0.22 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.511 -0.922 . . . . 30.34 108.511 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.25 149.61 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.003 . . . . 27.51 109.258 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -133.97 171.81 13.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.429 -0.794 . . . . 23.34 109.766 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -106.88 -153.93 0.51 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.493 -0.754 . . . . 22.64 109.479 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -77.78 -59.94 2.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.922 . . . . 23.28 109.014 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -42.21 -55.99 3.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.674 -0.641 . . . . 37.86 110.309 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -48.74 -47.15 41.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.932 -1.105 . . . . 31.39 109.005 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mp -63.13 -39.42 94.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 24.48 108.942 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.64 -19.0 61.78 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.399 -0.813 . . . . 31.48 109.878 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.43 -29.68 61.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 22.48 111.568 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -97.94 11.78 36.32 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.147 -0.971 . . . . 19.59 111.73 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.7 m -77.05 -175.71 3.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.641 -1.287 . . . . 20.62 109.196 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 118.029 -0.986 . . . . 24.65 109.368 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.439 0.638 . . . . 30.1 109.461 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.552 ' N ' HG22 ' A' ' 2' ' ' VAL . 7.5 p-10 -134.78 106.98 7.17 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.252 -1.018 . . . . 32.24 108.252 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -157.34 165.09 36.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 30.21 110.08 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -77.28 100.61 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.161 -2.163 . . . . 24.0 105.161 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.36 134.94 41.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 19.63 111.799 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.33 -162.44 0.89 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.152 -0.968 . . . . 17.19 111.636 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.51 -52.2 1.38 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 115.761 -0.654 . . . . 16.55 112.864 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -78.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.648 . . . . 19.55 110.669 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -55.47 33.28 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.106 -0.997 . . . . 0.0 110.136 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 67' ' ' ILE . 34.7 tp -51.09 -50.29 59.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.865 -1.147 . . . . 14.16 108.744 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.9 t -47.89 -55.87 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.65 -1.241 . . . . 15.31 107.65 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.09 -61.69 2.21 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.969 -1.123 . . . . 29.64 107.969 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.37 -59.32 2.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 13.96 109.975 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.88 -55.38 20.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.328 -1.482 . . . . 17.79 107.77 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -49.53 -48.94 47.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.255 -0.646 . . . . 16.84 109.255 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.4 mt -52.96 -25.88 13.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.984 -1.073 . . . . 22.76 108.587 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.92 -64.61 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 17.44 109.435 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.1 m -64.24 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 18.54 109.606 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 77.01 -133.14 12.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.718 -1.353 . . . . 23.17 109.718 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -49.45 -11.29 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -1.111 . . . . 39.77 109.594 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -63.7 -53.05 57.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 26.65 108.778 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.93 63.58 0.48 Allowed Glycine 0 N--CA 1.506 3.363 0 C-N-CA 119.941 -1.124 . . . . 20.26 111.562 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 26.0 p90 . . . . . 0 C--N 1.299 -1.61 0 O-C-N 121.166 -1.197 . . . . 17.79 109.935 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 11' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.157 -0.683 . . . . 17.42 109.157 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.4 t -52.09 -46.48 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.099 -1.001 . . . . 18.82 109.56 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.36 10.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 38.5 109.768 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 35.4 mt-30 -135.76 -10.56 2.08 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.127 -0.983 . . . . 36.83 110.843 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.5 m -123.84 -25.98 4.18 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.297 -0.877 . . . . 18.16 108.766 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.67 -39.68 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.299 -1.0 . . . . 18.46 108.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -88.03 -16.2 34.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -138.59 -142.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.461 -0.94 . . . . 30.34 108.461 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -144.91 142.0 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.041 -1.037 . . . . 27.51 109.15 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -129.07 173.58 10.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 23.34 109.631 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -112.17 -165.85 1.03 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.556 -0.715 . . . . 22.64 109.836 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 tp -64.26 -58.11 7.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 23.28 109.55 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -44.0 -58.19 2.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.813 . . . . 37.86 110.203 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -47.88 -47.64 31.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.147 . . . . 31.39 109.186 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.23 -40.03 94.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.02 -0.733 . . . . 24.48 109.02 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.98 -18.97 62.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 31.48 109.747 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -74.46 -29.87 61.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 22.48 111.48 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -97.16 11.79 35.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.114 -0.991 . . . . 19.59 111.796 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.6 m -77.38 -175.68 3.84 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.611 -1.305 . . . . 20.62 109.258 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 36.5 t-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.004 -0.998 . . . . 24.65 109.221 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.346 0.594 . . . . 30.1 109.492 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.504 ' N ' HG22 ' A' ' 2' ' ' VAL . 9.2 p-10 -131.99 106.94 8.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.455 -0.943 . . . . 32.24 108.455 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -157.59 163.01 38.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 30.21 109.686 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.45 100.78 6.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.125 -2.176 . . . . 24.0 105.125 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -97.68 132.93 42.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 19.63 111.996 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.67 -162.1 0.86 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.904 0.859 . . . . 17.19 111.427 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.14 -50.97 1.63 Allowed Glycine 0 N--CA 1.491 2.354 0 CA-C-N 115.957 -0.565 . . . . 16.55 112.888 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 p -79.38 -63.38 1.43 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.4 -1.647 . . . . 19.55 110.872 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -55.09 39.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 110.073 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 67' ' ' ILE . 29.0 tp -50.6 -49.77 55.67 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.728 -1.233 . . . . 14.16 108.429 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -48.24 -56.2 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.393 -1.336 . . . . 15.31 107.393 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -55.79 -61.46 2.35 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.843 -1.143 . . . . 29.64 108.036 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.98 2.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 13.96 109.662 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 10.5 mt -51.22 -50.25 59.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.565 -1.334 . . . . 17.79 108.026 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -56.06 -41.99 75.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 16.84 109.211 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.79 -28.19 65.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.785 -1.197 . . . . 22.76 107.961 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.83 -64.66 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.461 -0.774 . . . . 17.44 109.547 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.474 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.5 m -64.6 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 18.54 109.801 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 76.51 -134.18 15.02 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.756 -1.338 . . . . 23.17 109.756 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -48.26 -11.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.415 -1.05 . . . . 39.77 109.8 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' GLY . 51.7 mtt180 -65.33 -52.52 53.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.058 . . . . 26.65 108.95 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.37 0.49 Allowed Glycine 0 N--CA 1.506 3.325 0 C-N-CA 119.786 -1.197 . . . . 20.26 111.663 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.0 p90 . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.213 -1.169 . . . . 17.79 109.896 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 11' ' ' LEU . 2.5 tt . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.17 -0.678 . . . . 17.42 109.17 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.473 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.6 t -48.77 -49.76 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.202 -0.936 . . . . 18.82 109.822 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -69.77 10.65 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 38.5 110.221 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.497 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 30.4 mt-30 -132.75 -16.53 2.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.215 -0.928 . . . . 36.83 110.781 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.0 m -119.35 -25.09 6.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.42 -0.8 . . . . 18.16 108.965 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.2 t -85.92 -37.85 18.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 18.46 108.676 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -90.37 -8.91 49.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 108.857 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -148.42 -145.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.624 -0.88 . . . . 30.34 108.624 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 75' ' ' ILE . 19.3 mt -143.76 123.13 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.17 -0.956 . . . . 27.51 109.132 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.3 m -104.15 177.87 4.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.535 -0.728 . . . . 23.34 109.531 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 m -112.11 176.72 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.522 -0.737 . . . . 22.64 109.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -51.01 -59.64 3.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 23.28 109.495 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -43.68 -55.0 4.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.438 -0.789 . . . . 37.86 110.163 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -49.48 -48.16 47.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.723 -1.236 . . . . 31.39 108.907 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.58 -38.65 88.32 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 24.48 108.967 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.98 -18.98 64.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.394 -0.816 . . . . 31.48 109.827 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -73.95 -29.4 61.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 22.48 111.522 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.83 11.72 36.33 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.133 -0.979 . . . . 19.59 111.693 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.71 -175.83 3.57 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.567 -1.333 . . . . 20.62 109.271 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 118.082 -0.961 . . . . 24.65 109.495 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.636 0.731 . . . . 30.1 110.107 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.549 ' N ' HG22 ' A' ' 2' ' ' VAL . 8.0 p-10 -135.03 107.8 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.13 -1.063 . . . . 32.24 108.13 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -156.82 166.95 31.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 30.21 109.657 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -77.34 100.66 6.0 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.025 -2.213 . . . . 24.0 105.025 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' CYS . 14.2 mt -99.15 134.55 41.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.527 -0.733 . . . . 19.63 111.683 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 m -122.63 -157.36 0.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.951 0.881 . . . . 17.19 112.473 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.65 -54.35 1.38 Allowed Glycine 0 N--CA 1.493 2.496 0 CA-C-N 116.042 -0.526 . . . . 16.55 113.012 -176.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -80.45 -60.38 2.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.47 -1.606 . . . . 19.55 111.04 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -55.63 32.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 110.474 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD21 HD13 ' A' ' 67' ' ' ILE . 25.5 tp -51.78 -47.03 64.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.68 -1.263 . . . . 14.16 108.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -49.72 -57.13 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.237 -1.394 . . . . 15.31 107.237 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -55.69 -61.34 2.43 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.009 -1.077 . . . . 29.64 108.276 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -44.87 -59.62 2.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.087 -1.008 . . . . 13.96 109.747 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.73 -51.46 55.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.389 -1.444 . . . . 17.79 107.94 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -54.16 -43.56 70.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.466 -0.771 . . . . 16.84 109.113 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.61 -28.88 61.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.926 -1.109 . . . . 22.76 108.238 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -94.03 -64.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 17.44 109.493 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.3 m -64.21 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 18.54 109.856 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 73.09 -129.81 13.13 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.635 -1.269 . . . . 23.17 110.034 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.3 pm0 -46.54 -13.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -1.003 . . . . 39.77 110.018 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' GLY . 60.7 mtt180 -68.06 -52.89 30.11 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.088 -1.008 . . . . 26.65 109.522 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.9 64.15 0.48 Allowed Glycine 0 N--CA 1.508 3.442 0 C-N-CA 119.717 -1.23 . . . . 20.26 111.698 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 26.1 p90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.165 -1.197 . . . . 17.79 110.039 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.946 -0.761 . . . . 17.42 108.946 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.0 t -50.85 -48.83 28.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 18.82 109.411 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.16 10.46 0.15 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.2 -0.937 . . . . 38.5 110.721 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 38.7 mt-30 -137.79 -14.21 1.43 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.921 -1.112 . . . . 36.83 111.005 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.1 m -120.82 -21.62 6.54 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.934 . . . . 18.16 109.108 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.7 t -90.82 -39.85 12.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.101 -1.074 . . . . 18.46 108.101 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -88.39 -18.77 27.68 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -140.12 -144.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.351 -0.981 . . . . 30.34 108.351 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.65 151.27 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.111 -0.993 . . . . 27.51 109.031 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -135.55 172.29 13.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.475 -0.765 . . . . 23.34 109.68 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 m -111.63 -176.47 2.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.519 -0.738 . . . . 22.64 110.076 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.48 -57.33 12.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 23.28 109.46 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -44.0 -50.57 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 37.86 110.027 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -57.06 -53.26 60.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.981 -1.074 . . . . 31.39 108.814 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.5 mp -55.51 -39.63 70.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.777 -0.823 . . . . 24.48 108.777 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.98 -18.71 65.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.528 -0.733 . . . . 31.48 109.944 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.95 -28.44 61.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 22.48 111.568 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 20.6 m-85 -101.0 12.08 38.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.252 -0.905 . . . . 19.59 111.991 -177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.1 m -76.75 -175.62 3.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.614 -1.304 . . . . 20.62 109.134 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 118.037 -0.982 . . . . 24.65 109.446 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.6 p . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.229 -0.656 . . . . 30.1 109.229 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 9.5 p30 -129.65 108.11 9.95 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.736 -0.839 . . . . 32.24 108.736 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -156.64 163.66 39.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 30.21 109.5 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -76.18 100.73 5.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.246 -2.131 . . . . 24.0 105.246 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.0 134.63 41.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 19.63 111.738 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.49 -161.46 0.89 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.093 -1.005 . . . . 17.19 111.806 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.22 -47.37 1.44 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.703 -0.68 . . . . 16.55 112.77 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -82.94 -62.46 1.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.349 -1.677 . . . . 19.55 110.734 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -55.49 34.5 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.006 -1.059 . . . . 0.0 109.993 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 29.8 tp -49.97 -50.92 45.15 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.698 -1.251 . . . . 14.16 108.269 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.05 -54.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.453 -1.314 . . . . 15.31 107.453 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.17 -61.71 2.28 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.949 -1.1 . . . . 29.64 108.257 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.34 -59.87 2.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.118 -0.989 . . . . 13.96 109.518 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.5 mt -51.05 -49.14 61.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.585 -1.322 . . . . 17.79 108.102 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.51 -40.72 79.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 16.84 109.011 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.63 -29.54 68.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.915 -1.116 . . . . 22.76 108.086 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.28 -64.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.479 -0.763 . . . . 17.44 109.555 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -64.34 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 18.54 109.685 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.59 -122.96 11.02 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.617 -1.277 . . . . 23.17 110.077 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -50.64 -11.7 0.09 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -1.055 . . . . 39.77 110.386 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' GLY . 31.1 mtt-85 -73.32 -52.09 15.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.871 -1.143 . . . . 26.65 109.668 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.03 64.31 0.48 Allowed Glycine 0 N--CA 1.508 3.467 0 C-N-CA 119.756 -1.211 . . . . 20.26 111.685 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.413 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.2 p90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.004 -1.292 . . . . 17.79 109.169 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.597 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.753 0.311 . . . . 17.42 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.597 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.1 t -54.96 -12.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.748 -1.22 . . . . 18.82 110.222 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -105.14 9.91 34.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 38.5 109.773 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -137.01 -14.91 1.55 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.283 -0.886 . . . . 36.83 109.857 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.8 m -112.49 -29.26 7.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.402 -0.811 . . . . 18.16 108.993 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.44 -44.47 11.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.105 . . . . 18.46 108.825 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -81.44 -14.56 56.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.4 t -147.71 -137.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.444 -0.947 . . . . 30.34 108.444 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.81 149.59 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.076 -1.015 . . . . 27.51 109.349 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -131.47 176.32 8.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.487 -0.758 . . . . 23.34 109.587 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.26 171.17 7.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.661 -0.649 . . . . 22.64 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 tp -45.09 -61.16 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 23.28 109.502 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -41.33 -54.73 2.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.692 . . . . 37.86 110.531 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.409 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 8.4 mp0 -52.16 -49.49 63.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 31.39 108.578 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -58.56 -40.01 81.84 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.655 -0.868 . . . . 24.48 108.655 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.84 -18.75 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.426 -0.796 . . . . 31.48 109.923 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.87 -29.02 61.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.813 . . . . 22.48 111.692 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -99.56 11.98 37.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.139 -0.976 . . . . 19.59 111.857 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -76.81 -175.82 3.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.579 -1.326 . . . . 20.62 109.025 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.018 -0.991 . . . . 24.65 109.292 179.771 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.349 -0.612 . . . . 30.1 109.349 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 7.5 p30 -127.54 106.4 9.15 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.547 -0.909 . . . . 32.24 108.547 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -157.09 164.27 38.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 30.21 109.574 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -78.37 100.61 6.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.264 -2.124 . . . . 24.0 105.264 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.22 135.02 40.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 19.63 111.671 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.8 m -123.99 -158.35 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.895 0.855 . . . . 17.19 112.438 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.56 -51.29 1.39 Allowed Glycine 0 N--CA 1.492 2.429 0 CA-C-N 115.991 -0.55 . . . . 16.55 112.997 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m -82.48 -60.95 2.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.382 -1.658 . . . . 19.55 110.975 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -55.68 31.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.376 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 67' ' ' ILE . 23.8 tp -50.53 -48.4 57.16 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.677 -1.264 . . . . 14.16 108.36 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.14 -54.3 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.128 -1.434 . . . . 15.31 107.128 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.78 -61.48 2.49 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.951 -1.1 . . . . 29.64 108.322 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.15 -60.3 2.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 13.96 109.653 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 67' ' ' ILE . 11.3 mt -51.22 -48.34 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.559 -1.338 . . . . 17.79 108.046 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -58.86 -39.49 81.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.535 -0.728 . . . . 16.84 109.119 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.65 -31.22 70.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 22.76 108.08 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -89.65 -64.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.519 -0.738 . . . . 17.44 109.496 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.1 m -64.0 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 18.54 109.37 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.97 -132.84 12.21 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.564 -1.414 . . . . 23.17 109.564 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 -13.65 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -1.132 . . . . 39.77 109.49 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -60.32 -53.27 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.94 . . . . 26.65 109.217 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.66 64.5 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.885 -1.15 . . . . 20.26 111.196 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.4 p90 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.213 -1.169 . . . . 17.79 110.172 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 108.79 -0.818 . . . . 17.42 108.79 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.45 -53.62 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.054 -1.029 . . . . 18.82 109.461 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.52 10.61 0.09 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.309 -0.869 . . . . 38.5 110.248 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -135.1 -16.28 1.92 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.979 -1.075 . . . . 36.83 110.69 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.65 -23.73 6.45 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.41 -0.806 . . . . 18.16 109.096 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.6 t -87.44 -36.74 17.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.342 -0.984 . . . . 18.46 108.342 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -91.45 -16.87 26.64 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -138.71 -144.66 0.18 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -145.11 117.29 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.982 -1.074 . . . . 27.51 109.37 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -100.5 177.41 5.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.382 -0.824 . . . . 23.34 109.852 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 m -112.36 -175.38 2.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.548 -0.72 . . . . 22.64 109.752 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 tp -57.26 -56.46 21.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.514 -0.741 . . . . 23.28 109.478 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -44.91 -57.43 3.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 37.86 109.933 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -48.6 -48.52 39.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.87 -1.144 . . . . 31.39 108.987 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -60.95 -39.93 91.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.814 -0.809 . . . . 24.48 108.814 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.27 -18.95 64.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 31.48 109.662 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -73.19 -29.78 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 22.48 111.589 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.04 12.21 36.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.036 -1.04 . . . . 19.59 111.788 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 77.9 m -76.66 -175.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.658 -1.277 . . . . 20.62 109.253 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.95 -1.024 . . . . 24.65 109.452 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.421 0.629 . . . . 30.1 109.533 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.525 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.7 p-10 -132.97 106.77 7.87 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.298 -1.001 . . . . 32.24 108.298 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -157.38 164.62 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 30.21 109.824 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -77.67 100.57 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.173 -2.158 . . . . 24.0 105.173 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.8 mt -99.44 135.31 41.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 19.63 111.72 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.2 m -122.91 -157.58 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.97 0.89 . . . . 17.19 112.424 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.72 -55.47 1.35 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-N 116.043 -0.526 . . . . 16.55 113.06 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -79.63 -58.49 3.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.383 -1.657 . . . . 19.55 111.152 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -55.94 27.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 110.419 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 67' ' ' ILE . 24.9 tp -51.12 -48.83 61.67 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.69 -1.256 . . . . 14.16 108.359 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -48.28 -55.06 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.451 -1.315 . . . . 15.31 107.451 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.97 -61.76 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.119 -1.067 . . . . 29.64 108.119 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.47 -59.6 2.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.102 -0.999 . . . . 13.96 109.686 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 11.2 mt -51.61 -53.46 38.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.486 -1.384 . . . . 17.79 107.906 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -52.11 -45.63 64.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.497 -0.752 . . . . 16.84 109.176 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -56.45 -30.98 63.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.957 -1.09 . . . . 22.76 108.336 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -89.94 -64.6 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.389 -0.819 . . . . 17.44 109.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -64.13 -79.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 18.54 109.45 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 75.81 -131.72 12.25 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.816 -1.314 . . . . 23.17 109.816 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -50.09 -10.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -1.088 . . . . 39.77 109.521 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.47 -52.97 49.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 26.65 108.994 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.75 63.93 0.49 Allowed Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.936 -1.126 . . . . 20.26 111.46 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 23.9 p90 . . . . . 0 C--N 1.3 -1.576 0 O-C-N 121.146 -1.208 . . . . 17.79 110.162 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 11' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.18 -0.674 . . . . 17.42 109.18 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.93 -50.3 19.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.208 -0.932 . . . . 18.82 109.663 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.23 10.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 38.5 110.644 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.1 mt-30 -137.83 -16.11 1.32 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.819 -1.176 . . . . 36.83 110.651 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.0 m -118.62 -23.06 7.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.339 -0.85 . . . . 18.16 109.216 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.3 t -89.72 -37.83 14.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.466 -0.939 . . . . 18.46 108.466 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 m -133.58 -141.96 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.839 . . . . 30.34 108.736 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.05 130.08 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.995 . . . . 27.51 109.23 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -114.27 175.54 5.43 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.672 -0.643 . . . . 23.34 109.77 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 m -112.53 -178.08 3.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.622 -0.674 . . . . 22.64 109.758 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.37 -60.82 2.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.494 -0.754 . . . . 23.28 109.629 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -42.33 -56.75 2.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 37.86 110.39 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -49.2 -47.65 45.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.761 -1.212 . . . . 31.39 108.921 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.35 -39.27 89.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 24.48 108.806 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 -18.82 64.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.495 -0.753 . . . . 31.48 109.745 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -73.21 -30.21 63.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 22.48 111.644 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 25.7 m-85 -98.8 12.14 36.58 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.145 -0.972 . . . . 19.59 111.805 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.6 m -76.71 -175.81 3.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.593 -1.317 . . . . 20.62 109.328 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 117.987 -1.006 . . . . 24.65 109.342 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.255 0.55 . . . . 30.1 109.546 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 10.3 p30 -131.37 107.66 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.471 -0.937 . . . . 32.24 108.471 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -156.63 163.14 39.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 30.21 109.448 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.02 101.09 5.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.212 -2.144 . . . . 24.0 105.212 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.15 136.85 37.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.772 . . . . 19.63 111.769 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.33 -164.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.145 -0.972 . . . . 17.19 111.675 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.51 -44.94 1.31 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 115.673 -0.694 . . . . 16.55 112.553 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.9 p -83.39 -62.77 1.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.388 -1.654 . . . . 19.55 110.494 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -55.2 38.16 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 67' ' ' ILE . 30.3 tp -49.72 -50.88 42.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.747 -1.221 . . . . 14.16 108.32 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.45 -55.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.489 -1.3 . . . . 15.31 107.489 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -56.93 -61.39 2.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.959 -1.126 . . . . 29.64 107.959 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.6 -59.55 2.68 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 13.96 109.692 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.57 -53.39 38.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.522 -1.361 . . . . 17.79 108.009 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -51.86 -48.36 64.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 16.84 109.151 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.12 -28.63 26.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.053 . . . . 22.76 108.588 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -93.9 -64.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.461 -0.774 . . . . 17.44 109.424 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -65.13 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 18.54 109.909 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.93 -122.91 17.44 Favored Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.605 -1.284 . . . . 23.17 110.191 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.03 -19.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -1.003 . . . . 39.77 109.776 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 73.0 mtt180 -67.07 -52.92 36.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.199 -0.938 . . . . 26.65 109.788 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.25 0.48 Allowed Glycine 0 N--CA 1.508 3.454 0 C-N-CA 119.728 -1.225 . . . . 20.26 111.931 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 18.2 p90 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.987 -1.302 . . . . 17.79 109.262 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 11' ' ' LEU . 2.0 tt . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 108.245 -1.02 . . . . 17.42 108.245 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' H ' HG23 ' A' ' 68' ' ' VAL . 3.9 t -52.37 -36.43 21.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.381 -0.824 . . . . 18.82 109.597 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -80.79 10.36 5.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 38.5 109.627 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.5 mt-30 -136.44 -10.11 1.91 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.042 -1.036 . . . . 36.83 110.57 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.7 m -121.85 -26.05 4.9 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.338 -0.852 . . . . 18.16 108.987 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.5 t -88.26 -39.5 14.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 18.46 108.607 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -84.77 -15.25 45.63 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -143.93 -138.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.114 -1.069 . . . . 30.34 108.114 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -145.52 148.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 27.51 109.045 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.6 m -131.05 173.57 10.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 23.34 109.707 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.8 m -112.16 -176.65 2.97 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.684 . . . . 22.64 109.613 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 tp -56.53 -59.25 5.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 23.28 109.412 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -43.12 -55.07 4.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 37.86 110.262 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -52.39 -48.97 65.33 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.877 -1.139 . . . . 31.39 108.952 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.09 -40.51 89.86 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.713 -0.847 . . . . 24.48 108.713 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.82 -18.87 61.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.506 -0.746 . . . . 31.48 109.952 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -29.82 62.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 22.48 111.742 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -97.79 11.56 36.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.082 -1.011 . . . . 19.59 111.807 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.96 -175.77 3.67 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.558 -1.339 . . . . 20.62 109.063 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 118.015 -0.993 . . . . 24.65 109.494 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.485 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 15.2 t80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.159 -0.682 . . . . 24.77 109.159 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p -86.47 148.17 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.231 -0.918 . . . . 30.1 110.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.557 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 6.7 p30 -116.68 107.25 14.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.941 -1.133 . . . . 32.24 107.941 178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.557 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 9.0 mm-40 -153.65 165.52 35.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.317 -0.865 . . . . 30.21 109.512 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -78.34 101.63 7.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.07 -2.196 . . . . 24.0 105.07 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -98.65 135.41 40.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.336 -0.853 . . . . 19.63 112.297 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.67 -161.16 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.275 -0.891 . . . . 17.19 111.656 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.11 -55.11 1.51 Allowed Glycine 0 N--CA 1.49 2.266 0 CA-C-N 115.899 -0.591 . . . . 16.55 112.75 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.7 p -76.73 -61.56 1.93 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.5 -1.588 . . . . 19.55 110.983 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -55.51 33.99 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.123 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 67' ' ' ILE . 30.6 tp -50.82 -49.9 57.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 14.16 108.476 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.76 -56.71 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.532 -1.284 . . . . 15.31 107.532 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -55.9 -61.0 2.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.026 -1.101 . . . . 29.64 108.026 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.19 -59.75 2.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.101 -0.999 . . . . 13.96 109.825 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.72 -50.48 60.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.425 -1.422 . . . . 17.79 107.891 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -55.29 -43.7 75.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 16.84 109.183 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.6 mt -56.53 -25.29 51.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 22.76 108.176 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -97.37 -64.43 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 17.44 109.431 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.8 m -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 18.54 110.005 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.98 -122.59 13.42 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.665 -1.255 . . . . 23.17 110.125 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.62 -18.67 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.425 -1.044 . . . . 39.77 110.237 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.526 HH11 ' HG2' ' A' ' 22' ' ' ARG . 9.5 mtt-85 -70.12 -53.07 18.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.974 -1.079 . . . . 26.65 110.097 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 64.02 0.5 Allowed Glycine 0 N--CA 1.508 3.475 0 C-N-CA 119.726 -1.226 . . . . 20.26 111.759 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.536 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 20.8 p90 -76.22 127.11 32.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.269 . . . . 17.79 110.098 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -96.88 104.16 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.838 -1.171 . . . . 18.55 107.838 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' CE1' HD23 ' A' ' 11' ' ' LEU . 6.3 t80 -57.14 128.27 36.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.087 -1.008 . . . . 21.49 109.27 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' PHE . 2.3 p -126.13 147.22 49.66 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.568 -0.707 . . . . 31.5 109.413 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -160.28 102.09 1.38 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.387 -0.821 . . . . 0.0 108.924 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.89 -29.99 88.15 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.77 0.98 . . . . 0.0 110.514 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.732 ' O ' HG23 ' A' ' 30' ' ' THR . 15.0 t -69.74 77.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.527 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -86.85 -21.88 26.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -156.0 62.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -46.91 120.49 3.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . -74.43 -144.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 58.32 -4.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 34' ' ' ALA . 21.8 t0 -96.65 -12.09 24.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.02 -1.05 . . . . 0.0 109.248 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.14 -160.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.3 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.0 mp0 -62.49 -160.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 109.53 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 t 61.68 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.68 -105.96 3.36 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.18 102.41 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -1.15 . . . . 0.0 108.287 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 43' ' ' GLU . 30.1 m -116.78 -41.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.602 -0.686 . . . . 0.0 109.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 42' ' ' VAL . 22.8 tt0 -176.36 -25.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.2 mp -91.34 57.46 3.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.66 -75.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -175.02 74.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.72 66.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.087 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.43 -11.24 8.1 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.362 1.375 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.57 160.84 43.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.49 66.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.153 . . . . 0.0 109.552 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.71 18.61 65.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 t -80.22 -33.03 38.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -78.13 161.81 27.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.096 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.564 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 159.25 80.72 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.53 130.36 29.69 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.121 1.214 . . . . 0.0 109.739 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.55 -27.22 57.14 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.408 -0.808 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.06 -61.06 2.37 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.316 -0.865 . . . . 0.0 110.006 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.8 mm? -59.62 -37.48 78.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.255 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -46.13 -34.81 4.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.91 -44.56 5.68 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LYS . 28.5 p -78.42 -7.5 57.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -1.155 . . . . 0.0 109.803 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -50.35 -61.34 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 108.849 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -86.34 -41.1 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -89.27 -160.23 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.057 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -150.91 -3.38 0.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.103 -0.998 . . . . 0.0 109.102 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.27 170.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 19.62 109.943 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 11' ' ' LEU . 2.7 tt -134.41 -42.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.967 . . . . 17.42 108.583 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -51.66 -41.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.2 -0.938 . . . . 18.82 109.425 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -76.48 10.31 2.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.3 -0.875 . . . . 38.5 110.014 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.4 mt-30 -136.51 -12.78 1.79 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.156 -0.965 . . . . 36.83 110.707 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.2 m -119.88 -27.12 5.47 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.376 -0.828 . . . . 18.16 109.071 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.2 t -86.36 -38.19 17.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.053 . . . . 18.46 108.515 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -87.76 -14.93 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.534 -0.729 . . . . 0.0 109.261 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 m -141.78 -141.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.527 -0.916 . . . . 30.34 108.527 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 75' ' ' ILE . 12.5 mt -145.8 128.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.958 . . . . 27.51 109.209 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -111.39 176.82 4.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.591 -0.693 . . . . 23.34 109.931 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -112.62 -170.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.472 0.653 . . . . 22.64 109.623 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.485 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.1 tp -62.24 -59.8 4.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.449 -0.782 . . . . 23.28 109.359 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -43.05 -57.92 2.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.768 . . . . 37.86 110.38 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -48.74 -45.02 39.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.857 -1.152 . . . . 31.39 109.018 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.47 -37.64 88.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 24.48 108.705 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.43 -18.72 64.99 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.795 . . . . 31.48 109.669 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.08 -30.36 63.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.527 -0.733 . . . . 22.48 111.581 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -98.05 12.07 35.54 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 19.59 111.975 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.9 m -76.55 -175.68 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.551 -1.343 . . . . 20.62 108.982 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.0 -1.0 . . . . 24.65 109.504 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.434 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.8 t80 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.294 -0.632 . . . . 24.77 109.294 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -168.08 160.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 30.1 109.22 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.465 ' N ' HG22 ' A' ' 2' ' ' VAL . 7.7 p30 -133.33 107.76 8.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.345 -0.983 . . . . 32.24 108.345 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -156.76 166.04 34.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -0.813 . . . . 30.21 110.083 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -77.26 100.99 6.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.64 136.88 38.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.72 . . . . 19.63 111.749 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.84 -160.51 0.85 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.216 1.007 . . . . 17.19 111.849 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.53 -54.06 1.76 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 115.552 -0.749 . . . . 16.55 112.772 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -78.9 -56.82 4.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.341 -1.682 . . . . 19.55 110.976 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.49 -55.54 26.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.928 -1.107 . . . . 0.0 110.337 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.75 -48.55 63.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.797 -1.19 . . . . 14.16 108.453 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 8' ' ' GLY . 3.2 t -48.84 -55.17 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.307 -1.368 . . . . 15.31 107.307 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.11 -61.91 2.06 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.098 -1.075 . . . . 29.64 108.098 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.75 -59.73 2.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.092 -1.005 . . . . 13.96 109.842 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.481 HD11 HD13 ' A' ' 67' ' ' ILE . 10.7 mt -51.98 -52.06 53.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.484 -1.385 . . . . 17.79 107.977 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -53.84 -46.32 71.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.527 -0.733 . . . . 16.84 109.216 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.23 -31.52 61.55 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.008 -1.058 . . . . 22.76 108.501 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -89.47 -64.67 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.785 . . . . 17.44 109.257 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' N ' HG12 ' A' ' 18' ' ' VAL . 12.9 m -63.81 -76.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 18.54 109.414 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.09 -139.69 22.97 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.538 -1.425 . . . . 23.17 109.538 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.4 pm0 -47.28 -15.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -1.166 . . . . 39.77 109.535 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' GLY . 56.1 mtt180 -57.33 -52.3 65.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -0.926 . . . . 26.65 109.036 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.38 64.82 0.48 Allowed Glycine 0 N--CA 1.507 3.399 0 C-N-CA 119.73 -1.224 . . . . 20.26 111.902 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.417 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 27.3 p90 -75.62 134.11 40.72 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.282 -1.128 . . . . 17.79 110.111 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.22 114.34 26.02 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.636 -0.875 . . . . 18.55 108.636 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' A' ' 11' ' ' LEU . 5.6 t80 -90.36 157.66 17.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 21.49 109.092 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.4 p -152.76 115.06 4.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.069 -1.019 . . . . 31.5 109.863 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -172.77 88.02 0.41 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -54.71 -29.2 60.68 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.043 1.162 . . . . 0.0 110.295 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.32 169.46 4.62 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -165.6 -89.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.031 . . . . 0.0 110.003 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -77.8 67.57 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.9 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -83.5 92.59 7.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.298 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . -157.24 -177.7 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.539 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 34' ' ' ALA . 47.8 mt-10 51.17 179.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 1.3 p30 -73.13 112.09 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.4 mm? -69.04 105.08 2.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.11 163.29 24.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.187 -0.946 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.4 t -147.05 158.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.426 -0.796 . . . . 0.0 109.263 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . -43.18 94.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER 20.0 75.72 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.233 0.54 . . . . 0.0 112.196 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 4.0 m -104.71 20.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 6.5 tt0 77.56 153.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.024 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.2 4.31 31.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.652 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -79.19 -18.47 74.31 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.55 80.59 0.14 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.52 67.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.56 -62.94 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.44 1.427 . . . . 0.0 109.937 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 163.82 102.49 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.38 59.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 -128.74 33.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -159.65 104.55 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 mt -136.05 -122.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.397 -0.814 . . . . 0.0 109.22 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -86.34 153.88 56.61 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 108.998 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.29 138.08 82.47 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.978 1.119 . . . . 0.0 109.845 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.9 mt -54.9 -37.65 66.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.56 -56.5 19.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.909 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -63.11 -45.04 93.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.98 . . . . 0.0 109.523 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -47.41 -28.46 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 109.794 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.12 -64.48 1.41 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -42.88 -30.11 0.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -1.045 . . . . 0.0 110.522 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.55 -31.56 71.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.48 -44.88 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 109.799 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -77.4 141.53 39.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.817 -1.177 . . . . 0.0 108.925 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -54.11 -57.31 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.08 40.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.535 -1.317 . . . . 19.62 111.089 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.0 tt -142.27 -50.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.311 . . . . 17.42 109.382 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.612 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.0 t -54.83 -31.59 24.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.829 -1.17 . . . . 18.82 108.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.77 10.56 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 38.5 109.397 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -136.67 -14.45 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.185 -0.947 . . . . 36.83 110.617 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m -115.41 -27.14 7.29 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.285 -0.884 . . . . 18.16 109.054 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.8 t -86.6 -42.03 13.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.826 -1.171 . . . . 18.46 108.413 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -82.37 -16.14 50.21 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -142.76 -139.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.491 -0.929 . . . . 30.34 108.491 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.33 148.7 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.018 -1.051 . . . . 27.51 109.332 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.6 m -133.61 175.61 9.28 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 23.34 109.852 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OE1' ' A' ' 80' ' ' GLN . 2.9 p -112.73 179.47 3.96 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.541 0.686 . . . . 22.64 109.8 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -52.34 -60.62 3.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 23.28 109.423 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -42.61 -56.86 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.536 -0.727 . . . . 37.86 110.376 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' OE1' ' OG ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -48.98 -48.48 43.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.815 -1.178 . . . . 31.39 108.801 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.45 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.67 -39.41 88.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 24.48 109.097 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.43 -19.01 64.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 31.48 109.966 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.81 -29.34 63.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 22.48 111.552 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.7 12.34 35.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.191 -0.943 . . . . 19.59 111.898 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.57 -175.81 3.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.569 -1.332 . . . . 20.62 109.306 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 118.007 -0.996 . . . . 24.65 109.424 179.781 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.7 t80 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.168 -0.678 . . . . 24.77 109.168 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -165.54 160.03 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 30.1 109.331 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 8.5 p30 -130.64 107.25 9.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.485 -0.931 . . . . 32.24 108.485 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -157.12 165.17 36.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 30.21 109.715 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -78.14 100.37 6.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.164 -2.161 . . . . 24.0 105.164 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.63 137.82 36.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.547 -0.721 . . . . 19.63 111.615 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 m -125.68 -160.49 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.038 0.923 . . . . 17.19 112.538 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -49.25 1.34 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 115.946 -0.57 . . . . 16.55 112.793 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -83.27 -60.71 2.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.402 -1.646 . . . . 19.55 110.802 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -55.57 31.86 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 110.308 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 67' ' ' ILE . 24.7 tp -51.38 -46.39 62.77 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.688 -1.258 . . . . 14.16 108.347 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.5 t -50.1 -56.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.932 -1.507 . . . . 15.31 106.932 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -56.07 -61.59 2.28 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.099 -1.041 . . . . 29.64 108.233 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.25 -60.04 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.073 -1.017 . . . . 13.96 109.807 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.26 -49.04 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.612 -1.305 . . . . 17.79 107.919 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.8 -43.06 85.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 16.84 109.232 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.37 -27.68 62.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.933 -1.105 . . . . 22.76 108.215 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -93.74 -64.66 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 17.44 109.535 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 18' ' ' VAL . 18.0 m -63.14 -74.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 18.54 109.567 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -132.54 11.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.92 -1.272 . . . . 23.17 109.92 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -57.24 -12.62 2.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.427 -1.043 . . . . 39.77 109.556 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 22' ' ' ARG . 12.1 mtt-85 -57.79 -51.86 67.85 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.007 -1.058 . . . . 26.65 109.233 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 65.47 0.48 Allowed Glycine 0 N--CA 1.508 3.451 0 C-N-CA 119.628 -1.272 . . . . 20.26 111.446 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 31.1 p90 -75.53 123.01 24.73 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.301 -1.117 . . . . 17.79 110.271 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.78 112.8 20.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.481 -0.762 . . . . 18.55 108.974 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 4.4 t80 -95.61 146.9 24.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 21.49 109.139 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -148.4 146.21 28.37 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 31.5 109.086 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -139.33 141.78 30.24 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.216 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 30' ' ' THR . 4.1 Cg_exo -55.26 -6.7 0.89 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.557 ' H ' ' C ' ' A' ' 28' ' ' LYS . 3.6 m 100.26 34.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 123.643 0.777 . . . . 0.0 109.157 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.414 ' HG3' HH11 ' A' ' 31' ' ' ARG . 29.2 mtm-85 43.09 -130.17 0.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.512 -0.742 . . . . 0.0 110.162 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.76 -166.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.26 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 57.06 43.55 24.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 36' ' ' ASP . . . -72.5 115.58 11.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 50.26 16.26 0.25 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.234 -0.916 . . . . 0.0 109.37 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' N ' ' C ' ' A' ' 34' ' ' ALA . 21.3 t0 64.0 87.97 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -101.35 -160.37 0.79 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -141.6 137.89 32.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.5 m -86.03 60.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.223 -0.923 . . . . 0.0 109.695 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . -172.5 122.47 0.94 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 40' ' ' GLY . 4.8 tp-100 48.74 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -174.55 -30.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.27 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 45' ' ' GLY . 11.9 pt-20 -125.55 -30.84 3.04 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.098 -1.002 . . . . 0.0 111.123 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.054 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -74.63 26.76 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.571 -1.331 . . . . 0.0 109.68 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 43' ' ' GLU . . . -152.87 -39.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.25 -156.82 28.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -115.31 4.3 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 49' ' ' GLY . 6.0 Cg_exo -56.31 -30.77 82.14 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 CA-C-N 119.143 1.471 . . . . 0.0 109.683 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 48' ' ' PRO . . . -50.44 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.36 -16.77 9.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -1.164 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.0 74.67 0.25 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -52.79 -43.07 65.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.086 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -81.06 -161.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.406 -0.809 . . . . 0.0 109.111 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.88 151.22 73.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 108.709 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -65.23 -178.84 0.91 Allowed 'Trans proline' 0 C--O 1.209 -0.959 0 N-CA-C 109.033 -1.18 . . . . 0.0 109.033 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.88 -31.69 8.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -59.56 3.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 110.171 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.583 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.8 mm? -50.24 -45.82 54.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.073 -1.017 . . . . 0.0 109.009 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -44.59 -35.28 2.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.6 -0.687 . . . . 0.0 109.726 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' SER . . . -87.07 -69.1 1.32 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' LYS . 51.7 p -37.57 -40.09 0.37 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.069 -0.665 . . . . 0.0 111.138 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -48.24 -18.15 0.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.876 -1.14 . . . . 0.0 108.915 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 61' ' ' SER . 39.0 tt0 -106.53 -18.46 13.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.742 -0.599 . . . . 0.0 109.974 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -154.28 -179.1 7.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.011 -1.055 . . . . 0.0 110.336 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -86.85 -34.46 19.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 108.759 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.59 129.22 3.67 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.38 -1.088 . . . . 19.62 110.38 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.4 tt -118.66 -40.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.673 -0.898 . . . . 17.42 108.597 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.5 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.8 t -55.36 -27.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.275 -0.891 . . . . 18.82 109.556 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -90.9 10.89 24.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 38.5 109.872 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.1 mt-30 -137.18 -10.43 1.72 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.075 -1.015 . . . . 36.83 110.841 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -120.32 -26.05 5.52 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.271 -0.893 . . . . 18.16 109.42 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.7 t -87.94 -37.91 16.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.93 -1.106 . . . . 18.46 108.112 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 t -86.08 -23.9 26.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -134.01 -140.71 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.443 -0.947 . . . . 30.34 108.443 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.4 mt -145.68 131.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.043 -1.036 . . . . 27.51 109.099 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.2 m -114.41 175.14 5.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.555 -0.716 . . . . 23.34 110.105 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m -112.52 -178.24 3.35 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.604 -0.685 . . . . 22.64 109.749 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -54.55 -61.8 2.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.482 -0.761 . . . . 23.28 109.716 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -42.04 -57.24 2.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.418 -0.801 . . . . 37.86 110.249 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -48.46 -45.58 36.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.852 -1.155 . . . . 31.39 109.14 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.97 -38.72 92.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 24.48 108.86 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.42 -19.0 64.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 31.48 109.786 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -72.74 -29.65 63.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 22.48 111.356 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -97.9 12.53 33.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.186 -0.946 . . . . 19.59 111.925 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.13 -175.93 3.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.58 -1.325 . . . . 20.62 109.101 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.025 -0.988 . . . . 24.65 109.589 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.51 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 19.6 t80 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.209 -0.663 . . . . 24.77 109.209 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.8 p -165.12 159.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 30.1 109.539 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 8.4 p30 -130.58 107.48 9.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.475 -0.935 . . . . 32.24 108.475 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -156.85 161.93 39.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 30.21 109.46 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m80 -76.97 100.95 5.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.285 -2.117 . . . . 24.0 105.285 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.27 133.63 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 19.63 111.808 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -159.76 0.78 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.136 -0.977 . . . . 17.19 111.532 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.82 -53.45 1.47 Allowed Glycine 0 N--CA 1.49 2.291 0 CA-C-N 115.843 -0.617 . . . . 16.55 112.977 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.4 m -78.7 -62.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.516 -1.579 . . . . 19.55 111.068 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.6 -55.5 34.05 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.215 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 67' ' ' ILE . 31.5 tp -50.49 -51.71 44.77 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.64 -1.288 . . . . 14.16 108.311 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -45.92 -55.46 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.643 -1.243 . . . . 15.31 107.643 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.45 -61.73 2.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.946 -1.131 . . . . 29.64 107.946 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.36 -59.59 2.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.161 -0.962 . . . . 13.96 109.708 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 67' ' ' ILE . 11.0 mt -51.77 -53.92 34.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.381 -1.449 . . . . 17.79 108.072 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.1 -48.26 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 16.84 109.018 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.34 -29.3 33.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.094 -1.004 . . . . 22.76 108.439 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -92.66 -64.72 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 17.44 109.586 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.1 m -64.8 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 18.54 109.684 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 76.71 -129.01 9.53 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.715 -1.354 . . . . 23.17 109.715 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -49.99 -18.9 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.364 -1.08 . . . . 39.77 109.256 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -57.14 -54.01 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 26.65 109.097 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.12 62.75 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.893 -1.146 . . . . 20.26 111.502 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 22.9 p90 -76.7 121.87 23.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.1 -1.235 . . . . 17.79 109.638 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.29 105.05 17.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.139 -0.976 . . . . 18.55 108.909 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.47 125.22 28.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.158 -0.964 . . . . 21.49 109.24 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.3 p -100.86 160.72 14.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.534 -0.729 . . . . 31.5 109.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 tttp 70.75 67.02 0.4 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.993 -0.442 . . . . 0.0 110.514 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.41 129.17 27.2 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.168 1.245 . . . . 0.0 108.867 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -145.93 142.28 28.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.989 -1.069 . . . . 0.0 110.005 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.7 -32.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.566 HH11 ' CG ' ' A' ' 32' ' ' ARG . 0.4 OUTLIER -152.75 47.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 108.877 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.09 11.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . -63.63 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 49.2 -172.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.648 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 1.4 p30 -70.82 129.83 40.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.1 97.51 8.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -93.39 -24.24 18.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.243 -0.91 . . . . 0.0 109.7 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.79 -38.24 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 29.08 4.23 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.98 75.24 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -1.007 . . . . 0.0 108.519 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.75 151.49 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -48.69 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.442 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.722 ' C ' HD22 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -159.17 -5.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.648 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.24 -41.35 11.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.34 74.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.29 68.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.8 -169.16 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.439 1.426 . . . . 0.0 109.708 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.68 43.31 2.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -23.05 50.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.452 -1.028 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 152.01 -15.23 0.78 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m 62.9 -71.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -1.013 . . . . 0.0 109.684 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLY . 17.7 mt 57.41 -143.33 0.69 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.903 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -76.87 154.73 83.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 108.702 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.41 134.25 57.37 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.029 1.153 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 45.2 mt -50.67 -41.31 55.5 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.576 -0.703 . . . . 0.0 109.511 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.59 -57.76 10.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.216 -0.928 . . . . 0.0 109.612 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -58.16 -45.48 87.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.192 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -50.38 -20.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.283 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.51 -55.46 3.93 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 t -49.46 -36.17 21.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -1.216 . . . . 0.0 109.427 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.5 -34.18 76.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.312 -0.868 . . . . 0.0 109.162 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -83.87 -52.25 6.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.256 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 2.9 mptp? -73.4 -172.72 1.22 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 108.97 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -153.04 -44.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.778 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.36 -97.08 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.846 -1.645 . . . . 19.62 111.383 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 11' ' ' LEU . 4.4 tt -43.39 -51.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.43 -1.041 . . . . 17.42 111.928 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.602 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -54.66 -17.36 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.524 -1.36 . . . . 18.82 110.012 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -100.74 9.97 41.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 38.5 109.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -137.65 -16.02 1.36 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.108 -0.995 . . . . 36.83 110.242 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.7 m -112.16 -30.87 7.06 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.362 -0.836 . . . . 18.16 109.256 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.6 -42.51 16.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 18.46 108.667 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -80.9 -22.4 39.79 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 m -139.98 -136.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.496 -0.927 . . . . 30.34 108.496 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.7 149.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 27.51 109.301 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.9 m -133.08 175.93 8.94 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 23.34 109.583 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m -112.24 -178.32 3.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 22.64 109.765 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.7 tp -55.16 -57.63 10.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.575 -0.703 . . . . 23.28 109.267 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -44.15 -51.64 7.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.423 -0.798 . . . . 37.86 110.001 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -54.93 -51.84 64.83 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.787 -1.196 . . . . 31.39 108.733 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -56.92 -39.5 74.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 24.48 108.855 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.76 -18.62 64.25 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.468 -0.77 . . . . 31.48 109.863 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -73.67 -30.04 62.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.826 . . . . 22.48 111.746 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -99.01 12.01 37.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.205 -0.934 . . . . 19.59 111.782 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.2 m -76.7 -175.4 3.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 20.62 109.194 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 118.019 -0.991 . . . . 24.65 109.359 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 20.4 t80 . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 109.27 -0.641 . . . . 24.77 109.27 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 3' ' ' ASN . 1.9 p -163.99 161.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.949 -1.094 . . . . 30.1 109.572 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.473 ' N ' HG22 ' A' ' 2' ' ' VAL . 5.5 p30 -133.78 107.14 7.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.35 -0.981 . . . . 32.24 108.35 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -156.58 161.21 39.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 30.21 109.261 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -76.59 100.77 5.44 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.251 -2.129 . . . . 24.0 105.251 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.11 132.8 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.464 -0.772 . . . . 19.63 111.784 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 -157.01 0.69 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.21 -0.931 . . . . 17.19 111.831 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -37.02 -55.24 1.46 Allowed Glycine 0 N--CA 1.49 2.288 0 CA-C-N 115.869 -0.605 . . . . 16.55 113.189 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.0 m -79.55 -58.41 3.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.483 -1.598 . . . . 19.55 111.42 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -55.37 34.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 110.39 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 31.2 tp -50.4 -50.51 51.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.74 -1.225 . . . . 14.16 108.24 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.25 -55.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.516 -1.29 . . . . 15.31 107.516 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.11 -61.76 2.23 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.878 -1.129 . . . . 29.64 108.421 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.39 -59.43 2.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 13.96 109.839 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.7 mt -51.36 -52.19 47.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 17.79 107.881 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -53.44 -45.89 69.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 16.84 109.141 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.44 -26.94 33.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.858 -1.151 . . . . 22.76 108.307 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.46 -64.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.448 -0.783 . . . . 17.44 109.401 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.455 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.7 m -62.18 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 18.54 109.842 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.08 -125.02 24.11 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.596 -1.288 . . . . 23.17 110.046 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -45.79 -22.11 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -1.074 . . . . 39.77 109.429 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 20' ' ' GLY . 13.8 mmt180 -61.81 -54.65 39.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.346 -0.846 . . . . 26.65 110.0 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.75 62.49 0.5 Allowed Glycine 0 N--CA 1.51 3.62 0 C-N-CA 119.915 -1.136 . . . . 20.26 112.075 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 15.1 p90 -77.06 130.02 36.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.338 . . . . 17.79 109.869 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 2.9 p90 -96.82 104.45 16.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 18.55 109.162 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -78.51 168.62 19.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 21.49 109.578 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -145.12 159.63 42.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 31.5 109.267 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt 59.39 67.18 1.96 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.544 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.86 -18.72 50.96 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.521 1.481 . . . . 0.0 109.881 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 m -87.53 138.62 31.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.447 0.641 . . . . 0.0 109.983 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' C ' ' CD ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -95.48 -72.29 0.63 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.345 -0.847 . . . . 0.0 108.781 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -110.49 143.75 40.36 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.41 44.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.95 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.23 63.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.715 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -67.89 -114.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -80.11 22.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 -35.22 26.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -71.72 131.97 43.88 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.265 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -47.78 115.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.16 -27.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.32 60.83 5.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -1.082 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.08 -42.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 108.719 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.97 -161.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.2 mp -94.63 -15.97 23.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.099 -1.001 . . . . 0.0 109.354 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.05 42.55 0.25 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.71 -141.03 1.17 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.87 68.61 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.73 -76.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.488 1.458 . . . . 0.0 110.234 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -68.99 -19.14 73.44 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.15 2.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -1.124 . . . . 0.0 109.764 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 49' ' ' GLY . . . -83.97 -155.45 21.32 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 53' ' ' LEU . 11.0 t 51.31 30.89 6.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.152 -1.204 . . . . 0.0 109.214 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 52' ' ' SER . 12.3 mt -36.54 -43.46 0.4 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.132 0.492 . . . . 0.0 110.756 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -98.72 152.07 37.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.222 -0.924 . . . . 0.0 108.829 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 9.5 Cg_endo -71.75 157.45 55.37 Favored 'Trans proline' 0 C--O 1.206 -1.09 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.8 mt -107.98 -16.99 14.16 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.595 -0.691 . . . . 0.0 110.497 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -37.34 21.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 112.14 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -24.04 13.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.89 -1.131 . . . . 0.0 111.432 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -51.67 -25.52 7.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.237 -1.539 . . . . 0.0 108.883 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.503 ' N ' ' OE2' ' A' ' 59' ' ' GLU . . . -87.55 -39.51 7.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.6 m -51.17 -10.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.413 -1.051 . . . . 0.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' GLY . 23.1 mt -82.62 -44.11 16.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.048 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 64' ' ' LYS . 14.6 mm100 -76.6 10.62 2.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.277 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.66 173.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.97 . . . . 0.0 109.717 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -88.61 -41.84 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 84' ' ' TYR . . . 141.76 13.97 0.43 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.219 -1.152 . . . . 19.62 110.219 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt -136.78 -45.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.206 -1.173 . . . . 17.42 109.658 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 67' ' ' ILE . 18.1 t -57.16 -7.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.893 -1.129 . . . . 18.82 109.19 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 67' ' ' ILE . 22.1 tt0 -109.83 9.5 24.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.49 -0.756 . . . . 38.5 109.313 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -137.56 -15.67 1.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.227 -0.921 . . . . 36.83 109.691 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.86 -29.94 7.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.529 -0.732 . . . . 18.16 109.12 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 52.5 t -84.85 -44.51 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 18.46 108.701 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -81.34 -17.91 47.51 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.445 -0.784 . . . . 0.0 109.093 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 m -144.07 -137.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.296 -1.001 . . . . 30.34 108.296 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.45 150.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 27.51 109.333 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 m -133.18 175.88 9.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 23.34 109.55 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -111.62 -174.89 2.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.703 . . . . 22.64 109.566 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.6 tp -57.75 -57.56 12.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 23.28 109.608 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -44.5 -55.23 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.39 -0.819 . . . . 37.86 110.038 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 59.2 mm-40 -50.55 -49.85 54.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.816 -1.177 . . . . 31.39 108.898 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.407 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -59.53 -40.97 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.921 -0.77 . . . . 24.48 108.921 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -61.88 -19.04 62.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.448 -0.783 . . . . 31.48 109.651 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -73.14 -30.18 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.598 -0.688 . . . . 22.48 111.889 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.408 ' CE1' ' O ' ' A' ' 66' ' ' GLY . 22.7 m-85 -100.07 11.8 38.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.157 -0.965 . . . . 19.59 111.939 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.0 m -76.82 -175.72 3.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.601 -1.312 . . . . 20.62 108.833 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.038 -0.982 . . . . 24.65 109.287 179.541 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.496 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.4 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.267 -0.642 . . . . 24.77 109.267 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -167.28 161.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.07 -1.019 . . . . 30.1 109.644 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 2' ' ' VAL . 9.7 p30 -132.73 107.85 8.64 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.485 -0.932 . . . . 32.24 108.485 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -156.86 164.23 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 30.21 109.64 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -76.52 100.6 5.33 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.168 -2.16 . . . . 24.0 105.168 176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.08 135.96 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.78 . . . . 19.63 111.59 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.1 m -124.14 -157.3 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.006 0.908 . . . . 17.19 112.693 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.79 -53.8 1.45 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 115.977 -0.556 . . . . 16.55 112.884 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.84 -58.47 2.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.315 -1.697 . . . . 19.55 111.096 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -60.47 -55.76 29.63 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.925 -1.11 . . . . 0.0 110.464 -178.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 25.7 tp -51.15 -50.04 59.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.203 . . . . 14.16 108.211 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -46.88 -55.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.525 -1.287 . . . . 15.31 107.525 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 20.6 tt0 -57.12 -61.8 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.018 -1.105 . . . . 29.64 108.018 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.18 -59.67 2.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 13.96 109.537 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.1 mt -51.57 -55.14 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.546 -1.346 . . . . 17.79 108.009 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.42 -50.48 40.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 16.84 108.952 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -52.22 -29.78 24.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 22.76 108.514 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -92.02 -64.45 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 17.44 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.447 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.7 m -65.66 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 18.54 109.946 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.3 -112.57 4.91 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.614 -1.279 . . . . 23.17 110.275 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -52.93 -20.5 3.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 39.77 110.116 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -69.03 -52.59 27.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 26.65 109.974 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.19 63.17 0.49 Allowed Glycine 0 N--CA 1.507 3.393 0 C-N-CA 119.729 -1.224 . . . . 20.26 111.689 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.0 p90 -76.13 137.41 40.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.047 -1.266 . . . . 17.79 109.221 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -106.42 106.49 17.04 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.398 -0.814 . . . . 18.55 109.892 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' HD23 ' A' ' 11' ' ' LEU . 3.6 t80 -81.81 120.12 24.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 21.49 109.135 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.2 p -153.31 117.01 4.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.152 -0.968 . . . . 31.5 109.266 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -171.8 108.92 0.38 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.0 . . . . 0.0 109.699 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.39 -14.1 15.08 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.71 134.25 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.536 0.684 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -61.35 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.064 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -59.03 132.09 53.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.842 . . . . 0.0 109.927 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 76.4 mt-10 -156.13 135.2 12.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . 72.31 -31.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.525 -0.734 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 33' ' ' GLU . 33.5 tt0 -56.38 -104.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.38 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 37' ' ' LEU . 9.5 t70 -80.96 162.56 23.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 4.1 mp -139.82 -130.17 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.427 -0.796 . . . . 0.0 109.248 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.553 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 4.0 mp0 -62.07 -167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.928 . . . . 0.0 109.299 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 40' ' ' GLY . 6.7 p -69.46 156.03 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.274 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -162.37 90.18 0.11 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? 48.27 80.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -1.121 . . . . 0.0 109.65 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 43' ' ' GLU . 2.8 p -167.43 -46.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' C ' HD12 ' A' ' 44' ' ' LEU . 29.8 tt0 -172.06 161.5 5.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 0.0 109.035 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.755 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.9 mp -96.24 5.44 51.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.577 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.55 70.06 0.26 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.85 -118.5 5.51 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' N ' ' OE1' ' A' ' 43' ' ' GLU . . . -157.44 177.53 34.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.3 Cg_endo -59.9 126.98 21.85 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.637 1.558 . . . . 0.0 110.108 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 48' ' ' PRO . . . 59.65 152.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.47 23.6 2.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -1.126 . . . . 0.0 109.435 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 91.11 20.11 40.19 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.9 m 52.26 -86.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.69 -171.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -62.32 148.75 89.08 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 108.93 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.24 134.07 46.88 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.934 1.089 . . . . 0.0 109.659 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.9 mt -57.41 -30.23 64.79 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.706 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.39 -55.15 26.73 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.309 -0.87 . . . . 0.0 109.815 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.5 mm? -63.17 -38.06 89.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 0.0 109.1 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -49.91 -31.72 12.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.51 -37.4 8.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.9 p -62.82 -16.72 59.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.163 . . . . 0.0 109.65 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.99 -52.67 5.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -85.58 18.76 2.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.76 140.06 3.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 66' ' ' GLY . 18.9 ttp180 -171.06 -9.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.427 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 65' ' ' ARG . . . -85.79 134.01 12.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.631 -1.388 . . . . 19.62 109.631 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 11' ' ' LEU . 4.0 tt -56.61 -46.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 17.42 109.755 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' N ' HG23 ' A' ' 67' ' ' ILE . 13.8 t -53.67 -31.71 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 18.82 109.247 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 9.99 6.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.956 -1.09 . . . . 38.5 110.119 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 38.2 mt-30 -141.16 -11.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.032 -1.043 . . . . 36.83 110.729 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.5 m -117.89 -26.45 6.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.408 -0.807 . . . . 18.16 109.357 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 t -88.83 -43.28 11.34 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.144 -1.058 . . . . 18.46 108.144 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 t -82.05 -28.04 32.66 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -131.75 -140.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.52 -0.918 . . . . 30.34 108.52 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mt -142.82 151.55 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.156 -0.965 . . . . 27.51 109.258 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -136.49 174.55 10.49 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 23.34 109.683 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -112.23 -178.46 3.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.546 -0.721 . . . . 22.64 109.736 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.4 tp -53.0 -61.51 2.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 23.28 109.573 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' C ' ' O ' ' A' ' 78' ' ' LEU . 1.7 m-85 -41.31 -55.83 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.449 -0.782 . . . . 37.86 110.356 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -49.46 -51.09 38.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.84 -1.162 . . . . 31.39 108.819 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.4 mp -58.23 -41.3 83.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.451 -0.781 . . . . 24.48 109.071 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.75 -18.76 61.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.408 -0.808 . . . . 31.48 110.075 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -74.31 -29.27 61.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 22.48 111.811 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 67' ' ' ILE . 23.8 m-85 -99.51 12.06 37.45 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.074 -1.016 . . . . 19.59 111.898 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.51 -175.74 3.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.745 -1.222 . . . . 20.62 108.931 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.046 -0.978 . . . . 24.65 109.399 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 15.1 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.287 -0.634 . . . . 24.77 109.287 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p -165.93 159.26 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 30.1 109.361 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.457 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.8 p30 -130.0 106.85 8.92 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.389 -0.967 . . . . 32.24 108.389 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 83.0 mm-40 -156.5 164.53 38.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.298 -0.876 . . . . 30.21 109.62 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -77.93 101.05 6.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -98.82 136.18 39.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.427 -0.796 . . . . 19.63 111.776 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.19 -160.38 0.83 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.189 -0.945 . . . . 17.19 111.691 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.15 -54.18 1.57 Allowed Glycine 0 N--CA 1.489 2.184 0 CA-C-N 115.685 -0.689 . . . . 16.55 112.667 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -77.8 -61.91 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.543 -1.563 . . . . 19.55 110.924 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -55.75 30.93 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.027 . . . . 0.0 110.427 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD11 ' A' ' 67' ' ' ILE . 28.2 tp -51.85 -47.7 64.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.723 -1.236 . . . . 14.16 108.499 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.17 -56.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.336 -1.357 . . . . 15.31 107.336 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.86 -61.23 2.51 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.971 -1.092 . . . . 29.64 108.246 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.28 -59.54 2.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 13.96 110.097 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 67' ' ' ILE . 10.1 mt -51.75 -51.55 55.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.389 -1.444 . . . . 17.79 107.715 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.122 -0.696 . . . . 16.84 109.122 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -56.74 -24.36 49.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.946 -1.096 . . . . 22.76 108.285 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -97.51 -64.55 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.35 -0.844 . . . . 17.44 109.557 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.4 m -64.39 -78.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 18.54 109.649 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.68 -132.23 11.77 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.72 -1.352 . . . . 23.17 109.72 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -49.69 -14.73 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -1.097 . . . . 39.77 109.518 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 20' ' ' GLY . 1.0 OUTLIER -59.78 -53.61 55.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 26.65 109.161 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.4 63.9 0.49 Allowed Glycine 0 N--CA 1.506 3.357 0 C-N-CA 119.951 -1.119 . . . . 20.26 111.245 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.7 p90 -75.61 124.68 27.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.069 -1.254 . . . . 17.79 110.063 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 33.9 p90 -92.79 109.84 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 18.55 108.971 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -70.61 165.75 22.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 21.49 109.231 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 p -146.17 144.37 29.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.127 -0.983 . . . . 31.5 109.771 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 30' ' ' THR . 14.4 ptmt -175.04 70.36 0.28 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.332 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -49.42 -14.21 0.56 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.489 ' N ' ' C ' ' A' ' 28' ' ' LYS . 2.3 p -92.06 104.59 16.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -100.68 124.72 46.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 109.597 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? 48.92 64.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.529 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -80.27 66.57 5.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -174.27 155.6 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 49.06 13.1 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ALA . 14.4 m-20 -143.28 52.05 1.36 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.389 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 mt -80.74 -149.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.922 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -148.71 11.7 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 40' ' ' GLY . 11.4 p -76.07 -15.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . 49.86 -178.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -75.68 129.87 37.82 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.63 -0.924 . . . . 0.0 108.909 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -146.25 -165.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -85.01 78.09 9.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.251 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp 49.04 -106.94 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.24 27.08 16.72 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.74 -49.12 67.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.15 67.99 1.78 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.15 -66.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.457 1.438 . . . . 0.0 109.76 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.79 135.23 46.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' GLY . . . -80.22 36.03 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -1.142 . . . . 0.0 109.575 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' ALA . . . -52.57 -98.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 53' ' ' LEU . 8.4 t 55.28 22.6 4.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -1.155 . . . . 0.0 109.502 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 52' ' ' SER . 22.5 mt -58.79 -153.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.522 -0.736 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.653 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -62.36 131.97 93.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.021 -1.049 . . . . 0.0 109.006 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.56 134.17 43.16 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.873 1.048 . . . . 0.0 109.763 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -54.42 -36.69 64.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.461 -0.774 . . . . 0.0 109.56 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.95 -56.01 27.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 0.0 109.934 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.5 mm? -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.449 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -47.77 -21.57 0.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.643 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.63 -44.77 6.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.54 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 48.1 p -71.21 -13.94 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.177 . . . . 0.0 109.696 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -85.63 -32.14 22.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' O ' ' C ' ' A' ' 64' ' ' LYS . 66.0 mm-40 -92.22 -34.09 14.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.272 -0.892 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 26.81 57.9 0.07 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.243 0.544 . . . . 0.0 111.529 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 29.6 ttm-85 -142.91 77.99 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.12 -0.987 . . . . 0.0 109.611 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 172.86 120.98 0.58 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.597 -1.401 . . . . 19.62 109.597 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.512 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt -52.67 -41.23 37.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.446 -1.032 . . . . 17.42 109.44 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -55.4 -22.05 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 18.82 109.467 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -95.49 10.45 36.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 38.5 109.703 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -137.38 -15.12 1.46 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 36.83 110.557 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.46 -27.86 7.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.305 -0.872 . . . . 18.16 109.425 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.29 -41.04 13.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.111 . . . . 18.46 108.519 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.7 t -83.63 -16.33 45.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 m -143.2 -139.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -145.11 137.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 27.51 109.257 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.6 m -119.47 176.97 5.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.676 -0.64 . . . . 23.34 110.261 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.9 175.74 5.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.506 0.67 . . . . 22.64 109.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 6.0 tp -51.8 -61.15 2.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.475 -0.766 . . . . 23.28 109.469 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -43.52 -54.7 4.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.795 . . . . 37.86 110.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -49.75 -44.8 48.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.757 -1.214 . . . . 31.39 109.002 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.25 -36.92 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 24.48 108.864 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.08 -18.93 64.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.417 -0.802 . . . . 31.48 109.78 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.31 -29.48 61.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 22.48 111.571 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -97.03 11.89 34.53 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.14 -0.975 . . . . 19.59 111.585 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 83.4 m -77.0 -175.52 3.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.761 -1.212 . . . . 20.62 109.315 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.956 -1.021 . . . . 24.65 109.233 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.3 t80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.223 -0.658 . . . . 24.77 109.223 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.0 p -165.8 161.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 30.1 109.375 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 3' ' ' ASN . 6.8 p30 -131.57 107.4 8.83 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.416 -0.957 . . . . 32.24 108.416 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -157.11 164.46 37.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 30.21 109.846 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.3 m80 -76.76 100.85 5.59 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.217 -2.142 . . . . 24.0 105.217 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.47 136.04 38.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 19.63 111.809 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.75 -161.34 0.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.023 0.916 . . . . 17.19 111.758 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.5 -53.08 1.81 Allowed Glycine 0 N--CA 1.49 2.248 0 CA-C-N 115.781 -0.645 . . . . 16.55 112.603 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -77.96 -60.91 2.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.486 -1.597 . . . . 19.55 110.898 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -55.53 33.55 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.334 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 67' ' ' ILE . 27.5 tp -51.4 -47.54 62.9 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.823 -1.173 . . . . 14.16 108.381 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.49 -56.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.192 -1.41 . . . . 15.31 107.192 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -55.18 -61.75 2.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.959 -1.096 . . . . 29.64 108.101 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -44.93 -60.0 2.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.246 -0.909 . . . . 13.96 109.709 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 67' ' ' ILE . 10.9 mt -51.75 -51.59 55.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.441 -1.412 . . . . 17.79 108.164 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.91 -40.49 73.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 16.84 109.457 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 14' ' ' ALA . 63.8 mt -60.62 -24.61 65.65 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.083 -1.08 . . . . 22.76 108.083 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -97.3 -64.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.543 -0.723 . . . . 17.44 109.294 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' VAL . 11.6 m -64.24 -76.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 18.54 109.638 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.87 -138.29 20.59 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.675 -1.37 . . . . 23.17 109.675 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 21' ' ' GLU . 8.2 tp10 -48.37 -17.03 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -1.104 . . . . 39.77 109.167 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' GLY . 50.3 mtt180 -54.88 -52.84 61.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 26.65 109.255 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.52 65.14 0.48 Allowed Glycine 0 N--CA 1.508 3.478 0 C-N-CA 119.745 -1.217 . . . . 20.26 111.722 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 28.7 p90 -76.04 131.23 39.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -1.138 . . . . 17.79 110.218 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.75 112.47 24.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.66 -0.65 . . . . 18.55 109.586 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' OH ' HD23 ' A' ' 11' ' ' LEU . 2.9 t80 -98.25 156.52 16.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 21.49 108.561 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.6 p -152.43 120.49 6.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.078 -1.014 . . . . 31.5 109.447 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 30' ' ' THR . 14.3 pttm -152.72 64.65 5.47 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 109.81 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -51.55 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 109.396 -1.04 . . . . 0.0 109.396 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -156.75 -7.19 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 56.49 6.07 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 108.818 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 ttm-85 -170.67 -111.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.422 -0.799 . . . . 0.0 108.868 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -157.04 8.97 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.667 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.26 120.95 2.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 109.75 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -91.21 -89.9 0.17 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -145.39 40.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.233 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.563 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -85.99 -11.95 51.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -66.69 -173.97 0.27 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.217 -0.927 . . . . 0.0 109.533 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLN . 8.0 m -95.46 35.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 0.0 109.572 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 42' ' ' VAL . . . -71.6 62.79 1.16 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 52.13 -82.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.895 . . . . 0.0 109.65 -179.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 40' ' ' GLY . 1.8 p 33.41 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 121.492 0.663 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 44' ' ' LEU . 34.6 tt0 41.29 81.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.459 -0.775 . . . . 0.0 109.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.798 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -39.26 -31.59 0.08 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.27 0.557 . . . . 0.0 110.074 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.55 91.01 1.37 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.42 -173.76 50.97 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.9 -174.96 50.07 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.37 -25.37 56.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.677 1.585 . . . . 0.0 109.803 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -47.44 132.24 15.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' H ' ' H ' ' A' ' 51' ' ' GLY . . . -168.17 -0.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -1.069 . . . . 0.0 109.088 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' H ' ' H ' ' A' ' 50' ' ' ALA . . . -87.98 -175.79 47.93 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t -74.2 -32.46 63.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -1.14 . . . . 0.0 109.316 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -49.53 152.87 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.857 . . . . 0.0 109.226 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -57.51 148.36 55.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 108.645 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.37 124.68 14.22 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 120.875 1.05 . . . . 0.0 109.91 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -53.32 -28.67 29.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.0 109.188 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.51 -63.75 1.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.9 mm? -53.23 -43.2 67.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 108.847 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -49.25 -17.95 0.3 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' LYS . . . -87.27 -65.1 1.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 p -55.76 -13.69 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -1.15 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -73.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' LYS . 6.6 pt20 -93.44 -10.26 35.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 108.692 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' GLY . 22.9 mttt 52.55 174.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' A' ' 65' ' ' ARG . 3.0 mtt-85 -81.46 -27.35 34.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.398 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.3 -137.87 14.52 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.703 -1.359 . . . . 19.62 109.703 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 11' ' ' LEU . 2.6 tt -45.54 -42.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -1.128 . . . . 17.42 109.875 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -50.21 -41.53 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.973 -1.079 . . . . 18.82 109.781 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -78.54 10.9 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 38.5 109.94 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -134.03 -13.82 2.43 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.058 -1.026 . . . . 36.83 110.837 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.2 m -119.28 -25.53 6.09 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.257 -0.902 . . . . 18.16 109.043 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.12 -37.36 17.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.961 -1.087 . . . . 18.46 108.483 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -89.36 -9.87 48.77 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -146.77 -144.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.507 -0.923 . . . . 30.34 108.507 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 mt -145.89 122.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.061 -1.024 . . . . 27.51 109.365 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.9 m -106.24 175.5 5.48 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.625 -0.672 . . . . 23.34 109.541 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 m -112.4 176.49 5.0 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.551 0.691 . . . . 22.64 109.826 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -48.78 -60.08 3.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.566 -0.709 . . . . 23.28 109.651 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -43.5 -56.03 3.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.332 -0.855 . . . . 37.86 110.226 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -49.93 -46.47 52.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.727 -1.233 . . . . 31.39 108.918 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.444 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.99 -38.64 89.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.686 -0.857 . . . . 24.48 108.686 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -64.2 -18.92 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.479 -0.763 . . . . 31.48 109.728 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.12 -29.74 63.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 22.48 111.63 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.0 12.17 35.12 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 19.59 111.804 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.8 m -76.59 -175.64 3.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.608 -1.307 . . . . 20.62 109.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.955 -1.021 . . . . 24.65 109.343 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.517 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.139 -0.689 . . . . 24.77 109.139 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -168.66 150.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 30.1 109.696 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.581 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 4.2 p30 -117.97 106.27 12.76 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.78 -1.192 . . . . 32.24 107.78 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.581 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 7.9 mm-40 -154.42 162.16 41.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.347 -0.846 . . . . 30.21 109.711 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -79.14 101.14 7.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.351 -2.092 . . . . 24.0 105.351 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.21 136.09 39.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.51 -0.744 . . . . 19.63 111.958 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.54 -162.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.07 0.938 . . . . 17.19 111.484 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.98 -51.68 1.55 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 115.662 -0.699 . . . . 16.55 112.774 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 p -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.458 -1.613 . . . . 19.55 110.792 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -55.2 38.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.29 -48.22 62.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.899 -1.125 . . . . 14.16 108.495 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -48.87 -55.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.204 -1.406 . . . . 15.31 107.204 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -56.06 -61.58 2.28 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.019 -1.104 . . . . 29.64 108.019 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.52 -59.54 2.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.01 -1.057 . . . . 13.96 109.679 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.53 -53.49 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.457 -1.402 . . . . 17.79 107.934 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.78 -49.92 61.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.508 -0.745 . . . . 16.84 109.108 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.86 -26.12 9.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.046 -1.034 . . . . 22.76 108.643 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.95 -64.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.352 -0.843 . . . . 17.44 109.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 9.9 m -64.32 -77.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 18.54 109.831 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 78.52 -133.82 13.28 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.773 -1.331 . . . . 23.17 109.773 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.42 -14.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.399 -1.06 . . . . 39.77 109.621 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 20' ' ' GLY . 8.8 mtp180 -59.01 -53.02 63.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 26.65 109.086 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.08 64.36 0.48 Allowed Glycine 0 N--CA 1.506 3.322 0 C-N-CA 119.744 -1.217 . . . . 20.26 111.531 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 29.8 p90 -75.77 124.35 27.15 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.287 -1.125 . . . . 17.79 109.848 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -88.68 110.77 21.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.753 . . . . 18.55 109.638 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' OH ' HD23 ' A' ' 11' ' ' LEU . 2.7 t80 -95.03 146.78 24.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.429 -0.795 . . . . 21.49 108.873 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -150.04 140.67 22.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.092 -1.005 . . . . 31.5 109.467 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -176.8 70.99 0.24 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.238 -0.913 . . . . 0.0 110.107 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' ARG . 12.9 Cg_exo -50.3 -24.69 12.17 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m 43.97 15.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.253 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER 45.74 61.66 2.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 109.956 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.51 HH22 ' NH1' ' A' ' 31' ' ' ARG . 31.9 mtm-85 48.35 25.02 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 109.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 51.45 11.89 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 109.903 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -82.53 -178.66 7.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.129 -0.982 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 50.96 9.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.668 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 34' ' ' ALA . 49.1 t0 -74.6 -74.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 37' ' ' LEU . 1.9 pt? -58.57 -157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 37' ' ' LEU . 7.5 tt0 76.93 179.0 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.745 . . . . 0.0 109.208 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t 60.9 112.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 109.297 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.93 -108.99 0.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -77.6 99.64 5.83 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.725 -0.868 . . . . 0.0 109.035 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -147.34 -3.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 26.1 tt0 84.3 167.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.5 mp -79.9 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.689 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.47 81.89 1.67 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.3 109.73 0.26 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.01 -175.15 37.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.11 156.1 61.04 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.686 1.59 . . . . 0.0 109.671 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.07 170.35 10.08 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.44 43.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -1.144 . . . . 0.0 109.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 52' ' ' SER . . . 77.45 160.18 12.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 51' ' ' GLY . 7.9 m 55.57 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -1.147 . . . . 0.0 109.763 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -162.51 154.46 18.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.201 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -102.66 125.74 34.92 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.198 -0.939 . . . . 0.0 108.742 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.09 138.49 67.65 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.845 1.03 . . . . 0.0 109.881 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 36.1 mt -54.43 -30.93 54.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.472 -0.767 . . . . 0.0 109.398 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.27 -60.5 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.961 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.6 mm? -60.39 -34.65 74.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.579 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 13.6 mm-40 -48.43 -22.97 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 109.689 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -87.1 -75.97 1.27 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 60' ' ' GLY . 4.4 m -38.17 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.874 -0.78 . . . . 0.0 110.988 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -50.75 -51.67 48.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.05 . . . . 0.0 109.062 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -88.3 -18.06 29.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.925 -1.11 . . . . 0.0 109.855 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 66' ' ' GLY . 9.8 mmmt -100.33 109.13 21.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.143 -0.973 . . . . 0.0 109.117 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -64.11 68.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.01 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -64.12 168.5 24.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.458 -1.457 . . . . 19.62 109.458 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt -92.31 -41.79 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -1.185 . . . . 17.42 109.004 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.478 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.5 t -52.3 -32.24 15.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.107 -0.996 . . . . 18.82 109.493 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -83.66 11.01 7.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 38.5 110.021 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 35.7 mt-30 -139.34 -12.89 1.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.051 . . . . 36.83 110.697 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.7 m -117.23 -30.58 5.57 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.407 -0.808 . . . . 18.16 109.099 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.34 -40.62 16.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 18.46 108.563 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -85.14 -12.52 52.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.477 -0.765 . . . . 0.0 109.213 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -145.72 -141.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.528 -0.916 . . . . 30.34 108.528 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.68 126.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.041 -1.037 . . . . 27.51 109.174 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.0 m -108.09 177.07 4.92 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.605 -0.685 . . . . 23.34 110.094 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.1 m -112.6 -178.99 3.53 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.49 0.662 . . . . 22.64 109.448 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -57.36 -56.05 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.779 . . . . 23.28 109.446 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -47.27 -50.94 20.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.395 -0.815 . . . . 37.86 110.171 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.96 -45.79 74.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.696 -1.253 . . . . 31.39 108.749 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.55 -37.72 84.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 24.48 108.643 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.29 -18.8 64.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.456 -0.778 . . . . 31.48 109.766 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -74.14 -29.51 61.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.711 . . . . 22.48 111.539 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -97.51 12.08 34.61 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.106 -0.997 . . . . 19.59 111.762 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 86.1 m -76.57 -175.77 3.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.597 -1.314 . . . . 20.62 109.207 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.018 -0.991 . . . . 24.65 109.441 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 17.8 t80 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.302 -0.629 . . . . 24.77 109.302 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -165.76 161.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 30.1 109.376 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.457 ' N ' ' CG2' ' A' ' 2' ' ' VAL . 10.7 p30 -132.52 107.88 8.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 32.24 108.533 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -156.55 162.75 39.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.511 -0.743 . . . . 30.21 109.417 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -76.46 100.72 5.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.25 -2.13 . . . . 24.0 105.25 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.21 136.05 39.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.386 -0.822 . . . . 19.63 111.707 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 m -124.06 -159.04 0.84 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.896 0.855 . . . . 17.19 112.168 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.49 -51.45 1.37 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.89 -0.506 . . . . 16.55 112.946 -176.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 m -81.82 -62.07 1.74 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.316 -1.696 . . . . 19.55 110.941 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -55.58 33.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 110.131 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 67' ' ' ILE . 26.7 tp -50.47 -51.36 47.74 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.782 -1.199 . . . . 14.16 108.369 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -46.66 -54.31 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.561 -1.274 . . . . 15.31 107.561 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.95 -61.85 2.24 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 29.64 108.098 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.51 -59.8 2.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.038 -1.039 . . . . 13.96 109.728 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 11.1 mt -51.17 -52.41 44.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.444 -1.41 . . . . 17.79 108.023 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -53.19 -45.8 68.71 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.1 -0.704 . . . . 16.84 109.1 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.08 -33.91 63.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.897 -1.127 . . . . 22.76 108.387 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -87.32 -64.84 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.369 -0.832 . . . . 17.44 109.378 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -63.18 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.897 . . . . 18.54 109.229 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.03 -130.55 10.53 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.772 -1.331 . . . . 23.17 109.772 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -50.22 -19.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 39.77 109.059 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' ' C ' ' A' ' 20' ' ' GLY . 7.6 mmt180 -55.47 -54.0 49.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 26.65 109.161 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.33 63.47 0.49 Allowed Glycine 0 N--CA 1.505 3.293 0 C-N-CA 119.958 -1.115 . . . . 20.26 111.681 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 18.6 p90 -75.97 122.71 24.59 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.04 -1.271 . . . . 17.79 109.75 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 7.3 p90 -93.5 103.67 15.85 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.292 -1.003 . . . . 18.55 108.292 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -59.85 154.52 18.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.196 -0.94 . . . . 21.49 108.639 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 18.1 p -140.63 161.6 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -0.848 . . . . 31.5 109.592 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 27' ' ' THR . 8.4 mmtt 120.06 129.41 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 C-N-CA 124.751 1.22 . . . . 0.0 107.81 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' C ' ' HG1' ' A' ' 30' ' ' THR . 8.8 Cg_exo -49.68 -22.57 6.95 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.442 ' HG1' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 177.56 -85.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -178.56 -55.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 33' ' ' GLU . 28.4 ptt180 -110.45 -20.82 12.45 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' ARG . 35.8 mt-10 54.6 167.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.497 0.665 . . . . 0.0 109.889 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.49 -50.78 6.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' OE2' ' OD1' ' A' ' 36' ' ' ASP . 18.5 tt0 59.11 -132.21 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' OD1' ' OE2' ' A' ' 35' ' ' GLU . 10.5 p-10 -96.52 121.5 38.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -76.35 135.9 39.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 109.149 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' LEU . 33.4 tt0 -63.2 -128.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.7 p -144.65 84.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.777 -1.202 . . . . 0.0 109.839 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.65 178.27 43.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -67.59 -5.75 16.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -1.152 . . . . 0.0 108.588 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.9 m 38.85 -145.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.56 ' OE2' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -56.71 127.58 32.23 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.142 -1.423 . . . . 0.0 107.24 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -42.87 90.07 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.344 -0.847 . . . . 0.0 112.088 -178.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 64.85 70.06 1.18 Allowed Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.998 -1.064 . . . . 0.0 111.612 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 43' ' ' GLU . . . -166.27 -125.25 0.76 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' CD ' ' A' ' 43' ' ' GLU . . . -163.51 129.58 2.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.74 116.32 3.17 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 118.931 1.365 . . . . 0.0 109.892 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.92 -169.09 22.4 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.79 -31.26 69.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.158 . . . . 0.0 109.463 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 46.86 70.31 0.71 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 48.1 m -66.7 -71.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -1.163 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? 43.24 -166.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -86.34 150.94 52.9 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -65.54 117.83 4.95 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.103 1.202 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.97 -8.86 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.33 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.26 -76.82 0.08 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 111.269 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.44 -17.08 64.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 110.444 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -47.0 -39.27 12.24 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.949 -1.095 . . . . 0.0 109.555 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.46 -53.24 2.82 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -50.83 -14.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -77.87 -31.43 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.0 109.356 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -104.86 -32.6 8.73 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.395 -0.816 . . . . 0.0 109.688 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -80.58 154.5 27.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.727 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.49 ' H ' ' NZ ' ' A' ' 28' ' ' LYS . 25.2 ptt180 -175.13 27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -177.63 22.46 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.87 -1.292 . . . . 19.62 109.87 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 11' ' ' LEU . 3.4 tt -49.61 -43.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -1.079 . . . . 17.42 109.353 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' ILE . 22.0 t -56.98 -6.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.386 -0.821 . . . . 18.82 109.712 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 64' ' ' LYS . 6.7 tt0 -108.52 9.59 27.4 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 38.5 109.039 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 17.6 mt-30 -137.82 -15.23 1.37 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.236 -0.915 . . . . 36.83 109.936 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.5 m -114.24 -24.18 9.07 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.479 -0.763 . . . . 18.16 109.273 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 51.6 t -91.48 -43.05 9.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 18.46 108.551 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -85.16 -21.42 29.21 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.628 0.728 . . . . 0.0 109.12 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -139.38 -136.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.478 -0.934 . . . . 30.34 108.478 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -145.86 147.48 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 27.51 109.204 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 1.9 m -131.09 174.64 9.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.539 -0.726 . . . . 23.34 109.313 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -112.39 -179.04 3.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.476 -0.765 . . . . 22.64 109.849 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.0 tp -53.46 -55.49 24.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.707 . . . . 23.28 109.371 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -46.01 -55.93 6.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 37.86 109.901 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -50.57 -50.43 53.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.821 -1.175 . . . . 31.39 108.997 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.2 mp -58.38 -41.3 84.5 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.448 -0.783 . . . . 24.48 108.936 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -62.64 -18.76 62.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 31.48 109.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -72.59 -29.74 63.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.423 -0.798 . . . . 22.48 111.742 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -100.62 12.16 37.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 19.59 112.051 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.3 m -76.87 -175.81 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.584 -1.323 . . . . 20.62 109.188 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.0 -1.0 . . . . 24.65 109.301 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 18.8 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.323 -0.621 . . . . 24.77 109.323 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p -81.05 164.33 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 30.1 109.89 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.557 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.5 p-10 -134.91 106.65 6.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.007 -1.109 . . . . 32.24 108.007 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -156.33 167.42 30.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 30.21 109.865 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -78.51 101.06 7.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.17 -2.159 . . . . 24.0 105.17 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.4 mt -99.2 136.5 39.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.514 -0.742 . . . . 19.63 111.903 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.34 -162.89 0.94 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.973 . . . . 17.19 111.44 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.89 -50.96 1.51 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-N 115.751 -0.659 . . . . 16.55 112.723 -176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.4 m -79.17 -62.93 1.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.475 -1.603 . . . . 19.55 110.686 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.47 -55.45 34.63 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.033 -1.042 . . . . 0.0 110.038 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 67' ' ' ILE . 30.2 tp -50.7 -50.12 55.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.824 -1.172 . . . . 14.16 108.452 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.83 -56.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.58 -1.267 . . . . 15.31 107.58 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -55.65 -61.57 2.26 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.883 -1.154 . . . . 29.64 107.883 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.58 -59.61 2.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.03 -1.044 . . . . 13.96 109.762 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.44 -54.0 31.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.481 -1.387 . . . . 17.79 107.822 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -50.86 -50.4 57.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.526 -0.733 . . . . 16.84 109.127 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.1 mt -51.01 -26.93 6.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 22.76 108.6 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.37 -64.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.375 -0.828 . . . . 17.44 109.419 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.3 m -66.04 -83.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 18.54 109.982 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.77 -124.56 12.21 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.583 -1.294 . . . . 23.17 110.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -45.25 -20.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -1.048 . . . . 39.77 110.076 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 20' ' ' GLY . 84.4 mtt180 -66.75 -53.13 36.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -0.951 . . . . 26.65 109.807 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.49 64.15 0.49 Allowed Glycine 0 N--CA 1.508 3.457 0 C-N-CA 119.634 -1.27 . . . . 20.26 111.782 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.1 p90 -75.78 126.69 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.296 . . . . 17.79 109.808 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 13.6 p90 -96.91 104.37 16.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 18.55 108.864 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE2' HD23 ' A' ' 11' ' ' LEU . 5.5 t80 -66.14 163.05 18.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 21.49 109.171 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -147.06 134.47 20.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 31.5 109.88 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' THR . 20.0 pttm -173.62 65.92 0.32 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.232 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -51.52 -10.03 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.137 1.224 . . . . 0.0 109.314 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' LYS . 6.0 m -145.01 142.51 29.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -91.71 -29.15 16.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 34' ' ' ALA . 8.2 tpm_? -161.75 94.67 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.47 39.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.515 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . 55.22 -105.9 0.29 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.346 -0.846 . . . . 0.0 110.311 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 67.52 -21.24 0.12 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.544 -0.723 . . . . 0.0 110.358 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -157.25 -30.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.012 -1.055 . . . . 0.0 109.735 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt 49.72 -119.4 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -87.76 -132.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.21 151.46 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.153 -0.967 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.54 -136.77 4.56 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -73.14 73.49 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -1.105 . . . . 0.0 109.192 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 43' ' ' GLU . 7.5 p -147.92 -46.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 42' ' ' VAL . 11.3 pt-20 -105.27 -20.14 13.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.352 -0.843 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.36 21.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 109.271 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.86 -15.79 0.05 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.84 66.25 2.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.43 -67.43 1.58 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.5 124.29 15.89 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.436 1.424 . . . . 0.0 110.021 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -79.52 -10.85 85.45 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . 69.13 -58.14 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.632 -0.923 . . . . 0.0 109.835 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 151.31 -154.4 25.54 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 53' ' ' LEU . 36.6 t -172.63 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -1.124 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' A' ' 52' ' ' SER . 75.0 mt -81.96 -96.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.703 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.67 152.61 95.0 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.029 . . . . 0.0 108.952 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.24 135.26 57.05 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 120.668 0.912 . . . . 0.0 109.858 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 42.2 mt -57.66 -17.61 15.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.553 -0.717 . . . . 0.0 110.427 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' GLU . . . -77.21 -77.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.037 -1.04 . . . . 0.0 110.679 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.721 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -73.72 17.36 0.16 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.908 -1.12 . . . . 0.0 109.558 -179.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.652 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -68.64 -48.01 65.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -89.11 -24.19 32.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 m -44.41 -14.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -1.188 . . . . 0.0 111.334 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.749 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -99.54 -24.47 14.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.892 -1.13 . . . . 0.0 108.884 178.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.673 ' H ' HD22 ' A' ' 62' ' ' LEU . 15.1 mm-40 -107.99 6.02 26.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -43.63 142.01 1.33 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.017 -1.052 . . . . 0.0 110.125 -179.343 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.461 HH11 ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.23 -57.32 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.683 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.81 -145.7 12.55 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.818 -1.313 . . . . 19.62 109.818 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.553 HD11 HD11 ' A' ' 11' ' ' LEU . 3.7 tt -53.12 -43.22 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 17.42 109.723 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' ILE . 6.3 t -54.26 -23.98 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.98 -1.075 . . . . 18.82 109.726 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -94.73 10.2 36.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.06 -1.025 . . . . 38.5 109.797 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.5 mt-30 -135.64 -14.26 1.92 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.067 -1.021 . . . . 36.83 110.391 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.28 -28.48 6.52 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.355 -0.841 . . . . 18.16 109.399 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.96 -38.85 16.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 18.46 108.656 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.4 t -87.83 -12.39 45.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.798 . . . . 0.0 109.062 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -145.8 -142.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.644 -0.873 . . . . 30.34 108.644 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.83 125.19 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.996 -1.065 . . . . 27.51 109.481 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -108.72 175.74 5.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.581 -0.7 . . . . 23.34 109.932 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -112.51 176.22 5.11 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.507 0.67 . . . . 22.64 109.644 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.8 tp -48.21 -60.02 2.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.518 -0.739 . . . . 23.28 109.506 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -42.03 -58.78 1.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 37.86 110.404 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 12.1 mp0 -48.62 -46.9 40.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.834 -1.166 . . . . 31.39 108.992 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.15 -38.81 90.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.704 -0.85 . . . . 24.48 108.704 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.58 -18.66 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.768 . . . . 31.48 109.631 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -74.05 -29.76 62.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.483 -0.76 . . . . 22.48 111.57 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -97.88 11.77 36.26 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.099 -1.001 . . . . 19.59 111.734 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.0 m -76.91 -175.76 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.606 -1.309 . . . . 20.62 109.111 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 117.967 -1.016 . . . . 24.65 109.255 179.732 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.248 -0.649 . . . . 24.77 109.248 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p -163.28 163.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 30.1 109.754 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.55 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.3 p-10 -133.2 106.58 7.66 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.204 -1.036 . . . . 32.24 108.204 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -156.57 164.08 38.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.226 -0.921 . . . . 30.21 109.382 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -77.46 101.17 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.154 -2.165 . . . . 24.0 105.154 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.38 132.21 44.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.875 . . . . 19.63 111.922 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.54 -158.53 0.74 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.163 -0.961 . . . . 17.19 111.697 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.26 -54.56 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 115.826 -0.625 . . . . 16.55 113.201 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -79.04 -63.25 1.46 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.273 -1.722 . . . . 19.55 111.085 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -55.81 28.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 110.371 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 67' ' ' ILE . 35.1 tp -50.42 -52.15 40.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.709 -1.244 . . . . 14.16 108.554 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -45.83 -55.83 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.71 -1.218 . . . . 15.31 107.71 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -56.46 -61.43 2.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.868 -1.16 . . . . 29.64 107.868 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.3 -59.73 2.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.011 . . . . 13.96 109.882 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 10.8 mt -52.16 -53.84 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.315 -1.491 . . . . 17.79 107.888 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -50.7 -47.41 58.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.009 -0.737 . . . . 16.84 109.009 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.48 -26.77 33.34 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.011 -1.056 . . . . 22.76 108.348 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.21 -64.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.887 . . . . 17.44 109.393 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.2 m -65.37 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.902 . . . . 18.54 110.036 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.37 -123.36 16.82 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.496 -1.335 . . . . 23.17 109.883 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.3 pm0 -44.9 -18.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.463 -1.022 . . . . 39.77 110.587 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 20' ' ' GLY . 26.1 mtt-85 -70.72 -52.67 19.41 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.936 -1.103 . . . . 26.65 110.159 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.22 64.34 0.5 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 119.611 -1.281 . . . . 20.26 111.529 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.4 p90 -75.3 134.96 40.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -1.209 . . . . 17.79 109.426 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 10.5 p90 -100.83 107.54 19.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 18.55 110.412 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.459 ' CE2' HD23 ' A' ' 11' ' ' LEU . 3.0 t80 -88.59 145.93 25.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.415 -0.803 . . . . 21.49 108.967 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -148.27 103.62 3.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.935 -1.103 . . . . 31.5 110.456 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -165.63 66.18 1.07 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' O ' ' OG1' ' A' ' 30' ' ' THR . 5.6 Cg_exo -59.88 105.14 0.26 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.473 1.449 . . . . 0.0 110.047 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 27.0 m -165.99 117.3 1.04 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 33' ' ' GLU . 9.8 tpp180 -95.75 113.95 25.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' A' ' 32' ' ' ARG . 4.2 mtt-85 48.82 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.321 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' ARG . 14.7 pt-20 36.33 33.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.763 -0.585 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -128.39 104.27 7.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.456 -0.778 . . . . 0.0 109.414 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' H ' HD23 ' A' ' 37' ' ' LEU . 38.4 tt0 -157.78 -55.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.812 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.39 36.52 1.15 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.315 -0.866 . . . . 0.0 110.042 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 35' ' ' GLU . 3.8 mm? -82.04 -14.97 55.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 109.068 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -83.79 169.96 14.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.246 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLY . 16.2 t -138.07 -15.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.508 -0.745 . . . . 0.0 109.708 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . 50.82 -179.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -1.212 . . . . 0.0 108.848 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 43' ' ' GLU . 13.1 m -146.42 -47.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.117 -0.989 . . . . 0.0 109.521 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.599 ' N ' HG23 ' A' ' 42' ' ' VAL . 29.9 tt0 -173.44 152.08 2.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -89.16 29.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.822 . . . . 0.0 108.912 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.19 -54.13 0.31 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.73 -102.73 0.16 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.073 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 49' ' ' GLY . . . -157.77 79.56 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.43 4.9 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.368 1.379 . . . . 0.0 110.133 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 47' ' ' GLY . . . -71.83 118.74 7.17 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.19 57.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -1.141 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 53' ' ' LEU . . . 79.1 -33.39 1.97 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.0 t 57.12 3.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -1.115 . . . . 0.0 109.792 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 51' ' ' GLY . 39.9 mt -60.52 169.51 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 109.213 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -68.06 148.42 98.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.707 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.71 127.64 20.2 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.768 0.978 . . . . 0.0 109.623 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -56.1 -23.66 35.52 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.394 -0.817 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.61 9.06 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.959 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.7 mm? -64.9 -37.19 86.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.226 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -47.48 -35.35 8.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.5 -32.96 36.28 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -87.42 -7.68 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 109.242 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 58' ' ' LEU . 1.6 tt -74.02 -67.48 0.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -95.88 -29.18 14.34 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.196 -0.94 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp 54.68 38.29 29.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.576 -0.702 . . . . 0.0 110.381 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.4 -68.03 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.862 -1.149 . . . . 0.0 108.192 179.138 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -72.89 0.58 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.395 -0.907 . . . . 19.62 111.807 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 11' ' ' LEU . 3.6 tt -42.84 -52.48 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.535 -0.979 . . . . 17.42 112.163 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' N ' HG23 ' A' ' 67' ' ' ILE . 15.4 t -57.97 -7.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.626 -1.296 . . . . 18.82 109.603 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 67' ' ' ILE . 20.5 tp10 -113.02 9.26 18.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.144 -0.687 . . . . 38.5 109.144 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.8 mt-30 -138.88 -8.67 1.38 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 36.83 109.533 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.55 -31.9 4.46 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.6 -0.889 . . . . 18.16 108.6 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.06 -43.1 18.33 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 18.46 108.323 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 t -82.2 -21.79 36.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -136.81 -137.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.496 -0.928 . . . . 30.34 108.496 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.52 150.03 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.993 . . . . 27.51 109.294 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.4 m -135.14 176.65 8.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.388 -0.82 . . . . 23.34 109.956 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -112.37 -163.91 0.88 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.671 -0.643 . . . . 22.64 109.48 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.7 tp -67.83 -60.75 2.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -0.755 . . . . 23.28 109.547 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -41.5 -57.38 2.24 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.574 -0.703 . . . . 37.86 110.522 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.71 -47.22 41.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.786 -1.196 . . . . 31.39 108.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.2 -38.18 88.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.291 -0.881 . . . . 24.48 108.987 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -18.79 64.84 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.504 -0.747 . . . . 31.48 109.75 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.32 -30.38 63.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 22.48 111.758 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.05 11.96 35.88 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.026 -1.046 . . . . 19.59 111.891 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.3 m -76.74 -175.62 3.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.682 -1.261 . . . . 20.62 109.096 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.984 -1.008 . . . . 24.65 109.403 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.156 -0.683 . . . . 24.77 109.156 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.7 p -165.57 159.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 30.1 109.326 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 9.1 p30 -129.23 107.76 9.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.583 -0.895 . . . . 32.24 108.583 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -156.73 163.04 39.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.846 . . . . 30.21 109.557 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -77.18 100.83 5.93 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.164 -2.162 . . . . 24.0 105.164 176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.44 134.68 41.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.784 . . . . 19.63 111.731 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.5 -159.63 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.802 0.81 . . . . 17.19 112.103 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -35.92 -53.15 1.18 Allowed Glycine 0 N--CA 1.493 2.48 0 O-C-N 121.858 -0.526 . . . . 16.55 113.233 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 m -80.37 -62.25 1.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.385 -1.656 . . . . 19.55 110.932 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -55.4 35.3 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.911 -1.118 . . . . 0.0 110.276 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 67' ' ' ILE . 29.7 tp -50.89 -50.49 57.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.813 -1.179 . . . . 14.16 108.619 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.4 t -46.2 -57.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.459 -1.312 . . . . 15.31 107.459 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -55.56 -61.43 2.35 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.903 -1.147 . . . . 29.64 107.903 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -59.56 2.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.022 -1.049 . . . . 13.96 110.045 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.43 -55.0 21.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.342 -1.474 . . . . 17.79 107.703 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -49.33 -51.17 36.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.025 -0.732 . . . . 16.84 109.025 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.6 -26.87 5.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.063 -1.023 . . . . 22.76 108.62 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.81 -64.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.375 -0.828 . . . . 17.44 109.247 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.8 m -64.61 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 18.54 109.825 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 66.8 -120.12 13.65 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.632 -1.27 . . . . 23.17 110.12 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -48.74 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -1.071 . . . . 39.77 110.04 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -78.31 -52.76 8.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.888 -1.133 . . . . 26.65 109.646 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.76 63.36 0.48 Allowed Glycine 0 N--CA 1.508 3.46 0 C-N-CA 119.939 -1.124 . . . . 20.26 111.64 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 16.7 p90 -76.28 131.18 39.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.955 -1.32 . . . . 17.79 109.975 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -96.87 106.96 19.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.522 -0.736 . . . . 18.55 109.793 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CE2' HD23 ' A' ' 11' ' ' LEU . 2.4 t80 -96.85 140.75 30.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 21.49 109.512 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.462 ' OG1' ' NE ' ' A' ' 65' ' ' ARG . 73.7 p -150.47 104.08 3.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.659 -0.867 . . . . 31.5 108.659 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.531 ' O ' HG23 ' A' ' 30' ' ' THR . 11.0 ptpt -100.79 109.25 57.25 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.346 -0.846 . . . . 0.0 109.83 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.02 -11.1 14.24 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 28' ' ' LYS . 2.9 p 62.52 132.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.325 0.583 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 HH11 ' HG2' ' A' ' 31' ' ' ARG . 13.8 mtt-85 -77.91 85.43 4.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.853 . . . . 0.0 109.863 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 31' ' ' ARG . 11.2 tpp180 54.88 103.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.596 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.31 37.94 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.362 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.35 84.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.333 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.9 pm0 -96.9 -173.13 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.289 -0.882 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.4 t0 58.17 36.89 26.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.6 mt -83.13 -124.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.42 164.88 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.958 . . . . 0.0 109.255 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 39' ' ' VAL . 28.3 m -151.49 127.78 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.854 . . . . 0.0 109.499 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.73 -148.84 11.51 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' O ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -78.33 117.23 19.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -1.23 . . . . 0.0 109.22 179.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.19 15.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 108.547 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 68.55 162.54 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -81.68 11.91 4.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.588 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.03 71.98 0.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.2 -71.01 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.35 1.26 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.5 -160.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.49 1.46 . . . . 0.0 110.071 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -157.46 16.49 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.2 9.79 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 49.17 -129.03 23.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 m 52.81 -87.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.067 . . . . 0.0 109.703 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.95 -177.1 0.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.129 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.568 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 16.6 mp0 -77.88 148.55 75.85 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.79 126.15 20.88 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 121.002 1.135 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 38.9 mt -55.97 -11.58 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.7 -79.03 0.06 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 111.076 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.699 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -59.29 -26.71 65.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 0.0 109.806 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -45.21 -41.09 7.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.003 -1.061 . . . . 0.0 109.647 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.03 -41.22 61.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 p -83.8 -7.17 59.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -1.094 . . . . 0.0 109.869 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' LEU . 3.3 tt -71.72 -57.27 4.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 109.598 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' A' ' 64' ' ' LYS . 1.0 OUTLIER -100.76 -19.19 16.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.291 -0.881 . . . . 0.0 109.85 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 10.86 99.56 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.739 0 CA-C-O 121.559 0.695 . . . . 0.0 112.104 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.462 ' NE ' ' OG1' ' A' ' 27' ' ' THR . 6.9 ttm-85 -46.85 -75.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.35 -91.14 0.13 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.624 -1.274 . . . . 19.62 111.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt -49.37 -50.12 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 17.42 111.675 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 67' ' ' ILE . 9.9 t -57.17 -7.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.646 -1.284 . . . . 18.82 109.97 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -110.99 9.65 22.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.175 -0.953 . . . . 38.5 109.403 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 37.9 mt-30 -138.38 -8.93 1.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.402 -0.811 . . . . 36.83 109.876 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.4 m -120.25 -23.54 6.2 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.439 -0.788 . . . . 18.16 109.065 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 41.3 t -91.21 -41.84 10.76 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.203 -1.036 . . . . 18.46 108.203 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -85.19 -27.64 25.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -129.66 -138.21 0.22 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.511 -0.922 . . . . 30.34 108.511 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.25 149.61 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.003 . . . . 27.51 109.258 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -133.97 171.81 13.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.429 -0.794 . . . . 23.34 109.766 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -106.88 -153.93 0.51 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.493 -0.754 . . . . 22.64 109.479 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -77.78 -59.94 2.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.922 . . . . 23.28 109.014 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -42.21 -55.99 3.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.674 -0.641 . . . . 37.86 110.309 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -48.74 -47.15 41.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.932 -1.105 . . . . 31.39 109.005 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mp -63.13 -39.42 94.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 24.48 108.942 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.64 -19.0 61.78 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.399 -0.813 . . . . 31.48 109.878 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.43 -29.68 61.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 22.48 111.568 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -97.94 11.78 36.32 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.147 -0.971 . . . . 19.59 111.73 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.7 m -77.05 -175.71 3.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.641 -1.287 . . . . 20.62 109.196 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 118.029 -0.986 . . . . 24.65 109.368 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.423 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.3 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.198 -0.667 . . . . 24.77 109.198 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p -166.49 164.0 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.997 . . . . 30.1 109.461 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.552 ' N ' HG22 ' A' ' 2' ' ' VAL . 7.5 p-10 -134.78 106.98 7.17 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.252 -1.018 . . . . 32.24 108.252 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -157.34 165.09 36.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 30.21 110.08 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -77.28 100.61 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.161 -2.163 . . . . 24.0 105.161 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.36 134.94 41.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 19.63 111.799 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.33 -162.44 0.89 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.152 -0.968 . . . . 17.19 111.636 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.51 -52.2 1.38 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 115.761 -0.654 . . . . 16.55 112.864 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -78.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.648 . . . . 19.55 110.669 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -55.47 33.28 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.106 -0.997 . . . . 0.0 110.136 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 67' ' ' ILE . 34.7 tp -51.09 -50.29 59.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.865 -1.147 . . . . 14.16 108.744 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.9 t -47.89 -55.87 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.65 -1.241 . . . . 15.31 107.65 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.09 -61.69 2.21 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.969 -1.123 . . . . 29.64 107.969 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.37 -59.32 2.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 13.96 109.975 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.88 -55.38 20.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.328 -1.482 . . . . 17.79 107.77 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -49.53 -48.94 47.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.255 -0.646 . . . . 16.84 109.255 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.4 mt -52.96 -25.88 13.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.984 -1.073 . . . . 22.76 108.587 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.92 -64.61 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 17.44 109.435 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.1 m -64.24 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 18.54 109.606 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 77.01 -133.14 12.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.718 -1.353 . . . . 23.17 109.718 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -49.45 -11.29 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -1.111 . . . . 39.77 109.594 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -63.7 -53.05 57.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 26.65 108.778 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.93 63.58 0.48 Allowed Glycine 0 N--CA 1.506 3.363 0 C-N-CA 119.941 -1.124 . . . . 20.26 111.562 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 26.0 p90 -76.12 123.17 25.4 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.166 -1.197 . . . . 17.79 109.935 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 9.1 p90 -92.74 107.0 18.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.845 . . . . 18.55 109.079 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CE2' HD23 ' A' ' 11' ' ' LEU . 6.4 t80 -68.48 162.48 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 21.49 109.486 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -154.05 151.61 29.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 31.5 109.681 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 30' ' ' THR . 12.1 pttm -173.14 65.56 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -50.95 92.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.154 1.236 . . . . 0.0 110.007 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 28' ' ' LYS . 4.3 m -162.37 81.27 0.53 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.48 0.657 . . . . 0.0 109.266 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HG3' HH11 ' A' ' 31' ' ' ARG . 26.8 mtm-85 -83.08 -43.12 16.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.803 . . . . 0.0 109.603 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -67.38 99.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.585 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -153.65 110.52 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . -166.15 153.15 9.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.413 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -39.76 166.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.522 0.677 . . . . 0.0 111.076 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' OD2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 78.99 23.07 0.58 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.554 0.692 . . . . 0.0 109.332 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 39' ' ' VAL . 2.3 mm? -67.73 152.1 46.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.003 -1.061 . . . . 0.0 108.399 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 52.43 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.533 -0.729 . . . . 0.0 109.677 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 37' ' ' LEU . 38.5 t -48.7 115.83 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . 170.19 135.57 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER 21.49 74.38 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.224 0.535 . . . . 0.0 112.005 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 p -153.64 150.12 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.07 -1.019 . . . . 0.0 109.372 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.01 134.34 21.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.59 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.74 -58.2 4.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.85 33.56 0.73 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 44' ' ' LEU . . . 51.29 -163.07 1.24 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -67.19 0.23 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.68 -48.52 16.59 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.403 1.402 . . . . 0.0 109.851 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 163.7 157.0 9.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.02 -23.81 59.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -1.211 . . . . 0.0 109.587 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.7 -175.52 50.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.1 p -160.67 -32.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.394 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.03 177.86 6.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.336 -0.853 . . . . 0.0 109.124 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -52.9 149.11 12.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.288 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.62 137.63 74.74 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.92 1.08 . . . . 0.0 109.86 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 41.4 mt -54.2 -35.11 62.03 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 -61.17 2.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 109.713 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.8 mm? -56.46 -43.95 80.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 109.163 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.8 -14.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.81 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . -84.4 -57.78 2.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 t -73.74 -7.99 54.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.274 -1.133 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 62' ' ' LEU . 3.1 tt -70.65 -57.21 4.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.164 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 65' ' ' ARG . 4.8 pt20 -90.62 -26.71 19.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 30.46 31.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.129 0.49 . . . . 0.0 111.468 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 63' ' ' GLN . 50.5 ttt180 -174.37 57.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.47 154.47 22.07 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.742 -1.343 . . . . 19.62 109.742 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 11' ' ' LEU . 2.9 tt -103.99 -40.18 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.534 -0.98 . . . . 17.42 109.157 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.4 t -52.09 -46.48 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.099 -1.001 . . . . 18.82 109.56 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.36 10.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 38.5 109.768 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 35.4 mt-30 -135.76 -10.56 2.08 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.127 -0.983 . . . . 36.83 110.843 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.5 m -123.84 -25.98 4.18 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.297 -0.877 . . . . 18.16 108.766 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.67 -39.68 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.299 -1.0 . . . . 18.46 108.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -88.03 -16.2 34.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -138.59 -142.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.461 -0.94 . . . . 30.34 108.461 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -144.91 142.0 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.041 -1.037 . . . . 27.51 109.15 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -129.07 173.58 10.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 23.34 109.631 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -112.17 -165.85 1.03 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.556 -0.715 . . . . 22.64 109.836 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.6 tp -64.26 -58.11 7.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 23.28 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -44.0 -58.19 2.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.813 . . . . 37.86 110.203 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -47.88 -47.64 31.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.147 . . . . 31.39 109.186 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.23 -40.03 94.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.02 -0.733 . . . . 24.48 109.02 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.98 -18.97 62.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 31.48 109.747 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -74.46 -29.87 61.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 22.48 111.48 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -97.16 11.79 35.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.114 -0.991 . . . . 19.59 111.796 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.6 m -77.38 -175.68 3.84 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.611 -1.305 . . . . 20.62 109.258 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 36.5 t-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.004 -0.998 . . . . 24.65 109.221 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 13.2 t80 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 24.77 109.237 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -164.78 163.87 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 30.1 109.492 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.504 ' N ' HG22 ' A' ' 2' ' ' VAL . 9.2 p-10 -131.99 106.94 8.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.455 -0.943 . . . . 32.24 108.455 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -157.59 163.01 38.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 30.21 109.686 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -77.45 100.78 6.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.125 -2.176 . . . . 24.0 105.125 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -97.68 132.93 42.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 19.63 111.996 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.67 -162.1 0.86 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.904 0.859 . . . . 17.19 111.427 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.14 -50.97 1.63 Allowed Glycine 0 N--CA 1.491 2.354 0 CA-C-N 115.957 -0.565 . . . . 16.55 112.888 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 p -79.38 -63.38 1.43 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.4 -1.647 . . . . 19.55 110.872 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -55.09 39.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 110.073 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 67' ' ' ILE . 29.0 tp -50.6 -49.77 55.67 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.728 -1.233 . . . . 14.16 108.429 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -48.24 -56.2 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.393 -1.336 . . . . 15.31 107.393 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -55.79 -61.46 2.35 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.843 -1.143 . . . . 29.64 108.036 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.98 2.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 13.96 109.662 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 10.5 mt -51.22 -50.25 59.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.565 -1.334 . . . . 17.79 108.026 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -56.06 -41.99 75.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 16.84 109.211 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.79 -28.19 65.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.785 -1.197 . . . . 22.76 107.961 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.83 -64.66 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.461 -0.774 . . . . 17.44 109.547 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.5 m -64.6 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 18.54 109.801 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 76.51 -134.18 15.02 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.756 -1.338 . . . . 23.17 109.756 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -48.26 -11.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.415 -1.05 . . . . 39.77 109.8 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' GLY . 51.7 mtt180 -65.33 -52.52 53.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.058 . . . . 26.65 108.95 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.37 0.49 Allowed Glycine 0 N--CA 1.506 3.325 0 C-N-CA 119.786 -1.197 . . . . 20.26 111.663 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.521 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.0 p90 -76.11 123.41 25.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.213 -1.169 . . . . 17.79 109.896 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 19.2 p90 -91.38 106.89 18.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.396 -0.815 . . . . 18.55 109.015 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' O ' HG23 ' A' ' 27' ' ' THR . 5.9 t80 -75.75 145.0 41.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 21.49 109.415 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 26' ' ' TYR . 27.4 p -155.71 159.41 39.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 31.5 109.5 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -158.96 109.3 1.58 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.165 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' THR . 4.7 Cg_exo -56.95 -21.31 40.61 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.66 0.907 . . . . 0.0 109.931 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 25.0 p -61.4 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.5 -0.75 . . . . 0.0 109.777 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.0 OUTLIER 74.32 -72.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.015 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.593 HH11 ' CG ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -95.39 95.42 8.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -0.799 . . . . 0.0 108.971 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.31 41.14 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.32 74.77 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 12.9 mp0 -81.05 -43.69 19.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.618 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -170.24 45.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.523 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt -72.15 109.0 5.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.262 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -81.56 133.62 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.316 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 39' ' ' VAL . 1.8 m -61.94 97.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . -176.69 104.86 0.19 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 40' ' ' GLY . 3.2 pp0? 25.42 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.73 0.776 . . . . 0.0 111.772 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' GLY . 13.4 m -143.7 -22.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.04 -1.038 . . . . 0.0 109.334 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.5 pt-20 -85.15 -9.49 57.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -47.51 98.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.99 . . . . 0.0 109.507 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 87.96 -50.67 3.96 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -171.0 -178.37 41.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 46' ' ' GLY . . . -50.96 179.18 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.35 -52.91 5.45 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.439 1.426 . . . . 0.0 109.869 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.11 85.4 0.69 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.67 36.06 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -1.12 . . . . 0.0 109.41 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.18 -125.63 0.78 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -161.4 13.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -1.172 . . . . 0.0 109.489 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.446 HD12 ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER -90.59 178.67 6.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.0 109.177 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' OE1' ' OE2' ' A' ' 59' ' ' GLU . 50.8 mt-30 -80.99 152.91 72.11 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 57' ' ' ALA . 2.1 Cg_endo -58.72 126.15 20.37 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.004 1.136 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 mt -54.13 -10.0 0.32 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.542 -0.723 . . . . 0.0 109.675 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 55' ' ' PRO . . . -71.69 -78.32 0.08 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.953 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -63.05 -20.44 65.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.923 -1.111 . . . . 0.0 109.82 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' OE2' ' OE1' ' A' ' 54' ' ' GLN . 16.1 mm-40 -45.67 -33.57 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.134 -0.979 . . . . 0.0 109.097 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 64' ' ' LYS . . . -84.43 -54.65 2.92 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -48.97 -28.57 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -1.103 . . . . 0.0 109.728 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 58' ' ' LEU . 4.4 mp -48.97 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.051 -1.03 . . . . 0.0 108.247 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 64' ' ' LYS . 68.2 mt-30 -96.25 5.97 49.82 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 54.25 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.405 0.622 . . . . 0.0 109.861 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -136.23 -22.39 1.35 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.315 -0.866 . . . . 0.0 109.223 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.75 17.89 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.682 -1.367 . . . . 19.62 109.682 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 11' ' ' LEU . 2.5 tt -100.56 -42.1 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -1.048 . . . . 17.42 109.17 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.473 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.6 t -48.77 -49.76 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.202 -0.936 . . . . 18.82 109.822 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -69.77 10.65 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 38.5 110.221 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.497 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 8.7 mt-30 -132.75 -16.53 2.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.215 -0.928 . . . . 36.83 110.781 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.0 m -119.35 -25.09 6.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.42 -0.8 . . . . 18.16 108.965 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.2 t -85.92 -37.85 18.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 18.46 108.676 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -90.37 -8.91 49.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 108.857 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -148.42 -145.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.624 -0.88 . . . . 30.34 108.624 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 75' ' ' ILE . 19.3 mt -143.76 123.13 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.17 -0.956 . . . . 27.51 109.132 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.3 m -104.15 177.87 4.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.535 -0.728 . . . . 23.34 109.531 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 m -112.11 176.72 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.522 -0.737 . . . . 22.64 109.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -51.01 -59.64 3.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 23.28 109.495 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -43.68 -55.0 4.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.438 -0.789 . . . . 37.86 110.163 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -49.48 -48.16 47.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.723 -1.236 . . . . 31.39 108.907 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.58 -38.65 88.32 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 24.48 108.967 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.98 -18.98 64.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.394 -0.816 . . . . 31.48 109.827 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -73.95 -29.4 61.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 22.48 111.522 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.83 11.72 36.33 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.133 -0.979 . . . . 19.59 111.693 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.71 -175.83 3.57 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.567 -1.333 . . . . 20.62 109.271 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 118.082 -0.961 . . . . 24.65 109.495 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 21.8 t80 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.322 -0.621 . . . . 24.77 109.322 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p -77.11 163.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.27 -0.894 . . . . 30.1 110.107 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.549 ' N ' HG22 ' A' ' 2' ' ' VAL . 8.0 p-10 -135.03 107.8 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.13 -1.063 . . . . 32.24 108.13 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -156.82 166.95 31.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 30.21 109.657 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -77.34 100.66 6.0 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.025 -2.213 . . . . 24.0 105.025 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' CYS . 14.2 mt -99.15 134.55 41.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.527 -0.733 . . . . 19.63 111.683 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 m -122.63 -157.36 0.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.951 0.881 . . . . 17.19 112.473 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.65 -54.35 1.38 Allowed Glycine 0 N--CA 1.493 2.496 0 CA-C-N 116.042 -0.526 . . . . 16.55 113.012 -176.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -80.45 -60.38 2.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.47 -1.606 . . . . 19.55 111.04 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -55.63 32.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 110.474 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD21 HD13 ' A' ' 67' ' ' ILE . 25.5 tp -51.78 -47.03 64.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.68 -1.263 . . . . 14.16 108.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -49.72 -57.13 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.237 -1.394 . . . . 15.31 107.237 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -55.69 -61.34 2.43 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.009 -1.077 . . . . 29.64 108.276 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -44.87 -59.62 2.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.087 -1.008 . . . . 13.96 109.747 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.73 -51.46 55.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.389 -1.444 . . . . 17.79 107.94 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -54.16 -43.56 70.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.466 -0.771 . . . . 16.84 109.113 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.61 -28.88 61.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.926 -1.109 . . . . 22.76 108.238 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -94.03 -64.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 17.44 109.493 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.3 m -64.21 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 18.54 109.856 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 73.09 -129.81 13.13 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.635 -1.269 . . . . 23.17 110.034 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 1.3 pm0 -46.54 -13.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -1.003 . . . . 39.77 110.018 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' GLY . 60.7 mtt180 -68.06 -52.89 30.11 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.088 -1.008 . . . . 26.65 109.522 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.9 64.15 0.48 Allowed Glycine 0 N--CA 1.508 3.442 0 C-N-CA 119.717 -1.23 . . . . 20.26 111.698 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 26.1 p90 -76.34 131.62 39.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -1.197 . . . . 17.79 110.039 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 28.2 p90 -98.09 109.42 22.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 18.55 109.133 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CE1' HD23 ' A' ' 11' ' ' LEU . 4.4 t80 -76.32 165.34 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 21.49 109.213 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -154.43 130.28 10.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.082 -1.011 . . . . 31.5 109.851 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -169.38 49.54 0.15 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.442 -0.786 . . . . 0.0 110.288 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 11.9 Cg_exo -43.13 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.582 1.521 . . . . 0.0 110.218 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 30' ' ' THR . 6.4 t -139.78 96.79 3.13 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 2.3 tpm_? -93.65 -76.39 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.672 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.607 HH11 ' CG ' ' A' ' 32' ' ' ARG . 0.1 OUTLIER -107.66 74.93 0.98 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.0 109.298 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.57 32.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.277 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.35 17.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.118 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -122.84 2.94 9.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.594 -0.691 . . . . 0.0 109.548 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' GLN . 32.3 t70 -152.0 4.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 39' ' ' VAL . 4.3 mp -56.07 -4.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.076 -1.015 . . . . 0.0 108.911 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 36' ' ' ASP . 11.2 mm100 -62.4 1.56 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.219 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' VAL . 10.1 p -44.06 126.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . -158.82 141.56 7.7 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLY . 1.2 tt0 57.39 107.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.404 -1.057 . . . . 0.0 109.056 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -145.33 -15.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.1 -1.0 . . . . 0.0 108.946 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 47' ' ' GLY . 6.1 tt0 -172.85 -166.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.8 mp -90.89 16.6 9.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 109.195 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.76 -31.9 1.21 Allowed Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -87.59 -134.88 4.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 43' ' ' GLU . . . 153.17 176.93 26.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.19 -59.84 0.62 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.493 1.462 . . . . 0.0 109.633 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.51 52.38 9.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.37 -5.22 6.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.379 -1.071 . . . . 0.0 109.2 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 26.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 53' ' ' LEU . 59.1 m -60.47 -67.74 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -1.14 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.9 mm? 43.72 -166.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -64.65 148.82 96.53 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.429 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.28 126.79 16.96 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.577 -0.971 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -58.51 -17.84 24.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.1 -73.19 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 58' ' ' LEU . 2.7 mm? -57.01 -30.21 63.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -43.75 -29.04 0.48 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.268 -0.895 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -84.32 -51.9 3.76 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -40.73 -20.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.743 -0.857 . . . . 0.0 111.074 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 60' ' ' GLY . 23.8 mt -75.71 -29.03 58.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.145 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -96.19 -21.13 18.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.023 -1.048 . . . . 0.0 110.632 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.38 163.98 12.83 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.924 -1.11 . . . . 0.0 109.209 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.54 65.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.29 128.72 10.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.95 -1.26 . . . . 19.62 109.95 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt -87.32 -39.13 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -1.052 . . . . 17.42 108.946 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.0 t -50.85 -48.83 28.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 18.82 109.411 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.16 10.46 0.15 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.2 -0.937 . . . . 38.5 110.721 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 38.7 mt-30 -137.79 -14.21 1.43 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.921 -1.112 . . . . 36.83 111.005 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.1 m -120.82 -21.62 6.54 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.934 . . . . 18.16 109.108 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.7 t -90.82 -39.85 12.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.101 -1.074 . . . . 18.46 108.101 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -88.39 -18.77 27.68 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -140.12 -144.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.351 -0.981 . . . . 30.34 108.351 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.65 151.27 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.111 -0.993 . . . . 27.51 109.031 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -135.55 172.29 13.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.475 -0.765 . . . . 23.34 109.68 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 m -111.63 -176.47 2.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.519 -0.738 . . . . 22.64 110.076 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.2 tp -55.48 -57.33 12.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 23.28 109.46 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -44.0 -50.57 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 37.86 110.027 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -57.06 -53.26 60.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.981 -1.074 . . . . 31.39 108.814 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.5 mp -55.51 -39.63 70.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.777 -0.823 . . . . 24.48 108.777 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.98 -18.71 65.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.528 -0.733 . . . . 31.48 109.944 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.95 -28.44 61.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 22.48 111.568 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 20.6 m-85 -101.0 12.08 38.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.252 -0.905 . . . . 19.59 111.991 -177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.1 m -76.75 -175.62 3.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.614 -1.304 . . . . 20.62 109.134 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 118.037 -0.982 . . . . 24.65 109.446 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.502 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 11.3 t80 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.187 -0.671 . . . . 24.77 109.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.6 p -139.46 159.87 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.238 -0.914 . . . . 30.1 109.229 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 9.5 p30 -129.65 108.11 9.95 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.736 -0.839 . . . . 32.24 108.736 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -156.64 163.66 39.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 30.21 109.5 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -76.18 100.73 5.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.246 -2.131 . . . . 24.0 105.246 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.0 134.63 41.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 19.63 111.738 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.49 -161.46 0.89 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.093 -1.005 . . . . 17.19 111.806 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.22 -47.37 1.44 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.703 -0.68 . . . . 16.55 112.77 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -82.94 -62.46 1.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.349 -1.677 . . . . 19.55 110.734 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -55.49 34.5 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.006 -1.059 . . . . 0.0 109.993 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 29.8 tp -49.97 -50.92 45.15 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.698 -1.251 . . . . 14.16 108.269 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.05 -54.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.453 -1.314 . . . . 15.31 107.453 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.17 -61.71 2.28 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.949 -1.1 . . . . 29.64 108.257 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.34 -59.87 2.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.118 -0.989 . . . . 13.96 109.518 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.5 mt -51.05 -49.14 61.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.585 -1.322 . . . . 17.79 108.102 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.51 -40.72 79.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 16.84 109.011 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.63 -29.54 68.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.915 -1.116 . . . . 22.76 108.086 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.28 -64.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.479 -0.763 . . . . 17.44 109.555 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -64.34 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 18.54 109.685 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.59 -122.96 11.02 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.617 -1.277 . . . . 23.17 110.077 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -50.64 -11.7 0.09 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -1.055 . . . . 39.77 110.386 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' GLY . 31.1 mtt-85 -73.32 -52.09 15.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.871 -1.143 . . . . 26.65 109.668 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.03 64.31 0.48 Allowed Glycine 0 N--CA 1.508 3.467 0 C-N-CA 119.756 -1.211 . . . . 20.26 111.685 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.413 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.2 p90 -75.08 135.6 41.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.004 -1.292 . . . . 17.79 109.169 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 24.1 p90 -103.69 107.66 18.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.458 -0.776 . . . . 18.55 110.663 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE2' HD23 ' A' ' 11' ' ' LEU . 2.0 t80 -87.97 143.76 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.226 -1.027 . . . . 21.49 108.226 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.53 ' OG1' ' NE ' ' A' ' 65' ' ' ARG . 17.5 p -146.25 98.53 3.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.866 -1.146 . . . . 31.5 110.36 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -174.33 68.89 0.31 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.43 108.19 0.35 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.508 1.472 . . . . 0.0 110.231 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -155.34 95.54 1.71 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 108.869 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -110.21 -94.99 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.622 -0.673 . . . . 0.0 110.031 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 33' ' ' GLU . 11.7 tpp180 -44.5 -26.06 0.32 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.0 110.033 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 5.6 pt-20 27.08 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.788 0.804 . . . . 0.0 111.611 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . 74.34 129.77 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.077 -1.015 . . . . 0.0 109.151 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -88.18 -94.86 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.083 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 1.2 p30 -61.72 103.79 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.37 -1.25 57.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.126 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -52.61 160.97 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.334 -0.853 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 40' ' ' GLY . 17.2 m -92.95 29.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . -62.41 -140.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -80.66 81.29 6.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -1.154 . . . . 0.0 109.541 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 1.2 m -142.85 13.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.263 -0.898 . . . . 0.0 108.821 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 12.2 tt0 81.01 146.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -99.93 73.4 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.462 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 46' ' ' GLY . . . 179.46 -2.15 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 45' ' ' GLY . . . 161.0 163.87 14.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.35 -179.08 46.34 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.6 -47.01 14.84 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.608 1.539 . . . . 0.0 109.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.39 122.55 0.47 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.08 -9.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -1.161 . . . . 0.0 109.554 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . -66.67 -116.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.6 p 73.07 -44.43 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -1.106 . . . . 0.0 109.644 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.62 -75.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -92.86 154.37 41.99 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.13 136.83 77.14 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.507 1.471 . . . . 0.0 110.881 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 45.9 mt -44.06 -39.66 4.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.715 -0.615 . . . . 0.0 110.064 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -51.8 67.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -0.997 . . . . 0.0 109.75 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.4 mm? -68.21 -37.57 81.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.353 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -51.36 -29.82 16.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.978 . . . . 0.0 109.52 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.9 -7.71 73.93 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 p -84.06 -40.27 18.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.077 -1.249 . . . . 0.0 110.611 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.657 HD13 ' H ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -88.52 -0.85 57.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.776 -1.203 . . . . 0.0 109.297 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' O ' ' C ' ' A' ' 64' ' ' LYS . 12.2 mt-30 -105.03 -66.35 0.98 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 14.61 64.65 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-O 121.609 0.719 . . . . 0.0 111.734 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' OG1' ' A' ' 27' ' ' THR . 20.5 tpt180 -45.33 -77.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 109.613 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.08 -114.19 0.5 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.346 -1.407 . . . . 19.62 110.412 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.597 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt -50.74 -49.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -1.015 . . . . 17.42 111.131 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.597 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.1 t -54.96 -12.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.748 -1.22 . . . . 18.82 110.222 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -105.14 9.91 34.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 38.5 109.773 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -137.01 -14.91 1.55 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.283 -0.886 . . . . 36.83 109.857 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.8 m -112.49 -29.26 7.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.402 -0.811 . . . . 18.16 108.993 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.44 -44.47 11.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.105 . . . . 18.46 108.825 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -81.44 -14.56 56.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.4 t -147.71 -137.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.444 -0.947 . . . . 30.34 108.444 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.81 149.59 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.076 -1.015 . . . . 27.51 109.349 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -131.47 176.32 8.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.487 -0.758 . . . . 23.34 109.587 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.26 171.17 7.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.661 -0.649 . . . . 22.64 109.444 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.502 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.4 tp -45.09 -61.16 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 23.28 109.502 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -41.33 -54.73 2.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.692 . . . . 37.86 110.531 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.409 ' N ' ' OE1' ' A' ' 80' ' ' GLN . 8.4 mp0 -52.16 -49.49 63.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 31.39 108.578 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -58.56 -40.01 81.84 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.655 -0.868 . . . . 24.48 108.655 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.84 -18.75 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.426 -0.796 . . . . 31.48 109.923 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.87 -29.02 61.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.813 . . . . 22.48 111.692 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -99.56 11.98 37.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.139 -0.976 . . . . 19.59 111.857 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -76.81 -175.82 3.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.579 -1.326 . . . . 20.62 109.025 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.018 -0.991 . . . . 24.65 109.292 179.771 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.519 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.4 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.239 -0.652 . . . . 24.77 109.239 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p -162.04 158.02 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 30.1 109.349 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 7.5 p30 -127.54 106.4 9.15 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.547 -0.909 . . . . 32.24 108.547 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -157.09 164.27 38.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 30.21 109.574 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -78.37 100.61 6.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.264 -2.124 . . . . 24.0 105.264 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.22 135.02 40.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 19.63 111.671 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.8 m -123.99 -158.35 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.895 0.855 . . . . 17.19 112.438 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.56 -51.29 1.39 Allowed Glycine 0 N--CA 1.492 2.429 0 CA-C-N 115.991 -0.55 . . . . 16.55 112.997 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m -82.48 -60.95 2.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.382 -1.658 . . . . 19.55 110.975 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -55.68 31.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.376 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 67' ' ' ILE . 23.8 tp -50.53 -48.4 57.16 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.677 -1.264 . . . . 14.16 108.36 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.14 -54.3 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.128 -1.434 . . . . 15.31 107.128 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.78 -61.48 2.49 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.951 -1.1 . . . . 29.64 108.322 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.15 -60.3 2.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 13.96 109.653 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 67' ' ' ILE . 11.3 mt -51.22 -48.34 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.559 -1.338 . . . . 17.79 108.046 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -58.86 -39.49 81.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.535 -0.728 . . . . 16.84 109.119 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.65 -31.22 70.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 22.76 108.08 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -89.65 -64.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.519 -0.738 . . . . 17.44 109.496 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.1 m -64.0 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 18.54 109.37 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.97 -132.84 12.21 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.564 -1.414 . . . . 23.17 109.564 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 -13.65 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -1.132 . . . . 39.77 109.49 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -60.32 -53.27 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.94 . . . . 26.65 109.217 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.66 64.5 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.885 -1.15 . . . . 20.26 111.196 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 27.4 p90 -75.82 124.74 27.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -1.169 . . . . 17.79 110.172 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 11.6 p90 -92.3 104.61 16.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.454 -0.779 . . . . 18.55 109.048 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -62.01 168.69 3.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.276 -0.89 . . . . 21.49 108.908 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 16.5 p -142.77 159.83 41.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.29 -0.881 . . . . 31.5 109.511 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 30' ' ' THR . 28.5 ttmt 76.18 69.92 0.22 Allowed Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.89 101.99 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.417 1.411 . . . . 0.0 110.098 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.691 HG23 ' H ' ' A' ' 31' ' ' ARG . 1.8 t -140.05 -109.67 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.402 -0.811 . . . . 0.0 109.057 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.691 ' H ' HG23 ' A' ' 30' ' ' THR . 21.6 ttt180 73.84 -61.21 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HG2' HH11 ' A' ' 32' ' ' ARG . 2.7 ttt-85 -155.95 119.08 4.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 0.0 109.227 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -153.36 -69.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.291 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.74 68.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -116.1 161.51 18.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.557 -0.714 . . . . 0.0 109.426 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 52.96 69.65 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.787 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.573 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.6 mm? -86.45 -109.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 109.051 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -111.21 140.28 45.9 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.425 -0.797 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 m -79.12 32.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.32 47.97 0.41 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.67 46.37 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -1.05 . . . . 0.0 108.214 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.63 -10.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 45' ' ' GLY . 21.7 tt0 64.44 98.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -44.17 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 110.33 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -117.49 53.08 0.66 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.12 -171.45 34.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.36 179.33 44.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.07 -33.62 98.62 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.491 1.46 . . . . 0.0 109.759 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.08 138.07 5.82 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.55 4.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -1.158 . . . . 0.0 109.208 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.77 171.04 7.44 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.9 m -83.76 103.46 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -1.184 . . . . 0.0 109.638 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 mt -140.54 -171.78 3.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.7 144.89 96.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.03 -1.044 . . . . 0.0 108.66 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.41 131.34 33.57 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.783 0.989 . . . . 0.0 109.743 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.1 mt -57.86 -21.74 44.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -52.74 19.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.608 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.5 mm? -71.18 -32.84 69.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.063 -1.023 . . . . 0.0 109.519 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -46.81 -43.69 18.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.39 -39.58 6.74 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 64' ' ' LYS . 32.0 t -80.89 -7.32 59.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.117 -1.225 . . . . 0.0 110.74 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -47.48 -64.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.29 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.05 -33.45 16.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 109.794 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 10.9 mptt -89.0 151.73 22.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 109.706 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -50.11 9.49 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' O ' ' NE2' ' A' ' 70' ' ' GLN . . . 85.21 146.85 8.71 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.96 -1.256 . . . . 19.62 109.96 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt -127.3 -42.39 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.608 -0.936 . . . . 17.42 108.79 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.45 -53.62 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.054 -1.029 . . . . 18.82 109.461 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.52 10.61 0.09 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.309 -0.869 . . . . 38.5 110.248 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 33.5 mt-30 -135.1 -16.28 1.92 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.979 -1.075 . . . . 36.83 110.69 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.65 -23.73 6.45 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.41 -0.806 . . . . 18.16 109.096 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.6 t -87.44 -36.74 17.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.342 -0.984 . . . . 18.46 108.342 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -91.45 -16.87 26.64 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -138.71 -144.66 0.18 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -145.11 117.29 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.982 -1.074 . . . . 27.51 109.37 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -100.5 177.41 5.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.382 -0.824 . . . . 23.34 109.852 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 m -112.36 -175.38 2.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.548 -0.72 . . . . 22.64 109.752 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.5 tp -57.26 -56.46 21.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.514 -0.741 . . . . 23.28 109.478 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -44.91 -57.43 3.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 37.86 109.933 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -48.6 -48.52 39.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.87 -1.144 . . . . 31.39 108.987 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -60.95 -39.93 91.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.814 -0.809 . . . . 24.48 108.814 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.27 -18.95 64.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 31.48 109.662 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -73.19 -29.78 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 22.48 111.589 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.04 12.21 36.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.036 -1.04 . . . . 19.59 111.788 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 77.9 m -76.66 -175.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.658 -1.277 . . . . 20.62 109.253 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.95 -1.024 . . . . 24.65 109.452 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.8 t80 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.275 -0.639 . . . . 24.77 109.275 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p -164.14 163.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 30.1 109.533 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.525 ' N ' HG22 ' A' ' 2' ' ' VAL . 6.7 p-10 -132.97 106.77 7.87 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.298 -1.001 . . . . 32.24 108.298 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -157.38 164.62 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 30.21 109.824 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -77.67 100.57 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.173 -2.158 . . . . 24.0 105.173 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.8 mt -99.44 135.31 41.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 19.63 111.72 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.2 m -122.91 -157.58 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.97 0.89 . . . . 17.19 112.424 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.72 -55.47 1.35 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-N 116.043 -0.526 . . . . 16.55 113.06 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -79.63 -58.49 3.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.383 -1.657 . . . . 19.55 111.152 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -55.94 27.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 110.419 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 67' ' ' ILE . 24.9 tp -51.12 -48.83 61.67 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.69 -1.256 . . . . 14.16 108.359 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -48.28 -55.06 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.451 -1.315 . . . . 15.31 107.451 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.97 -61.76 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.119 -1.067 . . . . 29.64 108.119 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.47 -59.6 2.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.102 -0.999 . . . . 13.96 109.686 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 11.2 mt -51.61 -53.46 38.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.486 -1.384 . . . . 17.79 107.906 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -52.11 -45.63 64.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.497 -0.752 . . . . 16.84 109.176 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -56.45 -30.98 63.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.957 -1.09 . . . . 22.76 108.336 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -89.94 -64.6 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.389 -0.819 . . . . 17.44 109.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -64.13 -79.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 18.54 109.45 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 75.81 -131.72 12.25 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.816 -1.314 . . . . 23.17 109.816 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -50.09 -10.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -1.088 . . . . 39.77 109.521 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.47 -52.97 49.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 26.65 108.994 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.75 63.93 0.49 Allowed Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.936 -1.126 . . . . 20.26 111.46 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 23.9 p90 -76.24 122.42 24.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.146 -1.208 . . . . 17.79 110.162 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 12.0 p90 -89.7 104.43 16.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.567 -0.901 . . . . 18.55 108.567 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 27' ' ' THR . 12.3 t80 -65.39 168.2 7.5 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.176 -0.952 . . . . 21.49 109.175 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.457 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.3 p -143.71 160.15 41.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.566 -0.901 . . . . 31.5 108.566 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 27' ' ' THR . 32.4 tttt 79.65 65.04 0.17 Allowed Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.15 -19.66 21.58 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 N-CA-C 108.848 -1.251 . . . . 0.0 108.848 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 128.89 38.35 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -143.91 4.07 1.27 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.237 -0.914 . . . . 0.0 109.221 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -158.56 53.18 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.375 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -73.18 91.46 1.66 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -164.31 -177.66 5.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' LEU . 20.7 mt-10 61.32 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 34' ' ' ALA . 30.3 t0 -44.34 -23.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.587 HD12 ' N ' ' A' ' 37' ' ' LEU . 10.0 mp -69.38 67.75 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.027 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 40' ' ' GLY . 38.6 tt0 -75.67 128.12 34.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.2 p -49.86 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.205 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 38' ' ' GLN . . . -85.07 -175.7 50.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -73.42 101.12 3.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.423 -1.045 . . . . 0.0 109.281 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.21 154.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.159 -0.963 . . . . 0.0 109.243 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.17 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 45' ' ' GLY . 0.8 OUTLIER -175.09 2.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.925 . . . . 0.0 109.479 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -178.51 49.35 0.09 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.21 68.46 1.49 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.42 142.22 94.77 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.429 1.419 . . . . 0.0 109.968 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.03 138.12 18.83 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.07 16.15 10.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.247 -1.149 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.77 -43.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.9 m -46.96 117.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -1.172 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 mt -80.56 -43.99 19.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.41 140.2 48.43 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 108.936 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.2 110.62 2.04 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 120.797 0.998 . . . . 0.0 109.796 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.7 mt -63.46 -6.94 5.61 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.533 -0.73 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.37 -59.65 2.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 111.245 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.99 -15.07 42.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.892 -1.13 . . . . 0.0 110.476 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -45.94 -45.83 15.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 109.815 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.53 -52.05 3.12 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -55.33 -8.66 0.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.31 -1.112 . . . . 0.0 110.304 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.8 -36.41 70.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 109.257 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -101.71 -35.38 9.1 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 10.8 mptt -84.88 -177.19 6.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 60.86 73.08 0.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.77 -113.65 3.56 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.096 -1.602 . . . . 19.62 109.096 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 11' ' ' LEU . 2.9 tt -50.61 -40.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -1.106 . . . . 17.42 109.18 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.93 -50.3 19.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.208 -0.932 . . . . 18.82 109.663 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.23 10.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 38.5 110.644 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 36.1 mt-30 -137.83 -16.11 1.32 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.819 -1.176 . . . . 36.83 110.651 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.0 m -118.62 -23.06 7.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.339 -0.85 . . . . 18.16 109.216 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.3 t -89.72 -37.83 14.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.466 -0.939 . . . . 18.46 108.466 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 m -133.58 -141.96 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.839 . . . . 30.34 108.736 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.05 130.08 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.995 . . . . 27.51 109.23 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -114.27 175.54 5.43 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.672 -0.643 . . . . 23.34 109.77 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 m -112.53 -178.08 3.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.622 -0.674 . . . . 22.64 109.758 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.7 tp -53.37 -60.82 2.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.494 -0.754 . . . . 23.28 109.629 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -42.33 -56.75 2.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 37.86 110.39 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -49.2 -47.65 45.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.761 -1.212 . . . . 31.39 108.921 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.35 -39.27 89.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 24.48 108.806 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 -18.82 64.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.495 -0.753 . . . . 31.48 109.745 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -73.21 -30.21 63.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 22.48 111.644 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 25.7 m-85 -98.8 12.14 36.58 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.145 -0.972 . . . . 19.59 111.805 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.6 m -76.71 -175.81 3.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.593 -1.317 . . . . 20.62 109.328 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 117.987 -1.006 . . . . 24.65 109.342 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PHE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 18.5 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.286 -0.635 . . . . 24.77 109.286 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -168.74 160.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.022 . . . . 30.1 109.546 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 3' ' ' ASN . 10.3 p30 -131.37 107.66 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.471 -0.937 . . . . 32.24 108.471 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -156.63 163.14 39.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 30.21 109.448 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.02 101.09 5.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.212 -2.144 . . . . 24.0 105.212 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.15 136.85 37.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.772 . . . . 19.63 111.769 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.33 -164.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.145 -0.972 . . . . 17.19 111.675 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.51 -44.94 1.31 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 115.673 -0.694 . . . . 16.55 112.553 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.9 p -83.39 -62.77 1.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.388 -1.654 . . . . 19.55 110.494 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -55.2 38.16 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 67' ' ' ILE . 30.3 tp -49.72 -50.88 42.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.747 -1.221 . . . . 14.16 108.32 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.45 -55.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.489 -1.3 . . . . 15.31 107.489 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -56.93 -61.39 2.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.959 -1.126 . . . . 29.64 107.959 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.6 -59.55 2.68 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 13.96 109.692 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.57 -53.39 38.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.522 -1.361 . . . . 17.79 108.009 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -51.86 -48.36 64.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 16.84 109.151 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.12 -28.63 26.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.053 . . . . 22.76 108.588 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -93.9 -64.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.461 -0.774 . . . . 17.44 109.424 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -65.13 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 18.54 109.909 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.93 -122.91 17.44 Favored Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.605 -1.284 . . . . 23.17 110.191 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.03 -19.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -1.003 . . . . 39.77 109.776 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 73.0 mtt180 -67.07 -52.92 36.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.199 -0.938 . . . . 26.65 109.788 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.25 0.48 Allowed Glycine 0 N--CA 1.508 3.454 0 C-N-CA 119.728 -1.225 . . . . 20.26 111.931 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 18.2 p90 -75.67 132.22 40.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.987 -1.302 . . . . 17.79 109.262 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.49 104.7 16.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.742 . . . . 18.55 109.832 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.5 t80 -82.86 137.94 34.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.923 -1.139 . . . . 21.49 107.923 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -149.54 101.23 3.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.771 -1.206 . . . . 31.5 110.417 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 30' ' ' THR . 13.0 tttt -171.8 70.4 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 108.816 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 30' ' ' THR . 2.3 Cg_endo -67.0 15.39 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.027 1.818 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -37.9 -86.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.104 0.478 . . . . 0.0 110.646 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.541 ' H ' HG23 ' A' ' 30' ' ' THR . 16.9 mmm-85 51.94 -113.75 0.76 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.123 -0.985 . . . . 0.0 109.113 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.94 129.4 37.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.0 109.409 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -151.44 71.89 1.02 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.151 -0.968 . . . . 0.0 109.302 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.53 128.71 37.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.218 -0.926 . . . . 0.0 109.525 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -162.37 -82.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.912 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.85 74.29 1.59 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.482 0.658 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -82.79 -37.05 25.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.772 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -71.74 125.32 26.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.84 133.26 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 161.36 10.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.2 64.16 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -1.082 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.728 HG22 ' N ' ' A' ' 43' ' ' GLU . 1.2 p -175.45 -95.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.728 ' N ' HG22 ' A' ' 42' ' ' VAL . 10.1 pt-20 -48.76 -41.02 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 109.371 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -65.63 -36.52 83.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.63 -35.72 81.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.31 -90.34 0.08 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 49' ' ' GLY . . . 158.53 73.9 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.27 -0.42 2.26 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 121.477 1.451 . . . . 0.0 109.704 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 47' ' ' GLY . . . 179.22 165.73 33.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.27 -36.66 9.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -1.167 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' LEU . . . 153.05 14.97 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 70.34 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -1.062 . . . . 0.0 109.437 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 53' ' ' LEU . 1.2 pp -177.78 179.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.35 150.0 36.58 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.167 -0.958 . . . . 0.0 108.718 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.94 128.66 27.44 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 120.9 1.067 . . . . 0.0 109.739 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 39.3 mt -56.94 -23.37 44.89 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 -59.06 4.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.245 -0.909 . . . . 0.0 109.906 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.7 mm? -62.07 -40.07 94.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 109.306 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -48.91 -38.88 24.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 0.0 109.781 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.59 -38.53 7.56 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.3 t -80.5 -11.47 59.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -1.23 . . . . 0.0 110.347 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 58' ' ' LEU . 3.0 mt -64.12 -34.18 77.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.84 -43.37 5.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.374 -0.829 . . . . 0.0 109.805 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 11.0 mptt -90.39 144.44 25.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 109.795 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -61.45 -56.72 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 108.533 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.6 1.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 19.62 110.612 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 11' ' ' LEU . 2.0 tt -121.98 -41.17 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.245 -1.02 . . . . 17.42 108.245 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.492 HG22 ' OH ' ' A' ' 26' ' ' TYR . 3.9 t -52.37 -36.43 21.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.381 -0.824 . . . . 18.82 109.597 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -80.79 10.36 5.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 38.5 109.627 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 33.9 mt-30 -136.44 -10.11 1.91 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.042 -1.036 . . . . 36.83 110.57 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.7 m -121.85 -26.05 4.9 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.338 -0.852 . . . . 18.16 108.987 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.5 t -88.26 -39.5 14.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 18.46 108.607 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -84.77 -15.25 45.63 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -143.93 -138.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.114 -1.069 . . . . 30.34 108.114 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -145.52 148.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 27.51 109.045 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.6 m -131.05 173.57 10.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 23.34 109.707 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.8 m -112.16 -176.65 2.97 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.684 . . . . 22.64 109.613 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.9 tp -56.53 -59.25 5.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 23.28 109.412 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -43.12 -55.07 4.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 37.86 110.262 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -52.39 -48.97 65.33 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.877 -1.139 . . . . 31.39 108.952 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.09 -40.51 89.86 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.713 -0.847 . . . . 24.48 108.713 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.82 -18.87 61.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.506 -0.746 . . . . 31.48 109.952 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -29.82 62.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 22.48 111.742 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -97.79 11.56 36.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.082 -1.011 . . . . 19.59 111.807 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.96 -175.77 3.67 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.558 -1.339 . . . . 20.62 109.063 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 118.015 -0.993 . . . . 24.65 109.494 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.517 0.675 . . . . 30.100000000000001 110.125 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.812 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -116.68 107.25 14.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.941 -1.133 . . . . 32.240000000000002 107.941 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.4 mm100 -153.65 165.52 35.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.317 -0.865 . . . . 30.210000000000001 109.512 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -78.34 101.63 7.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.07 -2.196 . . . . 24.0 105.07 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -98.65 135.41 40.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.336 -0.853 . . . . 19.629999999999999 112.297 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.67 -161.16 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.275 -0.891 . . . . 17.190000000000001 111.656 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.11 -55.11 1.51 Allowed Glycine 0 N--CA 1.49 2.266 0 CA-C-N 115.899 -0.591 . . . . 16.550000000000001 112.75 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.7 p -76.73 -61.56 1.93 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.5 -1.588 . . . . 19.550000000000001 110.983 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -55.51 33.99 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.123 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 67' ' ' ILE . 30.6 tp -50.82 -49.9 57.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 14.16 108.476 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.76 -56.71 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.532 -1.284 . . . . 15.31 107.532 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -55.9 -61.0 2.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.026 -1.101 . . . . 29.640000000000001 108.026 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.19 -59.75 2.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.101 -0.999 . . . . 13.960000000000001 109.825 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.72 -50.48 60.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.425 -1.422 . . . . 17.789999999999999 107.891 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -55.29 -43.7 75.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 16.84 109.183 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.6 mt -56.53 -25.29 51.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 22.760000000000002 108.176 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -97.37 -64.43 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 17.440000000000001 109.431 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.8 m -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 18.539999999999999 110.005 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.98 -122.59 13.42 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.665 -1.255 . . . . 23.170000000000002 110.125 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.62 -18.67 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.425 -1.044 . . . . 39.770000000000003 110.237 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HG2' HH11 ' A' ' 22' ' ' ARG . 9.5 mtt-85 -70.12 -53.07 18.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.974 -1.079 . . . . 26.649999999999999 110.097 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 64.02 0.5 Allowed Glycine 0 N--CA 1.508 3.475 0 C-N-CA 119.726 -1.226 . . . . 20.260000000000002 111.759 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 20.8 p90 . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.269 . . . . 17.789999999999999 110.098 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 11' ' ' LEU . 2.7 tt . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 108.583 -0.895 . . . . 17.420000000000002 108.583 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -51.66 -41.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.2 -0.938 . . . . 18.82 109.425 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -76.48 10.31 2.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.3 -0.875 . . . . 38.5 110.014 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.4 mt-30 -136.51 -12.78 1.79 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.156 -0.965 . . . . 36.829999999999998 110.707 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.2 m -119.88 -27.12 5.47 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.376 -0.828 . . . . 18.16 109.071 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.2 t -86.36 -38.19 17.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.053 . . . . 18.460000000000001 108.515 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -87.76 -14.93 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.534 -0.729 . . . . 0.0 109.261 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 m -141.78 -141.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.527 -0.916 . . . . 30.34 108.527 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 75' ' ' ILE . 12.5 mt -145.8 128.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.958 . . . . 27.510000000000002 109.209 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -111.39 176.82 4.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.591 -0.693 . . . . 23.34 109.931 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -112.62 -170.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.472 0.653 . . . . 22.640000000000001 109.623 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.24 -59.8 4.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.449 -0.782 . . . . 23.280000000000001 109.359 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -43.05 -57.92 2.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.768 . . . . 37.859999999999999 110.38 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -48.74 -45.02 39.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.857 -1.152 . . . . 31.390000000000001 109.018 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.47 -37.64 88.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 24.48 108.705 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.43 -18.72 64.99 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.795 . . . . 31.48 109.669 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.08 -30.36 63.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.527 -0.733 . . . . 22.48 111.581 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -98.05 12.07 35.54 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 19.59 111.975 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.9 m -76.55 -175.68 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.551 -1.343 . . . . 20.620000000000001 108.982 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.504 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.22 -0.659 . . . . 30.100000000000001 109.22 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.802 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.33 107.76 8.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.345 -0.983 . . . . 32.240000000000002 108.345 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -156.76 166.04 34.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -0.813 . . . . 30.210000000000001 110.083 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -77.26 100.99 6.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.64 136.88 38.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.72 . . . . 19.629999999999999 111.749 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.84 -160.51 0.85 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.216 1.007 . . . . 17.190000000000001 111.849 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.53 -54.06 1.76 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 115.552 -0.749 . . . . 16.550000000000001 112.772 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -78.9 -56.82 4.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.341 -1.682 . . . . 19.550000000000001 110.976 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.49 -55.54 26.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.928 -1.107 . . . . 0.0 110.337 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.75 -48.55 63.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.797 -1.19 . . . . 14.16 108.453 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 8' ' ' GLY . 3.2 t -48.84 -55.17 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.307 -1.368 . . . . 15.31 107.307 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.11 -61.91 2.06 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.75 -59.73 2.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.092 -1.005 . . . . 13.960000000000001 109.842 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.481 HD11 HD13 ' A' ' 67' ' ' ILE . 10.7 mt -51.98 -52.06 53.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.484 -1.385 . . . . 17.789999999999999 107.977 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -53.84 -46.32 71.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.527 -0.733 . . . . 16.84 109.216 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.23 -31.52 61.55 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.008 -1.058 . . . . 22.760000000000002 108.501 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -89.47 -64.67 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.785 . . . . 17.440000000000001 109.257 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' N ' HG12 ' A' ' 18' ' ' VAL . 12.9 m -63.81 -76.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 18.539999999999999 109.414 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.09 -139.69 22.97 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.538 -1.425 . . . . 23.170000000000002 109.538 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 pm0 -47.28 -15.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -1.166 . . . . 39.770000000000003 109.535 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' GLY . 56.1 mtt180 -57.33 -52.3 65.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -0.926 . . . . 26.649999999999999 109.036 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.38 64.82 0.48 Allowed Glycine 0 N--CA 1.507 3.399 0 C-N-CA 119.73 -1.224 . . . . 20.260000000000002 111.902 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.417 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 27.3 p90 . . . . . 0 C--N 1.298 -1.64 0 O-C-N 121.282 -1.128 . . . . 17.789999999999999 110.111 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.0 tt . . . . . 0 N--CA 1.497 1.922 0 N-CA-C 109.382 -0.599 . . . . 17.420000000000002 109.382 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.612 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.0 t -54.83 -31.59 24.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.829 -1.17 . . . . 18.82 108.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.77 10.56 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 38.5 109.397 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -136.67 -14.45 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.185 -0.947 . . . . 36.829999999999998 110.617 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m -115.41 -27.14 7.29 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.285 -0.884 . . . . 18.16 109.054 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.8 t -86.6 -42.03 13.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.826 -1.171 . . . . 18.460000000000001 108.413 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -82.37 -16.14 50.21 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -142.76 -139.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.491 -0.929 . . . . 30.34 108.491 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.33 148.7 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.018 -1.051 . . . . 27.510000000000002 109.332 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.6 m -133.61 175.61 9.28 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 23.34 109.852 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OE1' ' A' ' 80' ' ' GLN . 2.9 p -112.73 179.47 3.96 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.541 0.686 . . . . 22.640000000000001 109.8 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -52.34 -60.62 3.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 23.280000000000001 109.423 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -42.61 -56.86 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.536 -0.727 . . . . 37.859999999999999 110.376 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.421 ' OE1' ' OG ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -48.98 -48.48 43.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.815 -1.178 . . . . 31.390000000000001 108.801 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.45 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.67 -39.41 88.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 24.48 109.097 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.43 -19.01 64.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 31.48 109.966 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.81 -29.34 63.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 22.48 111.552 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.7 12.34 35.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.191 -0.943 . . . . 19.59 111.898 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.57 -175.81 3.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.569 -1.332 . . . . 20.620000000000001 109.306 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 118.007 -0.996 . . . . 24.649999999999999 109.424 179.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.331 -0.618 . . . . 30.100000000000001 109.331 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.837 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.64 107.25 9.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.485 -0.931 . . . . 32.240000000000002 108.485 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -157.12 165.17 36.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 30.210000000000001 109.715 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -78.14 100.37 6.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.164 -2.161 . . . . 24.0 105.164 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.63 137.82 36.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.547 -0.721 . . . . 19.629999999999999 111.615 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 m -125.68 -160.49 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.038 0.923 . . . . 17.190000000000001 112.538 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -49.25 1.34 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 115.946 -0.57 . . . . 16.550000000000001 112.793 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -83.27 -60.71 2.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.402 -1.646 . . . . 19.550000000000001 110.802 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -55.57 31.86 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 110.308 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 67' ' ' ILE . 24.7 tp -51.38 -46.39 62.77 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.688 -1.258 . . . . 14.16 108.347 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.5 t -50.1 -56.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.932 -1.507 . . . . 15.31 106.932 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -56.07 -61.59 2.28 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.099 -1.041 . . . . 29.640000000000001 108.233 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.25 -60.04 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.807 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.26 -49.04 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.612 -1.305 . . . . 17.789999999999999 107.919 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.8 -43.06 85.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 16.84 109.232 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.37 -27.68 62.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.933 -1.105 . . . . 22.760000000000002 108.215 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -93.74 -64.66 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 17.440000000000001 109.535 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 18' ' ' VAL . 18.0 m -63.14 -74.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 18.539999999999999 109.567 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -132.54 11.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.92 -1.272 . . . . 23.170000000000002 109.92 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -57.24 -12.62 2.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.427 -1.043 . . . . 39.770000000000003 109.556 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 22' ' ' ARG . 12.1 mtt-85 -57.79 -51.86 67.85 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.007 -1.058 . . . . 26.649999999999999 109.233 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 65.47 0.48 Allowed Glycine 0 N--CA 1.508 3.451 0 C-N-CA 119.628 -1.272 . . . . 20.260000000000002 111.446 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 24' ' ' PHE . 31.1 p90 . . . . . 0 C--N 1.299 -1.611 0 O-C-N 121.301 -1.117 . . . . 17.789999999999999 110.271 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.4 tt . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 108.597 -0.89 . . . . 17.420000000000002 108.597 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.5 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.8 t -55.36 -27.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.275 -0.891 . . . . 18.82 109.556 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -90.9 10.89 24.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 38.5 109.872 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mt-30 -137.18 -10.43 1.72 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.075 -1.015 . . . . 36.829999999999998 110.841 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -120.32 -26.05 5.52 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.271 -0.893 . . . . 18.16 109.42 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.7 t -87.94 -37.91 16.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.93 -1.106 . . . . 18.460000000000001 108.112 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 t -86.08 -23.9 26.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -134.01 -140.71 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.443 -0.947 . . . . 30.34 108.443 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.4 mt -145.68 131.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.043 -1.036 . . . . 27.510000000000002 109.099 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.2 m -114.41 175.14 5.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.555 -0.716 . . . . 23.34 110.105 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m -112.52 -178.24 3.35 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.604 -0.685 . . . . 22.640000000000001 109.749 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.55 -61.8 2.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.482 -0.761 . . . . 23.280000000000001 109.716 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -42.04 -57.24 2.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.418 -0.801 . . . . 37.859999999999999 110.249 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -48.46 -45.58 36.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.852 -1.155 . . . . 31.390000000000001 109.14 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.97 -38.72 92.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 24.48 108.86 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.42 -19.0 64.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 31.48 109.786 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -72.74 -29.65 63.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 22.48 111.356 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -97.9 12.53 33.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.186 -0.946 . . . . 19.59 111.925 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.13 -175.93 3.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.58 -1.325 . . . . 20.620000000000001 109.101 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.025 -0.988 . . . . 24.649999999999999 109.589 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.8 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.406 0.622 . . . . 30.100000000000001 109.539 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.851 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.58 107.48 9.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.475 -0.935 . . . . 32.240000000000002 108.475 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -156.85 161.93 39.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 30.210000000000001 109.46 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -76.97 100.95 5.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.285 -2.117 . . . . 24.0 105.285 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.27 133.63 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 19.629999999999999 111.808 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -159.76 0.78 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.136 -0.977 . . . . 17.190000000000001 111.532 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.82 -53.45 1.47 Allowed Glycine 0 N--CA 1.49 2.291 0 CA-C-N 115.843 -0.617 . . . . 16.550000000000001 112.977 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.4 m -78.7 -62.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.516 -1.579 . . . . 19.550000000000001 111.068 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.6 -55.5 34.05 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.215 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 67' ' ' ILE . 31.5 tp -50.49 -51.71 44.77 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.64 -1.288 . . . . 14.16 108.311 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -45.92 -55.46 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.643 -1.243 . . . . 15.31 107.643 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.45 -61.73 2.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.946 -1.131 . . . . 29.640000000000001 107.946 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.36 -59.59 2.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.161 -0.962 . . . . 13.960000000000001 109.708 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 67' ' ' ILE . 11.0 mt -51.77 -53.92 34.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.381 -1.449 . . . . 17.789999999999999 108.072 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.1 -48.26 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 16.84 109.018 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.34 -29.3 33.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.094 -1.004 . . . . 22.760000000000002 108.439 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -92.66 -64.72 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 17.440000000000001 109.586 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.1 m -64.8 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 18.539999999999999 109.684 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 76.71 -129.01 9.53 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.715 -1.354 . . . . 23.170000000000002 109.715 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -49.99 -18.9 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.364 -1.08 . . . . 39.770000000000003 109.256 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -57.14 -54.01 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 26.649999999999999 109.097 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.12 62.75 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.893 -1.146 . . . . 20.260000000000002 111.502 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.9 p90 . . . . . 0 C--N 1.298 -1.645 0 O-C-N 121.1 -1.235 . . . . 17.789999999999999 109.638 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 11' ' ' LEU . 4.4 tt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 111.928 0.344 . . . . 17.420000000000002 111.928 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.602 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -54.66 -17.36 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.524 -1.36 . . . . 18.82 110.012 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -100.74 9.97 41.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 38.5 109.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -137.65 -16.02 1.36 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.108 -0.995 . . . . 36.829999999999998 110.242 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.7 m -112.16 -30.87 7.06 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.362 -0.836 . . . . 18.16 109.256 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.6 -42.51 16.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 18.460000000000001 108.667 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -80.9 -22.4 39.79 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 m -139.98 -136.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.496 -0.927 . . . . 30.34 108.496 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.7 149.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 27.510000000000002 109.301 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.9 m -133.08 175.93 8.94 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 23.34 109.583 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m -112.24 -178.32 3.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 22.640000000000001 109.765 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.7 tp -55.16 -57.63 10.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.575 -0.703 . . . . 23.280000000000001 109.267 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -44.15 -51.64 7.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.423 -0.798 . . . . 37.859999999999999 110.001 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -54.93 -51.84 64.83 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.787 -1.196 . . . . 31.390000000000001 108.733 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -56.92 -39.5 74.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 24.48 108.855 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.76 -18.62 64.25 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.468 -0.77 . . . . 31.48 109.863 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -73.67 -30.04 62.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.826 . . . . 22.48 111.746 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -99.01 12.01 37.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.205 -0.934 . . . . 19.59 111.782 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.2 m -76.7 -175.4 3.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 20.620000000000001 109.194 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 118.019 -0.991 . . . . 24.649999999999999 109.359 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.442 0.639 . . . . 30.100000000000001 109.572 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.84 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.78 107.14 7.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.35 -0.981 . . . . 32.240000000000002 108.35 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.58 161.21 39.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 30.210000000000001 109.261 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.59 100.77 5.44 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.251 -2.129 . . . . 24.0 105.251 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.11 132.8 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.784 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 -157.01 0.69 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.21 -0.931 . . . . 17.190000000000001 111.831 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -37.02 -55.24 1.46 Allowed Glycine 0 N--CA 1.49 2.288 0 CA-C-N 115.869 -0.605 . . . . 16.550000000000001 113.189 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.0 m -79.55 -58.41 3.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.483 -1.598 . . . . 19.550000000000001 111.42 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -55.37 34.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 110.39 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 31.2 tp -50.4 -50.51 51.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.74 -1.225 . . . . 14.16 108.24 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.25 -55.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.516 -1.29 . . . . 15.31 107.516 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.11 -61.76 2.23 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.878 -1.129 . . . . 29.640000000000001 108.421 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.39 -59.43 2.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 13.960000000000001 109.839 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.7 mt -51.36 -52.19 47.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 17.789999999999999 107.881 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -53.44 -45.89 69.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 16.84 109.141 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.44 -26.94 33.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.858 -1.151 . . . . 22.760000000000002 108.307 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.46 -64.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.448 -0.783 . . . . 17.440000000000001 109.401 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.455 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.7 m -62.18 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 18.539999999999999 109.842 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.08 -125.02 24.11 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.596 -1.288 . . . . 23.170000000000002 110.046 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -45.79 -22.11 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -1.074 . . . . 39.770000000000003 109.429 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 20' ' ' GLY . 13.8 mmt180 -61.81 -54.65 39.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.346 -0.846 . . . . 26.649999999999999 110.0 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.75 62.49 0.5 Allowed Glycine 0 N--CA 1.51 3.62 0 C-N-CA 119.915 -1.136 . . . . 20.260000000000002 112.075 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 15.1 p90 . . . . . 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.338 . . . . 17.789999999999999 109.869 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.658 -0.497 . . . . 17.420000000000002 109.658 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 67' ' ' ILE . 18.1 t -57.16 -7.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.893 -1.129 . . . . 18.82 109.19 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 67' ' ' ILE . 22.1 tt0 -109.83 9.5 24.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.49 -0.756 . . . . 38.5 109.313 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -137.56 -15.67 1.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.227 -0.921 . . . . 36.829999999999998 109.691 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.86 -29.94 7.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.529 -0.732 . . . . 18.16 109.12 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 52.5 t -84.85 -44.51 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 18.460000000000001 108.701 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -81.34 -17.91 47.51 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.445 -0.784 . . . . 0.0 109.093 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 m -144.07 -137.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.296 -1.001 . . . . 30.34 108.296 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.45 150.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 27.510000000000002 109.333 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 m -133.18 175.88 9.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 23.34 109.55 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -111.62 -174.89 2.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.703 . . . . 22.640000000000001 109.566 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.75 -57.56 12.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 23.280000000000001 109.608 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -44.5 -55.23 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.39 -0.819 . . . . 37.859999999999999 110.038 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -50.55 -49.85 54.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.816 -1.177 . . . . 31.390000000000001 108.898 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.407 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -59.53 -40.97 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.921 -0.77 . . . . 24.48 108.921 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -61.88 -19.04 62.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.448 -0.783 . . . . 31.48 109.651 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -73.14 -30.18 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.598 -0.688 . . . . 22.48 111.889 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.404 ' CD2' HD12 ' A' ' 67' ' ' ILE . 22.7 m-85 -100.07 11.8 38.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.157 -0.965 . . . . 19.59 111.939 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.0 m -76.82 -175.72 3.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.601 -1.312 . . . . 20.620000000000001 108.833 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.038 -0.982 . . . . 24.649999999999999 109.287 179.541 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.369 0.604 . . . . 30.100000000000001 109.644 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.73 107.85 8.64 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.485 -0.932 . . . . 32.240000000000002 108.485 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -156.86 164.23 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 30.210000000000001 109.64 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 19.6 m-70 -76.52 100.6 5.33 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.168 -2.16 . . . . 24.0 105.168 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.08 135.96 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.78 . . . . 19.629999999999999 111.59 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.1 m -124.14 -157.3 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.006 0.908 . . . . 17.190000000000001 112.693 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.79 -53.8 1.45 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 115.977 -0.556 . . . . 16.550000000000001 112.884 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.84 -58.47 2.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.315 -1.697 . . . . 19.550000000000001 111.096 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -60.47 -55.76 29.63 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.925 -1.11 . . . . 0.0 110.464 -178.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 25.7 tp -51.15 -50.04 59.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.203 . . . . 14.16 108.211 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -46.88 -55.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.525 -1.287 . . . . 15.31 107.525 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 20.6 tt0 -57.12 -61.8 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.018 -1.105 . . . . 29.640000000000001 108.018 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.18 -59.67 2.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 13.960000000000001 109.537 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.1 mt -51.57 -55.14 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.546 -1.346 . . . . 17.789999999999999 108.009 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.42 -50.48 40.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 16.84 108.952 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -52.22 -29.78 24.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 22.760000000000002 108.514 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -92.02 -64.45 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.447 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.7 m -65.66 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 18.539999999999999 109.946 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.3 -112.57 4.91 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.614 -1.279 . . . . 23.170000000000002 110.275 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -52.93 -20.5 3.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 39.770000000000003 110.116 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -69.03 -52.59 27.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 26.649999999999999 109.974 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.19 63.17 0.49 Allowed Glycine 0 N--CA 1.507 3.393 0 C-N-CA 119.729 -1.224 . . . . 20.260000000000002 111.689 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.0 p90 . . . . . 0 N--CA 1.494 1.759 0 O-C-N 121.047 -1.266 . . . . 17.789999999999999 109.221 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 11' ' ' LEU . 4.0 tt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.755 -0.461 . . . . 17.420000000000002 109.755 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' N ' HG23 ' A' ' 67' ' ' ILE . 13.8 t -53.67 -31.71 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 18.82 109.247 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 9.99 6.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.956 -1.09 . . . . 38.5 110.119 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -141.16 -11.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.032 -1.043 . . . . 36.829999999999998 110.729 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.5 m -117.89 -26.45 6.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.408 -0.807 . . . . 18.16 109.357 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 t -88.83 -43.28 11.34 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.144 -1.058 . . . . 18.460000000000001 108.144 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 t -82.05 -28.04 32.66 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -131.75 -140.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.52 -0.918 . . . . 30.34 108.52 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mt -142.82 151.55 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.156 -0.965 . . . . 27.510000000000002 109.258 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -136.49 174.55 10.49 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 23.34 109.683 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -112.23 -178.46 3.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.546 -0.721 . . . . 22.640000000000001 109.736 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 79' ' ' TYR . 4.4 tp -53.0 -61.51 2.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 23.280000000000001 109.573 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.4 ' C ' ' O ' ' A' ' 78' ' ' LEU . 1.7 m-85 -41.31 -55.83 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.449 -0.782 . . . . 37.859999999999999 110.356 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -49.46 -51.09 38.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.84 -1.162 . . . . 31.390000000000001 108.819 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.4 mp -58.23 -41.3 83.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.451 -0.781 . . . . 24.48 109.071 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.75 -18.76 61.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.408 -0.808 . . . . 31.48 110.075 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -74.31 -29.27 61.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 22.48 111.811 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 67' ' ' ILE . 23.8 m-85 -99.51 12.06 37.45 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.074 -1.016 . . . . 19.59 111.898 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.51 -175.74 3.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.745 -1.222 . . . . 20.620000000000001 108.931 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.046 -0.978 . . . . 24.649999999999999 109.399 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.361 -0.607 . . . . 30.100000000000001 109.361 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.833 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.0 106.85 8.92 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.389 -0.967 . . . . 32.240000000000002 108.389 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 83.0 mm-40 -156.5 164.53 38.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.298 -0.876 . . . . 30.210000000000001 109.62 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -77.93 101.05 6.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -98.82 136.18 39.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.427 -0.796 . . . . 19.629999999999999 111.776 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.19 -160.38 0.83 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.189 -0.945 . . . . 17.190000000000001 111.691 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.15 -54.18 1.57 Allowed Glycine 0 N--CA 1.489 2.184 0 CA-C-N 115.685 -0.689 . . . . 16.550000000000001 112.667 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -77.8 -61.91 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.543 -1.563 . . . . 19.550000000000001 110.924 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -55.75 30.93 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.027 . . . . 0.0 110.427 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD11 ' A' ' 67' ' ' ILE . 28.2 tp -51.85 -47.7 64.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.723 -1.236 . . . . 14.16 108.499 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.17 -56.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.336 -1.357 . . . . 15.31 107.336 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.86 -61.23 2.51 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.971 -1.092 . . . . 29.640000000000001 108.246 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.28 -59.54 2.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 13.960000000000001 110.097 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 67' ' ' ILE . 10.1 mt -51.75 -51.55 55.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.715 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.122 -0.696 . . . . 16.84 109.122 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -56.74 -24.36 49.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.946 -1.096 . . . . 22.760000000000002 108.285 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -97.51 -64.55 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.35 -0.844 . . . . 17.440000000000001 109.557 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.476 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.4 m -64.39 -78.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 18.539999999999999 109.649 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.68 -132.23 11.77 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.72 -1.352 . . . . 23.170000000000002 109.72 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -49.69 -14.73 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -1.097 . . . . 39.770000000000003 109.518 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 20' ' ' GLY . 1.0 OUTLIER -59.78 -53.61 55.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 26.649999999999999 109.161 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.4 63.9 0.49 Allowed Glycine 0 N--CA 1.506 3.357 0 C-N-CA 119.951 -1.119 . . . . 20.260000000000002 111.245 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.7 p90 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.069 -1.254 . . . . 17.789999999999999 110.063 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.512 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 109.44 -0.578 . . . . 17.420000000000002 109.44 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.507 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -55.4 -22.05 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 18.82 109.467 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -95.49 10.45 36.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 38.5 109.703 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -137.38 -15.12 1.46 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 36.829999999999998 110.557 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.46 -27.86 7.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.305 -0.872 . . . . 18.16 109.425 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.29 -41.04 13.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.111 . . . . 18.460000000000001 108.519 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.7 t -83.63 -16.33 45.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 m -143.2 -139.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -145.11 137.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 27.510000000000002 109.257 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.6 m -119.47 176.97 5.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.676 -0.64 . . . . 23.34 110.261 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.9 175.74 5.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.506 0.67 . . . . 22.640000000000001 109.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.0 tp -51.8 -61.15 2.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.475 -0.766 . . . . 23.280000000000001 109.469 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -43.52 -54.7 4.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.795 . . . . 37.859999999999999 110.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -49.75 -44.8 48.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.757 -1.214 . . . . 31.390000000000001 109.002 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.25 -36.92 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 24.48 108.864 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.08 -18.93 64.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.417 -0.802 . . . . 31.48 109.78 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.31 -29.48 61.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 22.48 111.571 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -97.03 11.89 34.53 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.14 -0.975 . . . . 19.59 111.585 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 83.4 m -77.0 -175.52 3.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.761 -1.212 . . . . 20.620000000000001 109.315 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.956 -1.021 . . . . 24.649999999999999 109.233 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.375 -0.602 . . . . 30.100000000000001 109.375 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.82 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.57 107.4 8.83 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.416 -0.957 . . . . 32.240000000000002 108.416 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -157.11 164.46 37.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 30.210000000000001 109.846 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.543 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 6.0 m-70 -76.76 100.85 5.59 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.217 -2.142 . . . . 24.0 105.217 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.47 136.04 38.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 19.629999999999999 111.809 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.75 -161.34 0.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.023 0.916 . . . . 17.190000000000001 111.758 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.5 -53.08 1.81 Allowed Glycine 0 N--CA 1.49 2.248 0 CA-C-N 115.781 -0.645 . . . . 16.550000000000001 112.603 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -77.96 -60.91 2.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.486 -1.597 . . . . 19.550000000000001 110.898 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -55.53 33.55 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.334 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 67' ' ' ILE . 27.5 tp -51.4 -47.54 62.9 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.823 -1.173 . . . . 14.16 108.381 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.49 -56.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.192 -1.41 . . . . 15.31 107.192 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -55.18 -61.75 2.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.959 -1.096 . . . . 29.640000000000001 108.101 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -44.93 -60.0 2.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.246 -0.909 . . . . 13.960000000000001 109.709 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 67' ' ' ILE . 10.9 mt -51.75 -51.59 55.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.441 -1.412 . . . . 17.789999999999999 108.164 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.91 -40.49 73.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 16.84 109.457 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 14' ' ' ALA . 63.8 mt -60.62 -24.61 65.65 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.083 -1.08 . . . . 22.760000000000002 108.083 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -97.3 -64.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.543 -0.723 . . . . 17.440000000000001 109.294 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' VAL . 11.6 m -64.24 -76.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 18.539999999999999 109.638 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.87 -138.29 20.59 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.675 -1.37 . . . . 23.170000000000002 109.675 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 8.2 tp10 -48.37 -17.03 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -1.104 . . . . 39.770000000000003 109.167 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' GLY . 50.3 mtt180 -54.88 -52.84 61.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 26.649999999999999 109.255 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.52 65.14 0.48 Allowed Glycine 0 N--CA 1.508 3.478 0 C-N-CA 119.745 -1.217 . . . . 20.260000000000002 111.722 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 28.7 p90 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.265 -1.138 . . . . 17.789999999999999 110.218 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 11' ' ' LEU . 2.6 tt . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 120.996 0.427 . . . . 17.420000000000002 109.875 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -50.21 -41.53 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.973 -1.079 . . . . 18.82 109.781 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -78.54 10.9 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 38.5 109.94 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -134.03 -13.82 2.43 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.058 -1.026 . . . . 36.829999999999998 110.837 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.2 m -119.28 -25.53 6.09 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.257 -0.902 . . . . 18.16 109.043 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.12 -37.36 17.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.961 -1.087 . . . . 18.460000000000001 108.483 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -89.36 -9.87 48.77 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -146.77 -144.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.507 -0.923 . . . . 30.34 108.507 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 mt -145.89 122.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.061 -1.024 . . . . 27.510000000000002 109.365 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.9 m -106.24 175.5 5.48 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.625 -0.672 . . . . 23.34 109.541 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 m -112.4 176.49 5.0 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.551 0.691 . . . . 22.640000000000001 109.826 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -48.78 -60.08 3.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.651 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -43.5 -56.03 3.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.332 -0.855 . . . . 37.859999999999999 110.226 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -49.93 -46.47 52.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.727 -1.233 . . . . 31.390000000000001 108.918 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.444 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.99 -38.64 89.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.686 -0.857 . . . . 24.48 108.686 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -64.2 -18.92 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.479 -0.763 . . . . 31.48 109.728 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.12 -29.74 63.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 22.48 111.63 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.0 12.17 35.12 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 19.59 111.804 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.8 m -76.59 -175.64 3.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.608 -1.307 . . . . 20.620000000000001 109.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.955 -1.021 . . . . 24.649999999999999 109.343 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.447 0.642 . . . . 30.100000000000001 109.696 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.767 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -117.97 106.27 12.76 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.78 -1.192 . . . . 32.240000000000002 107.78 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.3 mm100 -154.42 162.16 41.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.711 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -79.14 101.14 7.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.351 -2.092 . . . . 24.0 105.351 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.21 136.09 39.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.51 -0.744 . . . . 19.629999999999999 111.958 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.54 -162.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.07 0.938 . . . . 17.190000000000001 111.484 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.98 -51.68 1.55 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 115.662 -0.699 . . . . 16.550000000000001 112.774 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 p -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.458 -1.613 . . . . 19.550000000000001 110.792 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -55.2 38.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.29 -48.22 62.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.899 -1.125 . . . . 14.16 108.495 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -48.87 -55.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.204 -1.406 . . . . 15.31 107.204 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -56.06 -61.58 2.28 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.019 -1.104 . . . . 29.640000000000001 108.019 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.52 -59.54 2.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.01 -1.057 . . . . 13.960000000000001 109.679 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.53 -53.49 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.457 -1.402 . . . . 17.789999999999999 107.934 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.78 -49.92 61.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.508 -0.745 . . . . 16.84 109.108 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.86 -26.12 9.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.046 -1.034 . . . . 22.760000000000002 108.643 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.95 -64.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.352 -0.843 . . . . 17.440000000000001 109.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 9.9 m -64.32 -77.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 18.539999999999999 109.831 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 78.52 -133.82 13.28 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.773 -1.331 . . . . 23.170000000000002 109.773 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.42 -14.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.399 -1.06 . . . . 39.770000000000003 109.621 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 20' ' ' GLY . 8.8 mtp180 -59.01 -53.02 63.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 26.649999999999999 109.086 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.08 64.36 0.48 Allowed Glycine 0 N--CA 1.506 3.322 0 C-N-CA 119.744 -1.217 . . . . 20.260000000000002 111.531 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 29.8 p90 . . . . . 0 C--N 1.299 -1.627 0 O-C-N 121.287 -1.125 . . . . 17.789999999999999 109.848 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.004 -0.739 . . . . 17.420000000000002 109.004 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.478 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.5 t -52.3 -32.24 15.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.107 -0.996 . . . . 18.82 109.493 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -83.66 11.01 7.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 38.5 110.021 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 19.0 mt-30 -139.34 -12.89 1.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.051 . . . . 36.829999999999998 110.697 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.7 m -117.23 -30.58 5.57 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.407 -0.808 . . . . 18.16 109.099 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.34 -40.62 16.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 18.460000000000001 108.563 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -85.14 -12.52 52.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.477 -0.765 . . . . 0.0 109.213 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -145.72 -141.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.528 -0.916 . . . . 30.34 108.528 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.68 126.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.174 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.0 m -108.09 177.07 4.92 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.605 -0.685 . . . . 23.34 110.094 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.1 m -112.6 -178.99 3.53 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.49 0.662 . . . . 22.640000000000001 109.448 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -57.36 -56.05 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.779 . . . . 23.280000000000001 109.446 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -47.27 -50.94 20.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.395 -0.815 . . . . 37.859999999999999 110.171 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.96 -45.79 74.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.696 -1.253 . . . . 31.390000000000001 108.749 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.55 -37.72 84.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 24.48 108.643 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.29 -18.8 64.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.456 -0.778 . . . . 31.48 109.766 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -74.14 -29.51 61.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.711 . . . . 22.48 111.539 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -97.51 12.08 34.61 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.106 -0.997 . . . . 19.59 111.762 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 86.1 m -76.57 -175.77 3.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.597 -1.314 . . . . 20.620000000000001 109.207 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.441 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.379 0.609 . . . . 30.100000000000001 109.376 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.85 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.52 107.88 8.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 32.240000000000002 108.533 179.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -156.55 162.75 39.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.511 -0.743 . . . . 30.210000000000001 109.417 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 15.8 m-70 -76.46 100.72 5.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.25 -2.13 . . . . 24.0 105.25 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.21 136.05 39.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.386 -0.822 . . . . 19.629999999999999 111.707 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 m -124.06 -159.04 0.84 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.896 0.855 . . . . 17.190000000000001 112.168 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.49 -51.45 1.37 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.89 -0.506 . . . . 16.550000000000001 112.946 -176.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 m -81.82 -62.07 1.74 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.316 -1.696 . . . . 19.550000000000001 110.941 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -55.58 33.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 110.131 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 67' ' ' ILE . 26.7 tp -50.47 -51.36 47.74 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.782 -1.199 . . . . 14.16 108.369 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -46.66 -54.31 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.561 -1.274 . . . . 15.31 107.561 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.95 -61.85 2.24 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.51 -59.8 2.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.038 -1.039 . . . . 13.960000000000001 109.728 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 11.1 mt -51.17 -52.41 44.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.444 -1.41 . . . . 17.789999999999999 108.023 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -53.19 -45.8 68.71 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.1 -0.704 . . . . 16.84 109.1 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.08 -33.91 63.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.897 -1.127 . . . . 22.760000000000002 108.387 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -87.32 -64.84 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.378 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -63.18 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.897 . . . . 18.539999999999999 109.229 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.03 -130.55 10.53 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.772 -1.331 . . . . 23.170000000000002 109.772 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -50.22 -19.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 39.770000000000003 109.059 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' ' C ' ' A' ' 20' ' ' GLY . 7.6 mmt180 -55.47 -54.0 49.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 26.649999999999999 109.161 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.33 63.47 0.49 Allowed Glycine 0 N--CA 1.505 3.293 0 C-N-CA 119.958 -1.115 . . . . 20.260000000000002 111.681 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 18.6 p90 . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.04 -1.271 . . . . 17.789999999999999 109.75 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 11' ' ' LEU . 3.4 tt . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.353 -0.61 . . . . 17.420000000000002 109.353 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' ILE . 22.0 t -56.98 -6.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.386 -0.821 . . . . 18.82 109.712 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' ILE . 6.7 tt0 -108.52 9.59 27.4 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 38.5 109.039 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 4.4 mt-30 -137.82 -15.23 1.37 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.236 -0.915 . . . . 36.829999999999998 109.936 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.5 m -114.24 -24.18 9.07 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.479 -0.763 . . . . 18.16 109.273 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 51.6 t -91.48 -43.05 9.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 18.460000000000001 108.551 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -85.16 -21.42 29.21 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.628 0.728 . . . . 0.0 109.12 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -139.38 -136.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.478 -0.934 . . . . 30.34 108.478 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -145.86 147.48 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 27.510000000000002 109.204 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 1.9 m -131.09 174.64 9.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.539 -0.726 . . . . 23.34 109.313 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -112.39 -179.04 3.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.476 -0.765 . . . . 22.640000000000001 109.849 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.0 tp -53.46 -55.49 24.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.707 . . . . 23.280000000000001 109.371 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -46.01 -55.93 6.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 37.859999999999999 109.901 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -50.57 -50.43 53.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.821 -1.175 . . . . 31.390000000000001 108.997 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.2 mp -58.38 -41.3 84.5 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.448 -0.783 . . . . 24.48 108.936 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -62.64 -18.76 62.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 31.48 109.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -72.59 -29.74 63.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.423 -0.798 . . . . 22.48 111.742 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -100.62 12.16 37.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 19.59 112.051 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.3 m -76.87 -175.81 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.584 -1.323 . . . . 20.620000000000001 109.188 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.301 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.545 0.688 . . . . 30.100000000000001 109.89 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.714 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.91 106.65 6.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.007 -1.109 . . . . 32.240000000000002 108.007 179.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -156.33 167.42 30.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 30.210000000000001 109.865 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -78.51 101.06 7.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.17 -2.159 . . . . 24.0 105.17 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.4 mt -99.2 136.5 39.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.514 -0.742 . . . . 19.629999999999999 111.903 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.34 -162.89 0.94 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.973 . . . . 17.190000000000001 111.44 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.89 -50.96 1.51 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-N 115.751 -0.659 . . . . 16.550000000000001 112.723 -176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.4 m -79.17 -62.93 1.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.475 -1.603 . . . . 19.550000000000001 110.686 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.47 -55.45 34.63 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.033 -1.042 . . . . 0.0 110.038 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 67' ' ' ILE . 30.2 tp -50.7 -50.12 55.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.824 -1.172 . . . . 14.16 108.452 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.83 -56.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.58 -1.267 . . . . 15.31 107.58 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -55.65 -61.57 2.26 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.883 -1.154 . . . . 29.640000000000001 107.883 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.58 -59.61 2.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.03 -1.044 . . . . 13.960000000000001 109.762 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.44 -54.0 31.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.481 -1.387 . . . . 17.789999999999999 107.822 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -50.86 -50.4 57.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.526 -0.733 . . . . 16.84 109.127 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.1 mt -51.01 -26.93 6.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 22.760000000000002 108.6 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.37 -64.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.419 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.3 m -66.04 -83.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 18.539999999999999 109.982 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.77 -124.56 12.21 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.583 -1.294 . . . . 23.170000000000002 110.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -45.25 -20.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -1.048 . . . . 39.770000000000003 110.076 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 20' ' ' GLY . 84.4 mtt180 -66.75 -53.13 36.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -0.951 . . . . 26.649999999999999 109.807 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.49 64.15 0.49 Allowed Glycine 0 N--CA 1.508 3.457 0 C-N-CA 119.634 -1.27 . . . . 20.260000000000002 111.782 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.1 p90 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.296 . . . . 17.789999999999999 109.808 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.553 HD11 HD11 ' A' ' 11' ' ' LEU . 3.7 tt . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.723 -0.473 . . . . 17.420000000000002 109.723 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' ILE . 6.3 t -54.26 -23.98 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.98 -1.075 . . . . 18.82 109.726 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -94.73 10.2 36.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.06 -1.025 . . . . 38.5 109.797 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.1 mt-30 -135.64 -14.26 1.92 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.067 -1.021 . . . . 36.829999999999998 110.391 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.28 -28.48 6.52 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.355 -0.841 . . . . 18.16 109.399 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.96 -38.85 16.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 18.460000000000001 108.656 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.4 t -87.83 -12.39 45.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.798 . . . . 0.0 109.062 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -145.8 -142.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.644 -0.873 . . . . 30.34 108.644 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.83 125.19 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.996 -1.065 . . . . 27.510000000000002 109.481 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -108.72 175.74 5.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.581 -0.7 . . . . 23.34 109.932 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -112.51 176.22 5.11 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.507 0.67 . . . . 22.640000000000001 109.644 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 tp -48.21 -60.02 2.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.518 -0.739 . . . . 23.280000000000001 109.506 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -42.03 -58.78 1.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 37.859999999999999 110.404 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 12.1 mp0 -48.62 -46.9 40.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.834 -1.166 . . . . 31.390000000000001 108.992 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.15 -38.81 90.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.704 -0.85 . . . . 24.48 108.704 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.58 -18.66 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.768 . . . . 31.48 109.631 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -74.05 -29.76 62.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.483 -0.76 . . . . 22.48 111.57 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -97.88 11.77 36.26 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.099 -1.001 . . . . 19.59 111.734 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.0 m -76.91 -175.76 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.606 -1.309 . . . . 20.620000000000001 109.111 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 117.967 -1.016 . . . . 24.649999999999999 109.255 179.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.445 0.64 . . . . 30.100000000000001 109.754 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.2 106.58 7.66 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.204 -1.036 . . . . 32.240000000000002 108.204 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -156.57 164.08 38.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.226 -0.921 . . . . 30.210000000000001 109.382 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -77.46 101.17 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.154 -2.165 . . . . 24.0 105.154 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.38 132.21 44.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.875 . . . . 19.629999999999999 111.922 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.54 -158.53 0.74 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.163 -0.961 . . . . 17.190000000000001 111.697 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.26 -54.56 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 115.826 -0.625 . . . . 16.550000000000001 113.201 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -79.04 -63.25 1.46 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.273 -1.722 . . . . 19.550000000000001 111.085 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -55.81 28.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 110.371 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 67' ' ' ILE . 35.1 tp -50.42 -52.15 40.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.709 -1.244 . . . . 14.16 108.554 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -45.83 -55.83 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.71 -1.218 . . . . 15.31 107.71 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -56.46 -61.43 2.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.868 -1.16 . . . . 29.640000000000001 107.868 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.3 -59.73 2.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.011 . . . . 13.960000000000001 109.882 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 10.8 mt -52.16 -53.84 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.315 -1.491 . . . . 17.789999999999999 107.888 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -50.7 -47.41 58.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.009 -0.737 . . . . 16.84 109.009 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.48 -26.77 33.34 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.011 -1.056 . . . . 22.760000000000002 108.348 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.21 -64.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.887 . . . . 17.440000000000001 109.393 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.2 m -65.37 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.902 . . . . 18.539999999999999 110.036 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.37 -123.36 16.82 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.496 -1.335 . . . . 23.170000000000002 109.883 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.609 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.3 pm0 -44.9 -18.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.463 -1.022 . . . . 39.770000000000003 110.587 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 20' ' ' GLY . 26.1 mtt-85 -70.72 -52.67 19.41 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.936 -1.103 . . . . 26.649999999999999 110.159 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.22 64.34 0.5 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 119.611 -1.281 . . . . 20.260000000000002 111.529 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.4 p90 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.145 -1.209 . . . . 17.789999999999999 109.426 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 11' ' ' LEU . 3.6 tt . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 112.163 0.431 . . . . 17.420000000000002 112.163 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.63 ' N ' HG23 ' A' ' 67' ' ' ILE . 15.4 t -57.97 -7.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.626 -1.296 . . . . 18.82 109.603 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 67' ' ' ILE . 20.5 tp10 -113.02 9.26 18.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.144 -0.687 . . . . 38.5 109.144 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.9 mt-30 -138.88 -8.67 1.38 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 36.829999999999998 109.533 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.55 -31.9 4.46 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.6 -0.889 . . . . 18.16 108.6 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.06 -43.1 18.33 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 18.460000000000001 108.323 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 t -82.2 -21.79 36.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -136.81 -137.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.496 -0.928 . . . . 30.34 108.496 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.52 150.03 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.993 . . . . 27.510000000000002 109.294 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.4 m -135.14 176.65 8.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.388 -0.82 . . . . 23.34 109.956 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -112.37 -163.91 0.88 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.671 -0.643 . . . . 22.640000000000001 109.48 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.83 -60.75 2.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -0.755 . . . . 23.280000000000001 109.547 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -41.5 -57.38 2.24 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.574 -0.703 . . . . 37.859999999999999 110.522 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.71 -47.22 41.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.786 -1.196 . . . . 31.390000000000001 108.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.2 -38.18 88.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.291 -0.881 . . . . 24.48 108.987 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -18.79 64.84 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.504 -0.747 . . . . 31.48 109.75 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.32 -30.38 63.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 22.48 111.758 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.05 11.96 35.88 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.026 -1.046 . . . . 19.59 111.891 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.3 m -76.74 -175.62 3.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.682 -1.261 . . . . 20.620000000000001 109.096 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.984 -1.008 . . . . 24.649999999999999 109.403 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.7 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.326 -0.62 . . . . 30.100000000000001 109.326 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.842 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.23 107.76 9.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.583 -0.895 . . . . 32.240000000000002 108.583 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -156.73 163.04 39.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.557 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.464 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 9.4 m-70 -77.18 100.83 5.93 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.164 -2.162 . . . . 24.0 105.164 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.44 134.68 41.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.784 . . . . 19.629999999999999 111.731 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.5 -159.63 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.802 0.81 . . . . 17.190000000000001 112.103 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -35.92 -53.15 1.18 Allowed Glycine 0 N--CA 1.493 2.48 0 O-C-N 121.858 -0.526 . . . . 16.550000000000001 113.233 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 m -80.37 -62.25 1.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.385 -1.656 . . . . 19.550000000000001 110.932 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -55.4 35.3 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.911 -1.118 . . . . 0.0 110.276 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 67' ' ' ILE . 29.7 tp -50.89 -50.49 57.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.813 -1.179 . . . . 14.16 108.619 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.4 t -46.2 -57.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.459 -1.312 . . . . 15.31 107.459 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -55.56 -61.43 2.35 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.903 -1.147 . . . . 29.640000000000001 107.903 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -59.56 2.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.022 -1.049 . . . . 13.960000000000001 110.045 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.43 -55.0 21.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.342 -1.474 . . . . 17.789999999999999 107.703 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -49.33 -51.17 36.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.025 -0.732 . . . . 16.84 109.025 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.6 -26.87 5.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.063 -1.023 . . . . 22.760000000000002 108.62 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.81 -64.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.247 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.8 m -64.61 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 18.539999999999999 109.825 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 66.8 -120.12 13.65 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.632 -1.27 . . . . 23.170000000000002 110.12 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -48.74 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -1.071 . . . . 39.770000000000003 110.04 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -78.31 -52.76 8.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.888 -1.133 . . . . 26.649999999999999 109.646 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.76 63.36 0.48 Allowed Glycine 0 N--CA 1.508 3.46 0 C-N-CA 119.939 -1.124 . . . . 20.260000000000002 111.64 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 16.7 p90 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.955 -1.32 . . . . 17.789999999999999 109.975 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.675 0.25 . . . . 17.420000000000002 111.675 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 67' ' ' ILE . 9.9 t -57.17 -7.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.646 -1.284 . . . . 18.82 109.97 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -110.99 9.65 22.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.175 -0.953 . . . . 38.5 109.403 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.1 mt-30 -138.38 -8.93 1.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.402 -0.811 . . . . 36.829999999999998 109.876 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.4 m -120.25 -23.54 6.2 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.439 -0.788 . . . . 18.16 109.065 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 41.3 t -91.21 -41.84 10.76 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.203 -1.036 . . . . 18.460000000000001 108.203 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -85.19 -27.64 25.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -129.66 -138.21 0.22 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.511 -0.922 . . . . 30.34 108.511 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.25 149.61 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.003 . . . . 27.510000000000002 109.258 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -133.97 171.81 13.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.429 -0.794 . . . . 23.34 109.766 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -106.88 -153.93 0.51 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.493 -0.754 . . . . 22.640000000000001 109.479 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 tp -77.78 -59.94 2.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.922 . . . . 23.280000000000001 109.014 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -42.21 -55.99 3.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.674 -0.641 . . . . 37.859999999999999 110.309 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -48.74 -47.15 41.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.932 -1.105 . . . . 31.390000000000001 109.005 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mp -63.13 -39.42 94.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 24.48 108.942 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.64 -19.0 61.78 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.399 -0.813 . . . . 31.48 109.878 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.43 -29.68 61.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 22.48 111.568 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -97.94 11.78 36.32 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.147 -0.971 . . . . 19.59 111.73 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.7 m -77.05 -175.71 3.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.641 -1.287 . . . . 20.620000000000001 109.196 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 118.029 -0.986 . . . . 24.649999999999999 109.368 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.439 0.638 . . . . 30.100000000000001 109.461 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.716 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.78 106.98 7.17 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.252 -1.018 . . . . 32.240000000000002 108.252 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -157.34 165.09 36.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 30.210000000000001 110.08 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -77.28 100.61 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.161 -2.163 . . . . 24.0 105.161 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.36 134.94 41.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 19.629999999999999 111.799 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.33 -162.44 0.89 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.152 -0.968 . . . . 17.190000000000001 111.636 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.51 -52.2 1.38 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 115.761 -0.654 . . . . 16.550000000000001 112.864 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -78.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.648 . . . . 19.550000000000001 110.669 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -55.47 33.28 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.106 -0.997 . . . . 0.0 110.136 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 67' ' ' ILE . 34.7 tp -51.09 -50.29 59.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.865 -1.147 . . . . 14.16 108.744 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.9 t -47.89 -55.87 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.65 -1.241 . . . . 15.31 107.65 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.09 -61.69 2.21 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.969 -1.123 . . . . 29.640000000000001 107.969 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.37 -59.32 2.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.975 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.88 -55.38 20.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.328 -1.482 . . . . 17.789999999999999 107.77 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -49.53 -48.94 47.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.255 -0.646 . . . . 16.84 109.255 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.4 mt -52.96 -25.88 13.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.984 -1.073 . . . . 22.760000000000002 108.587 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.92 -64.61 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 17.440000000000001 109.435 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.1 m -64.24 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 18.539999999999999 109.606 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 77.01 -133.14 12.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.718 -1.353 . . . . 23.170000000000002 109.718 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -49.45 -11.29 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -1.111 . . . . 39.770000000000003 109.594 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -63.7 -53.05 57.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 26.649999999999999 108.778 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.93 63.58 0.48 Allowed Glycine 0 N--CA 1.506 3.363 0 C-N-CA 119.941 -1.124 . . . . 20.260000000000002 111.562 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.0 p90 . . . . . 0 C--N 1.299 -1.61 0 O-C-N 121.166 -1.197 . . . . 17.789999999999999 109.935 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 11' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.157 -0.683 . . . . 17.420000000000002 109.157 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.4 t -52.09 -46.48 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.099 -1.001 . . . . 18.82 109.56 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.36 10.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 38.5 109.768 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.5 mt-30 -135.76 -10.56 2.08 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.127 -0.983 . . . . 36.829999999999998 110.843 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.5 m -123.84 -25.98 4.18 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.297 -0.877 . . . . 18.16 108.766 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.67 -39.68 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.299 -1.0 . . . . 18.460000000000001 108.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -88.03 -16.2 34.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -138.59 -142.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.461 -0.94 . . . . 30.34 108.461 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -144.91 142.0 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.15 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -129.07 173.58 10.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 23.34 109.631 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -112.17 -165.85 1.03 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.556 -0.715 . . . . 22.640000000000001 109.836 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.6 tp -64.26 -58.11 7.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 23.280000000000001 109.55 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -44.0 -58.19 2.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.813 . . . . 37.859999999999999 110.203 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -47.88 -47.64 31.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.147 . . . . 31.390000000000001 109.186 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.23 -40.03 94.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.02 -0.733 . . . . 24.48 109.02 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.98 -18.97 62.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 31.48 109.747 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -74.46 -29.87 61.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 22.48 111.48 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -97.16 11.79 35.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.114 -0.991 . . . . 19.59 111.796 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.6 m -77.38 -175.68 3.84 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.611 -1.305 . . . . 20.620000000000001 109.258 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 36.5 t-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.004 -0.998 . . . . 24.649999999999999 109.221 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.346 0.594 . . . . 30.100000000000001 109.492 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.99 106.94 8.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.455 -0.943 . . . . 32.240000000000002 108.455 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -157.59 163.01 38.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 30.210000000000001 109.686 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -77.45 100.78 6.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.125 -2.176 . . . . 24.0 105.125 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -97.68 132.93 42.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 19.629999999999999 111.996 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.67 -162.1 0.86 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.904 0.859 . . . . 17.190000000000001 111.427 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.14 -50.97 1.63 Allowed Glycine 0 N--CA 1.491 2.354 0 CA-C-N 115.957 -0.565 . . . . 16.550000000000001 112.888 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 p -79.38 -63.38 1.43 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.4 -1.647 . . . . 19.550000000000001 110.872 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -55.09 39.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 110.073 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 67' ' ' ILE . 29.0 tp -50.6 -49.77 55.67 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.728 -1.233 . . . . 14.16 108.429 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -48.24 -56.2 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.393 -1.336 . . . . 15.31 107.393 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -55.79 -61.46 2.35 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.843 -1.143 . . . . 29.640000000000001 108.036 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.98 2.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 13.960000000000001 109.662 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 10.5 mt -51.22 -50.25 59.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.565 -1.334 . . . . 17.789999999999999 108.026 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -56.06 -41.99 75.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 16.84 109.211 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.79 -28.19 65.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.785 -1.197 . . . . 22.760000000000002 107.961 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.83 -64.66 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.547 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.474 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.5 m -64.6 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 18.539999999999999 109.801 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 76.51 -134.18 15.02 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.756 -1.338 . . . . 23.170000000000002 109.756 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -48.26 -11.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.415 -1.05 . . . . 39.770000000000003 109.8 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' GLY . 51.7 mtt180 -65.33 -52.52 53.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.058 . . . . 26.649999999999999 108.95 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.37 0.49 Allowed Glycine 0 N--CA 1.506 3.325 0 C-N-CA 119.786 -1.197 . . . . 20.260000000000002 111.663 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.0 p90 . . . . . 0 C--N 1.299 -1.615 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 109.896 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 11' ' ' LEU . 2.5 tt . . . . . 0 N--CA 1.498 1.974 0 N-CA-C 109.17 -0.678 . . . . 17.420000000000002 109.17 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.473 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.6 t -48.77 -49.76 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.202 -0.936 . . . . 18.82 109.822 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -69.77 10.65 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 38.5 110.221 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.497 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 30.4 mt-30 -132.75 -16.53 2.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.215 -0.928 . . . . 36.829999999999998 110.781 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.0 m -119.35 -25.09 6.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.42 -0.8 . . . . 18.16 108.965 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.2 t -85.92 -37.85 18.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 18.460000000000001 108.676 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -90.37 -8.91 49.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 108.857 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -148.42 -145.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.624 -0.88 . . . . 30.34 108.624 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 75' ' ' ILE . 19.3 mt -143.76 123.13 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.17 -0.956 . . . . 27.510000000000002 109.132 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.3 m -104.15 177.87 4.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.535 -0.728 . . . . 23.34 109.531 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 m -112.11 176.72 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.522 -0.737 . . . . 22.640000000000001 109.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 tp -51.01 -59.64 3.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 23.280000000000001 109.495 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -43.68 -55.0 4.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.438 -0.789 . . . . 37.859999999999999 110.163 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -49.48 -48.16 47.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.723 -1.236 . . . . 31.390000000000001 108.907 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.58 -38.65 88.32 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 24.48 108.967 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.98 -18.98 64.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.394 -0.816 . . . . 31.48 109.827 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -73.95 -29.4 61.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 22.48 111.522 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.83 11.72 36.33 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.133 -0.979 . . . . 19.59 111.693 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.71 -175.83 3.57 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.567 -1.333 . . . . 20.620000000000001 109.271 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 118.082 -0.961 . . . . 24.649999999999999 109.495 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 121.636 0.731 . . . . 30.100000000000001 110.107 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.71 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -135.03 107.8 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.13 -1.063 . . . . 32.240000000000002 108.13 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -156.82 166.95 31.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 30.210000000000001 109.657 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -77.34 100.66 6.0 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.025 -2.213 . . . . 24.0 105.025 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' CYS . 14.2 mt -99.15 134.55 41.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.527 -0.733 . . . . 19.629999999999999 111.683 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 m -122.63 -157.36 0.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.951 0.881 . . . . 17.190000000000001 112.473 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.65 -54.35 1.38 Allowed Glycine 0 N--CA 1.493 2.496 0 CA-C-N 116.042 -0.526 . . . . 16.550000000000001 113.012 -176.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -80.45 -60.38 2.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.47 -1.606 . . . . 19.550000000000001 111.04 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -55.63 32.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 110.474 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD21 HD13 ' A' ' 67' ' ' ILE . 25.5 tp -51.78 -47.03 64.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.68 -1.263 . . . . 14.16 108.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -49.72 -57.13 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.237 -1.394 . . . . 15.31 107.237 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -55.69 -61.34 2.43 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.009 -1.077 . . . . 29.640000000000001 108.276 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -44.87 -59.62 2.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.087 -1.008 . . . . 13.960000000000001 109.747 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.73 -51.46 55.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.94 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -54.16 -43.56 70.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.466 -0.771 . . . . 16.84 109.113 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.61 -28.88 61.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.926 -1.109 . . . . 22.760000000000002 108.238 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -94.03 -64.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 17.440000000000001 109.493 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.3 m -64.21 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 18.539999999999999 109.856 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 73.09 -129.81 13.13 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.635 -1.269 . . . . 23.170000000000002 110.034 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.3 pm0 -46.54 -13.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 110.018 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' GLY . 60.7 mtt180 -68.06 -52.89 30.11 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.088 -1.008 . . . . 26.649999999999999 109.522 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.9 64.15 0.48 Allowed Glycine 0 N--CA 1.508 3.442 0 C-N-CA 119.717 -1.23 . . . . 20.260000000000002 111.698 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.1 p90 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.165 -1.197 . . . . 17.789999999999999 110.039 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 108.946 -0.761 . . . . 17.420000000000002 108.946 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 68' ' ' VAL . 3.0 t -50.85 -48.83 28.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 18.82 109.411 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.16 10.46 0.15 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.2 -0.937 . . . . 38.5 110.721 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.491 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.0 mt-30 -137.79 -14.21 1.43 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.921 -1.112 . . . . 36.829999999999998 111.005 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.1 m -120.82 -21.62 6.54 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.934 . . . . 18.16 109.108 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.7 t -90.82 -39.85 12.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.101 -1.074 . . . . 18.460000000000001 108.101 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -88.39 -18.77 27.68 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -140.12 -144.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.351 -0.981 . . . . 30.34 108.351 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.65 151.27 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.111 -0.993 . . . . 27.510000000000002 109.031 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -135.55 172.29 13.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.475 -0.765 . . . . 23.34 109.68 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 m -111.63 -176.47 2.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.519 -0.738 . . . . 22.640000000000001 110.076 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.48 -57.33 12.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.46 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -44.0 -50.57 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 37.859999999999999 110.027 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -57.06 -53.26 60.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.981 -1.074 . . . . 31.390000000000001 108.814 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.5 mp -55.51 -39.63 70.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.777 -0.823 . . . . 24.48 108.777 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.98 -18.71 65.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.528 -0.733 . . . . 31.48 109.944 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.95 -28.44 61.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 22.48 111.568 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 20.6 m-85 -101.0 12.08 38.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.252 -0.905 . . . . 19.59 111.991 -177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.1 m -76.75 -175.62 3.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.614 -1.304 . . . . 20.620000000000001 109.134 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 118.037 -0.982 . . . . 24.649999999999999 109.446 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.6 p . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 109.229 -0.656 . . . . 30.100000000000001 109.229 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.844 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.65 108.11 9.95 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.736 -0.839 . . . . 32.240000000000002 108.736 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -156.64 163.66 39.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 30.210000000000001 109.5 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -76.18 100.73 5.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.246 -2.131 . . . . 24.0 105.246 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.0 134.63 41.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 19.629999999999999 111.738 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.49 -161.46 0.89 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.093 -1.005 . . . . 17.190000000000001 111.806 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.22 -47.37 1.44 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.703 -0.68 . . . . 16.550000000000001 112.77 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -82.94 -62.46 1.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.349 -1.677 . . . . 19.550000000000001 110.734 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -55.49 34.5 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.006 -1.059 . . . . 0.0 109.993 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 29.8 tp -49.97 -50.92 45.15 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.698 -1.251 . . . . 14.16 108.269 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.05 -54.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.453 -1.314 . . . . 15.31 107.453 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.17 -61.71 2.28 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.949 -1.1 . . . . 29.640000000000001 108.257 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.34 -59.87 2.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.118 -0.989 . . . . 13.960000000000001 109.518 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.5 mt -51.05 -49.14 61.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.585 -1.322 . . . . 17.789999999999999 108.102 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.51 -40.72 79.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 16.84 109.011 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.63 -29.54 68.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.915 -1.116 . . . . 22.760000000000002 108.086 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.28 -64.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.479 -0.763 . . . . 17.440000000000001 109.555 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -64.34 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 18.539999999999999 109.685 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.59 -122.96 11.02 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.617 -1.277 . . . . 23.170000000000002 110.077 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -50.64 -11.7 0.09 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -1.055 . . . . 39.770000000000003 110.386 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' GLY . 31.1 mtt-85 -73.32 -52.09 15.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.871 -1.143 . . . . 26.649999999999999 109.668 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.03 64.31 0.48 Allowed Glycine 0 N--CA 1.508 3.467 0 C-N-CA 119.756 -1.211 . . . . 20.260000000000002 111.685 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.413 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.2 p90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.004 -1.292 . . . . 17.789999999999999 109.169 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.597 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.753 0.311 . . . . 17.420000000000002 111.131 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.597 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.1 t -54.96 -12.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.748 -1.22 . . . . 18.82 110.222 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -105.14 9.91 34.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 38.5 109.773 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -137.01 -14.91 1.55 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.283 -0.886 . . . . 36.829999999999998 109.857 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.8 m -112.49 -29.26 7.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.402 -0.811 . . . . 18.16 108.993 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.44 -44.47 11.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.105 . . . . 18.460000000000001 108.825 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -81.44 -14.56 56.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.4 t -147.71 -137.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.444 -0.947 . . . . 30.34 108.444 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.81 149.59 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.076 -1.015 . . . . 27.510000000000002 109.349 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -131.47 176.32 8.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.487 -0.758 . . . . 23.34 109.587 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' NE2' ' A' ' 80' ' ' GLN . 2.8 p -112.26 171.17 7.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.661 -0.649 . . . . 22.640000000000001 109.444 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 tp -45.09 -61.16 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 23.280000000000001 109.502 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -41.33 -54.73 2.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.692 . . . . 37.859999999999999 110.531 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.748 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.4 mp0 -52.16 -49.49 63.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 31.390000000000001 108.578 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -58.56 -40.01 81.84 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.655 -0.868 . . . . 24.48 108.655 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.84 -18.75 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.426 -0.796 . . . . 31.48 109.923 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.87 -29.02 61.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.813 . . . . 22.48 111.692 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -99.56 11.98 37.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.139 -0.976 . . . . 19.59 111.857 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -76.81 -175.82 3.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.579 -1.326 . . . . 20.620000000000001 109.025 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.292 179.771 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.349 -0.612 . . . . 30.100000000000001 109.349 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.838 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -127.54 106.4 9.15 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.547 -0.909 . . . . 32.240000000000002 108.547 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -157.09 164.27 38.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 30.210000000000001 109.574 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -78.37 100.61 6.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.264 -2.124 . . . . 24.0 105.264 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.22 135.02 40.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 19.629999999999999 111.671 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.8 m -123.99 -158.35 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.895 0.855 . . . . 17.190000000000001 112.438 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.56 -51.29 1.39 Allowed Glycine 0 N--CA 1.492 2.429 0 CA-C-N 115.991 -0.55 . . . . 16.550000000000001 112.997 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m -82.48 -60.95 2.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.382 -1.658 . . . . 19.550000000000001 110.975 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -55.68 31.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.376 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 67' ' ' ILE . 23.8 tp -50.53 -48.4 57.16 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.677 -1.264 . . . . 14.16 108.36 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.14 -54.3 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.128 -1.434 . . . . 15.31 107.128 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.78 -61.48 2.49 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.951 -1.1 . . . . 29.640000000000001 108.322 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.15 -60.3 2.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 13.960000000000001 109.653 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 67' ' ' ILE . 11.3 mt -51.22 -48.34 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.559 -1.338 . . . . 17.789999999999999 108.046 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -58.86 -39.49 81.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.535 -0.728 . . . . 16.84 109.119 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.65 -31.22 70.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 22.760000000000002 108.08 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -89.65 -64.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.519 -0.738 . . . . 17.440000000000001 109.496 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.1 m -64.0 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 18.539999999999999 109.37 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.97 -132.84 12.21 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.564 -1.414 . . . . 23.170000000000002 109.564 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 -13.65 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -1.132 . . . . 39.770000000000003 109.49 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -60.32 -53.27 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.94 . . . . 26.649999999999999 109.217 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.66 64.5 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.885 -1.15 . . . . 20.260000000000002 111.196 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.4 p90 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 110.172 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt . . . . . 0 N--CA 1.497 1.906 0 N-CA-C 108.79 -0.818 . . . . 17.420000000000002 108.79 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.45 -53.62 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.054 -1.029 . . . . 18.82 109.461 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.52 10.61 0.09 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.309 -0.869 . . . . 38.5 110.248 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -135.1 -16.28 1.92 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.979 -1.075 . . . . 36.829999999999998 110.69 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.65 -23.73 6.45 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.41 -0.806 . . . . 18.16 109.096 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.6 t -87.44 -36.74 17.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.342 -0.984 . . . . 18.460000000000001 108.342 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -91.45 -16.87 26.64 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -138.71 -144.66 0.18 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -145.11 117.29 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.982 -1.074 . . . . 27.510000000000002 109.37 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -100.5 177.41 5.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.382 -0.824 . . . . 23.34 109.852 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 m -112.36 -175.38 2.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.548 -0.72 . . . . 22.640000000000001 109.752 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.5 tp -57.26 -56.46 21.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.514 -0.741 . . . . 23.280000000000001 109.478 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -44.91 -57.43 3.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 37.859999999999999 109.933 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -48.6 -48.52 39.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.87 -1.144 . . . . 31.390000000000001 108.987 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -60.95 -39.93 91.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.814 -0.809 . . . . 24.48 108.814 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.27 -18.95 64.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 31.48 109.662 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -73.19 -29.78 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 22.48 111.589 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.04 12.21 36.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.036 -1.04 . . . . 19.59 111.788 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 77.9 m -76.66 -175.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.658 -1.277 . . . . 20.620000000000001 109.253 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.95 -1.024 . . . . 24.649999999999999 109.452 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.421 0.629 . . . . 30.100000000000001 109.533 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.97 106.77 7.87 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.298 -1.001 . . . . 32.240000000000002 108.298 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -157.38 164.62 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 30.210000000000001 109.824 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -77.67 100.57 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.173 -2.158 . . . . 24.0 105.173 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.8 mt -99.44 135.31 41.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 19.629999999999999 111.72 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.2 m -122.91 -157.58 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.97 0.89 . . . . 17.190000000000001 112.424 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.72 -55.47 1.35 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-N 116.043 -0.526 . . . . 16.550000000000001 113.06 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -79.63 -58.49 3.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.383 -1.657 . . . . 19.550000000000001 111.152 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -55.94 27.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 110.419 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 67' ' ' ILE . 24.9 tp -51.12 -48.83 61.67 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.69 -1.256 . . . . 14.16 108.359 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -48.28 -55.06 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.451 -1.315 . . . . 15.31 107.451 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.97 -61.76 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.119 -1.067 . . . . 29.640000000000001 108.119 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.47 -59.6 2.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.102 -0.999 . . . . 13.960000000000001 109.686 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 11.2 mt -51.61 -53.46 38.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.486 -1.384 . . . . 17.789999999999999 107.906 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -52.11 -45.63 64.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.497 -0.752 . . . . 16.84 109.176 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -56.45 -30.98 63.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.957 -1.09 . . . . 22.760000000000002 108.336 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -89.94 -64.6 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.389 -0.819 . . . . 17.440000000000001 109.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.441 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -64.13 -79.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 18.539999999999999 109.45 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 75.81 -131.72 12.25 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.816 -1.314 . . . . 23.170000000000002 109.816 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -50.09 -10.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -1.088 . . . . 39.770000000000003 109.521 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.47 -52.97 49.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 26.649999999999999 108.994 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.75 63.93 0.49 Allowed Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.936 -1.126 . . . . 20.260000000000002 111.46 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 23.9 p90 . . . . . 0 C--N 1.3 -1.576 0 O-C-N 121.146 -1.208 . . . . 17.789999999999999 110.162 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 11' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.18 -0.674 . . . . 17.420000000000002 109.18 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.93 -50.3 19.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.208 -0.932 . . . . 18.82 109.663 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.23 10.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 38.5 110.644 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -137.83 -16.11 1.32 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.819 -1.176 . . . . 36.829999999999998 110.651 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.0 m -118.62 -23.06 7.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.339 -0.85 . . . . 18.16 109.216 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.3 t -89.72 -37.83 14.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.466 -0.939 . . . . 18.460000000000001 108.466 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 m -133.58 -141.96 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.839 . . . . 30.34 108.736 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.05 130.08 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.995 . . . . 27.510000000000002 109.23 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -114.27 175.54 5.43 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.672 -0.643 . . . . 23.34 109.77 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 m -112.53 -178.08 3.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.622 -0.674 . . . . 22.640000000000001 109.758 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 tp -53.37 -60.82 2.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.494 -0.754 . . . . 23.280000000000001 109.629 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -42.33 -56.75 2.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 37.859999999999999 110.39 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -49.2 -47.65 45.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.761 -1.212 . . . . 31.390000000000001 108.921 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.35 -39.27 89.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 24.48 108.806 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 -18.82 64.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.495 -0.753 . . . . 31.48 109.745 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -73.21 -30.21 63.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 22.48 111.644 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 25.7 m-85 -98.8 12.14 36.58 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.145 -0.972 . . . . 19.59 111.805 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.6 m -76.71 -175.81 3.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.593 -1.317 . . . . 20.620000000000001 109.328 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 117.987 -1.006 . . . . 24.649999999999999 109.342 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.255 0.55 . . . . 30.100000000000001 109.546 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.854 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.37 107.66 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.471 -0.937 . . . . 32.240000000000002 108.471 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -156.63 163.14 39.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 30.210000000000001 109.448 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.02 101.09 5.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.212 -2.144 . . . . 24.0 105.212 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.15 136.85 37.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.769 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.33 -164.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.145 -0.972 . . . . 17.190000000000001 111.675 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.51 -44.94 1.31 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 115.673 -0.694 . . . . 16.550000000000001 112.553 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.9 p -83.39 -62.77 1.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.388 -1.654 . . . . 19.550000000000001 110.494 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -55.2 38.16 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 67' ' ' ILE . 30.3 tp -49.72 -50.88 42.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.747 -1.221 . . . . 14.16 108.32 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.45 -55.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.489 -1.3 . . . . 15.31 107.489 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -56.93 -61.39 2.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.959 -1.126 . . . . 29.640000000000001 107.959 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.6 -59.55 2.68 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 13.960000000000001 109.692 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.57 -53.39 38.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.522 -1.361 . . . . 17.789999999999999 108.009 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -51.86 -48.36 64.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 16.84 109.151 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.12 -28.63 26.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.053 . . . . 22.760000000000002 108.588 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -93.9 -64.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.424 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -65.13 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 18.539999999999999 109.909 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.93 -122.91 17.44 Favored Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.605 -1.284 . . . . 23.170000000000002 110.191 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.03 -19.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 109.776 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 73.0 mtt180 -67.07 -52.92 36.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.199 -0.938 . . . . 26.649999999999999 109.788 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.25 0.48 Allowed Glycine 0 N--CA 1.508 3.454 0 C-N-CA 119.728 -1.225 . . . . 20.260000000000002 111.931 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 18.2 p90 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.987 -1.302 . . . . 17.789999999999999 109.262 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 11' ' ' LEU . 2.0 tt . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 108.245 -1.02 . . . . 17.420000000000002 108.245 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' H ' HG23 ' A' ' 68' ' ' VAL . 3.9 t -52.37 -36.43 21.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.381 -0.824 . . . . 18.82 109.597 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -80.79 10.36 5.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 38.5 109.627 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.5 mt-30 -136.44 -10.11 1.91 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.042 -1.036 . . . . 36.829999999999998 110.57 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.7 m -121.85 -26.05 4.9 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.338 -0.852 . . . . 18.16 108.987 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.5 t -88.26 -39.5 14.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 18.460000000000001 108.607 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -84.77 -15.25 45.63 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -143.93 -138.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.114 -1.069 . . . . 30.34 108.114 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -145.52 148.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 27.510000000000002 109.045 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.6 m -131.05 173.57 10.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 23.34 109.707 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.8 m -112.16 -176.65 2.97 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.684 . . . . 22.640000000000001 109.613 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 tp -56.53 -59.25 5.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 23.280000000000001 109.412 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -43.12 -55.07 4.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 37.859999999999999 110.262 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -52.39 -48.97 65.33 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.877 -1.139 . . . . 31.390000000000001 108.952 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.09 -40.51 89.86 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.713 -0.847 . . . . 24.48 108.713 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.82 -18.87 61.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.506 -0.746 . . . . 31.48 109.952 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -29.82 62.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 22.48 111.742 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -97.79 11.56 36.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.082 -1.011 . . . . 19.59 111.807 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.96 -175.77 3.67 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.558 -1.339 . . . . 20.620000000000001 109.063 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 118.015 -0.993 . . . . 24.649999999999999 109.494 179.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.485 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 15.2 t80 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.159 -0.682 . . . . 24.77 109.159 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.9 p -86.47 148.17 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.231 -0.918 . . . . 30.100000000000001 110.125 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.812 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -116.68 107.25 14.45 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.941 -1.133 . . . . 32.240000000000002 107.941 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.451 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.4 mm100 -153.65 165.52 35.69 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.317 -0.865 . . . . 30.210000000000001 109.512 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.7 m-70 -78.34 101.63 7.31 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 105.07 -2.196 . . . . 24.0 105.07 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -98.65 135.41 40.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.336 -0.853 . . . . 19.629999999999999 112.297 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.67 -161.16 0.83 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.275 -0.891 . . . . 17.190000000000001 111.656 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.11 -55.11 1.51 Allowed Glycine 0 N--CA 1.49 2.266 0 CA-C-N 115.899 -0.591 . . . . 16.550000000000001 112.75 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.7 p -76.73 -61.56 1.93 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.5 -1.588 . . . . 19.550000000000001 110.983 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.83 -55.51 33.99 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.004 -1.06 . . . . 0.0 110.123 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 67' ' ' ILE . 30.6 tp -50.82 -49.9 57.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 14.16 108.476 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.76 -56.71 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 107.532 -1.284 . . . . 15.31 107.532 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -55.9 -61.0 2.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.026 -1.101 . . . . 29.640000000000001 108.026 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.19 -59.75 2.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.101 -0.999 . . . . 13.960000000000001 109.825 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -51.72 -50.48 60.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.425 -1.422 . . . . 17.789999999999999 107.891 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -55.29 -43.7 75.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 16.84 109.183 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.6 mt -56.53 -25.29 51.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 22.760000000000002 108.176 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -97.37 -64.43 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.44 -0.788 . . . . 17.440000000000001 109.431 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.468 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.8 m -64.53 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 18.539999999999999 110.005 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.98 -122.59 13.42 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 119.665 -1.255 . . . . 23.170000000000002 110.125 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -45.62 -18.67 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.425 -1.044 . . . . 39.770000000000003 110.237 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.526 ' HG2' HH11 ' A' ' 22' ' ' ARG . 9.5 mtt-85 -70.12 -53.07 18.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.974 -1.079 . . . . 26.649999999999999 110.097 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 64.02 0.5 Allowed Glycine 0 N--CA 1.508 3.475 0 C-N-CA 119.726 -1.226 . . . . 20.260000000000002 111.759 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.536 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 20.8 p90 -76.22 127.11 32.24 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.269 . . . . 17.789999999999999 110.098 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -96.88 104.16 16.14 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.838 -1.171 . . . . 18.550000000000001 107.838 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.403 ' CE1' HD23 ' A' ' 11' ' ' LEU . 6.3 t80 -57.14 128.27 36.14 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.087 -1.008 . . . . 21.489999999999998 109.27 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 25' ' ' PHE . 2.3 p -126.13 147.22 49.66 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.568 -0.707 . . . . 31.5 109.413 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -160.28 102.09 1.38 Allowed Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.387 -0.821 . . . . 0.0 108.924 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.89 -29.99 88.15 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.77 0.98 . . . . 0.0 110.514 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 30' ' ' THR . 15.0 t -69.74 77.28 0.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.132 -0.98 . . . . 0.0 109.527 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.9 ttp180 -86.85 -21.88 26.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.21 -0.931 . . . . 0.0 109.066 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -156.0 62.41 0.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -46.91 120.49 3.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.562 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . -74.43 -144.57 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.215 -0.928 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 58.32 -4.62 0.06 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.605 -0.684 . . . . 0.0 110.439 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.55 ' H ' ' C ' ' A' ' 34' ' ' ALA . 21.8 t0 -96.65 -12.09 24.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.02 -1.05 . . . . 0.0 109.248 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.14 -160.93 1.13 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.277 -0.889 . . . . 0.0 109.3 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 8.0 mp0 -62.49 -160.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 109.53 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 t 61.68 155.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.305 -0.872 . . . . 0.0 109.616 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.68 -105.96 3.36 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.625 ' H ' ' CD ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -68.18 102.41 1.35 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -1.15 . . . . 0.0 108.287 179.701 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 43' ' ' GLU . 30.1 m -116.78 -41.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.602 -0.686 . . . . 0.0 109.248 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 42' ' ' VAL . 22.8 tt0 -176.36 -25.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.2 mp -91.34 57.46 3.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 62.66 -75.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -175.02 74.85 0.08 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.72 66.79 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.087 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.43 -11.24 8.1 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 C-N-CA 121.362 1.375 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.57 160.84 43.96 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.69 -27.49 66.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.153 . . . . 0.0 109.552 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.71 18.61 65.4 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.0 t -80.22 -33.03 38.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.173 . . . . 0.0 109.528 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' H ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -78.13 161.81 27.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.912 . . . . 0.0 109.096 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.576 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 159.25 80.72 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -62.53 130.36 29.69 Favored 'Trans proline' 0 C--N 1.321 -0.918 0 C-N-CA 121.121 1.214 . . . . 0.0 109.739 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.0 mt -56.55 -27.22 57.14 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.408 -0.808 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.06 -61.06 2.37 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.316 -0.865 . . . . 0.0 110.006 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.8 mm? -59.62 -37.48 78.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.255 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -46.13 -34.81 4.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.91 -44.56 5.68 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 64' ' ' LYS . 28.5 p -78.42 -7.5 57.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -1.155 . . . . 0.0 109.803 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -50.35 -61.34 2.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.159 -0.963 . . . . 0.0 108.849 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -86.34 -41.1 14.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 109.117 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -89.27 -160.23 0.65 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 109.057 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -150.91 -3.38 0.33 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.103 -0.998 . . . . 0.0 109.102 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 55.27 170.54 0.07 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 19.620000000000001 109.943 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.547 HD11 HD11 ' A' ' 11' ' ' LEU . 2.7 tt -134.41 -42.26 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.556 -0.967 . . . . 17.420000000000002 108.583 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.477 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -51.66 -41.52 28.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.2 -0.938 . . . . 18.82 109.425 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -76.48 10.31 2.17 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.3 -0.875 . . . . 38.5 110.014 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.4 mt-30 -136.51 -12.78 1.79 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.156 -0.965 . . . . 36.829999999999998 110.707 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.2 m -119.88 -27.12 5.47 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.376 -0.828 . . . . 18.16 109.071 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.2 t -86.36 -38.19 17.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.053 . . . . 18.460000000000001 108.515 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.7 t -87.76 -14.93 38.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.534 -0.729 . . . . 0.0 109.261 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.4 m -141.78 -141.46 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.527 -0.916 . . . . 30.34 108.527 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 75' ' ' ILE . 12.5 mt -145.8 128.08 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.166 -0.958 . . . . 27.510000000000002 109.209 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -111.39 176.82 4.87 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.591 -0.693 . . . . 23.34 109.931 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.3 m -112.62 -170.18 1.62 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.472 0.653 . . . . 22.640000000000001 109.623 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.485 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.1 tp -62.24 -59.8 4.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.449 -0.782 . . . . 23.280000000000001 109.359 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -43.05 -57.92 2.68 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -0.768 . . . . 37.859999999999999 110.38 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -48.74 -45.02 39.07 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.857 -1.152 . . . . 31.390000000000001 109.018 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.47 -37.64 88.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 24.48 108.705 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.43 -18.72 64.99 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.427 -0.795 . . . . 31.48 109.669 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.08 -30.36 63.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.527 -0.733 . . . . 22.48 111.581 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -98.05 12.07 35.54 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.107 -0.996 . . . . 19.59 111.975 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 65.9 m -76.55 -175.68 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.551 -1.343 . . . . 20.620000000000001 108.982 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.504 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.434 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.8 t80 . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.294 -0.632 . . . . 24.77 109.294 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -168.08 160.91 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 30.100000000000001 109.22 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.802 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.33 107.76 8.3 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.345 -0.983 . . . . 32.240000000000002 108.345 179.24 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -156.76 166.04 34.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.4 -0.813 . . . . 30.210000000000001 110.083 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.6 m80 -77.26 100.99 6.04 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.3 mt -99.64 136.88 38.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.547 -0.72 . . . . 19.629999999999999 111.749 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.84 -160.51 0.85 Allowed 'General case' 0 N--CA 1.504 2.256 0 CA-C-O 122.216 1.007 . . . . 17.190000000000001 111.849 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.53 -54.06 1.76 Allowed Glycine 0 N--CA 1.487 2.049 0 CA-C-N 115.552 -0.749 . . . . 16.550000000000001 112.772 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -78.9 -56.82 4.11 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.341 -1.682 . . . . 19.550000000000001 110.976 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.49 -55.54 26.61 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.928 -1.107 . . . . 0.0 110.337 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.75 -48.55 63.64 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.797 -1.19 . . . . 14.16 108.453 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 8' ' ' GLY . 3.2 t -48.84 -55.17 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.307 -1.368 . . . . 15.31 107.307 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -56.11 -61.91 2.06 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.75 -59.73 2.62 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.092 -1.005 . . . . 13.960000000000001 109.842 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.481 HD11 HD13 ' A' ' 67' ' ' ILE . 10.7 mt -51.98 -52.06 53.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.484 -1.385 . . . . 17.789999999999999 107.977 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -53.84 -46.32 71.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.527 -0.733 . . . . 16.84 109.216 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.23 -31.52 61.55 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.008 -1.058 . . . . 22.760000000000002 108.501 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -89.47 -64.67 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.785 . . . . 17.440000000000001 109.257 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' N ' HG12 ' A' ' 18' ' ' VAL . 12.9 m -63.81 -76.33 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 18.539999999999999 109.414 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.09 -139.69 22.97 Favored Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.538 -1.425 . . . . 23.170000000000002 109.538 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.4 pm0 -47.28 -15.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -1.166 . . . . 39.770000000000003 109.535 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' GLY . 56.1 mtt180 -57.33 -52.3 65.91 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -0.926 . . . . 26.649999999999999 109.036 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.38 64.82 0.48 Allowed Glycine 0 N--CA 1.507 3.399 0 C-N-CA 119.73 -1.224 . . . . 20.260000000000002 111.902 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.417 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 27.3 p90 -75.62 134.11 40.72 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.282 -1.128 . . . . 17.789999999999999 110.111 -179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.22 114.34 26.02 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.636 -0.875 . . . . 18.550000000000001 108.636 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' A' ' 11' ' ' LEU . 5.6 t80 -90.36 157.66 17.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 21.489999999999998 109.092 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.4 p -152.76 115.06 4.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.069 -1.019 . . . . 31.5 109.863 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -172.77 88.02 0.41 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -54.71 -29.2 60.68 Favored 'Trans proline' 0 C--N 1.323 -0.79 0 C-N-CA 121.043 1.162 . . . . 0.0 110.295 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.32 169.46 4.62 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttt180 -165.6 -89.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.05 -1.031 . . . . 0.0 110.003 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -77.8 67.57 3.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.9 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -83.5 92.59 7.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.281 -0.887 . . . . 0.0 109.298 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . -157.24 -177.7 6.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.938 . . . . 0.0 109.539 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 34' ' ' ALA . 47.8 mt-10 51.17 179.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.3 p30 -73.13 112.09 8.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.4 mm? -69.04 105.08 2.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.244 -0.91 . . . . 0.0 109.134 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.11 163.29 24.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.187 -0.946 . . . . 0.0 109.236 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 41' ' ' GLN . 39.4 t -147.05 158.57 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.426 -0.796 . . . . 0.0 109.263 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . -43.18 94.77 0.01 OUTLIER Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' C ' ' O ' ' A' ' 40' ' ' GLY . 0.5 OUTLIER 20.0 75.72 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.233 0.54 . . . . 0.0 112.196 179.485 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 4.0 m -104.71 20.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.461 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 6.5 tt0 77.56 153.37 0.14 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.024 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.2 4.31 31.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.092 -1.005 . . . . 0.0 109.652 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.474 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -79.19 -18.47 74.31 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.55 80.59 0.14 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.52 67.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.56 -62.94 0.12 Allowed 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 121.44 1.427 . . . . 0.0 109.937 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 163.82 102.49 0.17 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.32 -9.38 59.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -1.115 . . . . 0.0 109.579 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 51.75 -128.74 33.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.8 m -159.65 104.55 1.59 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 27.3 mt -136.05 -122.37 0.15 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.397 -0.814 . . . . 0.0 109.22 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -86.34 153.88 56.61 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 108.998 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.29 138.08 82.47 Favored 'Trans proline' 0 C--N 1.324 -0.755 0 C-N-CA 120.978 1.119 . . . . 0.0 109.845 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.9 mt -54.9 -37.65 66.61 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.433 -0.792 . . . . 0.0 109.519 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.56 -56.5 19.61 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.328 -0.858 . . . . 0.0 109.909 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.6 mm? -63.11 -45.04 93.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.98 . . . . 0.0 109.523 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -47.41 -28.46 2.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.18 -0.95 . . . . 0.0 109.794 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.12 -64.48 1.41 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.0 p -42.88 -30.11 0.38 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -1.045 . . . . 0.0 110.522 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mt -61.55 -31.56 71.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.463 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -95.48 -44.88 7.33 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.141 -0.974 . . . . 0.0 109.799 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -77.4 141.53 39.74 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.817 -1.177 . . . . 0.0 108.925 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.7 mtp180 -54.11 -57.31 11.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.101 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 154.08 40.68 0.02 OUTLIER Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.535 -1.317 . . . . 19.620000000000001 111.089 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.612 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.0 tt -142.27 -50.13 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.971 -1.311 . . . . 17.420000000000002 109.382 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.612 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.0 t -54.83 -31.59 24.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.829 -1.17 . . . . 18.82 108.79 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -89.77 10.56 23.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.887 . . . . 38.5 109.397 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -136.67 -14.45 1.65 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.185 -0.947 . . . . 36.829999999999998 110.617 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.8 m -115.41 -27.14 7.29 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.285 -0.884 . . . . 18.16 109.054 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.8 t -86.6 -42.03 13.8 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.826 -1.171 . . . . 18.460000000000001 108.413 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -82.37 -16.14 50.21 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.1 t -142.76 -139.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.491 -0.929 . . . . 30.34 108.491 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.33 148.7 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.018 -1.051 . . . . 27.510000000000002 109.332 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.6 m -133.61 175.61 9.28 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 23.34 109.852 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.421 ' OG ' ' OE1' ' A' ' 80' ' ' GLN . 2.9 p -112.73 179.47 3.96 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.541 0.686 . . . . 22.640000000000001 109.8 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.434 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -52.34 -60.62 3.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.597 -0.689 . . . . 23.280000000000001 109.423 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -42.61 -56.86 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.536 -0.727 . . . . 37.859999999999999 110.376 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.421 ' OE1' ' OG ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -48.98 -48.48 43.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.815 -1.178 . . . . 31.390000000000001 108.801 179.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.45 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.67 -39.41 88.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.479 -0.763 . . . . 24.48 109.097 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.43 -19.01 64.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 31.48 109.966 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -72.81 -29.34 63.18 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.446 -0.784 . . . . 22.48 111.552 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.7 12.34 35.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.191 -0.943 . . . . 19.59 111.898 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.2 m -76.57 -175.81 3.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.569 -1.332 . . . . 20.620000000000001 109.306 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 118.007 -0.996 . . . . 24.649999999999999 109.424 179.781 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.451 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.7 t80 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.168 -0.678 . . . . 24.77 109.168 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -165.54 160.03 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 30.100000000000001 109.331 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.837 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.64 107.25 9.04 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.485 -0.931 . . . . 32.240000000000002 108.485 179.233 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -157.12 165.17 36.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.336 -0.853 . . . . 30.210000000000001 109.715 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -78.14 100.37 6.56 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.164 -2.161 . . . . 24.0 105.164 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -98.63 137.82 36.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.547 -0.721 . . . . 19.629999999999999 111.615 -176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 15.8 m -125.68 -160.49 0.97 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.038 0.923 . . . . 17.190000000000001 112.538 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.65 -49.25 1.34 Allowed Glycine 0 N--CA 1.492 2.392 0 CA-C-N 115.946 -0.57 . . . . 16.550000000000001 112.793 -176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -83.27 -60.71 2.06 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.402 -1.646 . . . . 19.550000000000001 110.802 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.45 -55.57 31.86 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.13 -0.981 . . . . 0.0 110.308 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 67' ' ' ILE . 24.7 tp -51.38 -46.39 62.77 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.688 -1.258 . . . . 14.16 108.347 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.5 t -50.1 -56.51 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.932 -1.507 . . . . 15.31 106.932 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -56.07 -61.59 2.28 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.099 -1.041 . . . . 29.640000000000001 108.233 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.25 -60.04 2.33 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.807 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.26 -49.04 61.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.612 -1.305 . . . . 17.789999999999999 107.919 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -57.8 -43.06 85.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.522 -0.736 . . . . 16.84 109.232 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.0 mt -57.37 -27.68 62.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.933 -1.105 . . . . 22.760000000000002 108.215 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -93.74 -64.66 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 17.440000000000001 109.535 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.486 ' N ' HG12 ' A' ' 18' ' ' VAL . 18.0 m -63.14 -74.05 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 18.539999999999999 109.567 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -132.54 11.38 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.92 -1.272 . . . . 23.170000000000002 109.92 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -57.24 -12.62 2.45 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.427 -1.043 . . . . 39.770000000000003 109.556 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 22' ' ' ARG . 12.1 mtt-85 -57.79 -51.86 67.85 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.007 -1.058 . . . . 26.649999999999999 109.233 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.6 65.47 0.48 Allowed Glycine 0 N--CA 1.508 3.451 0 C-N-CA 119.628 -1.272 . . . . 20.260000000000002 111.446 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 31.1 p90 -75.53 123.01 24.73 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.301 -1.117 . . . . 17.789999999999999 110.271 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -84.78 112.8 20.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.481 -0.762 . . . . 18.550000000000001 108.974 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.48 ' CZ ' HD23 ' A' ' 11' ' ' LEU . 4.4 t80 -95.61 146.9 24.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 21.489999999999998 109.139 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 p -148.4 146.21 28.37 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.247 -0.908 . . . . 31.5 109.086 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' C ' ' H ' ' A' ' 30' ' ' THR . 0.7 OUTLIER -139.33 141.78 30.24 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 109.216 179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 30' ' ' THR . 4.1 Cg_exo -55.26 -6.7 0.89 Allowed 'Trans proline' 0 C--N 1.323 -0.776 0 N-CA-C 108.701 -1.307 . . . . 0.0 108.701 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.557 ' H ' ' C ' ' A' ' 28' ' ' LYS . 3.6 m 100.26 34.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 123.643 0.777 . . . . 0.0 109.157 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.414 HH11 ' HG3' ' A' ' 31' ' ' ARG . 29.2 mtm-85 43.09 -130.17 0.69 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.512 -0.742 . . . . 0.0 110.162 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -83.76 -166.07 1.3 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 109.26 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 57.06 43.55 24.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 36' ' ' ASP . . . -72.5 115.58 11.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.935 . . . . 0.0 109.362 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 50.26 16.26 0.25 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.234 -0.916 . . . . 0.0 109.37 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.437 ' N ' ' C ' ' A' ' 34' ' ' ALA . 21.3 t0 64.0 87.97 0.11 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.594 -0.691 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -101.35 -160.37 0.79 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.409 -0.807 . . . . 0.0 109.291 179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -141.6 137.89 32.21 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' H ' HG22 ' A' ' 39' ' ' VAL . 10.5 m -86.03 60.27 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.223 -0.923 . . . . 0.0 109.695 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . -172.5 122.47 0.94 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.421 ' O ' ' O ' ' A' ' 40' ' ' GLY . 4.8 tp-100 48.74 92.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.25 -1.147 . . . . 0.0 109.183 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -174.55 -30.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.27 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 45' ' ' GLY . 11.9 pt-20 -125.55 -30.84 3.04 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.098 -1.002 . . . . 0.0 111.123 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.054 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -74.63 26.76 0.08 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.571 -1.331 . . . . 0.0 109.68 -179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 43' ' ' GLU . . . -152.87 -39.13 0.03 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.25 -156.82 28.3 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.54 -115.31 4.3 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 49' ' ' GLY . 6.0 Cg_exo -56.31 -30.77 82.14 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 CA-C-N 119.143 1.471 . . . . 0.0 109.683 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 48' ' ' PRO . . . -50.44 -94.8 0.01 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.36 -16.77 9.85 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.221 -1.164 . . . . 0.0 109.167 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 49.0 74.67 0.25 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.779 -1.329 . . . . 0.0 109.779 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 77.0 p -52.79 -43.07 65.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.234 -1.157 . . . . 0.0 109.086 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.1 mt -81.06 -161.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.406 -0.809 . . . . 0.0 109.111 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -79.88 151.22 73.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 108.709 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -65.23 -178.84 0.91 Allowed 'Trans proline' 0 C--O 1.209 -0.959 0 N-CA-C 109.033 -1.18 . . . . 0.0 109.033 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.1 mt -106.88 -31.69 8.25 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.54 -59.56 3.84 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.438 -0.789 . . . . 0.0 110.171 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.583 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.8 mm? -50.24 -45.82 54.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.073 -1.017 . . . . 0.0 109.009 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -44.59 -35.28 2.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.6 -0.687 . . . . 0.0 109.726 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 61' ' ' SER . . . -87.07 -69.1 1.32 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 64' ' ' LYS . 51.7 p -37.57 -40.09 0.37 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 122.069 -0.665 . . . . 0.0 111.138 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.7 mt -48.24 -18.15 0.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.876 -1.14 . . . . 0.0 108.915 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' N ' ' O ' ' A' ' 61' ' ' SER . 39.0 tt0 -106.53 -18.46 13.96 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.742 -0.599 . . . . 0.0 109.974 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -154.28 -179.1 7.61 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.011 -1.055 . . . . 0.0 110.336 -179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.8 mmt180 -86.85 -34.46 19.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.974 -1.079 . . . . 0.0 108.759 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.59 129.22 3.67 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 110.38 -1.088 . . . . 19.620000000000001 110.38 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 68' ' ' VAL . 3.4 tt -118.66 -40.43 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.673 -0.898 . . . . 17.420000000000002 108.597 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.5 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.8 t -55.36 -27.47 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.275 -0.891 . . . . 18.82 109.556 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -90.9 10.89 24.54 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 38.5 109.872 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.9 mt-30 -137.18 -10.43 1.72 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.075 -1.015 . . . . 36.829999999999998 110.841 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.3 m -120.32 -26.05 5.52 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.271 -0.893 . . . . 18.16 109.42 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.7 t -87.94 -37.91 16.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.93 -1.106 . . . . 18.460000000000001 108.112 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.9 t -86.08 -23.9 26.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.8 m -134.01 -140.71 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.443 -0.947 . . . . 30.34 108.443 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.4 mt -145.68 131.67 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.043 -1.036 . . . . 27.510000000000002 109.099 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.2 m -114.41 175.14 5.61 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.555 -0.716 . . . . 23.34 110.105 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.9 m -112.52 -178.24 3.35 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.604 -0.685 . . . . 22.640000000000001 109.749 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -54.55 -61.8 2.07 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.482 -0.761 . . . . 23.280000000000001 109.716 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -42.04 -57.24 2.53 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.418 -0.801 . . . . 37.859999999999999 110.249 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -48.46 -45.58 36.78 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.852 -1.155 . . . . 31.390000000000001 109.14 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.97 -38.72 92.11 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.282 -0.886 . . . . 24.48 108.86 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.42 -19.0 64.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.492 -0.755 . . . . 31.48 109.786 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -72.74 -29.65 63.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 22.48 111.356 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -97.9 12.53 33.76 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.186 -0.946 . . . . 19.59 111.925 -177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.13 -175.93 3.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.58 -1.325 . . . . 20.620000000000001 109.101 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.025 -0.988 . . . . 24.649999999999999 109.589 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.51 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 19.6 t80 . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.209 -0.663 . . . . 24.77 109.209 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.8 p -165.12 159.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.061 . . . . 30.100000000000001 109.539 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.851 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.58 107.48 9.23 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.475 -0.935 . . . . 32.240000000000002 108.475 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -156.85 161.93 39.7 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.246 -0.909 . . . . 30.210000000000001 109.46 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -76.97 100.95 5.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.285 -2.117 . . . . 24.0 105.285 176.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -99.27 133.63 43.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 19.629999999999999 111.808 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.2 -159.76 0.78 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.136 -0.977 . . . . 17.190000000000001 111.532 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.82 -53.45 1.47 Allowed Glycine 0 N--CA 1.49 2.291 0 CA-C-N 115.843 -0.617 . . . . 16.550000000000001 112.977 -176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.4 m -78.7 -62.35 1.72 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.516 -1.579 . . . . 19.550000000000001 111.068 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.6 -55.5 34.05 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.215 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.603 HD11 HD11 ' A' ' 67' ' ' ILE . 31.5 tp -50.49 -51.71 44.77 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.64 -1.288 . . . . 14.16 108.311 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -45.92 -55.46 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 107.643 -1.243 . . . . 15.31 107.643 177.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -56.45 -61.73 2.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.946 -1.131 . . . . 29.640000000000001 107.946 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.36 -59.59 2.6 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.161 -0.962 . . . . 13.960000000000001 109.708 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 67' ' ' ILE . 11.0 mt -51.77 -53.92 34.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.381 -1.449 . . . . 17.789999999999999 108.072 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -51.1 -48.26 61.74 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.5 -0.75 . . . . 16.84 109.018 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.7 mt -53.34 -29.3 33.28 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.094 -1.004 . . . . 22.760000000000002 108.439 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -92.66 -64.72 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.412 -0.805 . . . . 17.440000000000001 109.586 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.1 m -64.8 -80.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 18.539999999999999 109.684 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.409 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 76.71 -129.01 9.53 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.715 -1.354 . . . . 23.170000000000002 109.715 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -49.99 -18.9 0.6 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.364 -1.08 . . . . 39.770000000000003 109.256 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.0 OUTLIER -57.14 -54.01 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 26.649999999999999 109.097 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.12 62.75 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.893 -1.146 . . . . 20.260000000000002 111.502 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.9 p90 -76.7 121.87 23.89 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.1 -1.235 . . . . 17.789999999999999 109.638 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.29 105.05 17.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.139 -0.976 . . . . 18.550000000000001 108.909 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -75.47 125.22 28.56 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.158 -0.964 . . . . 21.489999999999998 109.24 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.3 p -100.86 160.72 14.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.534 -0.729 . . . . 31.5 109.45 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.7 tttp 70.75 67.02 0.4 Allowed Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.993 -0.442 . . . . 0.0 110.514 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.41 129.17 27.2 Favored 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.168 1.245 . . . . 0.0 108.867 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -145.93 142.28 28.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.989 -1.069 . . . . 0.0 110.005 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -151.7 -32.59 0.15 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.4 OUTLIER -152.75 47.94 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.365 -0.834 . . . . 0.0 108.877 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.09 11.39 0.21 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.715 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . -63.63 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 109.506 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 49.2 -172.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.295 -0.878 . . . . 0.0 109.648 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.4 p30 -70.82 129.83 40.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.606 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.1 97.51 8.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.32 -0.863 . . . . 0.0 109.355 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -93.39 -24.24 18.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.243 -0.91 . . . . 0.0 109.7 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -81.79 -38.24 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 109.785 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 29.08 4.23 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.98 75.24 1.49 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.487 -1.007 . . . . 0.0 108.519 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -151.75 151.49 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.295 -0.878 . . . . 0.0 109.02 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -48.69 -76.02 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 109.442 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.722 HD22 ' C ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -159.17 -5.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.217 -0.927 . . . . 0.0 109.648 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' N ' HD22 ' A' ' 44' ' ' LEU . . . -46.24 -41.35 11.47 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.71 20.34 74.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.29 68.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.8 -169.16 0.1 OUTLIER 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 121.439 1.426 . . . . 0.0 109.708 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.68 43.31 2.76 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.39 -23.05 50.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.452 -1.028 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 152.01 -15.23 0.78 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.5 m 62.9 -71.52 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -1.013 . . . . 0.0 109.684 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLY . 17.7 mt 57.41 -143.33 0.69 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.256 -0.903 . . . . 0.0 109.321 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -76.87 154.73 83.13 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.139 -0.975 . . . . 0.0 108.702 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.41 134.25 57.37 Favored 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 121.029 1.153 . . . . 0.0 109.861 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 45.2 mt -50.67 -41.31 55.5 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.576 -0.703 . . . . 0.0 109.511 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.59 -57.76 10.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.216 -0.928 . . . . 0.0 109.612 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.485 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.6 mm? -58.16 -45.48 87.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.202 -0.936 . . . . 0.0 109.192 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -50.38 -20.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.283 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -78.51 -55.46 3.93 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.2 t -49.46 -36.17 21.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -1.216 . . . . 0.0 109.427 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.5 -34.18 76.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.312 -0.868 . . . . 0.0 109.162 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -83.87 -52.25 6.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.256 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 2.9 mptp? -73.4 -172.72 1.22 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.337 -0.852 . . . . 0.0 108.97 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -153.04 -44.24 0.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.778 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.36 -97.08 0.11 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.846 -1.645 . . . . 19.620000000000001 111.383 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.603 HD11 HD11 ' A' ' 11' ' ' LEU . 4.4 tt -43.39 -51.68 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.43 -1.041 . . . . 17.420000000000002 111.928 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.602 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -54.66 -17.36 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.524 -1.36 . . . . 18.82 110.012 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -100.74 9.97 41.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.303 -0.873 . . . . 38.5 109.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -137.65 -16.02 1.36 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.108 -0.995 . . . . 36.829999999999998 110.242 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.7 m -112.16 -30.87 7.06 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.362 -0.836 . . . . 18.16 109.256 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -83.6 -42.51 16.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.972 -1.08 . . . . 18.460000000000001 108.667 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.2 t -80.9 -22.4 39.79 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.3 m -139.98 -136.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.496 -0.927 . . . . 30.34 108.496 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.5 mt -145.7 149.99 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 27.510000000000002 109.301 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.9 m -133.08 175.93 8.94 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 23.34 109.583 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.8 m -112.24 -178.32 3.38 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.574 -0.704 . . . . 22.640000000000001 109.765 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.7 tp -55.16 -57.63 10.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.575 -0.703 . . . . 23.280000000000001 109.267 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -44.15 -51.64 7.92 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.423 -0.798 . . . . 37.859999999999999 110.001 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 -54.93 -51.84 64.83 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.787 -1.196 . . . . 31.390000000000001 108.733 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.445 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -56.92 -39.5 74.58 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 24.48 108.855 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.76 -18.62 64.25 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.468 -0.77 . . . . 31.48 109.863 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -73.67 -30.04 62.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.826 . . . . 22.48 111.746 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -99.01 12.01 37.29 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.205 -0.934 . . . . 19.59 111.782 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.2 m -76.7 -175.4 3.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.674 -1.266 . . . . 20.620000000000001 109.194 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 118.019 -0.991 . . . . 24.649999999999999 109.359 179.77 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 20.4 t80 . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 109.27 -0.641 . . . . 24.77 109.27 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' N ' ' A' ' 3' ' ' ASN . 1.9 p -163.99 161.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.949 -1.094 . . . . 30.100000000000001 109.572 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.84 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.78 107.14 7.72 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.35 -0.981 . . . . 32.240000000000002 108.35 179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -156.58 161.21 39.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 30.210000000000001 109.261 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -76.59 100.77 5.44 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 105.251 -2.129 . . . . 24.0 105.251 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.9 mt -99.11 132.8 44.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.784 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 -157.01 0.69 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.21 -0.931 . . . . 17.190000000000001 111.831 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -37.02 -55.24 1.46 Allowed Glycine 0 N--CA 1.49 2.288 0 CA-C-N 115.869 -0.605 . . . . 16.550000000000001 113.189 -176.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 65.0 m -79.55 -58.41 3.21 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.483 -1.598 . . . . 19.550000000000001 111.42 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -55.37 34.34 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 110.39 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 31.2 tp -50.4 -50.51 51.48 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.74 -1.225 . . . . 14.16 108.24 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 11' ' ' LEU . 2.4 t -46.25 -55.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.516 -1.29 . . . . 15.31 107.516 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -57.11 -61.76 2.23 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.878 -1.129 . . . . 29.640000000000001 108.421 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.39 -59.43 2.69 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 13.960000000000001 109.839 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.7 mt -51.36 -52.19 47.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.478 -1.389 . . . . 17.789999999999999 107.881 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -53.44 -45.89 69.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.389 -0.819 . . . . 16.84 109.141 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.44 -26.94 33.83 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.858 -1.151 . . . . 22.760000000000002 108.307 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.46 -64.87 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.448 -0.783 . . . . 17.440000000000001 109.401 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.455 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.7 m -62.18 -81.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.318 -0.864 . . . . 18.539999999999999 109.842 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.08 -125.02 24.11 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.596 -1.288 . . . . 23.170000000000002 110.046 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -45.79 -22.11 0.16 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -1.074 . . . . 39.770000000000003 109.429 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 20' ' ' GLY . 13.8 mmt180 -61.81 -54.65 39.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.346 -0.846 . . . . 26.649999999999999 110.0 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.75 62.49 0.5 Allowed Glycine 0 N--CA 1.51 3.62 0 C-N-CA 119.915 -1.136 . . . . 20.260000000000002 112.075 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.444 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 15.1 p90 -77.06 130.02 36.84 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.926 -1.338 . . . . 17.789999999999999 109.869 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 2.9 p90 -96.82 104.45 16.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 18.550000000000001 109.162 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -78.51 168.62 19.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 21.489999999999998 109.578 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.4 p -145.12 159.63 42.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 31.5 109.267 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt 59.39 67.18 1.96 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.657 -0.652 . . . . 0.0 109.544 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -59.86 -18.72 50.96 Favored 'Trans proline' 0 C--N 1.319 -1.01 0 C-N-CA 121.521 1.481 . . . . 0.0 109.881 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.1 m -87.53 138.62 31.32 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.447 0.641 . . . . 0.0 109.983 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' C ' ' CD ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER -95.48 -72.29 0.63 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.345 -0.847 . . . . 0.0 108.781 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -110.49 143.75 40.36 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.41 44.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.181 -0.95 . . . . 0.0 109.497 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -166.23 63.51 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.17 -0.956 . . . . 0.0 109.715 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -67.89 -114.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.672 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -80.11 22.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 109.444 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.8 tp -82.7 -35.22 26.94 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.276 -0.89 . . . . 0.0 108.838 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -71.72 131.97 43.88 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.095 -1.003 . . . . 0.0 109.265 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.3 t -47.78 115.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 109.529 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.16 -27.14 0.02 OUTLIER Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.32 60.83 5.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -1.082 . . . . 0.0 109.137 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -152.08 -42.94 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.232 -0.918 . . . . 0.0 108.719 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.97 -161.33 0.22 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.59 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.2 mp -94.63 -15.97 23.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.099 -1.001 . . . . 0.0 109.354 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -167.05 42.55 0.25 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.71 -141.03 1.17 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 160.87 68.61 0.02 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.73 -76.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 121.488 1.458 . . . . 0.0 110.234 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -68.99 -19.14 73.44 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 57.15 2.47 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -1.124 . . . . 0.0 109.764 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 49' ' ' GLY . . . -83.97 -155.45 21.32 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 53' ' ' LEU . 11.0 t 51.31 30.89 6.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.152 -1.204 . . . . 0.0 109.214 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 52' ' ' SER . 12.3 mt -36.54 -43.46 0.4 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.132 0.492 . . . . 0.0 110.756 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.72 152.07 37.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.222 -0.924 . . . . 0.0 108.829 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.446 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 9.5 Cg_endo -71.75 157.45 55.37 Favored 'Trans proline' 0 C--O 1.206 -1.09 0 N-CA-C 108.228 -1.489 . . . . 0.0 108.228 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.8 mt -107.98 -16.99 14.16 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.595 -0.691 . . . . 0.0 110.497 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -84.61 -37.34 21.22 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.183 -0.948 . . . . 0.0 112.14 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -24.04 13.64 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.89 -1.131 . . . . 0.0 111.432 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 60' ' ' GLY . 0.5 OUTLIER -51.67 -25.52 7.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.237 -1.539 . . . . 0.0 108.883 -179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.503 ' N ' ' OE2' ' A' ' 59' ' ' GLU . . . -87.55 -39.51 7.17 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.692 -1.763 . . . . 0.0 108.692 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.6 m -51.17 -10.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.413 -1.051 . . . . 0.0 109.374 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 60' ' ' GLY . 23.1 mt -82.62 -44.11 16.17 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -0.883 . . . . 0.0 109.048 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.403 ' O ' ' O ' ' A' ' 64' ' ' LYS . 14.6 mm100 -76.6 10.62 2.04 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.281 -0.887 . . . . 0.0 109.277 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -48.66 173.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.147 -0.97 . . . . 0.0 109.717 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -88.61 -41.84 12.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.17 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 84' ' ' TYR . . . 141.76 13.97 0.43 Allowed Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.219 -1.152 . . . . 19.620000000000001 110.219 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt -136.78 -45.73 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.206 -1.173 . . . . 17.420000000000002 109.658 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.555 ' N ' HG23 ' A' ' 67' ' ' ILE . 18.1 t -57.16 -7.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.893 -1.129 . . . . 18.82 109.19 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 67' ' ' ILE . 22.1 tt0 -109.83 9.5 24.64 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.49 -0.756 . . . . 38.5 109.313 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -137.56 -15.67 1.39 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.227 -0.921 . . . . 36.829999999999998 109.691 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.86 -29.94 7.21 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.529 -0.732 . . . . 18.16 109.12 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 52.5 t -84.85 -44.51 13.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.969 -1.082 . . . . 18.460000000000001 108.701 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -81.34 -17.91 47.51 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.445 -0.784 . . . . 0.0 109.093 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.7 m -144.07 -137.51 0.1 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.296 -1.001 . . . . 30.34 108.296 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mt -145.45 150.22 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.073 -1.017 . . . . 27.510000000000002 109.333 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 2.7 m -133.18 175.88 9.0 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.484 -0.76 . . . . 23.34 109.55 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -111.62 -174.89 2.57 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.576 -0.703 . . . . 22.640000000000001 109.566 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.6 tp -57.75 -57.56 12.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.412 -0.805 . . . . 23.280000000000001 109.608 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -44.5 -55.23 5.27 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.39 -0.819 . . . . 37.859999999999999 110.038 -179.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -50.55 -49.85 54.97 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.816 -1.177 . . . . 31.390000000000001 108.898 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.407 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -59.53 -40.97 88.89 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.921 -0.77 . . . . 24.48 108.921 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -61.88 -19.04 62.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.448 -0.783 . . . . 31.48 109.651 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -73.14 -30.18 63.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.598 -0.688 . . . . 22.48 111.889 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.408 ' CE1' ' O ' ' A' ' 66' ' ' GLY . 22.7 m-85 -100.07 11.8 38.45 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.157 -0.965 . . . . 19.59 111.939 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 68.0 m -76.82 -175.72 3.58 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.601 -1.312 . . . . 20.620000000000001 108.833 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.038 -0.982 . . . . 24.649999999999999 109.287 179.541 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.496 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.4 t80 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.267 -0.642 . . . . 24.77 109.267 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -167.28 161.42 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.07 -1.019 . . . . 30.100000000000001 109.644 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.73 107.85 8.64 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.485 -0.932 . . . . 32.240000000000002 108.485 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -156.86 164.23 38.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 30.210000000000001 109.64 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 19.6 m-70 -76.52 100.6 5.33 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 105.168 -2.16 . . . . 24.0 105.168 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -99.08 135.96 39.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.453 -0.78 . . . . 19.629999999999999 111.59 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.1 m -124.14 -157.3 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 122.006 0.908 . . . . 17.190000000000001 112.693 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.79 -53.8 1.45 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 115.977 -0.556 . . . . 16.550000000000001 112.884 -176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -81.84 -58.47 2.97 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.315 -1.697 . . . . 19.550000000000001 111.096 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.3 OUTLIER -60.47 -55.76 29.63 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.925 -1.11 . . . . 0.0 110.464 -178.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 67' ' ' ILE . 25.7 tp -51.15 -50.04 59.68 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.776 -1.203 . . . . 14.16 108.211 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -46.88 -55.34 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.525 -1.287 . . . . 15.31 107.525 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.403 ' O ' ' C ' ' A' ' 14' ' ' ALA . 20.6 tt0 -57.12 -61.8 2.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.018 -1.105 . . . . 29.640000000000001 108.018 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.18 -59.67 2.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.032 -1.042 . . . . 13.960000000000001 109.537 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 11.1 mt -51.57 -55.14 20.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.546 -1.346 . . . . 17.789999999999999 108.009 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -49.42 -50.48 40.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 16.84 108.952 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -52.22 -29.78 24.31 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.107 -0.996 . . . . 22.760000000000002 108.514 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -92.02 -64.45 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.296 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.447 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.7 m -65.66 -83.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.265 -0.897 . . . . 18.539999999999999 109.946 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 67.3 -112.57 4.91 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.614 -1.279 . . . . 23.170000000000002 110.275 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -52.93 -20.5 3.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.402 -1.058 . . . . 39.770000000000003 110.116 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.9 mtt-85 -69.03 -52.59 27.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 26.649999999999999 109.974 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.19 63.17 0.49 Allowed Glycine 0 N--CA 1.507 3.393 0 C-N-CA 119.729 -1.224 . . . . 20.260000000000002 111.689 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.403 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 15.0 p90 -76.13 137.41 40.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.047 -1.266 . . . . 17.789999999999999 109.221 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -106.42 106.49 17.04 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.398 -0.814 . . . . 18.550000000000001 109.892 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.404 ' CE2' HD23 ' A' ' 11' ' ' LEU . 3.6 t80 -81.81 120.12 24.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 21.489999999999998 109.135 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.2 p -153.31 117.01 4.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.152 -0.968 . . . . 31.5 109.266 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -171.8 108.92 0.38 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.101 -1.0 . . . . 0.0 109.699 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -57.39 -14.1 15.08 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 N-CA-C 109.406 -1.036 . . . . 0.0 109.406 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.71 134.25 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.536 0.684 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -61.35 -165.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.064 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -59.03 132.09 53.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.354 -0.842 . . . . 0.0 109.927 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 76.4 mt-10 -156.13 135.2 12.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.267 -0.896 . . . . 0.0 109.254 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . 72.31 -31.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.525 -0.734 . . . . 0.0 109.785 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.478 ' H ' ' C ' ' A' ' 33' ' ' GLU . 33.5 tt0 -56.38 -104.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.38 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 37' ' ' LEU . 9.5 t70 -80.96 162.56 23.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.942 -1.099 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 36' ' ' ASP . 4.1 mp -139.82 -130.17 0.11 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.427 -0.796 . . . . 0.0 109.248 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.553 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 4.0 mp0 -62.07 -167.32 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.214 -0.928 . . . . 0.0 109.299 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 40' ' ' GLY . 6.7 p -69.46 156.03 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.274 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 39' ' ' VAL . . . -162.37 90.18 0.11 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? 48.27 80.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.294 -1.121 . . . . 0.0 109.65 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 43' ' ' GLU . 2.8 p -167.43 -46.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' C ' HD12 ' A' ' 44' ' ' LEU . 29.8 tt0 -172.06 161.5 5.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.347 -0.846 . . . . 0.0 109.035 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.755 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.9 mp -96.24 5.44 51.0 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.332 -0.855 . . . . 0.0 109.577 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -157.55 70.06 0.26 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.85 -118.5 5.51 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' N ' ' OE1' ' A' ' 43' ' ' GLU . . . -157.44 177.53 34.21 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 49' ' ' GLY . 2.3 Cg_endo -59.9 126.98 21.85 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.637 1.558 . . . . 0.0 110.108 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 48' ' ' PRO . . . 59.65 152.9 0.01 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.47 23.6 2.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -1.126 . . . . 0.0 109.435 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 91.11 20.11 40.19 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.9 m 52.26 -86.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -65.69 -171.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.142 -0.974 . . . . 0.0 109.136 -179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -62.32 148.75 89.08 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.156 -0.965 . . . . 0.0 108.93 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.24 134.07 46.88 Favored 'Trans proline' 0 C--N 1.323 -0.77 0 C-N-CA 120.934 1.089 . . . . 0.0 109.659 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.9 mt -57.41 -30.23 64.79 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.387 -0.821 . . . . 0.0 109.706 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.39 -55.15 26.73 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.309 -0.87 . . . . 0.0 109.815 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.536 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.5 mm? -63.17 -38.06 89.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.166 -0.959 . . . . 0.0 109.1 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -49.91 -31.72 12.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.51 -37.4 8.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.9 p -62.82 -16.72 59.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -1.163 . . . . 0.0 109.65 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -87.99 -52.67 5.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.254 -0.904 . . . . 0.0 109.422 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -85.58 18.76 2.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.24 -0.912 . . . . 0.0 109.582 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -45.76 140.06 3.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 0.0 110.07 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' H ' ' H ' ' A' ' 66' ' ' GLY . 18.9 ttp180 -171.06 -9.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.427 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.403 ' H ' ' H ' ' A' ' 65' ' ' ARG . . . -85.79 134.01 12.24 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.631 -1.388 . . . . 19.620000000000001 109.631 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 11' ' ' LEU . 4.0 tt -56.61 -46.92 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 17.420000000000002 109.755 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' N ' HG23 ' A' ' 67' ' ' ILE . 13.8 t -53.67 -31.71 20.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.999 -1.063 . . . . 18.82 109.247 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.25 9.99 6.16 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.956 -1.09 . . . . 38.5 110.119 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -141.16 -11.45 0.96 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.032 -1.043 . . . . 36.829999999999998 110.729 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 59.5 m -117.89 -26.45 6.46 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.408 -0.807 . . . . 18.16 109.357 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 46.3 t -88.83 -43.28 11.34 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.144 -1.058 . . . . 18.460000000000001 108.144 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.5 t -82.05 -28.04 32.66 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.6 t -131.75 -140.08 0.21 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.52 -0.918 . . . . 30.34 108.52 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.0 mt -142.82 151.55 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.156 -0.965 . . . . 27.510000000000002 109.258 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -136.49 174.55 10.49 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.387 -0.821 . . . . 23.34 109.683 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 16.1 m -112.23 -178.46 3.42 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.546 -0.721 . . . . 22.640000000000001 109.736 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.4 tp -53.0 -61.51 2.25 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 23.280000000000001 109.573 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.4 ' C ' ' O ' ' A' ' 78' ' ' LEU . 1.7 m-85 -41.31 -55.83 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.449 -0.782 . . . . 37.859999999999999 110.356 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -49.46 -51.09 38.12 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.84 -1.162 . . . . 31.390000000000001 108.819 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.466 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.4 mp -58.23 -41.3 83.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.451 -0.781 . . . . 24.48 109.071 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -61.75 -18.76 61.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.408 -0.808 . . . . 31.48 110.075 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -74.31 -29.27 61.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.435 -0.791 . . . . 22.48 111.811 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.402 ' CD2' HD12 ' A' ' 67' ' ' ILE . 23.8 m-85 -99.51 12.06 37.45 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.074 -1.016 . . . . 19.59 111.898 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 70.2 m -76.51 -175.74 3.43 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.745 -1.222 . . . . 20.620000000000001 108.931 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 118.046 -0.978 . . . . 24.649999999999999 109.399 179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.494 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 15.1 t80 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.287 -0.634 . . . . 24.77 109.287 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p -165.93 159.26 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.202 -0.936 . . . . 30.100000000000001 109.361 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.833 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -130.0 106.85 8.92 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.389 -0.967 . . . . 32.240000000000002 108.389 179.118 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' O ' ' A' ' 3' ' ' ASN . 83.0 mm-40 -156.5 164.53 38.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.298 -0.876 . . . . 30.210000000000001 109.62 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -77.93 101.05 6.66 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.357 -2.09 . . . . 24.0 105.357 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -98.82 136.18 39.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.427 -0.796 . . . . 19.629999999999999 111.776 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.19 -160.38 0.83 Allowed 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.189 -0.945 . . . . 17.190000000000001 111.691 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.15 -54.18 1.57 Allowed Glycine 0 N--CA 1.489 2.184 0 CA-C-N 115.685 -0.689 . . . . 16.550000000000001 112.667 -176.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 57.8 m -77.8 -61.91 1.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.543 -1.563 . . . . 19.550000000000001 110.924 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.94 -55.75 30.93 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.057 -1.027 . . . . 0.0 110.427 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.512 HD11 HD11 ' A' ' 67' ' ' ILE . 28.2 tp -51.85 -47.7 64.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.723 -1.236 . . . . 14.16 108.499 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.17 -56.58 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 107.336 -1.357 . . . . 15.31 107.336 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -55.86 -61.23 2.51 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.971 -1.092 . . . . 29.640000000000001 108.246 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.28 -59.54 2.6 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 13.960000000000001 110.097 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 67' ' ' ILE . 10.1 mt -51.75 -51.55 55.32 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.715 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -54.14 -44.4 71.35 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.122 -0.696 . . . . 16.84 109.122 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.3 mt -56.74 -24.36 49.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.946 -1.096 . . . . 22.760000000000002 108.285 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -97.51 -64.55 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.35 -0.844 . . . . 17.440000000000001 109.557 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.476 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.4 m -64.39 -78.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.176 -0.952 . . . . 18.539999999999999 109.649 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.45 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.68 -132.23 11.77 Favored Glycine 0 N--CA 1.485 1.962 0 N-CA-C 109.72 -1.352 . . . . 23.170000000000002 109.72 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -49.69 -14.73 0.13 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.336 -1.097 . . . . 39.770000000000003 109.518 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.45 ' N ' ' C ' ' A' ' 20' ' ' GLY . 1.0 OUTLIER -59.78 -53.61 55.93 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.202 -0.936 . . . . 26.649999999999999 109.161 -179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.4 63.9 0.49 Allowed Glycine 0 N--CA 1.506 3.357 0 C-N-CA 119.951 -1.119 . . . . 20.260000000000002 111.245 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.513 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.7 p90 -75.61 124.68 27.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.069 -1.254 . . . . 17.789999999999999 110.063 -178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 33.9 p90 -92.79 109.84 21.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 18.550000000000001 108.971 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -70.61 165.75 22.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.223 -0.923 . . . . 21.489999999999998 109.231 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.6 p -146.17 144.37 29.9 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.127 -0.983 . . . . 31.5 109.771 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 30' ' ' THR . 14.4 ptmt -175.04 70.36 0.28 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.451 -0.781 . . . . 0.0 109.332 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -49.42 -14.21 0.56 Allowed 'Trans proline' 0 C--N 1.315 -1.193 0 N-CA-C 109.211 -1.111 . . . . 0.0 109.211 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.489 ' N ' ' C ' ' A' ' 28' ' ' LYS . 2.3 p -92.06 104.59 16.97 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -100.68 124.72 46.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.431 -0.793 . . . . 0.0 109.597 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? 48.92 64.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.529 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -80.27 66.57 5.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -174.27 155.6 2.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 49.06 13.1 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.186 -0.946 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 34' ' ' ALA . 14.4 m-20 -143.28 52.05 1.36 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.389 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.7 mt -80.74 -149.16 0.06 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.922 . . . . 0.0 109.316 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -148.71 11.7 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.24 -0.912 . . . . 0.0 109.405 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 40' ' ' GLY . 11.4 p -76.07 -15.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.186 -0.946 . . . . 0.0 109.481 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . 49.86 -178.46 0.03 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -75.68 129.87 37.82 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.63 -0.924 . . . . 0.0 108.909 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 m -146.25 -165.54 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.253 -0.904 . . . . 0.0 109.405 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -85.01 78.09 9.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.251 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 44' ' ' LEU . 9.0 mp 49.04 -106.94 0.21 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.24 27.08 16.72 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.74 -49.12 67.56 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.15 67.99 1.78 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.15 -66.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.319 -0.99 0 C-N-CA 121.457 1.438 . . . . 0.0 109.76 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.79 135.23 46.54 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 51' ' ' GLY . . . -80.22 36.03 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.259 -1.142 . . . . 0.0 109.575 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 50' ' ' ALA . . . -52.57 -98.54 0.01 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 53' ' ' LEU . 8.4 t 55.28 22.6 4.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -1.155 . . . . 0.0 109.502 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 52' ' ' SER . 22.5 mt -58.79 -153.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.522 -0.736 . . . . 0.0 109.64 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.653 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -62.36 131.97 93.98 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.021 -1.049 . . . . 0.0 109.006 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.56 134.17 43.16 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.873 1.048 . . . . 0.0 109.763 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -54.42 -36.69 64.27 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.461 -0.774 . . . . 0.0 109.56 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.95 -56.01 27.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.197 -0.939 . . . . 0.0 109.934 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.5 mm? -63.14 -40.21 96.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.272 -0.892 . . . . 0.0 109.449 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -47.77 -21.57 0.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.643 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -83.63 -44.77 6.71 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.54 ' O ' ' NZ ' ' A' ' 64' ' ' LYS . 48.1 p -71.21 -13.94 62.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -1.177 . . . . 0.0 109.696 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.4 mt -85.63 -32.14 22.19 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.162 -0.961 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' O ' ' C ' ' A' ' 64' ' ' LYS . 66.0 mm-40 -92.22 -34.09 14.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.272 -0.892 . . . . 0.0 109.858 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 61' ' ' SER . 0.0 OUTLIER 26.81 57.9 0.07 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.243 0.544 . . . . 0.0 111.529 -179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' HG3' ' NH1' ' A' ' 65' ' ' ARG . 29.6 ttm-85 -142.91 77.99 1.59 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.12 -0.987 . . . . 0.0 109.611 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 172.86 120.98 0.58 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.597 -1.401 . . . . 19.620000000000001 109.597 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.512 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt -52.67 -41.23 37.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.446 -1.032 . . . . 17.420000000000002 109.44 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.507 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.6 t -55.4 -22.05 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.127 -0.983 . . . . 18.82 109.467 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -95.49 10.45 36.48 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.233 -0.917 . . . . 38.5 109.703 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -137.38 -15.12 1.46 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.132 -0.98 . . . . 36.829999999999998 110.557 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 65.1 m -114.46 -27.86 7.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.305 -0.872 . . . . 18.16 109.425 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.29 -41.04 13.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.923 -1.111 . . . . 18.460000000000001 108.519 178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.7 t -83.63 -16.33 45.58 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.506 -0.746 . . . . 0.0 109.163 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.4 m -143.2 -139.87 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.9 mt -145.11 137.52 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 27.510000000000002 109.257 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 4.6 m -119.47 176.97 5.1 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.676 -0.64 . . . . 23.34 110.261 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 p -112.9 175.74 5.31 Favored 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.506 0.67 . . . . 22.640000000000001 109.459 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.494 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 6.0 tp -51.8 -61.15 2.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.475 -0.766 . . . . 23.280000000000001 109.469 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -43.52 -54.7 4.69 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.795 . . . . 37.859999999999999 110.328 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -49.75 -44.8 48.83 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.757 -1.214 . . . . 31.390000000000001 109.002 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.25 -36.92 85.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.344 -0.848 . . . . 24.48 108.864 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -64.08 -18.93 64.87 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.417 -0.802 . . . . 31.48 109.78 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.31 -29.48 61.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 22.48 111.571 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -97.03 11.89 34.53 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.14 -0.975 . . . . 19.59 111.585 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 83.4 m -77.0 -175.52 3.58 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.761 -1.212 . . . . 20.620000000000001 109.315 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 117.956 -1.021 . . . . 24.649999999999999 109.233 179.671 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.462 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.3 t80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.223 -0.658 . . . . 24.77 109.223 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.466 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.0 p -165.8 161.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.136 -0.978 . . . . 30.100000000000001 109.375 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.82 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.57 107.4 8.83 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.416 -0.957 . . . . 32.240000000000002 108.416 179.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -157.11 164.46 37.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.375 -0.828 . . . . 30.210000000000001 109.846 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.543 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 6.0 m-70 -76.76 100.85 5.59 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.217 -2.142 . . . . 24.0 105.217 176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.8 mt -97.47 136.04 38.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.31 -0.869 . . . . 19.629999999999999 111.809 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.75 -161.34 0.86 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.023 0.916 . . . . 17.190000000000001 111.758 179.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.5 -53.08 1.81 Allowed Glycine 0 N--CA 1.49 2.248 0 CA-C-N 115.781 -0.645 . . . . 16.550000000000001 112.603 -177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 p -77.96 -60.91 2.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.486 -1.597 . . . . 19.550000000000001 110.898 -178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -55.53 33.55 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.334 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 67' ' ' ILE . 27.5 tp -51.4 -47.54 62.9 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.823 -1.173 . . . . 14.16 108.381 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.49 -56.59 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.192 -1.41 . . . . 15.31 107.192 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -55.18 -61.75 2.12 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.959 -1.096 . . . . 29.640000000000001 108.101 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 17' ' ' LEU . . . -44.93 -60.0 2.28 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.246 -0.909 . . . . 13.960000000000001 109.709 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 67' ' ' ILE . 10.9 mt -51.75 -51.59 55.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.441 -1.412 . . . . 17.789999999999999 108.164 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -55.91 -40.49 73.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.513 -0.742 . . . . 16.84 109.457 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 14' ' ' ALA . 63.8 mt -60.62 -24.61 65.65 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.083 -1.08 . . . . 22.760000000000002 108.083 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.3 t -97.3 -64.28 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.543 -0.723 . . . . 17.440000000000001 109.294 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.471 ' N ' HG12 ' A' ' 18' ' ' VAL . 11.6 m -64.24 -76.2 0.07 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 18.539999999999999 109.638 -179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 78.87 -138.29 20.59 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 109.675 -1.37 . . . . 23.170000000000002 109.675 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 8.2 tp10 -48.37 -17.03 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.323 -1.104 . . . . 39.770000000000003 109.167 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' GLY . 50.3 mtt180 -54.88 -52.84 61.58 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.124 -0.985 . . . . 26.649999999999999 109.255 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.52 65.14 0.48 Allowed Glycine 0 N--CA 1.508 3.478 0 C-N-CA 119.745 -1.217 . . . . 20.260000000000002 111.722 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.422 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 28.7 p90 -76.04 131.23 39.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -1.138 . . . . 17.789999999999999 110.218 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -92.75 112.47 24.44 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.66 -0.65 . . . . 18.550000000000001 109.586 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.493 ' OH ' HD23 ' A' ' 11' ' ' LEU . 2.9 t80 -98.25 156.52 16.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 21.489999999999998 108.561 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.6 p -152.43 120.49 6.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.078 -1.014 . . . . 31.5 109.447 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 30' ' ' THR . 14.3 pttm -152.72 64.65 5.47 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.244 -0.91 . . . . 0.0 109.81 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -51.55 87.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.435 0 N-CA-C 109.396 -1.04 . . . . 0.0 109.396 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.533 ' N ' ' O ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -156.75 -7.19 0.1 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 56.49 6.07 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.155 -0.966 . . . . 0.0 108.818 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' THR . 16.1 ttm-85 -170.67 -111.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.422 -0.799 . . . . 0.0 108.868 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -157.04 8.97 0.19 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.994 -1.066 . . . . 0.0 109.667 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -160.26 120.95 2.98 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 109.75 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -91.21 -89.9 0.17 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.333 -0.854 . . . . 0.0 109.518 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -145.39 40.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.328 -0.857 . . . . 0.0 109.233 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -85.99 -11.95 51.64 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.503 -0.748 . . . . 0.0 109.35 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -66.69 -173.97 0.27 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.217 -0.927 . . . . 0.0 109.533 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 41' ' ' GLN . 8.0 m -95.46 35.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.31 -0.869 . . . . 0.0 109.572 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.562 ' O ' ' N ' ' A' ' 42' ' ' VAL . . . -71.6 62.79 1.16 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 52.13 -82.85 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.895 . . . . 0.0 109.65 -179.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 40' ' ' GLY . 1.8 p 33.41 88.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 CA-C-O 121.492 0.663 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 44' ' ' LEU . 34.6 tt0 41.29 81.84 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.459 -0.775 . . . . 0.0 109.887 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.798 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -39.26 -31.59 0.08 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.27 0.557 . . . . 0.0 110.074 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.55 91.01 1.37 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.42 -173.76 50.97 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.9 -174.96 50.07 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.37 -25.37 56.49 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 121.677 1.585 . . . . 0.0 109.803 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -47.44 132.24 15.22 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.445 ' H ' ' H ' ' A' ' 51' ' ' GLY . . . -168.17 -0.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -1.069 . . . . 0.0 109.088 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' H ' ' H ' ' A' ' 50' ' ' ALA . . . -87.98 -175.79 47.93 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.1 t -74.2 -32.46 63.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -1.14 . . . . 0.0 109.316 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.0 mt -49.53 152.87 1.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.328 -0.857 . . . . 0.0 109.226 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -57.51 148.36 55.65 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 108.645 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -63.37 124.68 14.22 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 120.875 1.05 . . . . 0.0 109.91 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -53.32 -28.67 29.73 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.0 109.188 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.51 -63.75 1.17 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.303 -0.873 . . . . 0.0 109.373 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -53.23 -43.2 67.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.193 -0.942 . . . . 0.0 108.847 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -49.25 -17.95 0.3 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.373 -0.829 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 64' ' ' LYS . . . -87.27 -65.1 1.38 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.5 p -55.76 -13.69 1.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -1.15 . . . . 0.0 109.499 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -73.96 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.426 ' O ' ' O ' ' A' ' 64' ' ' LYS . 6.6 pt20 -93.44 -10.26 35.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 108.692 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 60' ' ' GLY . 22.9 mttt 52.55 174.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.471 -0.768 . . . . 0.0 109.778 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' CG ' HH11 ' A' ' 65' ' ' ARG . 3.0 mtt-85 -81.46 -27.35 34.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 0.0 109.398 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.3 -137.87 14.52 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 109.703 -1.359 . . . . 19.620000000000001 109.703 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.51 HD11 HD11 ' A' ' 11' ' ' LEU . 2.6 tt -45.54 -42.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.282 -1.128 . . . . 17.420000000000002 109.875 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.5 t -50.21 -41.53 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.973 -1.079 . . . . 18.82 109.781 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -78.54 10.9 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 38.5 109.94 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -134.03 -13.82 2.43 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.058 -1.026 . . . . 36.829999999999998 110.837 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 69.2 m -119.28 -25.53 6.09 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.257 -0.902 . . . . 18.16 109.043 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.12 -37.36 17.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.961 -1.087 . . . . 18.460000000000001 108.483 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.2 t -89.36 -9.87 48.77 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.0 m -146.77 -144.17 0.15 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.507 -0.923 . . . . 30.34 108.507 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.2 mt -145.89 122.32 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.061 -1.024 . . . . 27.510000000000002 109.365 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.486 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.9 m -106.24 175.5 5.48 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.625 -0.672 . . . . 23.34 109.541 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 m -112.4 176.49 5.0 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.551 0.691 . . . . 22.640000000000001 109.826 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -48.78 -60.08 3.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.651 179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -43.5 -56.03 3.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.332 -0.855 . . . . 37.859999999999999 110.226 -179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.0 mp0 -49.93 -46.47 52.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.727 -1.233 . . . . 31.390000000000001 108.918 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.444 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.99 -38.64 89.37 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.686 -0.857 . . . . 24.48 108.686 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -64.2 -18.92 64.97 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.479 -0.763 . . . . 31.48 109.728 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.12 -29.74 63.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.46 -0.775 . . . . 22.48 111.63 -178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -98.0 12.17 35.12 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.178 -0.951 . . . . 19.59 111.804 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.8 m -76.59 -175.64 3.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.608 -1.307 . . . . 20.620000000000001 109.341 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 C--N 1.302 -1.463 0 CA-C-O 117.955 -1.021 . . . . 24.649999999999999 109.343 179.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.517 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.139 -0.689 . . . . 24.77 109.139 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.6 p -168.66 150.03 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.079 -1.013 . . . . 30.100000000000001 109.696 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.767 ' H ' ' ND2' ' A' ' 3' ' ' ASN . 0.1 OUTLIER -117.97 106.27 12.76 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 107.78 -1.192 . . . . 32.240000000000002 107.78 178.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.461 ' OE1' ' O ' ' A' ' 3' ' ' ASN . 15.3 mm100 -154.42 162.16 41.31 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.711 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -79.14 101.14 7.75 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 105.351 -2.092 . . . . 24.0 105.351 176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.2 mt -99.21 136.09 39.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.51 -0.744 . . . . 19.629999999999999 111.958 -175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.54 -162.48 0.92 Allowed 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.07 0.938 . . . . 17.190000000000001 111.484 179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.98 -51.68 1.55 Allowed Glycine 0 N--CA 1.488 2.115 0 CA-C-N 115.662 -0.699 . . . . 16.550000000000001 112.774 -176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 p -78.87 -62.01 1.83 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.458 -1.613 . . . . 19.550000000000001 110.792 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.49 -55.2 38.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 -178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.515 HD11 HD11 ' A' ' 67' ' ' ILE . 29.6 tp -51.29 -48.22 62.33 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.899 -1.125 . . . . 14.16 108.495 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -48.87 -55.92 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.204 -1.406 . . . . 15.31 107.204 177.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -56.06 -61.58 2.28 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.019 -1.104 . . . . 29.640000000000001 108.019 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.52 -59.54 2.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.01 -1.057 . . . . 13.960000000000001 109.679 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 67' ' ' ILE . 10.6 mt -51.53 -53.49 37.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.457 -1.402 . . . . 17.789999999999999 107.934 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -51.78 -49.92 61.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.508 -0.745 . . . . 16.84 109.108 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.86 -26.12 9.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.046 -1.034 . . . . 22.760000000000002 108.643 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.95 -64.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.352 -0.843 . . . . 17.440000000000001 109.44 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 9.9 m -64.32 -77.42 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 18.539999999999999 109.831 -179.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 78.52 -133.82 13.28 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 109.773 -1.331 . . . . 23.170000000000002 109.773 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -50.42 -14.74 0.19 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.399 -1.06 . . . . 39.770000000000003 109.621 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 20' ' ' GLY . 8.8 mtp180 -59.01 -53.02 63.13 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.084 -1.01 . . . . 26.649999999999999 109.086 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.08 64.36 0.48 Allowed Glycine 0 N--CA 1.506 3.322 0 C-N-CA 119.744 -1.217 . . . . 20.260000000000002 111.531 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 29.8 p90 -75.77 124.35 27.15 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.287 -1.125 . . . . 17.789999999999999 109.848 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -88.68 110.77 21.23 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.494 -0.753 . . . . 18.550000000000001 109.638 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.469 ' OH ' HD23 ' A' ' 11' ' ' LEU . 2.7 t80 -95.03 146.78 24.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.429 -0.795 . . . . 21.489999999999998 108.873 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.7 p -150.04 140.67 22.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.092 -1.005 . . . . 31.5 109.467 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.5 pttt -176.8 70.99 0.24 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.238 -0.913 . . . . 0.0 110.107 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 31' ' ' ARG . 12.9 Cg_exo -50.3 -24.69 12.17 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 N-CA-C 108.408 -1.42 . . . . 0.0 108.408 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 m 43.97 15.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.206 0.527 . . . . 0.0 110.253 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER 45.74 61.66 2.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.107 -0.996 . . . . 0.0 109.956 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.51 HH22 ' NH1' ' A' ' 31' ' ' ARG . 31.9 mtm-85 48.35 25.02 0.8 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.197 -0.94 . . . . 0.0 109.74 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 51.45 11.89 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.951 . . . . 0.0 109.903 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -82.53 -178.66 7.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.129 -0.982 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 50.96 9.39 0.05 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.668 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 34' ' ' ALA . 49.1 t0 -74.6 -74.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.574 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 37' ' ' LEU . 1.9 pt? -58.57 -157.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.352 -0.842 . . . . 0.0 109.791 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.483 ' CB ' ' O ' ' A' ' 37' ' ' LEU . 7.5 tt0 76.93 179.0 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.509 -0.745 . . . . 0.0 109.208 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t 60.9 112.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.374 -0.829 . . . . 0.0 109.297 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.93 -108.99 0.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.5 tp60 -77.6 99.64 5.83 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.725 -0.868 . . . . 0.0 109.035 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -147.34 -3.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 26.1 tt0 84.3 167.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.5 mp -79.9 -93.3 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.173 -0.955 . . . . 0.0 109.689 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.47 81.89 1.67 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.3 109.73 0.26 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.01 -175.15 37.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -64.11 156.1 61.04 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.686 1.59 . . . . 0.0 109.671 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.07 170.35 10.08 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.62 -22.44 43.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -1.144 . . . . 0.0 109.442 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 52' ' ' SER . . . 77.45 160.18 12.35 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 51' ' ' GLY . 7.9 m 55.57 103.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.25 -1.147 . . . . 0.0 109.763 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -162.51 154.46 18.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.201 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -102.66 125.74 34.92 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.198 -0.939 . . . . 0.0 108.742 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.09 138.49 67.65 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 120.845 1.03 . . . . 0.0 109.881 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.417 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 36.1 mt -54.43 -30.93 54.15 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.472 -0.767 . . . . 0.0 109.398 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.27 -60.5 2.92 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.311 -0.868 . . . . 0.0 109.961 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.6 mm? -60.39 -34.65 74.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 109.579 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 13.6 mm-40 -48.43 -22.97 0.81 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.91 . . . . 0.0 109.689 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -87.1 -75.97 1.27 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 60' ' ' GLY . 4.4 m -38.17 -23.15 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.874 -0.78 . . . . 0.0 110.988 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.6 OUTLIER -50.75 -51.67 48.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.019 -1.05 . . . . 0.0 109.062 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -88.3 -18.06 29.34 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.925 -1.11 . . . . 0.0 109.855 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' O ' ' N ' ' A' ' 66' ' ' GLY . 9.8 mmmt -100.33 109.13 21.32 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.143 -0.973 . . . . 0.0 109.117 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -64.11 68.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.476 -0.765 . . . . 0.0 110.01 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 64' ' ' LYS . . . -64.12 168.5 24.64 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.458 -1.457 . . . . 19.620000000000001 109.458 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 11' ' ' LEU . 3.3 tt -92.31 -41.79 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.186 -1.185 . . . . 17.420000000000002 109.004 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.478 ' N ' HG23 ' A' ' 67' ' ' ILE . 4.5 t -52.3 -32.24 15.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.107 -0.996 . . . . 18.82 109.493 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -83.66 11.01 7.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 38.5 110.021 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 19.0 mt-30 -139.34 -12.89 1.18 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.018 -1.051 . . . . 36.829999999999998 110.697 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.7 m -117.23 -30.58 5.57 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.407 -0.808 . . . . 18.16 109.099 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 45.5 t -85.34 -40.62 16.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 18.460000000000001 108.563 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -85.14 -12.52 52.63 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.477 -0.765 . . . . 0.0 109.213 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 t -145.72 -141.89 0.12 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.528 -0.916 . . . . 30.34 108.528 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mt -145.68 126.25 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.174 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.496 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.0 m -108.09 177.07 4.92 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.605 -0.685 . . . . 23.34 110.094 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.1 m -112.6 -178.99 3.53 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.49 0.662 . . . . 22.640000000000001 109.448 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.517 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -57.36 -56.05 26.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.454 -0.779 . . . . 23.280000000000001 109.446 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -47.27 -50.94 20.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.395 -0.815 . . . . 37.859999999999999 110.171 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -54.96 -45.79 74.95 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.696 -1.253 . . . . 31.390000000000001 108.749 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -61.55 -37.72 84.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 24.48 108.643 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -64.29 -18.8 64.94 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.456 -0.778 . . . . 31.48 109.766 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -74.14 -29.51 61.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.563 -0.711 . . . . 22.48 111.539 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -97.51 12.08 34.61 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.106 -0.997 . . . . 19.59 111.762 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 86.1 m -76.57 -175.77 3.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.597 -1.314 . . . . 20.620000000000001 109.207 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.441 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 17.8 t80 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.302 -0.629 . . . . 24.77 109.302 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -165.76 161.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.101 -0.999 . . . . 30.100000000000001 109.376 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.85 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.52 107.88 8.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 32.240000000000002 108.533 179.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -156.55 162.75 39.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.511 -0.743 . . . . 30.210000000000001 109.417 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.413 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 15.8 m-70 -76.46 100.72 5.33 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 105.25 -2.13 . . . . 24.0 105.25 176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.21 136.05 39.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.386 -0.822 . . . . 19.629999999999999 111.707 -176.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 m -124.06 -159.04 0.84 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 121.896 0.855 . . . . 17.190000000000001 112.168 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.49 -51.45 1.37 Allowed Glycine 0 N--CA 1.492 2.424 0 O-C-N 121.89 -0.506 . . . . 16.550000000000001 112.946 -176.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.5 m -81.82 -62.07 1.74 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.316 -1.696 . . . . 19.550000000000001 110.941 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -55.58 33.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.948 -1.095 . . . . 0.0 110.131 -178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 67' ' ' ILE . 26.7 tp -50.47 -51.36 47.74 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.782 -1.199 . . . . 14.16 108.369 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -46.66 -54.31 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.561 -1.274 . . . . 15.31 107.561 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.95 -61.85 2.24 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.098 -1.075 . . . . 29.640000000000001 108.098 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.434 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.51 -59.8 2.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.038 -1.039 . . . . 13.960000000000001 109.728 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 11.1 mt -51.17 -52.41 44.46 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.444 -1.41 . . . . 17.789999999999999 108.023 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -53.19 -45.8 68.71 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.1 -0.704 . . . . 16.84 109.1 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 71.7 mt -55.08 -33.91 63.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.897 -1.127 . . . . 22.760000000000002 108.387 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -87.32 -64.84 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.369 -0.832 . . . . 17.440000000000001 109.378 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -63.18 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.897 . . . . 18.539999999999999 109.229 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.411 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.03 -130.55 10.53 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.772 -1.331 . . . . 23.170000000000002 109.772 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -50.22 -19.4 0.78 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.259 -1.142 . . . . 39.770000000000003 109.059 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' N ' ' C ' ' A' ' 20' ' ' GLY . 7.6 mmt180 -55.47 -54.0 49.35 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 26.649999999999999 109.161 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.33 63.47 0.49 Allowed Glycine 0 N--CA 1.505 3.293 0 C-N-CA 119.958 -1.115 . . . . 20.260000000000002 111.681 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.544 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 18.6 p90 -75.97 122.71 24.59 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.04 -1.271 . . . . 17.789999999999999 109.75 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 25' ' ' PHE . 7.3 p90 -93.5 103.67 15.85 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.292 -1.003 . . . . 18.550000000000001 108.292 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -59.85 154.52 18.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.196 -0.94 . . . . 21.489999999999998 108.639 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.534 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 18.1 p -140.63 161.6 37.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.343 -0.848 . . . . 31.5 109.592 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 27' ' ' THR . 8.4 mmtt 120.06 129.41 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.182 0 C-N-CA 124.751 1.22 . . . . 0.0 107.81 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.442 ' C ' ' HG1' ' A' ' 30' ' ' THR . 8.8 Cg_exo -49.68 -22.57 6.95 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 N-CA-C 108.517 -1.378 . . . . 0.0 108.517 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.442 ' HG1' ' C ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 177.56 -85.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -178.56 -55.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' O ' ' O ' ' A' ' 33' ' ' GLU . 28.4 ptt180 -110.45 -20.82 12.45 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.435 ' O ' ' O ' ' A' ' 32' ' ' ARG . 35.8 mt-10 54.6 167.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.497 0.665 . . . . 0.0 109.889 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.49 -50.78 6.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.863 . . . . 0.0 109.565 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' OE2' ' OD1' ' A' ' 36' ' ' ASP . 18.5 tt0 59.11 -132.21 1.03 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' OD1' ' OE2' ' A' ' 35' ' ' GLU . 10.5 p-10 -96.52 121.5 38.42 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.132 -0.98 . . . . 0.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -76.35 135.9 39.54 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.256 -0.902 . . . . 0.0 109.149 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 37' ' ' LEU . 5.3 tt0 -63.2 -128.47 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 39' ' ' VAL . 7.7 p -144.65 84.95 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.777 -1.202 . . . . 0.0 109.839 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.65 178.27 43.08 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.515 ' NE2' ' O ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -67.59 -5.75 16.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -1.152 . . . . 0.0 108.588 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 33.9 m 38.85 -145.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.56 ' OE2' ' N ' ' A' ' 46' ' ' GLY . 0.6 OUTLIER -56.71 127.58 32.23 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.142 -1.423 . . . . 0.0 107.24 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -42.87 90.07 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.344 -0.847 . . . . 0.0 112.088 -178.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 64.85 70.06 1.18 Allowed Glycine 0 N--CA 1.494 2.513 0 O-C-N 120.998 -1.064 . . . . 0.0 111.612 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' N ' ' OE2' ' A' ' 43' ' ' GLU . . . -166.27 -125.25 0.76 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' N ' ' CD ' ' A' ' 43' ' ' GLU . . . -163.51 129.58 2.05 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.74 116.32 3.17 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 CA-C-N 118.931 1.365 . . . . 0.0 109.892 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 63.92 -169.09 22.4 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.79 -31.26 69.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -1.158 . . . . 0.0 109.463 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 46.86 70.31 0.71 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 53' ' ' LEU . 48.1 m -66.7 -71.39 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.223 -1.163 . . . . 0.0 109.536 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 53' ' ' LEU . 3.0 mm? 43.24 -166.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -86.34 150.94 52.9 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -65.54 117.83 4.95 Favored 'Trans proline' 0 C--N 1.324 -0.751 0 C-N-CA 121.103 1.202 . . . . 0.0 110.214 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -57.97 -8.86 1.12 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.489 -0.757 . . . . 0.0 109.33 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.26 -76.82 0.08 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.425 -0.797 . . . . 0.0 111.269 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.667 HD23 ' H ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -67.44 -17.08 64.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.141 -0.974 . . . . 0.0 110.444 -178.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -47.0 -39.27 12.24 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.949 -1.095 . . . . 0.0 109.555 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.46 -53.24 2.82 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.1 m -50.83 -14.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -1.148 . . . . 0.0 110.251 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -77.87 -31.43 51.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.974 -1.079 . . . . 0.0 109.356 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -104.86 -32.6 8.73 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.395 -0.816 . . . . 0.0 109.688 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -80.58 154.5 27.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.727 -179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.49 ' H ' ' NZ ' ' A' ' 28' ' ' LYS . 25.2 ptt180 -175.13 27.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -107.57 -177.63 22.46 Favored Glycine 0 N--CA 1.5 2.938 0 N-CA-C 109.87 -1.292 . . . . 19.620000000000001 109.87 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 11' ' ' LEU . 3.4 tt -49.61 -43.14 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.366 -1.079 . . . . 17.420000000000002 109.353 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 67' ' ' ILE . 22.0 t -56.98 -6.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.386 -0.821 . . . . 18.82 109.712 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 64' ' ' LYS . 6.7 tt0 -108.52 9.59 27.4 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.317 -0.864 . . . . 38.5 109.039 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.482 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 4.4 mt-30 -137.82 -15.23 1.37 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.236 -0.915 . . . . 36.829999999999998 109.936 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.534 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.5 m -114.24 -24.18 9.07 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.479 -0.763 . . . . 18.16 109.273 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 51.6 t -91.48 -43.05 9.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 18.460000000000001 108.551 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -85.16 -21.42 29.21 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.628 0.728 . . . . 0.0 109.12 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -139.38 -136.84 0.12 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.478 -0.934 . . . . 30.34 108.478 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -145.86 147.48 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 27.510000000000002 109.204 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.482 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 1.9 m -131.09 174.64 9.82 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.539 -0.726 . . . . 23.34 109.313 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.1 m -112.39 -179.04 3.56 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.476 -0.765 . . . . 22.640000000000001 109.849 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.0 tp -53.46 -55.49 24.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.568 -0.707 . . . . 23.280000000000001 109.371 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -46.01 -55.93 6.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 37.859999999999999 109.901 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -50.57 -50.43 53.66 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.821 -1.175 . . . . 31.390000000000001 108.997 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.2 mp -58.38 -41.3 84.5 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.448 -0.783 . . . . 24.48 108.936 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -62.64 -18.76 62.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.434 -0.791 . . . . 31.48 109.848 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -72.59 -29.74 63.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.423 -0.798 . . . . 22.48 111.742 -178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -100.62 12.16 37.96 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.174 -0.954 . . . . 19.59 112.051 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 78.3 m -76.87 -175.81 3.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.584 -1.323 . . . . 20.620000000000001 109.188 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 118.0 -1.0 . . . . 24.649999999999999 109.301 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.45 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 18.8 t80 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.323 -0.621 . . . . 24.77 109.323 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p -81.05 164.33 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 30.100000000000001 109.89 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.714 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.91 106.65 6.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.007 -1.109 . . . . 32.240000000000002 108.007 179.308 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -156.33 167.42 30.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.227 -0.921 . . . . 30.210000000000001 109.865 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.9 m80 -78.51 101.06 7.16 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 105.17 -2.159 . . . . 24.0 105.17 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.4 mt -99.2 136.5 39.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.514 -0.742 . . . . 19.629999999999999 111.903 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -119.34 -162.89 0.94 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.144 -0.973 . . . . 17.190000000000001 111.44 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.499 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.89 -50.96 1.51 Allowed Glycine 0 N--CA 1.49 2.273 0 CA-C-N 115.751 -0.659 . . . . 16.550000000000001 112.723 -176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.4 m -79.17 -62.93 1.54 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.475 -1.603 . . . . 19.550000000000001 110.686 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.47 -55.45 34.63 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.033 -1.042 . . . . 0.0 110.038 -178.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 67' ' ' ILE . 30.2 tp -50.7 -50.12 55.81 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.824 -1.172 . . . . 14.16 108.452 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.83 -56.39 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.58 -1.267 . . . . 15.31 107.58 178.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -55.65 -61.57 2.26 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.883 -1.154 . . . . 29.640000000000001 107.883 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.58 -59.61 2.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.03 -1.044 . . . . 13.960000000000001 109.762 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.44 -54.0 31.36 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.481 -1.387 . . . . 17.789999999999999 107.822 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -50.86 -50.4 57.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.526 -0.733 . . . . 16.84 109.127 179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.1 mt -51.01 -26.93 6.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.996 -1.065 . . . . 22.760000000000002 108.6 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.4 t -95.37 -64.31 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.419 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.478 ' N ' HG12 ' A' ' 18' ' ' VAL . 8.3 m -66.04 -83.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 18.539999999999999 109.982 -178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.77 -124.56 12.21 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.583 -1.294 . . . . 23.170000000000002 110.104 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -45.25 -20.53 0.05 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.419 -1.048 . . . . 39.770000000000003 110.076 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 20' ' ' GLY . 84.4 mtt180 -66.75 -53.13 36.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.178 -0.951 . . . . 26.649999999999999 109.807 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.49 64.15 0.49 Allowed Glycine 0 N--CA 1.508 3.457 0 C-N-CA 119.634 -1.27 . . . . 20.260000000000002 111.782 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 22.1 p90 -75.78 126.69 31.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.997 -1.296 . . . . 17.789999999999999 109.808 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 13.6 p90 -96.91 104.37 16.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.814 . . . . 18.550000000000001 108.864 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE2' HD23 ' A' ' 11' ' ' LEU . 5.5 t80 -66.14 163.05 18.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 21.489999999999998 109.171 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 38.2 p -147.06 134.47 20.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.081 -1.012 . . . . 31.5 109.88 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' THR . 20.0 pttm -173.62 65.92 0.32 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.833 . . . . 0.0 109.232 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -51.52 -10.03 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 121.137 1.224 . . . . 0.0 109.314 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' LYS . 6.0 m -145.01 142.51 29.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.719 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.5 OUTLIER -91.71 -29.15 16.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.393 -0.817 . . . . 0.0 109.051 179.615 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.464 ' C ' ' H ' ' A' ' 34' ' ' ALA . 8.2 tpm_? -161.75 94.67 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.47 39.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.515 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' C ' ' H ' ' A' ' 36' ' ' ASP . . . 55.22 -105.9 0.29 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.346 -0.846 . . . . 0.0 110.311 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 67.52 -21.24 0.12 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.544 -0.723 . . . . 0.0 110.358 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 34' ' ' ALA . 1.0 OUTLIER -157.25 -30.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.012 -1.055 . . . . 0.0 109.735 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.8 mt 49.72 -119.4 1.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -87.76 -132.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 p -158.21 151.46 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.153 -0.967 . . . . 0.0 109.447 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.54 -136.77 4.56 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -73.14 73.49 1.24 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -1.105 . . . . 0.0 109.192 179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 43' ' ' GLU . 7.5 p -147.92 -46.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 0.0 109.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 42' ' ' VAL . 11.3 pt-20 -105.27 -20.14 13.59 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.352 -0.843 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.36 21.78 0.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.214 -0.929 . . . . 0.0 109.271 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.86 -15.79 0.05 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.84 66.25 2.23 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.43 -67.43 1.58 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.5 124.29 15.89 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.436 1.424 . . . . 0.0 110.021 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.547 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -79.52 -10.85 85.45 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 49' ' ' GLY . . . 69.13 -58.14 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.632 -0.923 . . . . 0.0 109.835 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 49' ' ' GLY . . . 151.31 -154.4 25.54 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.403 ' H ' ' H ' ' A' ' 53' ' ' LEU . 36.6 t -172.63 3.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -1.124 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.403 ' H ' ' H ' ' A' ' 52' ' ' SER . 75.0 mt -81.96 -96.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.703 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -66.67 152.61 95.0 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.029 . . . . 0.0 108.952 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.24 135.26 57.05 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 120.668 0.912 . . . . 0.0 109.858 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 42.2 mt -57.66 -17.61 15.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.553 -0.717 . . . . 0.0 110.427 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 59' ' ' GLU . . . -77.21 -77.22 0.15 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.037 -1.04 . . . . 0.0 110.679 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.721 HD23 ' H ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -73.72 17.36 0.16 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.908 -1.12 . . . . 0.0 109.558 -179.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.652 ' O ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -68.64 -48.01 65.13 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.156 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -89.11 -24.19 32.63 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 m -44.41 -14.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -1.188 . . . . 0.0 111.334 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.749 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -99.54 -24.47 14.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.892 -1.13 . . . . 0.0 108.884 178.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.673 ' H ' HD22 ' A' ' 62' ' ' LEU . 15.1 mm-40 -107.99 6.02 26.73 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.317 -0.864 . . . . 0.0 109.707 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -43.63 142.01 1.33 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.017 -1.052 . . . . 0.0 110.125 -179.343 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.461 HH11 ' HB2' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -66.23 -57.32 7.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.683 -179.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.81 -145.7 12.55 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.818 -1.313 . . . . 19.620000000000001 109.818 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.553 HD11 HD11 ' A' ' 11' ' ' LEU . 3.7 tt -53.12 -43.22 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.12 . . . . 17.420000000000002 109.723 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 67' ' ' ILE . 6.3 t -54.26 -23.98 11.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 120.98 -1.075 . . . . 18.82 109.726 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -94.73 10.2 36.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.06 -1.025 . . . . 38.5 109.797 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.1 mt-30 -135.64 -14.26 1.92 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.067 -1.021 . . . . 36.829999999999998 110.391 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.0 m -116.28 -28.48 6.52 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.355 -0.841 . . . . 18.16 109.399 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.2 t -86.96 -38.85 16.26 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.942 -1.099 . . . . 18.460000000000001 108.656 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.4 t -87.83 -12.39 45.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.798 . . . . 0.0 109.062 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -145.8 -142.99 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.644 -0.873 . . . . 30.34 108.644 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.83 125.19 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.996 -1.065 . . . . 27.510000000000002 109.481 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -108.72 175.74 5.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.581 -0.7 . . . . 23.34 109.932 -179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.4 p -112.51 176.22 5.11 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.507 0.67 . . . . 22.640000000000001 109.644 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.8 tp -48.21 -60.02 2.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.518 -0.739 . . . . 23.280000000000001 109.506 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -42.03 -58.78 1.97 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 37.859999999999999 110.404 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.492 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 12.1 mp0 -48.62 -46.9 40.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.834 -1.166 . . . . 31.390000000000001 108.992 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.15 -38.81 90.42 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.704 -0.85 . . . . 24.48 108.704 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.58 -18.66 65.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.768 . . . . 31.48 109.631 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -74.05 -29.76 62.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.483 -0.76 . . . . 22.48 111.57 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -97.88 11.77 36.26 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.099 -1.001 . . . . 19.59 111.734 -177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.0 m -76.91 -175.76 3.64 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.606 -1.309 . . . . 20.620000000000001 109.111 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 117.967 -1.016 . . . . 24.649999999999999 109.255 179.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.47 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.248 -0.649 . . . . 24.77 109.248 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.5 p -163.28 163.43 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.077 -1.014 . . . . 30.100000000000001 109.754 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -133.2 106.58 7.66 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.204 -1.036 . . . . 32.240000000000002 108.204 179.324 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -156.57 164.08 38.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.226 -0.921 . . . . 30.210000000000001 109.382 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -77.46 101.17 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.154 -2.165 . . . . 24.0 105.154 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.38 132.21 44.86 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.301 -0.875 . . . . 19.629999999999999 111.922 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.54 -158.53 0.74 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.163 -0.961 . . . . 17.190000000000001 111.697 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.26 -54.56 1.26 Allowed Glycine 0 N--CA 1.49 2.281 0 CA-C-N 115.826 -0.625 . . . . 16.550000000000001 113.201 -176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.3 m -79.04 -63.25 1.46 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.273 -1.722 . . . . 19.550000000000001 111.085 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.09 -55.81 28.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 110.371 -178.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD11 HD11 ' A' ' 67' ' ' ILE . 35.1 tp -50.42 -52.15 40.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.709 -1.244 . . . . 14.16 108.554 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -45.83 -55.83 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 107.71 -1.218 . . . . 15.31 107.71 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -56.46 -61.43 2.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.868 -1.16 . . . . 29.640000000000001 107.868 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.3 -59.73 2.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.083 -1.011 . . . . 13.960000000000001 109.882 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 10.8 mt -52.16 -53.84 38.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.315 -1.491 . . . . 17.789999999999999 107.888 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -50.7 -47.41 58.97 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.009 -0.737 . . . . 16.84 109.009 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -54.48 -26.77 33.34 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.011 -1.056 . . . . 22.760000000000002 108.348 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -96.21 -64.46 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.28 -0.887 . . . . 17.440000000000001 109.393 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.452 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.2 m -65.37 -83.02 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -0.902 . . . . 18.539999999999999 110.036 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 68.37 -123.36 16.82 Favored Glycine 0 N--CA 1.484 1.834 0 C-N-CA 119.496 -1.335 . . . . 23.170000000000002 109.883 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.609 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.3 pm0 -44.9 -18.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.463 -1.022 . . . . 39.770000000000003 110.587 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 20' ' ' GLY . 26.1 mtt-85 -70.72 -52.67 19.41 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.936 -1.103 . . . . 26.649999999999999 110.159 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.22 64.34 0.5 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 119.611 -1.281 . . . . 20.260000000000002 111.529 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.41 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.4 p90 -75.3 134.96 40.93 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.145 -1.209 . . . . 17.789999999999999 109.426 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 10.5 p90 -100.83 107.54 19.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.437 -0.79 . . . . 18.550000000000001 110.412 -179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.459 ' CE2' HD23 ' A' ' 11' ' ' LEU . 3.0 t80 -88.59 145.93 25.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.415 -0.803 . . . . 21.489999999999998 108.967 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -148.27 103.62 3.46 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.935 -1.103 . . . . 31.5 110.456 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -165.63 66.18 1.07 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.339 178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' O ' ' OG1' ' A' ' 30' ' ' THR . 5.6 Cg_exo -59.88 105.14 0.26 Allowed 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.473 1.449 . . . . 0.0 110.047 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 29' ' ' PRO . 27.0 m -165.99 117.3 1.04 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.925 . . . . 0.0 109.366 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.513 ' O ' ' N ' ' A' ' 33' ' ' GLU . 9.8 tpp180 -95.75 113.95 25.64 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.236 -0.915 . . . . 0.0 110.065 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 32' ' ' ARG . 4.2 mtt-85 48.82 10.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 110.321 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 31' ' ' ARG . 14.7 pt-20 36.33 33.98 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.763 -0.585 . . . . 0.0 110.814 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' ARG . . . -128.39 104.27 7.62 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.456 -0.778 . . . . 0.0 109.414 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' H ' HD23 ' A' ' 37' ' ' LEU . 38.4 tt0 -157.78 -55.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.207 -0.933 . . . . 0.0 109.812 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.39 36.52 1.15 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.315 -0.866 . . . . 0.0 110.042 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 35' ' ' GLU . 3.8 mm? -82.04 -14.97 55.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 109.068 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -83.79 169.96 14.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.25 -0.906 . . . . 0.0 109.246 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLY . 16.2 t -138.07 -15.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.508 -0.745 . . . . 0.0 109.708 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . 50.82 -179.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.33 134.0 45.27 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.139 -1.212 . . . . 0.0 108.848 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.599 HG23 ' N ' ' A' ' 43' ' ' GLU . 13.1 m -146.42 -47.23 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.117 -0.989 . . . . 0.0 109.521 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.599 ' N ' HG23 ' A' ' 42' ' ' VAL . 29.9 tt0 -173.44 152.08 2.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.249 -0.907 . . . . 0.0 109.349 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -89.16 29.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.822 . . . . 0.0 108.912 179.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -117.19 -54.13 0.31 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.73 -102.73 0.16 Allowed Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.073 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 49' ' ' GLY . . . -157.77 79.56 0.18 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.43 4.9 0.29 Allowed 'Trans proline' 0 C--N 1.319 -1.007 0 C-N-CA 121.368 1.379 . . . . 0.0 110.133 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 47' ' ' GLY . . . -71.83 118.74 7.17 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.05 -17.19 57.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -1.141 . . . . 0.0 109.675 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 53' ' ' LEU . . . 79.1 -33.39 1.97 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.0 t 57.12 3.3 0.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.304 -1.115 . . . . 0.0 109.792 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 51' ' ' GLY . 39.9 mt -60.52 169.51 1.72 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.2 -0.938 . . . . 0.0 109.213 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -68.06 148.42 98.35 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.1 -1.0 . . . . 0.0 108.707 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -63.71 127.64 20.2 Favored 'Trans proline' 0 C--N 1.323 -0.782 0 C-N-CA 120.768 0.978 . . . . 0.0 109.623 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.9 mt -56.1 -23.66 35.52 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.394 -0.817 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.33 -56.61 9.06 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.959 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.7 mm? -64.9 -37.19 86.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.104 -0.998 . . . . 0.0 109.226 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -47.48 -35.35 8.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.359 -0.838 . . . . 0.0 109.333 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -79.5 -32.96 36.28 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.7 t -87.42 -7.68 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.234 -1.157 . . . . 0.0 109.242 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 58' ' ' LEU . 1.6 tt -74.02 -67.48 0.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -95.88 -29.18 14.34 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.196 -0.94 . . . . 0.0 109.505 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp 54.68 38.29 29.75 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.576 -0.702 . . . . 0.0 110.381 179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 65' ' ' ARG . 0.0 OUTLIER -53.4 -68.03 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.862 -1.149 . . . . 0.0 108.192 179.138 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -72.89 0.58 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 120.395 -0.907 . . . . 19.620000000000001 111.807 177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.715 HD11 HD11 ' A' ' 11' ' ' LEU . 3.6 tt -42.84 -52.48 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.535 -0.979 . . . . 17.420000000000002 112.163 -177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.63 ' N ' HG23 ' A' ' 67' ' ' ILE . 15.4 t -57.97 -7.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.626 -1.296 . . . . 18.82 109.603 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 67' ' ' ILE . 20.5 tp10 -113.02 9.26 18.65 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.144 -0.687 . . . . 38.5 109.144 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.403 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.9 mt-30 -138.88 -8.67 1.38 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.301 -0.874 . . . . 36.829999999999998 109.533 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 64.3 m -119.55 -31.9 4.46 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.6 -0.889 . . . . 18.16 108.6 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.9 t -82.06 -43.1 18.33 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 18.460000000000001 108.323 178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 t -82.2 -21.79 36.26 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 t -136.81 -137.38 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.496 -0.928 . . . . 30.34 108.496 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.6 mt -145.52 150.03 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.993 . . . . 27.510000000000002 109.294 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.4 m -135.14 176.65 8.47 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.388 -0.82 . . . . 23.34 109.956 -179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.8 m -112.37 -163.91 0.88 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.671 -0.643 . . . . 22.640000000000001 109.48 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.7 tp -67.83 -60.75 2.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.491 -0.755 . . . . 23.280000000000001 109.547 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -41.5 -57.38 2.24 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.574 -0.703 . . . . 37.859999999999999 110.522 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -48.71 -47.22 41.36 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.786 -1.196 . . . . 31.390000000000001 108.919 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.2 -38.18 88.15 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.291 -0.881 . . . . 24.48 108.987 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.2 -18.79 64.84 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.504 -0.747 . . . . 31.48 109.75 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -73.32 -30.38 63.33 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 22.48 111.758 -178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -98.05 11.96 35.88 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.026 -1.046 . . . . 19.59 111.891 -177.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 69.3 m -76.74 -175.62 3.49 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.682 -1.261 . . . . 20.620000000000001 109.096 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.984 -1.008 . . . . 24.649999999999999 109.403 179.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.467 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.0 t80 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.156 -0.683 . . . . 24.77 109.156 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.432 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.7 p -165.57 159.48 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.072 -1.018 . . . . 30.100000000000001 109.326 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.842 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.23 107.76 9.8 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.583 -0.895 . . . . 32.240000000000002 108.583 179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -156.73 163.04 39.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.347 -0.846 . . . . 30.210000000000001 109.557 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.464 ' H ' ' CD2' ' A' ' 5' ' ' HIS . 9.4 m-70 -77.18 100.83 5.93 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 105.164 -2.162 . . . . 24.0 105.164 176.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.7 mt -99.44 134.68 41.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.445 -0.784 . . . . 19.629999999999999 111.731 -176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.8 m -122.5 -159.63 0.84 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.802 0.81 . . . . 17.190000000000001 112.103 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -35.92 -53.15 1.18 Allowed Glycine 0 N--CA 1.493 2.48 0 O-C-N 121.858 -0.526 . . . . 16.550000000000001 113.233 -176.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.0 m -80.37 -62.25 1.73 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.385 -1.656 . . . . 19.550000000000001 110.932 -178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -55.4 35.3 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.911 -1.118 . . . . 0.0 110.276 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.559 HD11 HD11 ' A' ' 67' ' ' ILE . 29.7 tp -50.89 -50.49 57.18 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.813 -1.179 . . . . 14.16 108.619 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.4 t -46.2 -57.26 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 107.459 -1.312 . . . . 15.31 107.459 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -55.56 -61.43 2.35 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.903 -1.147 . . . . 29.640000000000001 107.903 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.64 -59.56 2.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.022 -1.049 . . . . 13.960000000000001 110.045 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 67' ' ' ILE . 10.0 mt -51.43 -55.0 21.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.342 -1.474 . . . . 17.789999999999999 107.703 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -49.33 -51.17 36.04 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 109.025 -0.732 . . . . 16.84 109.025 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 mt -50.6 -26.87 5.85 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.063 -1.023 . . . . 22.760000000000002 108.62 179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.81 -64.21 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.375 -0.828 . . . . 17.440000000000001 109.247 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.8 m -64.61 -83.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 18.539999999999999 109.825 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 66.8 -120.12 13.65 Favored Glycine 0 N--CA 1.484 1.891 0 C-N-CA 119.632 -1.27 . . . . 23.170000000000002 110.12 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -48.74 -9.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.379 -1.071 . . . . 39.770000000000003 110.04 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -78.31 -52.76 8.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.888 -1.133 . . . . 26.649999999999999 109.646 -179.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.76 63.36 0.48 Allowed Glycine 0 N--CA 1.508 3.46 0 C-N-CA 119.939 -1.124 . . . . 20.260000000000002 111.64 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.408 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 16.7 p90 -76.28 131.18 39.09 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.955 -1.32 . . . . 17.789999999999999 109.975 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -96.87 106.96 19.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.522 -0.736 . . . . 18.550000000000001 109.793 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CE2' HD23 ' A' ' 11' ' ' LEU . 2.4 t80 -96.85 140.75 30.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.746 . . . . 21.489999999999998 109.512 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.462 ' OG1' ' NE ' ' A' ' 65' ' ' ARG . 73.7 p -150.47 104.08 3.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.659 -0.867 . . . . 31.5 108.659 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.531 ' O ' HG23 ' A' ' 30' ' ' THR . 11.0 ptpt -100.79 109.25 57.25 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.346 -0.846 . . . . 0.0 109.83 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.02 -11.1 14.24 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 28' ' ' LYS . 2.9 p 62.52 132.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.325 0.583 . . . . 0.0 109.502 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HG2' HH11 ' A' ' 31' ' ' ARG . 13.8 mtt-85 -77.91 85.43 4.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.336 -0.853 . . . . 0.0 109.863 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 31' ' ' ARG . 11.2 tpp180 54.88 103.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.812 . . . . 0.0 109.596 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -78.31 37.94 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 109.362 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -158.35 84.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.333 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.9 pm0 -96.9 -173.13 2.62 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.289 -0.882 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.4 t0 58.17 36.89 26.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.36 -0.837 . . . . 0.0 109.767 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.6 mt -83.13 -124.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.243 -0.91 . . . . 0.0 109.323 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.42 164.88 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.166 -0.958 . . . . 0.0 109.255 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 39' ' ' VAL . 28.3 m -151.49 127.78 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.333 -0.854 . . . . 0.0 109.499 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.73 -148.84 11.51 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 3.6 pp0? -78.33 117.23 19.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.109 -1.23 . . . . 0.0 109.22 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -144.19 15.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 0.0 108.547 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 68.55 162.54 0.21 Allowed 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.1 mp -81.68 11.91 4.36 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.21 -0.931 . . . . 0.0 109.588 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -159.03 71.98 0.23 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.2 -71.01 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 53.98 69.35 1.26 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -61.5 -160.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.114 0 C-N-CA 121.49 1.46 . . . . 0.0 110.071 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 51' ' ' GLY . . . -157.46 16.49 0.34 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 51.2 9.79 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.381 -1.07 . . . . 0.0 109.564 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' LEU . . . 49.17 -129.03 23.39 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 34.3 m 52.81 -87.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.387 -1.067 . . . . 0.0 109.703 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -67.95 -177.1 0.77 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -0.93 . . . . 0.0 109.129 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 16.6 mp0 -77.88 148.55 75.85 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.158 -0.964 . . . . 0.0 109.23 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.79 126.15 20.88 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 121.002 1.135 . . . . 0.0 109.944 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 38.9 mt -55.97 -11.58 1.11 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.7 -79.03 0.06 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 111.076 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.699 HD23 ' H ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -59.29 -26.71 65.2 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 0.0 109.806 -178.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -45.21 -41.09 7.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.003 -1.061 . . . . 0.0 109.647 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.03 -41.22 61.27 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.121 -1.591 . . . . 0.0 109.121 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.0 p -83.8 -7.17 59.52 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -1.094 . . . . 0.0 109.869 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.55 ' N ' ' O ' ' A' ' 58' ' ' LEU . 3.3 tt -71.72 -57.27 4.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -0.972 . . . . 0.0 109.598 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.543 ' O ' ' C ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.76 -19.19 16.12 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.291 -0.881 . . . . 0.0 109.85 -179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.543 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 10.86 99.56 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.739 0 CA-C-O 121.559 0.695 . . . . 0.0 112.104 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.462 ' NE ' ' OG1' ' A' ' 27' ' ' THR . 6.9 ttm-85 -46.85 -75.55 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 151.35 -91.14 0.13 Allowed Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.624 -1.274 . . . . 19.620000000000001 111.003 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt -49.37 -50.12 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.295 -1.12 . . . . 17.420000000000002 111.675 -178.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.587 ' N ' HG23 ' A' ' 67' ' ' ILE . 9.9 t -57.17 -7.46 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.646 -1.284 . . . . 18.82 109.97 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -110.99 9.65 22.19 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.175 -0.953 . . . . 38.5 109.403 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.1 mt-30 -138.38 -8.93 1.48 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.402 -0.811 . . . . 36.829999999999998 109.876 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.47 ' O ' ' N ' ' A' ' 6' ' ' LEU . 57.4 m -120.25 -23.54 6.2 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.439 -0.788 . . . . 18.16 109.065 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 41.3 t -91.21 -41.84 10.76 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.203 -1.036 . . . . 18.460000000000001 108.203 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.4 t -85.19 -27.64 25.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -129.66 -138.21 0.22 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.511 -0.922 . . . . 30.34 108.511 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.25 149.61 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.095 -1.003 . . . . 27.510000000000002 109.258 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.9 m -133.97 171.81 13.67 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.429 -0.794 . . . . 23.34 109.766 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -106.88 -153.93 0.51 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.493 -0.754 . . . . 22.640000000000001 109.479 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.467 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.2 tp -77.78 -59.94 2.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.922 . . . . 23.280000000000001 109.014 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -42.21 -55.99 3.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.674 -0.641 . . . . 37.859999999999999 110.309 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -48.74 -47.15 41.74 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.932 -1.105 . . . . 31.390000000000001 109.005 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.9 mp -63.13 -39.42 94.63 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 24.48 108.942 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -61.64 -19.0 61.78 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.399 -0.813 . . . . 31.48 109.878 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -74.43 -29.68 61.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 22.48 111.568 -178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -97.94 11.78 36.32 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.147 -0.971 . . . . 19.59 111.73 -177.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.7 m -77.05 -175.71 3.69 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.641 -1.287 . . . . 20.620000000000001 109.196 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 118.029 -0.986 . . . . 24.649999999999999 109.368 179.728 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.423 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 16.3 t80 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.198 -0.667 . . . . 24.77 109.198 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.552 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p -166.49 164.0 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.104 -0.997 . . . . 30.100000000000001 109.461 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.716 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -134.78 106.98 7.17 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.252 -1.018 . . . . 32.240000000000002 108.252 179.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -157.34 165.09 36.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.218 -0.926 . . . . 30.210000000000001 110.08 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -77.28 100.61 5.93 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.161 -2.163 . . . . 24.0 105.161 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.36 134.94 41.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 19.629999999999999 111.799 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -118.33 -162.44 0.89 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.152 -0.968 . . . . 17.190000000000001 111.636 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.51 -52.2 1.38 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 115.761 -0.654 . . . . 16.550000000000001 112.864 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.9 t -78.58 -63.25 1.45 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.399 -1.648 . . . . 19.550000000000001 110.669 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.46 -55.47 33.28 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.106 -0.997 . . . . 0.0 110.136 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD11 HD11 ' A' ' 67' ' ' ILE . 34.7 tp -51.09 -50.29 59.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.865 -1.147 . . . . 14.16 108.744 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.9 t -47.89 -55.87 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.65 -1.241 . . . . 15.31 107.65 178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -56.09 -61.69 2.21 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.969 -1.123 . . . . 29.640000000000001 107.969 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.37 -59.32 2.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.073 -1.017 . . . . 13.960000000000001 109.975 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.8 mt -51.88 -55.38 20.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.328 -1.482 . . . . 17.789999999999999 107.77 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -49.53 -48.94 47.89 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.255 -0.646 . . . . 16.84 109.255 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.4 mt -52.96 -25.88 13.37 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.984 -1.073 . . . . 22.760000000000002 108.587 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -95.92 -64.61 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.348 -0.845 . . . . 17.440000000000001 109.435 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 6.1 m -64.24 -79.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.173 -0.955 . . . . 18.539999999999999 109.606 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 77.01 -133.14 12.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.718 -1.353 . . . . 23.170000000000002 109.718 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -49.45 -11.29 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -1.111 . . . . 39.770000000000003 109.594 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -63.7 -53.05 57.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.091 -1.006 . . . . 26.649999999999999 108.778 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.93 63.58 0.48 Allowed Glycine 0 N--CA 1.506 3.363 0 C-N-CA 119.941 -1.124 . . . . 20.260000000000002 111.562 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.0 p90 -76.12 123.17 25.4 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.166 -1.197 . . . . 17.789999999999999 109.935 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 9.1 p90 -92.74 107.0 18.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.845 . . . . 18.550000000000001 109.079 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.4 ' CE2' HD23 ' A' ' 11' ' ' LEU . 6.4 t80 -68.48 162.48 25.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.911 . . . . 21.489999999999998 109.486 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -154.05 151.61 29.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.225 -0.922 . . . . 31.5 109.681 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 30' ' ' THR . 12.1 pttm -173.14 65.56 0.33 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -50.95 92.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.161 0 C-N-CA 121.154 1.236 . . . . 0.0 110.007 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 28' ' ' LYS . 4.3 m -162.37 81.27 0.53 Allowed 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.48 0.657 . . . . 0.0 109.266 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 31' ' ' ARG . 26.8 mtm-85 -83.08 -43.12 16.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.416 -0.803 . . . . 0.0 109.603 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.1 OUTLIER -67.38 99.17 0.7 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.299 -0.875 . . . . 0.0 109.585 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -153.65 110.52 3.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 35' ' ' GLU . . . -166.15 153.15 9.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.413 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 35' ' ' GLU . 1.7 pm0 -39.76 166.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.522 0.677 . . . . 0.0 111.076 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.481 ' OD2' ' O ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER 78.99 23.07 0.58 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.554 0.692 . . . . 0.0 109.332 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' O ' ' N ' ' A' ' 39' ' ' VAL . 2.3 mm? -67.73 152.1 46.14 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.003 -1.061 . . . . 0.0 108.399 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 52.43 -87.6 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.533 -0.729 . . . . 0.0 109.677 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 37' ' ' LEU . 38.5 t -48.7 115.83 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . 170.19 135.57 1.93 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' C ' ' O ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER 21.49 74.38 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.454 0 CA-C-O 121.224 0.535 . . . . 0.0 112.005 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.5 p -153.64 150.12 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.07 -1.019 . . . . 0.0 109.372 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -50.01 134.34 21.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.875 . . . . 0.0 109.59 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.647 ' H ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -47.74 -58.2 4.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -72.85 33.56 0.73 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 44' ' ' LEU . . . 51.29 -163.07 1.24 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.0 -67.19 0.23 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -57.68 -48.52 16.59 Favored 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 121.403 1.402 . . . . 0.0 109.851 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 163.7 157.0 9.02 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -74.02 -23.81 59.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -1.211 . . . . 0.0 109.587 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.7 -175.52 50.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.1 p -160.67 -32.6 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.394 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.03 177.86 6.05 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.336 -0.853 . . . . 0.0 109.124 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -52.9 149.11 12.31 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 0.0 109.288 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.62 137.63 74.74 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 120.92 1.08 . . . . 0.0 109.86 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 41.4 mt -54.2 -35.11 62.03 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.63 -61.17 2.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.237 -0.914 . . . . 0.0 109.713 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 60' ' ' GLY . 3.8 mm? -56.46 -43.95 80.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.224 -0.923 . . . . 0.0 109.163 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -47.8 -14.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.405 -0.81 . . . . 0.0 109.537 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . -84.4 -57.78 2.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 t -73.74 -7.99 54.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.274 -1.133 . . . . 0.0 109.407 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 62' ' ' LEU . 3.1 tt -70.65 -57.21 4.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.939 . . . . 0.0 109.164 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.584 ' O ' ' N ' ' A' ' 65' ' ' ARG . 4.8 pt20 -90.62 -26.71 19.51 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.181 -0.95 . . . . 0.0 109.61 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 30.46 31.35 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 121.129 0.49 . . . . 0.0 111.468 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' A' ' 63' ' ' GLN . 50.5 ttt180 -174.37 57.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -136.47 154.47 22.07 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.742 -1.343 . . . . 19.620000000000001 109.742 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.66 HD11 HD11 ' A' ' 11' ' ' LEU . 2.9 tt -103.99 -40.18 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.534 -0.98 . . . . 17.420000000000002 109.157 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.47 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.4 t -52.09 -46.48 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.099 -1.001 . . . . 18.82 109.56 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.36 10.48 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 38.5 109.768 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 9.5 mt-30 -135.76 -10.56 2.08 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.127 -0.983 . . . . 36.829999999999998 110.843 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.5 m -123.84 -25.98 4.18 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.297 -0.877 . . . . 18.16 108.766 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.7 t -86.67 -39.68 15.83 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.299 -1.0 . . . . 18.460000000000001 108.299 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -88.03 -16.2 34.28 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.3 t -138.59 -142.73 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.461 -0.94 . . . . 30.34 108.461 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.0 mt -144.91 142.0 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.041 -1.037 . . . . 27.510000000000002 109.15 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -129.07 173.58 10.32 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.554 -0.716 . . . . 23.34 109.631 -179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -112.17 -165.85 1.03 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.556 -0.715 . . . . 22.640000000000001 109.836 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.423 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.6 tp -64.26 -58.11 7.49 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 23.280000000000001 109.55 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -44.0 -58.19 2.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.813 . . . . 37.859999999999999 110.203 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -47.88 -47.64 31.81 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.865 -1.147 . . . . 31.390000000000001 109.186 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -62.23 -40.03 94.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.02 -0.733 . . . . 24.48 109.02 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.98 -18.97 62.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.35 -0.844 . . . . 31.48 109.747 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -74.46 -29.87 61.63 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 22.48 111.48 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -97.16 11.79 35.07 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.114 -0.991 . . . . 19.59 111.796 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 79.6 m -77.38 -175.68 3.84 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.611 -1.305 . . . . 20.620000000000001 109.258 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.4 ' OD1' ' C ' ' A' ' 86' ' ' ASN . 36.5 t-20 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.004 -0.998 . . . . 24.649999999999999 109.221 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.483 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 13.2 t80 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 24.77 109.237 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.1 p -164.78 163.87 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 30.100000000000001 109.492 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.99 106.94 8.35 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.455 -0.943 . . . . 32.240000000000002 108.455 179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -157.59 163.01 38.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 30.210000000000001 109.686 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -77.45 100.78 6.13 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.125 -2.176 . . . . 24.0 105.125 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 mt -97.68 132.93 42.88 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.487 -0.758 . . . . 19.629999999999999 111.996 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.67 -162.1 0.86 Allowed 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.904 0.859 . . . . 17.190000000000001 111.427 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.507 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -37.14 -50.97 1.63 Allowed Glycine 0 N--CA 1.491 2.354 0 CA-C-N 115.957 -0.565 . . . . 16.550000000000001 112.888 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.3 p -79.38 -63.38 1.43 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.4 -1.647 . . . . 19.550000000000001 110.872 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -55.09 39.33 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.903 -1.123 . . . . 0.0 110.073 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.539 HD11 HD11 ' A' ' 67' ' ' ILE . 29.0 tp -50.6 -49.77 55.67 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.728 -1.233 . . . . 14.16 108.429 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.7 t -48.24 -56.2 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.393 -1.336 . . . . 15.31 107.393 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -55.79 -61.46 2.35 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.843 -1.143 . . . . 29.640000000000001 108.036 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.27 -59.98 2.37 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.98 -1.075 . . . . 13.960000000000001 109.662 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 HD11 HD13 ' A' ' 67' ' ' ILE . 10.5 mt -51.22 -50.25 59.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.565 -1.334 . . . . 17.789999999999999 108.026 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -56.06 -41.99 75.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.535 -0.728 . . . . 16.84 109.211 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.79 -28.19 65.74 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.785 -1.197 . . . . 22.760000000000002 107.961 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.83 -64.66 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.547 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.474 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.5 m -64.6 -79.31 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 18.539999999999999 109.801 -179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 76.51 -134.18 15.02 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.756 -1.338 . . . . 23.170000000000002 109.756 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -48.26 -11.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.415 -1.05 . . . . 39.770000000000003 109.8 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' GLY . 51.7 mtt180 -65.33 -52.52 53.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.008 -1.058 . . . . 26.649999999999999 108.95 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.37 0.49 Allowed Glycine 0 N--CA 1.506 3.325 0 C-N-CA 119.786 -1.197 . . . . 20.260000000000002 111.663 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.0 p90 -76.11 123.41 25.77 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 109.896 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 19.2 p90 -91.38 106.89 18.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.396 -0.815 . . . . 18.550000000000001 109.015 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.413 ' O ' HG23 ' A' ' 27' ' ' THR . 5.9 t80 -75.75 145.0 41.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 21.489999999999998 109.415 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 26' ' ' TYR . 27.4 p -155.71 159.41 39.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 31.5 109.5 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -158.96 109.3 1.58 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.172 -0.955 . . . . 0.0 109.165 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 30' ' ' THR . 4.7 Cg_exo -56.95 -21.31 40.61 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 120.66 0.907 . . . . 0.0 109.931 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 31' ' ' ARG . 25.0 p -61.4 -138.93 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.5 -0.75 . . . . 0.0 109.777 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 31' ' ' ARG . 0.0 OUTLIER 74.32 -72.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.341 -0.85 . . . . 0.0 109.015 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.593 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.0 OUTLIER -95.39 95.42 8.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.422 -0.799 . . . . 0.0 108.971 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.31 41.14 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -159.32 74.77 0.64 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.43 ' N ' ' CD ' ' A' ' 35' ' ' GLU . 12.9 mp0 -81.05 -43.69 19.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.217 -0.927 . . . . 0.0 109.618 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -170.24 45.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.523 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt -72.15 109.0 5.63 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.262 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -81.56 133.62 35.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.316 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.462 HG22 ' H ' ' A' ' 39' ' ' VAL . 1.8 m -61.94 97.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 109.404 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.473 ' O ' ' C ' ' A' ' 41' ' ' GLN . . . -176.69 104.86 0.19 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' C ' ' O ' ' A' ' 40' ' ' GLY . 3.2 pp0? 25.42 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.401 0 CA-C-O 121.73 0.776 . . . . 0.0 111.772 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' O ' ' O ' ' A' ' 46' ' ' GLY . 13.4 m -143.7 -22.75 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.04 -1.038 . . . . 0.0 109.334 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 45' ' ' GLY . 15.5 pt-20 -85.15 -9.49 57.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.199 -0.938 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.579 ' N ' HD12 ' A' ' 44' ' ' LEU . 10.4 mp -47.51 98.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.99 . . . . 0.0 109.507 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 43' ' ' GLU . . . 87.96 -50.67 3.96 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -171.0 -178.37 41.5 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 46' ' ' GLY . . . -50.96 179.18 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.35 -52.91 5.45 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.439 1.426 . . . . 0.0 109.869 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.11 85.4 0.69 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -98.67 36.06 1.72 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.297 -1.12 . . . . 0.0 109.41 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.18 -125.63 0.78 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.9 t -161.4 13.77 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.208 -1.172 . . . . 0.0 109.489 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -90.59 178.67 6.02 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.244 -0.91 . . . . 0.0 109.177 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' OE1' ' OE2' ' A' ' 59' ' ' GLU . 50.8 mt-30 -80.99 152.91 72.11 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.289 -0.882 . . . . 0.0 108.988 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 57' ' ' ALA . 2.1 Cg_endo -58.72 126.15 20.37 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 121.004 1.136 . . . . 0.0 110.122 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.7 mt -54.13 -10.0 0.32 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.542 -0.723 . . . . 0.0 109.675 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.434 ' H ' ' C ' ' A' ' 55' ' ' PRO . . . -71.69 -78.32 0.08 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.326 -0.859 . . . . 0.0 110.953 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -63.05 -20.44 65.33 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.923 -1.111 . . . . 0.0 109.82 -178.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' OE2' ' OE1' ' A' ' 54' ' ' GLN . 16.1 mm-40 -45.67 -33.57 3.01 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.134 -0.979 . . . . 0.0 109.097 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.576 ' O ' ' N ' ' A' ' 64' ' ' LYS . . . -84.43 -54.65 2.92 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -48.97 -28.57 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -1.103 . . . . 0.0 109.728 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD13 ' O ' ' A' ' 58' ' ' LEU . 4.4 mp -48.97 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.051 -1.03 . . . . 0.0 108.247 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' O ' ' A' ' 64' ' ' LYS . 19.6 mt-30 -96.25 5.97 49.82 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.576 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.1 OUTLIER 54.25 110.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.405 0.622 . . . . 0.0 109.861 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -136.23 -22.39 1.35 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.315 -0.866 . . . . 0.0 109.223 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.43 149.75 17.89 Favored Glycine 0 N--CA 1.498 2.797 0 N-CA-C 109.682 -1.367 . . . . 19.620000000000001 109.682 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.539 HD11 HD11 ' A' ' 11' ' ' LEU . 2.5 tt -100.56 -42.1 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.419 -1.048 . . . . 17.420000000000002 109.17 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.473 ' N ' HG23 ' A' ' 67' ' ' ILE . 3.6 t -48.77 -49.76 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.202 -0.936 . . . . 18.82 109.822 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -69.77 10.65 0.36 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.885 . . . . 38.5 110.221 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.568 HE22 ' CG ' ' A' ' 64' ' ' LYS . 30.4 mt-30 -132.75 -16.53 2.59 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.215 -0.928 . . . . 36.829999999999998 110.781 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.0 m -119.35 -25.09 6.17 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.42 -0.8 . . . . 18.16 108.965 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 48.2 t -85.92 -37.85 18.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.14 -0.975 . . . . 18.460000000000001 108.676 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.3 t -90.37 -8.91 49.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.392 -0.818 . . . . 0.0 108.857 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.5 m -148.42 -145.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.624 -0.88 . . . . 30.34 108.624 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 75' ' ' ILE . 19.3 mt -143.76 123.13 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.17 -0.956 . . . . 27.510000000000002 109.132 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.3 m -104.15 177.87 4.72 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.535 -0.728 . . . . 23.34 109.531 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 6.5 m -112.11 176.72 4.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.522 -0.737 . . . . 22.640000000000001 109.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 5.0 tp -51.01 -59.64 3.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.481 -0.762 . . . . 23.280000000000001 109.495 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -43.68 -55.0 4.64 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.438 -0.789 . . . . 37.859999999999999 110.163 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -49.48 -48.16 47.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.723 -1.236 . . . . 31.390000000000001 108.907 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.58 -38.65 88.32 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 24.48 108.967 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -63.98 -18.98 64.82 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.394 -0.816 . . . . 31.48 109.827 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -73.95 -29.4 61.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.446 -0.784 . . . . 22.48 111.522 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -97.83 11.72 36.33 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.133 -0.979 . . . . 19.59 111.693 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 76.3 m -76.71 -175.83 3.57 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.567 -1.333 . . . . 20.620000000000001 109.271 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 118.082 -0.961 . . . . 24.649999999999999 109.495 179.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.461 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 21.8 t80 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.322 -0.621 . . . . 24.77 109.322 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.4 p -77.11 163.93 3.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.27 -0.894 . . . . 30.100000000000001 110.107 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.71 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -135.03 107.8 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.13 -1.063 . . . . 32.240000000000002 108.13 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -156.82 166.95 31.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.233 -0.917 . . . . 30.210000000000001 109.657 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -77.34 100.66 6.0 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.025 -2.213 . . . . 24.0 105.025 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 71' ' ' CYS . 14.2 mt -99.15 134.55 41.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.527 -0.733 . . . . 19.629999999999999 111.683 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 43.6 m -122.63 -157.36 0.74 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.951 0.881 . . . . 17.190000000000001 112.473 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.65 -54.35 1.38 Allowed Glycine 0 N--CA 1.493 2.496 0 CA-C-N 116.042 -0.526 . . . . 16.550000000000001 113.012 -176.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.9 t -80.45 -60.38 2.34 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.47 -1.606 . . . . 19.550000000000001 111.04 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -55.63 32.59 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.038 -1.039 . . . . 0.0 110.474 -178.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD21 HD13 ' A' ' 67' ' ' ILE . 25.5 tp -51.78 -47.03 64.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.68 -1.263 . . . . 14.16 108.42 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.6 t -49.72 -57.13 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.237 -1.394 . . . . 15.31 107.237 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -55.69 -61.34 2.43 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.009 -1.077 . . . . 29.640000000000001 108.276 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -44.87 -59.62 2.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.087 -1.008 . . . . 13.960000000000001 109.747 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.73 -51.46 55.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.389 -1.444 . . . . 17.789999999999999 107.94 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -54.16 -43.56 70.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.466 -0.771 . . . . 16.84 109.113 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.5 mt -56.61 -28.88 61.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.926 -1.109 . . . . 22.760000000000002 108.238 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -94.03 -64.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.489 -0.757 . . . . 17.440000000000001 109.493 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.467 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.3 m -64.21 -81.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 18.539999999999999 109.856 -178.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 73.09 -129.81 13.13 Favored Glycine 0 N--CA 1.485 1.955 0 C-N-CA 119.635 -1.269 . . . . 23.170000000000002 110.034 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.3 pm0 -46.54 -13.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 110.018 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 20' ' ' GLY . 60.7 mtt180 -68.06 -52.89 30.11 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.088 -1.008 . . . . 26.649999999999999 109.522 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.9 64.15 0.48 Allowed Glycine 0 N--CA 1.508 3.442 0 C-N-CA 119.717 -1.23 . . . . 20.260000000000002 111.698 179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.433 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.1 p90 -76.34 131.62 39.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -1.197 . . . . 17.789999999999999 110.039 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.521 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 28.2 p90 -98.09 109.42 22.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 18.550000000000001 109.133 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' CE1' HD23 ' A' ' 11' ' ' LEU . 4.4 t80 -76.32 165.34 24.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.208 -0.932 . . . . 21.489999999999998 109.213 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -154.43 130.28 10.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.082 -1.011 . . . . 31.5 109.851 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.572 ' N ' ' CD ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -169.38 49.54 0.15 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.442 -0.786 . . . . 0.0 110.288 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.541 ' CD ' ' N ' ' A' ' 28' ' ' LYS . 11.9 Cg_exo -43.13 94.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.582 1.521 . . . . 0.0 110.218 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 30' ' ' THR . 6.4 t -139.78 96.79 3.13 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 2.3 tpm_? -93.65 -76.39 0.48 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.191 -0.943 . . . . 0.0 109.672 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.607 ' CG ' HH11 ' A' ' 32' ' ' ARG . 0.1 OUTLIER -107.66 74.93 0.98 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.0 109.298 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -148.57 32.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.249 -0.907 . . . . 0.0 109.277 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.35 17.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.393 -0.817 . . . . 0.0 109.118 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -122.84 2.94 9.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.594 -0.691 . . . . 0.0 109.548 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 38' ' ' GLN . 32.3 t70 -152.0 4.98 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.897 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 39' ' ' VAL . 4.3 mp -56.07 -4.41 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.076 -1.015 . . . . 0.0 108.911 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' H ' ' C ' ' A' ' 36' ' ' ASP . 11.2 mm100 -62.4 1.56 0.34 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -0.966 . . . . 0.0 109.219 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 39' ' ' VAL . 10.1 p -44.06 126.12 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.4 -0.813 . . . . 0.0 109.925 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 41' ' ' GLN . . . -158.82 141.56 7.7 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLY . 1.2 tt0 57.39 107.16 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.404 -1.057 . . . . 0.0 109.056 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.9 m -145.33 -15.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.1 -1.0 . . . . 0.0 108.946 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 47' ' ' GLY . 6.1 tt0 -172.85 -166.4 0.36 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 44' ' ' LEU . 7.8 mp -90.89 16.6 9.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.107 -0.996 . . . . 0.0 109.195 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.76 -31.9 1.21 Allowed Glycine 0 N--CA 1.493 2.433 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -87.59 -134.88 4.5 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' N ' ' OE1' ' A' ' 43' ' ' GLU . . . 153.17 176.93 26.2 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.19 -59.84 0.62 Allowed 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.493 1.462 . . . . 0.0 109.633 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 45.51 52.38 9.03 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.37 -5.22 6.89 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.379 -1.071 . . . . 0.0 109.2 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 26.83 0.06 OUTLIER Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 53' ' ' LEU . 59.1 m -60.47 -67.74 0.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -1.14 . . . . 0.0 109.819 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 2.9 mm? 43.72 -166.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.616 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.65 148.82 96.53 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.019 -1.051 . . . . 0.0 108.429 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -65.28 126.79 16.96 Favored 'Trans proline' 0 C--N 1.323 -0.766 0 N-CA-C 109.577 -0.971 . . . . 0.0 109.577 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.1 mt -58.51 -17.84 24.44 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.354 -0.841 . . . . 0.0 109.792 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.1 -73.19 0.26 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.183 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.732 ' H ' HD22 ' A' ' 58' ' ' LEU . 2.7 mm? -57.01 -30.21 63.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 109.604 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -43.75 -29.04 0.48 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.268 -0.895 . . . . 0.0 109.671 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 62' ' ' LEU . . . -84.32 -51.9 3.76 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 87.9 p -40.73 -20.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.743 -0.857 . . . . 0.0 111.074 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 60' ' ' GLY . 23.8 mt -75.71 -29.03 58.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.867 -1.145 . . . . 0.0 110.067 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -96.19 -21.13 18.08 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.023 -1.048 . . . . 0.0 110.632 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.416 ' CD ' ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.38 163.98 12.83 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 120.924 -1.11 . . . . 0.0 109.209 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' H ' ' CD ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -71.54 65.35 0.46 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.211 179.867 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.29 128.72 10.85 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.95 -1.26 . . . . 19.620000000000001 109.95 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.514 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt -87.32 -39.13 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.411 -1.052 . . . . 17.420000000000002 108.946 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 68' ' ' VAL . 3.0 t -50.85 -48.83 28.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.319 -0.863 . . . . 18.82 109.411 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -67.16 10.46 0.15 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.2 -0.937 . . . . 38.5 110.721 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.491 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.0 mt-30 -137.79 -14.21 1.43 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.921 -1.112 . . . . 36.829999999999998 111.005 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.1 m -120.82 -21.62 6.54 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.205 -0.934 . . . . 18.16 109.108 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.7 t -90.82 -39.85 12.12 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.101 -1.074 . . . . 18.460000000000001 108.101 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.1 t -88.39 -18.77 27.68 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.3 t -140.12 -144.56 0.17 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.351 -0.981 . . . . 30.34 108.351 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 56.7 mt -139.65 151.27 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.111 -0.993 . . . . 27.510000000000002 109.031 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 3.2 m -135.55 172.29 13.22 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.475 -0.765 . . . . 23.34 109.68 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 41.1 m -111.63 -176.47 2.95 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.519 -0.738 . . . . 22.640000000000001 110.076 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.461 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.2 tp -55.48 -57.33 12.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.566 -0.709 . . . . 23.280000000000001 109.46 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -44.0 -50.57 8.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.379 -0.826 . . . . 37.859999999999999 110.027 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -57.06 -53.26 60.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.981 -1.074 . . . . 31.390000000000001 108.814 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 14' ' ' ALA . 7.5 mp -55.51 -39.63 70.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.777 -0.823 . . . . 24.48 108.777 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.98 -18.71 65.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.528 -0.733 . . . . 31.48 109.944 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.95 -28.44 61.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.438 -0.789 . . . . 22.48 111.568 -177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 20.6 m-85 -101.0 12.08 38.4 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.252 -0.905 . . . . 19.59 111.991 -177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.1 m -76.75 -175.62 3.5 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.614 -1.304 . . . . 20.620000000000001 109.134 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 C--N 1.303 -1.441 0 CA-C-O 118.037 -0.982 . . . . 24.649999999999999 109.446 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.502 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 11.3 t80 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.187 -0.671 . . . . 24.77 109.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.6 p -139.46 159.87 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.238 -0.914 . . . . 30.100000000000001 109.229 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.844 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -129.65 108.11 9.95 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.736 -0.839 . . . . 32.240000000000002 108.736 179.397 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -156.64 163.66 39.06 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.312 -0.868 . . . . 30.210000000000001 109.5 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -76.18 100.73 5.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.246 -2.131 . . . . 24.0 105.246 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.0 134.63 41.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 19.629999999999999 111.738 -176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.49 -161.46 0.89 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.093 -1.005 . . . . 17.190000000000001 111.806 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.22 -47.37 1.44 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.703 -0.68 . . . . 16.550000000000001 112.77 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.5 m -82.94 -62.46 1.59 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.349 -1.677 . . . . 19.550000000000001 110.734 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.93 -55.49 34.5 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.006 -1.059 . . . . 0.0 109.993 -178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 67' ' ' ILE . 29.8 tp -49.97 -50.92 45.15 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.698 -1.251 . . . . 14.16 108.269 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -47.05 -54.86 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.453 -1.314 . . . . 15.31 107.453 177.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -57.17 -61.71 2.28 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.949 -1.1 . . . . 29.640000000000001 108.257 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.34 -59.87 2.45 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.118 -0.989 . . . . 13.960000000000001 109.518 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 19' ' ' CYS . 10.5 mt -51.05 -49.14 61.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.585 -1.322 . . . . 17.789999999999999 108.102 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.51 -40.72 79.35 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.42 -0.8 . . . . 16.84 109.011 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 76.9 mt -59.63 -29.54 68.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.915 -1.116 . . . . 22.760000000000002 108.086 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -92.28 -64.75 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.479 -0.763 . . . . 17.440000000000001 109.555 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -64.34 -81.59 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 18.539999999999999 109.685 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 70.59 -122.96 11.02 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.617 -1.277 . . . . 23.170000000000002 110.077 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -50.64 -11.7 0.09 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.406 -1.055 . . . . 39.770000000000003 110.386 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 20' ' ' GLY . 31.1 mtt-85 -73.32 -52.09 15.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.871 -1.143 . . . . 26.649999999999999 109.668 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 112.03 64.31 0.48 Allowed Glycine 0 N--CA 1.508 3.467 0 C-N-CA 119.756 -1.211 . . . . 20.260000000000002 111.685 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.413 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 22.2 p90 -75.08 135.6 41.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.004 -1.292 . . . . 17.789999999999999 109.169 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.507 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 24.1 p90 -103.69 107.66 18.61 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.458 -0.776 . . . . 18.550000000000001 110.663 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CE2' HD23 ' A' ' 11' ' ' LEU . 2.0 t80 -87.97 143.76 26.92 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.226 -1.027 . . . . 21.489999999999998 108.226 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.53 ' OG1' ' NE ' ' A' ' 65' ' ' ARG . 17.5 p -146.25 98.53 3.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.866 -1.146 . . . . 31.5 110.36 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -174.33 68.89 0.31 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -57.43 108.19 0.35 Allowed 'Trans proline' 0 C--N 1.316 -1.155 0 C-N-CA 121.508 1.472 . . . . 0.0 110.231 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -155.34 95.54 1.71 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.82 . . . . 0.0 108.869 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -110.21 -94.99 0.42 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.622 -0.673 . . . . 0.0 110.031 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 33' ' ' GLU . 11.7 tpp180 -44.5 -26.06 0.32 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.0 110.033 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 34' ' ' ALA . 5.6 pt-20 27.08 101.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 CA-C-O 121.788 0.804 . . . . 0.0 111.611 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 33' ' ' GLU . . . 74.34 129.77 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.077 -1.015 . . . . 0.0 109.151 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -88.18 -94.86 0.1 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.191 -0.943 . . . . 0.0 110.083 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 1.2 p30 -61.72 103.79 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.807 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.37 -1.25 57.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.126 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -52.61 160.97 0.78 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.334 -0.853 . . . . 0.0 109.378 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' O ' ' A' ' 40' ' ' GLY . 17.2 m -92.95 29.92 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.44 -0.787 . . . . 0.0 109.713 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 39' ' ' VAL . . . -62.41 -140.28 0.01 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -80.66 81.29 6.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.238 -1.154 . . . . 0.0 109.541 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 43' ' ' GLU . 1.2 m -142.85 13.11 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.263 -0.898 . . . . 0.0 108.821 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 12.2 tt0 81.01 146.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -99.93 73.4 1.75 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 109.462 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 46' ' ' GLY . . . 179.46 -2.15 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' H ' ' H ' ' A' ' 45' ' ' GLY . . . 161.0 163.87 14.82 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.35 -179.08 46.34 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.6 -47.01 14.84 Favored 'Trans proline' 0 C--N 1.316 -1.167 0 C-N-CA 121.608 1.539 . . . . 0.0 109.869 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.39 122.55 0.47 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.08 -9.82 0.99 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.227 -1.161 . . . . 0.0 109.554 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 52' ' ' SER . . . -66.67 -116.52 0.01 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 51' ' ' GLY . 1.6 p 73.07 -44.43 0.59 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -1.106 . . . . 0.0 109.644 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.62 -75.46 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.598 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -92.86 154.37 41.99 Favored Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.13 136.83 77.14 Favored 'Trans proline' 0 N--CA 1.481 0.753 0 C-N-CA 121.507 1.471 . . . . 0.0 110.881 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 56' ' ' LEU . 45.9 mt -44.06 -39.66 4.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.715 -0.615 . . . . 0.0 110.064 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.06 -51.8 67.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -0.997 . . . . 0.0 109.75 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.4 mm? -68.21 -37.57 81.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.906 . . . . 0.0 109.353 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -51.36 -29.82 16.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.134 -0.978 . . . . 0.0 109.52 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.9 -7.71 73.93 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.9 p -84.06 -40.27 18.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.077 -1.249 . . . . 0.0 110.611 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.657 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -88.52 -0.85 57.66 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.776 -1.203 . . . . 0.0 109.297 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' O ' ' C ' ' A' ' 64' ' ' LYS . 12.2 mt-30 -105.03 -66.35 0.98 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER 14.61 64.65 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.472 0 CA-C-O 121.609 0.719 . . . . 0.0 111.734 179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' NE ' ' OG1' ' A' ' 27' ' ' THR . 20.5 tpt180 -45.33 -77.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 109.613 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 174.08 -114.19 0.5 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.346 -1.407 . . . . 19.620000000000001 110.412 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.597 HG23 ' N ' ' A' ' 68' ' ' VAL . 4.0 tt -50.74 -49.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -1.015 . . . . 17.420000000000002 111.131 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.597 ' N ' HG23 ' A' ' 67' ' ' ILE . 5.1 t -54.96 -12.97 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.748 -1.22 . . . . 18.82 110.222 -178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -105.14 9.91 34.04 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.282 -0.886 . . . . 38.5 109.773 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -137.01 -14.91 1.55 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.283 -0.886 . . . . 36.829999999999998 109.857 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 62.8 m -112.49 -29.26 7.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.402 -0.811 . . . . 18.16 108.993 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 49.1 t -86.44 -44.47 11.98 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.933 -1.105 . . . . 18.460000000000001 108.825 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 t -81.44 -14.56 56.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.4 t -147.71 -137.36 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.444 -0.947 . . . . 30.34 108.444 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.81 149.59 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.076 -1.015 . . . . 27.510000000000002 109.349 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 3.2 m -131.47 176.32 8.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.487 -0.758 . . . . 23.34 109.587 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' NE2' ' A' ' 80' ' ' GLN . 2.8 p -112.26 171.17 7.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.661 -0.649 . . . . 22.640000000000001 109.444 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.502 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.4 tp -45.09 -61.16 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.576 -0.703 . . . . 23.280000000000001 109.502 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -41.33 -54.73 2.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.594 -0.692 . . . . 37.859999999999999 110.531 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.748 ' NE2' ' H ' ' A' ' 80' ' ' GLN . 1.4 mp0 -52.16 -49.49 63.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.82 -1.175 . . . . 31.390000000000001 108.578 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -58.56 -40.01 81.84 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.655 -0.868 . . . . 24.48 108.655 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.84 -18.75 64.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.426 -0.796 . . . . 31.48 109.923 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.87 -29.02 61.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.4 -0.813 . . . . 22.48 111.692 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -99.56 11.98 37.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.139 -0.976 . . . . 19.59 111.857 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 67.8 m -76.81 -175.82 3.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.579 -1.326 . . . . 20.620000000000001 109.025 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.018 -0.991 . . . . 24.649999999999999 109.292 179.771 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.519 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.4 t80 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.239 -0.652 . . . . 24.77 109.239 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p -162.04 158.02 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 30.100000000000001 109.349 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.838 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -127.54 106.4 9.15 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.547 -0.909 . . . . 32.240000000000002 108.547 179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -157.09 164.27 38.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.411 -0.806 . . . . 30.210000000000001 109.574 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -78.37 100.61 6.85 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 105.264 -2.124 . . . . 24.0 105.264 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -98.22 135.02 40.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 19.629999999999999 111.671 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 32.8 m -123.99 -158.35 0.81 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.895 0.855 . . . . 17.190000000000001 112.438 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -36.56 -51.29 1.39 Allowed Glycine 0 N--CA 1.492 2.429 0 CA-C-N 115.991 -0.55 . . . . 16.550000000000001 112.997 -176.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.9 m -82.48 -60.95 2.02 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.382 -1.658 . . . . 19.550000000000001 110.975 -178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -55.68 31.08 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.976 -1.077 . . . . 0.0 110.376 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 67' ' ' ILE . 23.8 tp -50.53 -48.4 57.16 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.677 -1.264 . . . . 14.16 108.36 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.475 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.7 t -49.14 -54.3 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.128 -1.434 . . . . 15.31 107.128 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -57.78 -61.48 2.49 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.951 -1.1 . . . . 29.640000000000001 108.322 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.15 -60.3 2.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.045 -1.034 . . . . 13.960000000000001 109.653 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.436 HD11 HD13 ' A' ' 67' ' ' ILE . 11.3 mt -51.22 -48.34 62.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.559 -1.338 . . . . 17.789999999999999 108.046 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -58.86 -39.49 81.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.535 -0.728 . . . . 16.84 109.119 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.1 mt -60.65 -31.22 70.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.896 -1.128 . . . . 22.760000000000002 108.08 178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.7 t -89.65 -64.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.519 -0.738 . . . . 17.440000000000001 109.496 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.45 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.1 m -64.0 -78.65 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.142 -0.974 . . . . 18.539999999999999 109.37 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' C ' ' N ' ' A' ' 22' ' ' ARG . . . 77.97 -132.84 12.21 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.564 -1.414 . . . . 23.170000000000002 109.564 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 -13.65 0.12 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.276 -1.132 . . . . 39.770000000000003 109.49 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' N ' ' C ' ' A' ' 20' ' ' GLY . 0.3 OUTLIER -60.32 -53.27 59.61 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.94 . . . . 26.649999999999999 109.217 -179.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.66 64.5 0.49 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.885 -1.15 . . . . 20.260000000000002 111.196 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 27.4 p90 -75.82 124.74 27.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.213 -1.169 . . . . 17.789999999999999 110.172 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 11.6 p90 -92.3 104.61 16.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.454 -0.779 . . . . 18.550000000000001 109.048 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -62.01 168.69 3.06 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.276 -0.89 . . . . 21.489999999999998 108.908 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' A' ' 28' ' ' LYS . 16.5 p -142.77 159.83 41.49 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.29 -0.881 . . . . 31.5 109.511 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.496 ' O ' HG22 ' A' ' 30' ' ' THR . 28.5 ttmt 76.18 69.92 0.22 Allowed Pre-proline 0 N--CA 1.496 1.832 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -59.89 101.99 0.16 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 121.417 1.411 . . . . 0.0 110.098 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.691 HG23 ' H ' ' A' ' 31' ' ' ARG . 1.8 t -140.05 -109.67 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.402 -0.811 . . . . 0.0 109.057 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.691 ' H ' HG23 ' A' ' 30' ' ' THR . 21.6 ttt180 73.84 -61.21 0.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HG2' HH11 ' A' ' 32' ' ' ARG . 2.7 ttt-85 -155.95 119.08 4.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.761 . . . . 0.0 109.227 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -153.36 -69.55 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.291 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -171.74 68.25 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.327 -0.858 . . . . 0.0 109.423 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -116.1 161.51 18.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.557 -0.714 . . . . 0.0 109.426 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.2 t70 52.96 69.65 0.67 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.404 -0.81 . . . . 0.0 109.787 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.573 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.6 mm? -86.45 -109.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 109.051 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -111.21 140.28 45.9 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.425 -0.797 . . . . 0.0 109.281 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 m -79.12 32.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.556 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.32 47.97 0.41 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -150.67 46.37 0.87 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.414 -1.05 . . . . 0.0 108.214 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.63 -10.42 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 45' ' ' GLY . 21.7 tt0 64.44 98.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -44.17 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 110.33 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.666 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -117.49 53.08 0.66 Allowed Glycine 0 N--CA 1.5 2.936 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.12 -171.45 34.51 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 174.36 179.33 44.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -59.07 -33.62 98.62 Favored 'Trans proline' 0 C--N 1.314 -1.243 0 C-N-CA 121.491 1.46 . . . . 0.0 109.759 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -156.08 138.07 5.82 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -166.55 4.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.232 -1.158 . . . . 0.0 109.208 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.77 171.04 7.44 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 35.9 m -83.76 103.46 13.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -1.184 . . . . 0.0 109.638 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.3 mt -140.54 -171.78 3.3 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.7 144.89 96.57 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.03 -1.044 . . . . 0.0 108.66 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -62.41 131.34 33.57 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 120.783 0.989 . . . . 0.0 109.743 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.1 mt -57.86 -21.74 44.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.393 -0.817 . . . . 0.0 109.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.53 -52.74 19.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.608 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.5 mm? -71.18 -32.84 69.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.063 -1.023 . . . . 0.0 109.519 -179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -46.81 -43.69 18.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -88.39 -39.58 6.74 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.403 ' O ' ' O ' ' A' ' 64' ' ' LYS . 32.0 t -80.89 -7.32 59.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.117 -1.225 . . . . 0.0 110.74 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -47.48 -64.32 0.82 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.986 -1.071 . . . . 0.0 109.29 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -90.05 -33.45 16.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.24 -0.913 . . . . 0.0 109.794 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.485 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 10.9 mptt -89.0 151.73 22.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 0.0 109.706 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -50.11 9.49 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.21 146.85 8.71 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.96 -1.256 . . . . 19.620000000000001 109.96 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 11' ' ' LEU . 3.0 tt -127.3 -42.39 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.608 -0.936 . . . . 17.420000000000002 108.79 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.494 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.45 -53.62 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.054 -1.029 . . . . 18.82 109.461 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.52 10.61 0.09 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.309 -0.869 . . . . 38.5 110.248 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.509 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.4 mt-30 -135.1 -16.28 1.92 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.979 -1.075 . . . . 36.829999999999998 110.69 -179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 63.9 m -119.65 -23.73 6.45 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.41 -0.806 . . . . 18.16 109.096 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.6 t -87.44 -36.74 17.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.342 -0.984 . . . . 18.460000000000001 108.342 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -91.45 -16.87 26.64 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.8 m -138.71 -144.66 0.18 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.572 -0.899 . . . . 30.34 108.572 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -145.11 117.29 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.982 -1.074 . . . . 27.510000000000002 109.37 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.7 m -100.5 177.41 5.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.382 -0.824 . . . . 23.34 109.852 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 24.4 m -112.36 -175.38 2.67 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.548 -0.72 . . . . 22.640000000000001 109.752 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.519 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.5 tp -57.26 -56.46 21.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.514 -0.741 . . . . 23.280000000000001 109.478 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -44.91 -57.43 3.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 37.859999999999999 109.933 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -48.6 -48.52 39.11 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.87 -1.144 . . . . 31.390000000000001 108.987 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.42 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.8 mp -60.95 -39.93 91.36 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.814 -0.809 . . . . 24.48 108.814 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.27 -18.95 64.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 31.48 109.662 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -73.19 -29.78 63.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.465 -0.772 . . . . 22.48 111.589 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -99.04 12.21 36.69 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.036 -1.04 . . . . 19.59 111.788 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 77.9 m -76.66 -175.69 3.49 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.658 -1.277 . . . . 20.620000000000001 109.253 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 117.95 -1.024 . . . . 24.649999999999999 109.452 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.469 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 14.8 t80 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.275 -0.639 . . . . 24.77 109.275 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 3' ' ' ASN . 2.3 p -164.14 163.2 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.117 -0.989 . . . . 30.100000000000001 109.533 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.707 HD22 ' N ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -132.97 106.77 7.87 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.298 -1.001 . . . . 32.240000000000002 108.298 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -157.38 164.62 37.34 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.278 -0.889 . . . . 30.210000000000001 109.824 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -77.67 100.57 6.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 105.173 -2.158 . . . . 24.0 105.173 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 71' ' ' CYS . 13.8 mt -99.44 135.31 41.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 19.629999999999999 111.72 -176.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.2 m -122.91 -157.58 0.75 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.97 0.89 . . . . 17.190000000000001 112.424 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 12' ' ' VAL . . . -36.72 -55.47 1.35 Allowed Glycine 0 N--CA 1.493 2.459 0 CA-C-N 116.043 -0.526 . . . . 16.550000000000001 113.06 -176.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -79.63 -58.49 3.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.383 -1.657 . . . . 19.550000000000001 111.152 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.44 -55.94 27.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.974 -1.079 . . . . 0.0 110.419 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 67' ' ' ILE . 24.9 tp -51.12 -48.83 61.67 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.69 -1.256 . . . . 14.16 108.359 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 8' ' ' GLY . 2.8 t -48.28 -55.06 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 107.451 -1.315 . . . . 15.31 107.451 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -56.97 -61.76 2.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.119 -1.067 . . . . 29.640000000000001 108.119 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.442 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.47 -59.6 2.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.102 -0.999 . . . . 13.960000000000001 109.686 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.41 HD11 HD13 ' A' ' 67' ' ' ILE . 11.2 mt -51.61 -53.46 38.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.486 -1.384 . . . . 17.789999999999999 107.906 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -52.11 -45.63 64.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.497 -0.752 . . . . 16.84 109.176 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.0 mt -56.45 -30.98 63.52 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.957 -1.09 . . . . 22.760000000000002 108.336 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.6 t -89.94 -64.6 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.389 -0.819 . . . . 17.440000000000001 109.223 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.441 ' N ' HG12 ' A' ' 18' ' ' VAL . 5.9 m -64.13 -79.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 18.539999999999999 109.45 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 75.81 -131.72 12.25 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 109.816 -1.314 . . . . 23.170000000000002 109.816 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -50.09 -10.41 0.05 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.35 -1.088 . . . . 39.770000000000003 109.521 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 22' ' ' ARG . 0.0 OUTLIER -65.47 -52.97 49.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 26.649999999999999 108.994 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.75 63.93 0.49 Allowed Glycine 0 N--CA 1.506 3.349 0 C-N-CA 119.936 -1.126 . . . . 20.260000000000002 111.46 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.523 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 23.9 p90 -76.24 122.42 24.35 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.146 -1.208 . . . . 17.789999999999999 110.162 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 12.0 p90 -89.7 104.43 16.99 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.567 -0.901 . . . . 18.550000000000001 108.567 179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 27' ' ' THR . 12.3 t80 -65.39 168.2 7.5 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.176 -0.952 . . . . 21.489999999999998 109.175 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.457 ' N ' ' CD1' ' A' ' 26' ' ' TYR . 15.3 p -143.71 160.15 41.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.566 -0.901 . . . . 31.5 108.566 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 27' ' ' THR . 32.4 tttt 79.65 65.04 0.17 Allowed Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -55.15 -19.66 21.58 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 N-CA-C 108.848 -1.251 . . . . 0.0 108.848 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.5 128.89 38.35 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -143.91 4.07 1.27 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.237 -0.914 . . . . 0.0 109.221 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -158.56 53.18 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.288 -0.882 . . . . 0.0 109.375 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -73.18 91.46 1.66 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' ASP . . . -164.31 -177.66 5.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.422 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 37' ' ' LEU . 20.7 mt-10 61.32 -71.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 34' ' ' ALA . 30.3 t0 -44.34 -23.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 37' ' ' LEU . 10.0 mp -69.38 67.75 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.027 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 40' ' ' GLY . 38.6 tt0 -75.67 128.12 34.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.409 ' O ' HG22 ' A' ' 39' ' ' VAL . 1.2 p -49.86 96.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.357 -0.839 . . . . 0.0 109.205 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 38' ' ' GLN . . . -85.07 -175.7 50.65 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -73.42 101.12 3.4 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.423 -1.045 . . . . 0.0 109.281 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.21 154.01 2.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.159 -0.963 . . . . 0.0 109.243 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -49.17 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.158 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 45' ' ' GLY . 0.8 OUTLIER -175.09 2.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.219 -0.925 . . . . 0.0 109.479 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 44' ' ' LEU . . . -178.51 49.35 0.09 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.17 -85.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.21 68.46 1.49 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -61.42 142.22 94.77 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 121.429 1.419 . . . . 0.0 109.968 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.03 138.12 18.83 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.07 16.15 10.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.247 -1.149 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.77 -43.91 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.9 m -46.96 117.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.208 -1.172 . . . . 0.0 109.551 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.6 mt -80.56 -43.99 19.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.196 -0.94 . . . . 0.0 109.525 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -81.41 140.2 48.43 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 108.936 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.2 110.62 2.04 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 120.797 0.998 . . . . 0.0 109.796 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 25.7 mt -63.46 -6.94 5.61 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.533 -0.73 . . . . 0.0 109.154 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.37 -59.65 2.65 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 111.245 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.99 -15.07 42.65 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.892 -1.13 . . . . 0.0 110.476 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -45.94 -45.83 15.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.115 -0.991 . . . . 0.0 109.815 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.53 -52.05 3.12 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 m -55.33 -8.66 0.35 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.31 -1.112 . . . . 0.0 110.304 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.8 -36.41 70.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.022 -1.049 . . . . 0.0 109.257 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -101.71 -35.38 9.1 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.523 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 10.8 mptt -84.88 -177.19 6.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.047 -1.033 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 60.86 73.08 0.49 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 110.121 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.77 -113.65 3.56 Favored Glycine 0 N--CA 1.498 2.829 0 N-CA-C 109.096 -1.602 . . . . 19.620000000000001 109.096 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 11' ' ' LEU . 2.9 tt -50.61 -40.36 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.32 -1.106 . . . . 17.420000000000002 109.18 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 70' ' ' GLN . 3.7 t -49.93 -50.3 19.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.208 -0.932 . . . . 18.82 109.663 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.23 10.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.247 -0.908 . . . . 38.5 110.644 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.499 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 10.5 mt-30 -137.83 -16.11 1.32 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.819 -1.176 . . . . 36.829999999999998 110.651 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 6' ' ' LEU . 60.0 m -118.62 -23.06 7.22 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.339 -0.85 . . . . 18.16 109.216 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.3 t -89.72 -37.83 14.29 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.466 -0.939 . . . . 18.460000000000001 108.466 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.0 t -90.27 -22.83 21.41 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 39.5 m -133.58 -141.96 0.2 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.736 -0.839 . . . . 30.34 108.736 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.6 mt -145.05 130.08 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.107 -0.995 . . . . 27.510000000000002 109.23 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 2.8 m -114.27 175.54 5.43 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.672 -0.643 . . . . 23.34 109.77 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 m -112.53 -178.08 3.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.622 -0.674 . . . . 22.640000000000001 109.758 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.469 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 4.7 tp -53.37 -60.82 2.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.494 -0.754 . . . . 23.280000000000001 109.629 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -42.33 -56.75 2.84 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.381 -0.824 . . . . 37.859999999999999 110.39 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.1 mm-40 -49.2 -47.65 45.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.761 -1.212 . . . . 31.390000000000001 108.921 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.7 mp -61.35 -39.27 89.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.365 -0.834 . . . . 24.48 108.806 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 -18.82 64.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.495 -0.753 . . . . 31.48 109.745 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -73.21 -30.21 63.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.535 -0.728 . . . . 22.48 111.644 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.419 ' CD2' HD12 ' A' ' 67' ' ' ILE . 25.7 m-85 -98.8 12.14 36.58 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.145 -0.972 . . . . 19.59 111.805 -177.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 84.6 m -76.71 -175.81 3.56 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.593 -1.317 . . . . 20.620000000000001 109.328 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 . . . . . 0 C--N 1.303 -1.447 0 CA-C-O 117.987 -1.006 . . . . 24.649999999999999 109.342 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PHE . . . . . 0.454 ' CD1' ' CD1' ' A' ' 78' ' ' LEU . 18.5 t80 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.286 -0.635 . . . . 24.77 109.286 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.444 ' CG2' ' N ' ' A' ' 3' ' ' ASN . 1.9 p -168.74 160.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.022 . . . . 30.100000000000001 109.546 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.854 HD22 ' H ' ' A' ' 3' ' ' ASN . 0.0 OUTLIER -131.37 107.66 9.09 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.471 -0.937 . . . . 32.240000000000002 108.471 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -156.63 163.14 39.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 30.210000000000001 109.448 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -77.02 101.09 5.88 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.212 -2.144 . . . . 24.0 105.212 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.15 136.85 37.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.464 -0.772 . . . . 19.629999999999999 111.769 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -120.33 -164.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.145 -0.972 . . . . 17.190000000000001 111.675 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' O ' ' CG2' ' A' ' 12' ' ' VAL . . . -37.51 -44.94 1.31 Allowed Glycine 0 N--CA 1.489 2.205 0 CA-C-N 115.673 -0.694 . . . . 16.550000000000001 112.553 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.9 p -83.39 -62.77 1.5 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.388 -1.654 . . . . 19.550000000000001 110.494 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.88 -55.2 38.16 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.028 -1.045 . . . . 0.0 109.829 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.526 HD11 HD11 ' A' ' 67' ' ' ILE . 30.3 tp -49.72 -50.88 42.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.747 -1.221 . . . . 14.16 108.32 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' GLY . 2.6 t -47.45 -55.23 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 107.489 -1.3 . . . . 15.31 107.489 177.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -56.93 -61.39 2.48 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 107.959 -1.126 . . . . 29.640000000000001 107.959 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' HB1' HD21 ' A' ' 81' ' ' LEU . . . -45.6 -59.55 2.68 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 13.960000000000001 109.692 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.4 mt -51.57 -53.39 38.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.522 -1.361 . . . . 17.789999999999999 108.009 178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -51.86 -48.36 64.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.52 -0.737 . . . . 16.84 109.151 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.5 mt -53.12 -28.63 26.66 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.053 . . . . 22.760000000000002 108.588 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 19' ' ' CYS . 2.5 t -93.9 -64.38 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.461 -0.774 . . . . 17.440000000000001 109.424 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.462 ' N ' HG12 ' A' ' 18' ' ' VAL . 7.8 m -65.13 -82.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.212 -0.93 . . . . 18.539999999999999 109.909 -178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ARG . . . 67.93 -122.91 17.44 Favored Glycine 0 N--CA 1.484 1.859 0 C-N-CA 119.605 -1.284 . . . . 23.170000000000002 110.191 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -47.03 -19.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -1.003 . . . . 39.770000000000003 109.776 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' GLY . 73.0 mtt180 -67.07 -52.92 36.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.199 -0.938 . . . . 26.649999999999999 109.788 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.94 64.25 0.48 Allowed Glycine 0 N--CA 1.508 3.454 0 C-N-CA 119.728 -1.225 . . . . 20.260000000000002 111.931 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB3' ' SG ' ' A' ' 19' ' ' CYS . 18.2 p90 -75.67 132.22 40.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.987 -1.302 . . . . 17.789999999999999 109.262 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -100.49 104.7 16.09 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.514 -0.742 . . . . 18.550000000000001 109.832 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.5 t80 -82.86 137.94 34.1 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.923 -1.139 . . . . 21.489999999999998 107.923 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.4 p -149.54 101.23 3.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.771 -1.206 . . . . 31.5 110.417 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 30' ' ' THR . 13.0 tttt -171.8 70.4 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.324 -0.86 . . . . 0.0 108.816 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 30' ' ' THR . 2.3 Cg_endo -67.0 15.39 0.12 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 C-N-CA 122.027 1.818 . . . . 0.0 110.872 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.541 HG23 ' H ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -37.9 -86.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.104 0.478 . . . . 0.0 110.646 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.541 ' H ' HG23 ' A' ' 30' ' ' THR . 16.9 mmm-85 51.94 -113.75 0.76 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.123 -0.985 . . . . 0.0 109.113 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -91.94 129.4 37.91 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.194 -0.941 . . . . 0.0 109.409 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -151.44 71.89 1.02 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.151 -0.968 . . . . 0.0 109.302 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.53 128.71 37.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.218 -0.926 . . . . 0.0 109.525 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -162.37 -82.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.912 . . . . 0.0 109.455 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.85 74.29 1.59 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.482 0.658 . . . . 0.0 109.277 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 37' ' ' LEU . 3.5 mm? -82.79 -37.05 25.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.464 -0.772 . . . . 0.0 109.422 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -71.74 125.32 26.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.167 -0.958 . . . . 0.0 109.64 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -154.84 133.26 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.332 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.67 161.36 10.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 62.2 64.16 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.36 -1.082 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.728 HG22 ' N ' ' A' ' 43' ' ' GLU . 1.2 p -175.45 -95.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.256 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.728 ' N ' HG22 ' A' ' 42' ' ' VAL . 10.1 pt-20 -48.76 -41.02 30.89 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.831 -1.168 . . . . 0.0 109.371 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mp -65.63 -36.52 83.94 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -68.63 -35.72 81.39 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.31 -90.34 0.08 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 49' ' ' GLY . . . 158.53 73.9 0.02 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -63.27 -0.42 2.26 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 C-N-CA 121.477 1.451 . . . . 0.0 109.704 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 47' ' ' GLY . . . 179.22 165.73 33.94 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.27 -36.66 9.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -1.167 . . . . 0.0 109.567 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' LEU . . . 153.05 14.97 0.06 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.266 -1.534 . . . . 0.0 109.266 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 t 70.34 -19.59 0.21 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.394 -1.062 . . . . 0.0 109.437 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.587 ' C ' HD12 ' A' ' 53' ' ' LEU . 1.2 pp -177.78 179.05 0.92 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.922 . . . . 0.0 109.223 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -96.35 150.0 36.58 Favored Pre-proline 0 N--CA 1.495 1.814 0 O-C-N 121.167 -0.958 . . . . 0.0 108.718 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.94 128.66 27.44 Favored 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 120.9 1.067 . . . . 0.0 109.739 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 39.3 mt -56.94 -23.37 44.89 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.19 -59.06 4.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.245 -0.909 . . . . 0.0 109.906 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.7 mm? -62.07 -40.07 94.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.182 -0.949 . . . . 0.0 109.306 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -48.91 -38.88 24.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 0.0 109.781 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.59 -38.53 7.56 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.3 t -80.5 -11.47 59.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -1.23 . . . . 0.0 110.347 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 58' ' ' LEU . 3.0 mt -64.12 -34.18 77.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.94 -1.1 . . . . 0.0 108.97 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -104.84 -43.37 5.11 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.374 -0.829 . . . . 0.0 109.805 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.449 ' N ' ' CD ' ' A' ' 64' ' ' LYS . 11.0 mptt -90.39 144.44 25.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 109.795 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -61.45 -56.72 17.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.18 -0.95 . . . . 0.0 108.533 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.28 132.6 1.34 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.612 -0.995 . . . . 19.620000000000001 110.612 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 11' ' ' LEU . 2.0 tt -121.98 -41.17 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.245 -1.02 . . . . 17.420000000000002 108.245 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.492 HG22 ' OH ' ' A' ' 26' ' ' TYR . 3.9 t -52.37 -36.43 21.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.381 -0.824 . . . . 18.82 109.597 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -80.79 10.36 5.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.248 -0.908 . . . . 38.5 109.627 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.49 ' O ' ' SG ' ' A' ' 76' ' ' CYS . 11.5 mt-30 -136.44 -10.11 1.91 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.042 -1.036 . . . . 36.829999999999998 110.57 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 68.7 m -121.85 -26.05 4.9 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.338 -0.852 . . . . 18.16 108.987 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 44.5 t -88.26 -39.5 14.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.072 -1.017 . . . . 18.460000000000001 108.607 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.5 t -84.77 -15.25 45.63 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 42.0 m -143.93 -138.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.114 -1.069 . . . . 30.34 108.114 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 mt -145.52 148.56 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.08 -1.013 . . . . 27.510000000000002 109.045 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 70' ' ' GLN . 4.6 m -131.05 173.57 10.87 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 23.34 109.707 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.8 m -112.16 -176.65 2.97 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.605 -0.684 . . . . 22.640000000000001 109.613 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.454 ' CD1' ' CD1' ' A' ' 1' ' ' PHE . 3.9 tp -56.53 -59.25 5.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.429 -0.794 . . . . 23.280000000000001 109.412 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 1.1 m-85 -43.12 -55.07 4.07 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.444 -0.785 . . . . 37.859999999999999 110.262 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -52.39 -48.97 65.33 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.877 -1.139 . . . . 31.390000000000001 108.952 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' HB1' ' A' ' 14' ' ' ALA . 6.3 mp -60.09 -40.51 89.86 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.713 -0.847 . . . . 24.48 108.713 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.82 -18.87 61.59 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.506 -0.746 . . . . 31.48 109.952 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.01 -29.82 62.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 22.48 111.742 -178.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -97.79 11.56 36.83 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.082 -1.011 . . . . 19.59 111.807 -177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.4 m -76.96 -175.77 3.67 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.558 -1.339 . . . . 20.620000000000001 109.063 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 C--N 1.302 -1.487 0 CA-C-O 118.015 -0.993 . . . . 24.649999999999999 109.494 179.887 . . . . . . . . 0 0 . 1 stop_ save_